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Zusammenfassung 
 
Teil I. Enzymatische Eigenschaften und gelenkte Evolution der Transketolase 
 
• TK Assay für das Substrat-Fingerprinting 
Transketolase (TK, EC 2.2.1.1) katalysiert den stereospezifischen Transfer einer C2-  
Ketoleinheit auf das Carbonylende einer Reihe von Aldehyden. Die Verwendung der TK zum 
Aufbau von Kohlenstoff-Kohlenstoff-Bindungen erhält wegen der hoch stereoselektiven 
Bildung eines (S)-konfigurierten, chiralen Zentrums unter gleichzeitiger Racematspaltung von 
(2R)-Hydroxyaldehyden vermehrte Beachtung. Insbesondere beim Einsatz von 
Hydroxypyruvat (HPA) als Donor führt die Freisetzung von CO2 zu einer irreversiblen 
Reaktion wobei das freigesetzte Bicarbonat den pH-Wert des Reaktionssystems erhöht. 
Aufbauend auf diesem Prinzip wurde, mit HPA als Donor und Phenolrot als empfindlichem 
pH Indikator, eine neue, kontinuierliche pH-basierte Assaymethode für das 
Hochdurchsatzscreening der TK entwickelt. Dieser generische Assay kann zuverlässig für die 
Colorimetrische Bestimmung der spezifischen Enzymaktivität und zur Messung kinetischer 
Konstanten benutzt werden. Mit dieser Methode wurden sowohl die kinetischen Konstanten 
und die Akzeptoraffinitäten der TK aus Escherichia coli (TKeco) und Saccharomyces cerevisiae 
(TKyst) als auch zweier TKeco-Mutanten, (TK
D469E 
eco und TK
H26Y 
eco ), für einen detailierten Vergleich 
untereinander ermittelt. Die quantitativen Daten zeigen, dass das katalytische Potenzial von 
Wildtyp-TKeco und TKyst sehr ähnlich sind und nur eine geringe Variation aufweisen. Wildtyp-
TK-Enzyme haben eine hohe Präferenz für α-hydroxylierte Akzeptoren, zusammen mit einer 
ausgeprägten Stereoselektivität gegenüber der (2R)-Konfiguration. Die Variante TKD469E eco  zeigt 
signifikant höhere Aktivität gegenüber 2-deoxygenierten Aldehyden als das entsprechende 
Wildtyp Enzym. 
 
 
 
 
Abbildung 1. Das Prinzip einer neuen, pH-basierten Testmethode für Transketolase und ihre Anwendung zur 
Bestimmung der spezifischen Enzymaktivität.  
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• TK Test auf allgerneine Aldehyd Toleranz 
Die TK aus Geobacillus stearothermophilus (TKgst) ist ein neues Enzym, das kürzlich kloniert 
wurde und eine beeindruckende Thermostabilität aufweist. Ähnlich wie andere TKs zeigt es 
eine geringe Aktivität bei nicht α-hydroxylierten Aldehyden. Um diese Aktivität zu erhöhen 
wurden in einem ersten Versuch Sättigungsmutagenesebibliotheken der TKgst an den 
Positionen Leu382 und Asp470 erstellt. Leu382 and Asp470 sind die entsprechenden 
Aminosäurereste zur Bindung der Hydroxymethylen-Gruppe von α-hydroxylierten Aldehyden. 
Das Screening der Bibliothek lieferte mehrere positive Varianten, sowohl aus der einfach, als 
auch aus der doppelt mutierten Bibliothek. Als herausragende Mutante konnte die Variante 
Asp469Ile mit einer 17-, 13- und 8.6-fachen Aktivitätsverbesserung im Vergleich zum Wildtyp-
Enzym gegenüber Propanal, Butanal and Methoxyethanal identifiziert werden. Ihre hohe 
Thermostabilität mit einer  Tm von 74 °C bleibt erhalten. 
 
 
 
 
 
 
Abbildung 2. Kupplung von Propanal als Substratanalog für TKD469I gst . Asp470Ile und Leu382 bilden eine unpolare 
Oberfläche um die aliphatische Kette von Propanal mit höherer Affinität zu binden. 
 
Teil II. Chemoenzymatische Synthese von Neosialokonjugaten 
 
• SiaT Assay für die Enzymkinetik 
Sialinsäuren sind Kohlenhydrat-Derivate bestehend aus neun Kohlenstoffatomen die eine 
Carboxylaruppe besitzen. Sie kommen weit verbreitet frei oder konjungiert an Glycanen der 
Zelloberfläche von und erfüllen dort wichitge Funktionen in der Zellphysiologie. Deshalb ist 
es wichtig, Methoden für die Synthese spezifisch sialokonjugierter Epitope in vitro zu 
entwickeln, um die Forschung von Kohlenydrat-Protein-Interaktionen in physiologischen 
Prozessen zu ermöglichen. Sialinsäurereste werden von α/β-Galactosyl-α-2,3/2,6-
   Seite III 
Sialyltransferasen auf die terminale Galactoseeinheit von Oligosacchariden übertragen. 
Deshalb stellen diese nützliche Werkzeuge für die Synthese von Sialokonjugaten in vitro dar. 
Zu diesem Zweck wurden α-2,3- und 2,6-Sialyltransferasen aus Photobacterium phosphoreum 
(2,3SiaTpph) und entsprechend aus Photobacterium leiognathi JT-SHIZ-145 (2,6SiaTple) 
kloniert. Um die Substratspezifität dieser beiden SiaTs zu untersuchen, wurde zur 
Bestimmung der kinetischen Konstanten und der Substrattoleranz ein pH-basierter Assay 
etabliert, in dem Phenolrot als pH-Indikator in schwach gepuffertem Medium dient. Diese pH-
Assay-Methode ist schnell, empfindlich und kontinuierlich und konnte zur Bestimmung der 
kinetischen Konstanten und der Substrattoleranz von 2,3SiaTpph und 2,6SiaTple herangezogen 
werden. Diese beiden SiaTs weisen eine deutlich unterschiedliche Akzeptorspezifität auf. 
Während die 2,3SiaTpph α- und β-Galactoside, Lactoside, Glc, Man und GalNAc gut 
akzeptieren kann, zeigt die 2,6SiaTple nur gegenüber β-Galactosiden und Lactosiden eine hohe 
Aktivität.  
 
 
 
 
 
 
Abbildung 3. Das Prinzip einer neuen, pH -basierten Testmethode für Sialyltransferase und ihre Anwendung zur 
Bestimmung der spezifischen Enzymaktivität. 
 
• β-SiaT Engineering für α-Substrattoeranz 
Durch den Strukturabgleich zwischen 2,3SiaTpph and 2,6SiaTple wurde Trp347 als Ursache für 
die Blockade des aktiven Zentrums für α-Galactoside identifiziert. Um die Aktivität der 
2,6SiaTple bezüglich α-Galactosiden zu verbessern wurden drei Mutagenesebibliotheken 
erstellt. Hierfür wurde die Hochdurchsatz-Screeningmethode mit Methyl-α-D-
galactopyranosid als Akzeptor verwendet. Es konnte jedoch keine positive Variante 
identifiziert werden, was zeigt, dass Trp347 in der 2,6SiaTple offenbar nicht problemlos 
ersetzbar ist. Es ist zu vermuten, dass Trp347 zur Bindung zwischen Donor und Akzeptor 
beiträgt und die korrekte Akzeptor-Konformation für die Bildung von 2,6-sialisierten 
Produkten stabilisiert. 
 Seite IV 
 
• CSS Engineering für sterisch auspruchsvolle Substrate 
Die CMP-Sialinsäure-Synthetase (CSS, E.C. 2.7.7.43) katalysiert die CMP-Aktivierung von 
Sialinsäuren unter Verwendung von CTP als Donor und Mg2+ als Cofaktor. Es konnte gezeigt 
werden, dass eine Reihe von Neu5Ac-Analogen mit einer sterisch auspruchsvollen 
Modifikation an der Acylamino-Gruppe von CSS aus Neisseria meningitidis (CSSnme) akzeptiert 
werden können, obwohl ihre korrespondierenden  kcat/KM Werte viel niedriger sind als 
diejenigen des natürlichen Substrates  Neu5Ac. Durch ein Alignment des aktiven Zentrums für 
die Akzeptorbindung der CSSnme wurden  Phe192 und Phe193 als die entsprecheuden Reste 
für die Bindung der Acylaminogruppe in Neu5Ac identifiziert. Darauf aufbauend wurden vier 
Sättigungsmutagenesebibliotheken an den Positionen Phe192 und Phe193 konstruiert, um die 
Aktivität gegen Neu5Ac-OBz, Neu5Hex und Neu5PenN3 zu verbessern. Aus dem Screening mit 
der pH-basierten Hochdurchsatzmethode ergaben sich CSSnme-Phe192Cys/Phe193Tyr, CSSnme-
Phe192Ser, und CSSnme-Phe192Ser/Phe193Tyr als die besten Kandidaten mit jeweils 14.1-, 
4.6- und 4.0-facher Aktivitätssteigerung gegen Neu5Ac-OBz, Neu5Hex und Neu5PenN3. Um 
die verbesserte Aktivität zu validieren, wurden diese drei CSS-Varianten zusammen mit der 
2,6SiaTple für eine präparative Synthese von neuen Neo-Sialokonjugaten verwendet. Die 
Ausbeuten der Endprodukte betrugen 50%, 64% bzw. 70%. 
 
• Enzymklonierung für die Synthese von LacNAc 
Oligosacharide mit einer endständigen N-Acetyl-D-lactosamin Einheite (LacNAc) sind ein 
wichtiges natürliches Substrat der SiaTs. Die Synthese von LacNAc und seiner Derivate in 
vitro erweitert daher die Akzeptor Vielfalt für die Herstellung von Neo-Sialokonjugaten. Für 
diesen Zureck wurden die β-1,4-Galactosyltransferase aus Helicobacter pylori (GalThpy) und die 
UDP-Galactose-4-Epimerase aus E. Coli (GalEeco) kloniert und in einem E. coli-
Expressionssystem exprimiert. Mit Hilfe dieser beiden rekombinanten Enzyme wurden freies 
LacNAc und LacNAc-D-T-P-Acr aus UDP-Glc als Donor sowie den entsprechenden 
Akzeptorsubstraten in isolierten Ausbeuten von 88%, 92% und 85% jeweils im 100 mg-
Maßstab für weitere präparative Zwecke synthetisiert. 
 
• Präparative Synthese von Neo-Sialokonjugaten 
Unter Verwendung der 2,3SiaTpph bzw. 2,6SiaTple  sowie der neuen CSS-Varianten wurden die 
Neo-2,3- und 2,6-Sialokonjugate in einer Eintopf-Reaktion mit zwei Enzymen synthetisiert. 
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Sechs typische Sialinsäuren (Neu5Ac, Neu5Gc, Kdn, epi-Kdn, Neu5Ac-9-N3 und Neu5NPhAc) 
mit Modifikationen an C5 und C9 wurden als Donoren an fluoreszente Lactose (Lac-D-T-P-
Acr) und  N-Acetyl-D-lactosamin (LacNAc-D-T-P-Acr) mit α-2,3- and α-2,6-Konfiguration 
gekuppelt. Die 2,3SiaTpph und 2,6SiaTple zeigen sehr ähnliche Donorspezifitäten gegen über 
diesen sechs Sialinsäuren. Beide akzeptieren Neu5Ac, Neu5Gc, Kdn und Neu5Ac-9-N3 gut,  
reagieren jedoch mit dem sterisch auspruchsvollen Neu5NPhAc schlechter. Darüber hinaus 
kann die 2,6SiaTple das epi-Kdn besser als die 2,3SiaTpph akzeptieren. 
 
 
 
 
 
 
 
 
 
 
 
 
Abbildung 4. Chemoenzymatische Syntheseroute für die fluorogenen Sialokonjugate.  
 
• Charakterisierung einerpotentiellen neuen SiaT 
Kürzlich wurde eine neue potentielle Sialyltransferase aus Shewanella piezotolerans (SiaTspi) 
beruhend auf der genomischen DNA-Sequenz von S. piezotolerans beschrieben. Über eine 
Klonierung, Expression und einen Aktivitätstest der  SiaTspi liegen jedoch noch keine Berichte 
vor. Deshalb wurde das künstliche Gen im Rahmen dieser Arbeit kloniert, modifiziert und 
optimal im E. coli und  Yarrowia-Expressionssystem exprimiert. Der Sequenz-BLAST und die 
strukturelle Übereinstimmung mit anderen 2,3SiaT-Sequenzen innerhalb der  CAZy-Familie 
GT80 ließen eine funktionelle upstream-Sequenz erkennen. Die Deletion eines Loops mit 12 
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N-Acetylneuraminic acid aldolase
from E. coli
Pyruvate
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Aminosäurenresten verbesserte die Identifizierung der 2,3-SiaT-Aktivität durch eine Reaktion  
mit fluoreszenzmarkiertem Akzeptor, insbesondere bei Koexpression mit Chaperonen. Die 
geringe Expression an löslichem Protein sowohl im E. coli-, als auch im Y. lipolytica-
Expressionssystem vereitelte jedoch eine weitergehende Charakterisieng des Enzymes. 
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Abbreviation 
 
 
2,3SiaT α/β-galactoside α-2,3-sialyltransferase
2,3SiaTpph α/β-galactoside α-2,3-sialyltransferase from Photobacterium phosphoreum  
2,6SiaT β-galactoside α-2,6-sialyltransferase
2,6SiaTpda 2,6SiaT from Photobacterium damselae JT0160  
2,6SiaTple 2,6SiaT from Photobacterium leiognathi JT-SHIZ-145  
2,6SiaTpsp 2,6SiaT from Photobacterium sp. JT-ISH-224  
AA amino acid 
Ac acetyl 
AcOH acetic acid 
Acridon/Acr 10H-acridin-9-OH 
Amp ampicillin 
Bn benzyl 
BuOH butanol 
CAZy  The Carbohydrate-Active Enzymes Database
CDP cytidine diphosphate
CMP cytidine monophosphate
CSS CMP-Neu5Ac synthetase 
CSSmmu CSS from Mus musculus  
CSSnme CSS from Neisseria meningitidis 
CTP cytidine triphosphate
ddH2O double-distilled water
DHAP triose phosphates dihydroxyacetone phosphate 
DHEThDP α,β-dihydroxyethyl ThDP
E4P D-erythrose 4-phosphate 
EC Enzyme Commission
EtOH ethanol 
F6P D-fructose-6-phosphate 
FruA fructose-1,6-bisphosphate aldolase
FucThpy fucosyltransferase from Helicobacter pylori  
G3P/GAP D-glyceraldehyde-3-phosphate
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Gal galactose  
GalE UDP-galactose 4-epimerase
GalEeco UDP-galactose 4-epimerase from E. coli 
GalNAc N-acetylgalactosamine 
GalT β-1,4-galactosyltransferase 
GalThpy β-1,4-galactosyltransferase from Helicobacter pylori 
GalTngo β-1,4-galactosyltransferase from Neisseria gonorrhoeae 
GalTnme β-1,4-galactosyltransferase from Neisseria meningitides  
GalU UTP-glucose-1-phosphate uridylyltransferase 
Glc glucose 
GlcNAc N-acetylglucosamine 
GNE UDP-GlcNAc 2-epimerase/ManNAc-6-kinase 
GT-B glycosyltransferase-B
HPA hydroxypyruvate 
HPLC high-performance liquid chromatography
IPTG isopropyl β-D-1-thiogalactopyranoside 
ISM  Iterative Saturation Mutagenesis
Kan kanamycin 
kcat Michaelis-Menten equation 
Kdn deaminoneuraminic acid 
KM Michaelis constant 
Lac lactose 
LacNAc N-acetyl-D-lactosamine 
LB Lysogeny Broth 
LOD limit of detection 
LOQ limit of quantification
Man mannose 
ManNAc N-acetyl-D-mannosamine 
ManNAc-6-P N-acetyl-D-mannosamine-6-phosphate 
MBP maltose binding protein 
MeOH methanol 
NAD+ nicotinamide adenine dinucleotide
NADH reduced nicotinamide adenine dinucleotide 
NANP Neu5Ac-9-phosphate phosphatase 
NANS Neu5Ac-9-phosphate synthase
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Neu neuraminic acid 
Neu5Ac N-acetylneuraminic acid 
Neu5Gc N-glycolylneuraminic acid
NeuC UDP-GlcNAc 2-epimerase 
NeuS Neu5Ac synthase 
NMR nuclear magnetic resonance
PCR polymerase chain reaction
PDB The Protein Data Bank
PEP phosphoenolpyruvate
PGA penicillin G acylase 
PGMs post-glycosylation modifications 
PhAc phenylacetyl
Pi/P phosphate 
pKa acid dissociation constant 
pNP-Man 4-nitrophenyl labeled mannose  
PPase inorganic pyrophosphatase
PPi pyrophosphoric acid
R5P D-ribose 5-phostphate 
R5P D-ribose-5-phostphate
Rf retardation factor 
S7P D-sedoheptulose-7-phosphate
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SiaT sialyltransferase
SiaTspi  SiaT from Shewanella piezotolerans 
SLX Sialyl LewisX
TB Terrific Broth
TEA triethanolamine
TEED The Thiamine Diphosphate Dependent Enzyme Engineering Database
ThDP thiamine diphosphate 
THF tetrahydrofuran
TK transketolase
TKban transketolase from Bacillus anthracis 
TKeco transketolase from E. coli 
TKgst transketolase from Geobacillus stearothermophilus  
TKyst transketolase from baker’s yeast
TLC thin layer chromatography
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Tris 2-amino-2-hydroxymethyl-propane-1,3-diol
UDP uridine triphosphate
UV ultraviolet 
V volumn 
Vmax the maximum reaction rate
X5P D-xylulose 5-phosphate 
X-gal 5-bromo-4-chloro-indolyl-β-D-galactopyranoside
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1. General Introduction——White Biotechnology and Its Research Progress 
 
 
White biotechnology, also known as industrial biotechnology, is a subject which applies the 
tool of nature for the manufacture of chemical products.[1, 2] In the vast majority of cases, 
bioactive molecules (mainly isolated enzymes) and/or whole cells are utilized as biocatalysts 
in the production of valuable intermediates or secondary metabolites as final products. The 
application of white biotechnology to the synthesis of organic fine chemicals and chiral 
intermediates also led to a “green chemistry” revolution in the chemical industry.[3-5] 
Because of the biocatalysts’ high catalytic efficiency, substrate specificity and product 
stereoselectivity, as well as its environment friendliness, the application of biocatalytic process 
is creating a trend to replace conventional chemical synthesis in pharmaceutical,[6-8] fine 
chemical,[8, 9] material,[10-12] energy,[12, 13] and environment protection[11, 12] 
industries, in order to increase the quality and consistency of products, save energy 
consumption and reduce environmental pollution.[14] 
Biocatalysis has experienced a rapid development in the past century, during which many new 
technologies have been applied for broadening the use of biocatalysts. The application of 
thermophilic enzymes and immobilization greatly improved the stability of biocatalysts for 
synthesis.[15, 16] Coenzyme regeneration technology and whole cell catalysis ensure the 
sustainability and decrease the cost of biocatalytic reactions.[17] Biocatalysis in organic 
solvents changes the behavior of the enzymes and extend the scope for their application.[17-
20] Multiphase reaction systems are advantageous to improve the catalytic efficiency and 
facilitate product separation.[21] The improvement of enzyme reactors, especially the 
construction of microreactors, helps to optimize the enzymatic reaction conditions.[22, 23] 
Owing to the technology above, the substrates and products of biocatalysis are no longer 
confined to the natural molecule diversity, but also applicable to many non-natural target 
compounds which are of interest as pharmaceutical intermediates and fine chemicals of 
interest.[24]  
The discovery of suitable or improved biocatalysts is the main theme in biocatalysis. Screening 
tens of thousands of microorganisms in the environment is a traditional but currently still 
important and indispensable method. However, with a view to numerous nonculturable 
microorganisms, the traditional cultivation and screening method cannot meet the 
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requirements from an increasing demand for new and better catalysts. Fortunately, 
metagenomic technology enables us to exploit the genetic database of microbial communities 
without any cultivation step.[25] Based on the bioinformatic analysis, potential isozymes can 
be identified relatively easy by sequence alignment. In the past decades, new DNA 
technologies, especially low cost but high-throughput DNA sequencing and artificial 
synthesis,[24] and new bioinformatic arithmetics have been well developed and paved the 
way for metagenomics, which develops to  become a hot topic in the field of biocatalysis.[25] 
On the other hand, protein engineering has created new ways for the modification of the 
physical and chemical properties of existing biocatalysts.[24] Based on the structural analysis 
of known enzymes, and through the rational or non-rational design of variants together with 
high throughput screening methods for the desired function, directed evolution becomes an 
efficient approach to obtain novel enzyme variants with improved specific activity, substrate 
specificity, stereoselectivity, thermostability and organic solvent tolerance, or even new 
catalytic capability. Protein crystal structure analysis with substrate docking simulation 
supports the design of modified structure and function and prediction of variants of interest, 
which ultimate provides the theoretical basis for the rational protein design, making de novo 
design of novel enzymes possible.[24] Owing to the combination of rational design and 
directed evolution, focused cassette and saturation mutagenesis can immensely reduce the 
size of a mutagenesis library and improve the efficiency of forward mutation in comparison 
with the irrational approaches.[26] All of these technological developments in biotechnology 
and bioinformatics have accelerated to a third wave in biocatalysis.[24] 
After many years of technological development, a vast diversity of  all kinds of enzyme classes 
have been successfully used as biocatalysts in organic synthesis, including oxidoreductases, 
transferases, hydrolases, lyases, isomerases and ligases.[5, 14, 27-29] Among them, enzymatic 
carboligation and glycosylation have become very important reactions for the synthesis of 
monosaccharides, oligosaccharides and their derivatives in vitro.  
Several enzymes are involved in the enzymatic carboligation, which can rapidly build a new 
C-C bond up under mild conditions with high chemical efficiency and uncompromised 
stereochemical fidelity, without a need for protection of sensitive or reactive functional 
groups.[30] Aldolase is such kind of biocatalyst containing various members. Fructose-1,6-
bisphosphate aldolase (FruA, EC 4.1.2.13) is a well-known aldolase, which transfers the aldol 
and fructose 1,6-bisphosphate into the triose phosphates dihydroxyacetone phosphate (DHAP) 
and glyceraldehyde 3-phosphate (GAP).[29] However, the reversibility of the reaction limits 
the maximum yield of the final product. Transketolase (TK, EC 2.2.1.1) is another essential 
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enzyme in carbohydrate metabolism. It transfers a terminal two-carbon hydroxyacetyl unit 
from a donor ketose phosphate to an acceptor aldose phosphate.[31] Although in principle 
this is also a reversible enzymatic reaction, the utilization of hydoxypruvate as an alternative 
donor analog can release carbon dioxide during the reaction, which recedes the transfer 
irreversible.[32] Therefore, TK is an emerging catalyst for asymmetric carbon-carbon bond 
formation and sugar-like compound synthesis.[30] The first part of this thesis focuses on the 
development of TK for preparatic asymmetric synthesis, including the study of its substrate 
specificity, kinetics, and directed evolution of substrate tolerance towards non-α-hydroxylated 
substrates. 
 
 
 
 
 
 
 
Scheme 1.1. Carboligation catalyzed by fructose-1,6-bisphosphate aldolase and transketolase 
 
Glycosyltransferases are catalyzing in the glycosylation reactions in the assembly of 
oligosaccharides. The monosaccharide donor sugars are mostly required in the activated form 
of nucleoside diphosphate or monophosphate sugars, lipid phosphates, and free anomeric 
phosphates.[33] Sialyltransferases are one kind of nucleoside monophosphate sugar 
dependent glycosyltransferases that transfer CMP-activated sialic acids onto galactosides, or to 
other sialic acids, forming an α-2,3, α-2,6 or α-2,8 glycosidic bond, respectively.[34] The sialic 
acid terminus in oligosaccharides plays a very important role in cell information display and 
exchange in the physical activities, such as cellular adhesiveness and recognition, blood 
components and clotting, immunology and infection, transmission of nerve impulses, 
hormonal regulation, and so on.[34, 35] Therefore, the chemoenzymatic synthesis of 
sialoconjugates in vitro has significance for the interpretation of physiological functions of 
specific oligosaccharide structures and for potential drug design. In part II of this thesis, 
bacterial sialyltransferases are studied for the synthesis of neo-sialoconjugates. 
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acetylneuraminate synthetase are also included owing to their involvement in the acceptor 
synthesis and donor activation.  
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Part I. Enzymatic Properties and Directed Evolution of Transketolases 
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2. Introduction of Part I 
 
 
2.1. ThDP-dependent enzymes  
 
Thiamine diphosphate (ThDP) -dependent enzymes are a large family of natural biocatalysts 
with ThDP as an essential cofactor that catalyze the clearage and formation of carbon-sulfur, 
carbon-oxygen, carbon-nitrogen and carbon-carbon bonds.[36, 37] A data base named “The 
Thiamine Diphosphate Dependent Enzyme Engineering Database” (TEED) has been 
established including the identified ThDP-dependent enzymes as well as potential 
sequences.[38] Up to the present, more than 9,000 ThDP-dependant enzymes have been 
identified and additional 3,000 analogous sequences are listed in GenBank.[38] According to 
their structural arrangement of domains, ThDP-dependent enzymes are classified into six 
superfamilies, including DC (decarboxylase), TK (transketolase), OR (oxidoreductase), KDH 
(α-ketoglutarate dehydrogenase), and two subfamilies K1 and K2 of the KD (2-ketoacid 
dehydrogenase). In each category, the amino acid residue sequences of the enzymes have 
highly conserved domains which are in charge of the ThDP and functional group binding.[38] 
Due to their intrinsic chiral function, ThDP-dependent enzymes have been broadly applied in 
enzymatic synthesis, especially for carbon-carbon bond formation.[39-43]  
 
2.2. Transketolase  
 
Transketolase (EC 2.2.1.1, TK) is a ThDP-dependent enzyme performing C-C bond formation 
and cleavage.[42] It plays an important role in both the pentose phosphate pathway and the 
Calvin cycle of photosynthesis in vivo, catalyzing a reversible 2-carbon fragment transfer 
reaction between an aldose and a ketose. In the pentose phosphate pathway, it transfers the 
2-carbon fragment from D-xylulose 5-phosphate (X5P) to D-ribose 5-phostphate (R5P), and 
also from X5P to D-erythrose 4-phosphate (E4P). In the Calvin cycle of photosynthesis, it 
operates in an opposite direction (Scheme 2.1). 
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Scheme 2.1. Transketolase function in the pentose phosphate pathway and the Calvin cycle of photosynthesis 
 
As a key enzyme in metabolism, TK has been found widely in both eukaryotes and 
prokaryotes, including animal, plant, yeast, bacteria, and so on.[42, 44] Among them, 
bacterial TK have particularly high advantages for chemoenzymatic synthesis, such as high 
soluble expression in prokaryotic expression systems, relatively high stability and broad 
substrate range.[42] The most extensively studied bacterial TKs are those from E. coli 
(TKeco)[45] and yeast (TKyst)[46]. The substrate specificity determination of TKeco and TKyst 
shows that both of them also have a wide acceptor tolerance for non-phosphorylated aldose 
sugers.[46-49] When the carbon chain of aldoses is longer than four, the activity of TK 
decreases very fast, mainly because of the intramolecular formation of cyclic hemiacetals. On 
the other hand, TK has very strict enantioselectivity towards the α-position of the aldehyde 
acceptors, for which a hydroxyl group in D-configuration is required for activity. Deoxy-
aldedydes or L-α-hydroxylated aldehydes, such as propanal and L-glyceraldehyde, respectively, 
cannot be well accepted by TK.[46-49] 
The TKs share common domains with each other, which contain a pyrophosphate and a 
pyrimidine domain, as well as the TK C-terminal domain.[38] From the determination of the 
crystal structures of TKeco (PDB code 2R8O and 2R8P),[50, 51] TKyst (PDB code 1GPU)[52] 
and TK from Bacillus anthracis (TKban, PDB code 3M49), it became apparent that these three 
bacterial TKs have almost the same active site arrangement (Figure 2.1),  which indicates that 
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TKeco, TKyst and TKban have the same catalytic mechanism for their ketol transfer reactions, 
because of the highly conserved protein residues that form their active sites. The key residues 
were identified as Glu418 and His481 (numbers refer to the TKyst sequence), in which the 
former forms a hydrogen bond to N1’ of the aminopyrimidine ring of ThDP, while the latter is 
positioned to abstract the proton from the active imino group.[42]   
 
       a) 
 
 
 
 
 
 
 
 
        b) 
 
 
 
 
 
Figure 2.1. Active site alignment of TKeco (blue, PDB code 2R8O and 2R8P), TKyst (yellow, PDB code 1GPU) and TKban 
(green, PDB code 3M49). a) Active psite alignment for substrate binding D-erythrose 4-phosphate (E4P). b) Active 
site alignment for ThDP cofactor binding.  
 
The kinetic analysis of TKeco indicated that the catalysis of TK is consistent with a Ping Pong Bi 
Bi mechanism, where the ketol donor is bound to the enzyme first, followed by the binding of 
the aldehyde acceptor and subsequent release of the product.[53] The catalytic mechanism of 
E4P
ThDP
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this ketol transfer reaction has been elucidated in detail in the resent literature.[51, 54-57] 
The catalytic reaction starts by the deprotonation of ThDP at the thiazolium ring to form a 
carbanion. Then, this carbanion binds to the carbonyl of the ketose donor substrate (e.g. X5P) 
followed by the cleavage of the C2-C3 bond. After the release of the truncated donor fragment 
(e.g. G3P), ThDP carries the covalent bonding keto fragment affording an α,β-dihydroxyethyl 
ThDP (DHEThDP) enamine. When an acceptor substrate (e.g. R5P) enters the active site and 
binds to the DHEThDP enamine, the ketol fragment is transferred to the acceptor forming the 
product (e.g. S7P), which is subsequently released. Because the product also contains a ketol 
group, it can also serve as a ketol donor, which makes this reaction fully reversible (Scheme 
2.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.2. Mechanism of ketol transfer reaction catalyzed by TK.[51]  
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2.3. Directed evolution of transketolase 
 
Although TK can accept non-phosphorylated suger substrates, the activity of TK is much lower 
than towards natural phosphorylated acceptors. In order to improve its activity, saturation 
mutagenesis libraries have been constructed on the active sites of TKeco and TKyst.[58-60] 
Twenty amino acid residues surrounding ThDP and acceptor have been chosen as the 
candidates for mutation.[58] The top variant TKH461S eco shows a 4.8 fold activity improvement 
towards glycoaldehyde when using hydroxypyruvate (HPA) as donor.[58]  On the other hand, 
owing to the strict enantioselectivity of TK towards the α-hydroxyl group of its acceptors, the 
saturation mutagenesis libraries have also been screened for extending the substrate range of 
TK towards non-α-hydroxylated aldehydes which led to a variant TKD469E eco  with eight fold 
activity increase and improved stereoselectivity (doubling the ee) for propanal as compared to 
the wild-type.[59, 61] Moreover, one single-point mutation (TKH26Y eco ) was found to reverse the 
stereoselectivity of TKeco towards propanal, thereby forming a product with 3R configuration 
preferentially.[61] 
 
2.4. Synthetic application of transketolase  
 
TK performs the transfer of a two-carbon hydroxyacetyl unit to an aldehyde with carbon-
carbon bond formation and induction of a chiral hydroxyl methylene group at the C3 position 
of the product. This makes TK a potent biocatalyst for chiral synthesis, especially in the 
synthesis of ketose-type intermediates, which is difficult to achieve by chemical methods.[39] 
However, a major challenge for applications in practical synthesis is that the TK reaction is 
reversible, which leads to an equilibrium between substrates and products, requires tedious 
separation,  and limits the product yields. To deal with this problem, hydroxypyruvate (HPA) 
was introduced as a very suitable donor that forms CO2 after the two-carbon unit 
transformation.[62] The release of CO2 makes the reaction essentially non-reversible, and the 
reaction can be completed totally. With HPA as donor, a series of chiral polyhydroxyketones 
have been synthesized including, but not limited to, monosaccharide derivatives and 
deoxyketose-type products.[46-48, 63, 64]  
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2.5. Specific aim 
 
The substrate specificity and kinetic constants of TK enzymes from diverse resources have 
been previously determined independently by a variety of assay methods, which makes a 
direct comparison of their substrate preferences highly inaccurate. Therefore, a rapid, 
sensitive, continuous and universal assay method for TK needs to be established first for the 
activity comparison between diverse TKs, as well as for a facile screening of mutation libraries.  
Based on such a “universal” method, the kinetic constants and acceptor specificity of TKeco and 
TKyst could be determined for a detailed comparison among each other.  
Recently, a thermostable TK from Geobacillus stearothermophilus (TKgst) has been cloned and 
expressed in an E. coli expression system.[65] Similar to other TKs, it also has low activity 
towards non-α-hydroxylated aldehydes. In order to improve its activity, in vitro mutagenesis 
of TKgst promises a rapid route to novel variants with advanced properties. 
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3. Study of the Enzymatic Properties of Transketolase Using a pH-Based Assay 
Method 
 
 
3.1. Introduction 
 
The enzymatic properties, especially the substrate specificity of bacterial TKs including 
towards phosphorylated and non-phosphorylated acceptor aldehydes, have been well 
determined in several studies.[39, 42] Unfortunately, most of the specificity data of TKs from 
various resources were determined under different assay methods, which makes the 
comparison of absolute data impossible. Therefore, it is still significant to compare the 
substrate tolerance of various TKs with a common real-time tracking, high-throughput assay 
method. 
The assay methods used in specificity determination of TK enzymes are various. The 
conventional method for measuring TK activity uses D-ribose-5-phosphate (R5P) and D-
xylulose-5-phosphate (X5P)[66] because of their superior substrate quality as acceptor and 
donor, respectively, and the reaction is followed spectrophotometrically by the amount of 
reduced nicotinamide adenine dinucleotide (NADH) consumed by auxiliary enzyme catalyzed 
reactions.[67, 68] Similar multi-enzyme assays have been reported using alternative acceptor 
or donor substrates of TK.[69-71] An umbelliferone-based sensitive fluorogenic assay has 
been devised to determine TK activity and stereoselectivity.[72-74] Although operated in a 
continuous mode like the standard method, none of these highly substrate-specific methods is 
adaptable to probe the kinetics of TK for other non-natural substrate analogs.  
Several assay formats have been developed to probe the substrate tolerance of TK by direct 
measurement of remaining substrate or product formed. Measurement of chiral product 
formation by optical activity[75] or ellipsometry[76] is highly dependent on substrate 
structure and thus not of generic utility. Determination of HPA depletion by near-UV 
spectroscopic monitoring,[77] enzymatic assay[78] or HPLC analysis[79, 80] is hampered by 
low sensitivity or low throughput. Colorimetric determination of ketose formation by 
heterocyclic condensation reactions is limited by low specificity,[81], while tetrazolium red-
based oxidation is restricted to non-hydroxylated aldehyde acceptors such as used for 
modified propanal tolerance;[82] in addition, both latter methods require multiple reagent 
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handling steps and are thus time consuming and laborious. A major disadvantage of all 
methods that involve substrate/product determination is, however, that they are 
discontinuous and do not allow direct measurement of enzyme kinetics, which not only is 
tedious but also a significant source of experimental error.  
In the TK catalytic reaction with HPA as the donor, one equivalent of bicarbonate is produced 
upon HPA decarboxylation with each ketol transfer cycle by TK, which causes the pH value of 
the reaction system to rise (Scheme 3.1). Direct monitoring of pH changes by a pH indicator is 
highly convenient, and independent of the structure of an acceptor substrate. This assay 
principle has been successfully developed to monitor enzymatic reactions that involve various 
types of ester hydrolysis,[83-85] phosphoryl transfer,[86] nucleotidyl transfer[87] and 
glycosyltransfer[88, 89] as well as decarboxylation reactions.[90] The advantages of pH 
based assay methods are obvious: pH indicators are inexpensive; no auxiliary enzymes are 
necessary; initial reaction rates can be monitored in real-time, and the reactions should be 
easily adaptable to high-throughput mode in microtiter plate format. Indeed, based on this 
principle Hübner et al. have reported a pH based assay method for TK using p-nitrophenol as 
pH indicator,[91] but the low sensitivity of the latter (light yellow color development) makes 
this method ineffective for kinetic determinations of low enzyme activities that are typical 
with non-natural acceptor substrates. 
 
 
 
 
Scheme 3.1. Principle of the pH based assay method for TK activity determination 
 
In this chapter, a new continuous pH-based assay method has been developed for the high-
throughput screening of TK, based on HPA as donor and phenol red as sensitive pH indicator, 
which is generic and can be used for the reliable colorimetric determination of specific 
enzyme activity and measurement of kinetic constants. This method is particularly suitable for 
mapping the substrate tolerance of TKs from different sources with a broad variety of natural 
and non-natural, α-hydroxylated and non-hydroxylated, non-phosphorylated acceptor 
substrates. The results obtained from kinetic measurements are verified by exemplary 
preparative synthesis and characterization of the corresponding chiral products. Because of its 
simplicity, the method should also prove valuable for the quantitative screening of mutant TK 
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libraries required in the directed evolution of novel enzyme properties. 
 
3.2. Results and discussion 
 
3.2.1. Development of pH-based assay for transketolase 
 
Protons released or consumed in an enzymatic reaction can be detected via color change of a 
suitable pH indicator. An assay based on colorimetrical determinations of this type is a direct 
measure of the enzyme of interest, allowing both for rapid qualitative and, under suitably 
controlled conditions, also for quantitative measurements.[92] The TK catalyzed 
decarboxylation of HPA produces one equivalent of the corresponding bicarbonate salt per 
catalytic cycle. In the TK reaction described in Scheme 3.1, HPA is a medium strength acid 
with a pKa value lower than 2, while aldehyde acceptor and the chiral hydroxyketone 
produced are both neutral. At the pH optimum of the TK reaction (around 7.5)[42] none of 
them will affect the pH of reaction system. However, the bicarbonate ion is the dissociated 
form of carbonic acid, which by its effective first pKa1 of 6.33, owing to its unfavorable 
dehydration equilibrium, actually is a significantly weaker acid than HPA (pKa2 is 10.22).[93] 
Bicarbonate is amphoteric and involved in dynamic dissociation equilibria in water (Scheme 
3.2), and its solutions react alkaline due to the partial formation of hydroxide. Therefore, the 
pH of the TK reaction system rises upon conversion of HPA. This pH change is revealed in the 
presence of a pH indicator by a color change, and the stoichiometric formation of bicarbonate 
can be determined photometrically for absolute quantification. 
 
 
 
Scheme 3.2. Dynamic dissociation equilibrium of bicarbonate in water 
 
To ensure maximum sensitivity and fidelity of a pH-dependent enzyme assay, the color 
change interval of the indicator needs to be around the optimal pH of the biocatalysis reaction. 
For our study, we chose phenol red as the pH indicator because of its high absorption 
coefficient (ε = 56,000 M-1·cm-1 at 557 nm)[86], and because its pKa of 7.4 and applicable pH 
range (6.8–8.2) coincide with the appropriate pH optimum of TK catalysis (around pH 7.5 
CO32- + H3O+ HCO3- + H2O H2CO3 + OH- H2O + CO2 + OH-
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depending on the source of TK).[42] Phenol red exposed to alkali changes its color from 
yellow to bright red and thus can be easily observed by the human eye, with sensitivity higher 
by at least one order of magnitude when compared to p-nitrophenol. The highest sensitivity 
results at low buffer concentrations and high indicator concentrations, but in unbuffered 
solution the background absorbance level changes too readily upon very small experimental 
variations. For our study, a buffer concentration as low as 2 mM was found to be satisfactory, 
and phenol red concentration at 10 mg/L (0.028 mM) was optimal for signal intensity; at 
least up to this concentration level no inhibition of TK activity was notable by the presence of 
phenol red.  
For a choice of buffer, its pKa and the pKa of indicator dye should be as similar as possible to 
ensure that the color change is proportional to the number of produced protons.[90] TK 
activity is usually determined in Tris (pKa 8.06) or Gly-Gly (pKa2 8.25) buffer solution.[94] 
However, upon tests with Tris buffer we consistently noted an initial absorbance decrease of 
the assay solution before addition of HPA to start the reaction that continued for several 
minutes before reaching a steady absorption level (Figure 3.1). This decrease, which indicates 
a slight acidification of the solution, was only observed when the assay mixture contained Tris 
buffer plus any one of the aldehyde or HPA components. Apparently, the primary amine 
group of Tris slowly reacts with electrophilic carbonyl compounds (aldehyde and HPA) to 
form covalent products such as carbinolamine, imine, or oxazolidine,[95-97] which due to 
their lower basicity lead to a release of protons (Scheme 3.3). As Tris buffer proved unsuitable 
for this assay, it was switched to triethanolamine (TEA), which has a similar pKa (7.8) but 
lacks a reactive primary amino group. Indeed, TEA buffer produced a stable absorption signal 
for the assay system with no detectable pH variation from chemical reactivity and therefore 
was chosen for further development. Although certain tertiary amines have been shown to 
catalyze decomposition of HPA reminiscent to the TK reaction at elevated temperature,[98, 99] 
no reaction occurred with TEA under moderate conditions. 
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Figure 3.1. Observation of pH changes from chemical background reactivity of amine buffers. □ 2 mM TEA (pH 7.5), 
● 2 mM Tris-HCl (pH 7.5). Samples contained 0.028 mM phenol red and 50 mM glycolaldehyde in 200 µL of 2 mM 
amine-HCl buffer at a starting pH 7.5. Absorbance was measured at 560 nm by plate reader. 
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Scheme 3.3. Covalent interaction between Tris and HPA 
 
The relationship between the quantity of HCO3- produced upon HPA conversion and the 
absorbance of indicator was determined by titration of the entire TK assay mixture with 
NaHCO3, that is, with all potentially buffering elements included, but omitting an aldehyde 
substrate to exclude catalytic turnover. A calibration curve (Figure 3.2a) was measured at 560 
nm with variation of the HCO3- concentration from 0.0 to 0.8 mM mimicking the low degree 
of HPA conversion by TK under initial rate conditions. This standard curve, which shows good 
linearity over the entire range, was used to calculate the increase of HCO3- concentration 
during the catalytic reaction. The limits of detection (LOD) and limits of quantification (LOQ) 
values derived from the linear regression curve[100, 101] are 0.04 mM and 0.11 mM HCO3-, 
respectively. 
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Figure 3.2. Development of the assay method. Samples contained 0.028 mM phenol red, 2.4 mM ThDP, and 9 mM 
MgCl2 in 200 µL of 2 mM TEA buffer (pH 7.5) as well as enzyme and acceptor as specified. After addition of 50 mM 
LiHPA, absorbance was measured at 560 nm using a plate reader. (a) Standard curve; reaction mixtures contained 
12 µg TKyst and varying amounts of NaHCO3 (0–0.8 mM). (b) Time curve of absorbance change using different 
acceptors substrates. Assay solutions contained 12 µg TKyst and various aldehydes;  50 mM D-glyceraldehyde,  50 
mM D,L-glyceraldehyde,  50 mM D-erythrose,  200 mM D-ribose (32 µg TKyst);  control without enzyme. (c) 
Time curve for absolute data. Absorbance data from (b) for 50 mM D-glyceraldehyde was converted into 
equivalent HCO3- concentration according to the calibration curve. The slope of the resultant curve was used for 
calculating the specific activity. (d) Dependence of rate on amount of enzyme; reaction mixtures contained 50 mM 
D-glyceraldehyde and varying amounts of 0-4 µg TKyst. 
 
A practical test of the assay was performed by using TKyst as catalyst with some non-
phosphorylated hydroxyaldehydes that were reported to span a wider kinetic range of activity 
such as D-glyceraldehyde, D-erythrose, and D-ribose.[49, 94, 102] Resultant time curves for 
absorption changes (Figure 3.2b) clearly demonstrate a steady signal development and 
distinct activity within the acceptor series that correlates with known substrate quality 
determined by conventional assays. 
For a quantitative interpretation, time curves of absorbance data for D-glyceraldehyde as 
acceptor (Figure 3.2c) were converted into absolute concentration of HCO3- according to the 
calibration curve. Assuming initial rate conditions the slope of the resultant curve was used 
for calculating the specific activity of TKyst according to Formula 3.1. Thus, 1 U is defined as 
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the amount of enzyme required to produce 1 μmol of HCO3- from HPA per minute under the 
assay conditions.  
  
 slope×103μM/s×60s×200×10-6L 
specific activity U/mg = ────────────────────────        (Formula 3.1) 
                                                    amount of TK mg 
 
Variation of the amount of TKyst catalyst confirmed a linear relationship between activity and 
amount of enzyme (Figure 3.2d), which demonstrates that this method can be used for 
quantitative determination of the absolute and relative specific activity of different TK 
enzymes. The observable LOD and LOQ values[100, 101] are 2.5 mU and 7.5 mU, 
respectively.  
 
3.2.2. Determination of kinetic constants 
 
In order to evaluate the data quality resulting from the pH-dependent assay format, 
quantitative substrate kinetics were attempted to be determined using TKeco and TKyst for a 
comparison against published data available from conventional assay measurements. In 
addition to the HPA donor, known good acceptor substrates were included such as 
glycolaldehyde, D-glyceraldehyde, and D-erythrose, but omitted D-ribose because of its >1 M 
apparent KM value.[94] The kinetic constants were determined by varying the concentration 
of the individual substrate (LiHPA or aldehyde) while keeping all other parameters constant. 
The results are listed in Table 3.1. For HPA the KM value of 5.5 mM determined with TKeco is 
almost identical to the recently published value of 5.3 mM using the same acceptor 
component and an HPLC method,[103] but is at variance to a value of 18 mM determined 
photometrically by using a phosphorylated acceptor component.[94] The KM of 3.4 mM with 
TKyst is somewhat smaller than that of 7 mM measured with a phosphorylated acceptor.[104] 
Regarding the acceptor components, the glycolaldehyde KM value of 13.4 mM determined 
with TKeco exactly matches the published value (13.4 mM), while those for D,L-glyceraldehyde 
and D-erythrose are somewhat higher (57.3 mM vs. 10 mM, and 194 mM vs. 150 mM, 
respectively). Taking into account that most of the published data resulted from conventional 
assays using phosphorylated donor and acceptor components in coupled enzyme systems, it is 
believed that our pH-based method yields data that are sufficiently reliable for direct 
comparison but easier and more rapid to determine. The results summarized in Table 3.1 
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demonstrate that overall catalytic efficiency (kcat/KM) of the wild-type TK enzymes decreases 
about one order of magnitude upon increasing the acceptor chain length from C2 to C4 
(glycolaldehyde to D-erythrose). In particular, for glycolaldehyde TKeco shows significantly 
higher affinity and rate when compared to TKyst, but otherwise it appears that the kinetic 
values of both TKeco and TKyst for D-glyceraldehyde, D,L-glyceraldehyde, and D-erythrose are 
rather similar.  
Recently, Smith et al. have found that an active-site replacement D469E in TKeco causes an 
eight-fold higher activity than wild-type towards the non-hydroxylated substrate analog 
propanal with twofold improved stereoselectivity, while the variant H26Y leads to the 
enantiomeric product due to a reversal in the aldehyde attack.[105] For a broader kinetic 
comparison, these two enzyme variants TKD469E eco  and TK
H26Y 
eco  have been reconstructed and 
purified to be included in the comparison with wild-type activity. According to our kinetic 
analysis the TKD469E eco  variant has a KM value (1.3 mM) for HPA that is lower than that of its 
parent wild type, but since kcat is also much reduced the overall efficiency for the donor 
substrate conversion remains practically unchanged. However, the variant’s KM for 
glycolaldehyde, D-glyceraldehyde, D,L-glyceraldehyde and D-erythrose are higher than those 
of wild-type TKeco by a factor of about 2-3, and kcat values reduced by factors of 0.5-0.1, so 
that an overall reduction in catalytic efficiency results to 5-14% of the parent, which indicates 
that the enzyme variant has lost much of its catalytic capacity towards 2-hydroxyaldehydes as 
compared to its parent. Surprisingly, however, the TKH26Y eco variant showed much lower activity 
than wild-type against the entire panel of substrates, quite in contrast to the reported four-
fold higher activity for propanal with respect to wild-type TKeco.[105] DNA sequencing proved 
the genetic construct to be correct, which excludes that undesired amino acid exchanges had 
been introduced at any other location in the TK protein sequence. Currently, it is unable to 
present a conclusive explanation as to the discrepancy between the kinetic studies here and 
the reported assay results concerning the same TK enzyme variant. However, it may be 
notable that the alleged higher activity of the TKH26Y eco  variant stands in contrast to the inability 
of the authors to identify this mutant protein during earlier screenings of libraries made by 
site-specific saturation mutagenesis.[106] Due to the low specific activity of this variant 
kinetic values determined for most of the substrates were found to be rather low with large 
experimental error and thus had to be omitted from the subsequent comparison with other TK 
enzymes. 
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Table 3.1. Determination of kinetic constants for different TK enzymes 
 TKyst TKeco TKD469E eco  
 
KM 
(mM) 
kcat 
(s-1) 
kcat/KM 
(s-1·mM-1) 
KM 
(mM) 
kcat 
(s-1) 
kcat/KM 
(s-1·mM-1) 
KM 
(mM) 
kcat 
(s-1) 
kcat/KM 
(s-1·mM-1) 
LiHPA 3.4±0.3 28.4±0.6 8.27 5.5±0.5 33.2±0.8 6.02 1.3±0.2 9.2±0.2 6.85 
glycolaldehyde 20.5±2.5 29.2±1.5 1.43 13.4±2.0 34.2±1.7 2.56 43.2±2.7 16.1±0.5 0.37 
D-glyceraldehyde 39.9±2.4 24.2±0.7 0.61 47.8±3.8 31.8±1.3 0.67 152±16 7.9±0.6 0.05 
D,L-glyceraldehyde 44.6±4.1 10.8±0.5 0.24 57.3±5.5 11.3±0.6 0.20 114±14 2.3±0.2 0.02 
D-erythrose 214±17 39.2±2.0 0.18 194±33 38.4±4.0 0.20 230±35 2.3±0.2 0.01 
 
3.2.3. Determination of acceptor specificities 
 
Several authors have contributed to the determination of the substrate specificity of TK 
enzymes from different sources, and particularly the specific activities of wild type TKeco[94] 
and TKyst[104] towards various phosphorylated and unphosphorylated aldoses or aldehydes 
have been reported. Unfortunately, most data were obtained under very different reaction 
conditions using different assay methods, and therefore an absolute comparison is difficult or 
impossible. Thus, the new pH-based assay method has been used in an attempt to determine 
the catalytic capacities of TKyst, TKeco and variants TK
D469E 
eco and TK
H26Y 
eco in parallel under identical 
reaction conditions for direct comparison towards various acceptor aldehydes.  
The four different TK catalysts were tested against a larger variety of aldehydes as substrate 
analogs. The substrate library included aldehydes having a chain length from C1 to C6, with 
varying degree of hydroxylation. Among the 2-hydroxylated aldehydes, preference was given 
to those compounds bearing a (2R)-configuration to match the natural TK specificity. A test 
plate for a selected typical subset of experiments is shown in Figure 3.3, which clearly 
demonstrates the broad range of color intensity that developed during the reaction in 
individual wells, depending on the different kinds of acceptor substrates and TK catalysts. For 
good substrates, the bright red coloration indicates that practically complete reaction takes 
place in less than 30 min, while weak substrates require monitoring for longer time, e.g. up to 
a few hours, or use of larger enzyme quantity. The specific activity data corresponding to the 
quantitative evaluation for the entire substrate library is shown in Figure 3.4.  
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From a quantitative comparison of the specific data, it becomes apparent that the catalytic 
capabilities of wild-type TKeco and TKyst are quite similar with only very little variation. Both 
enzymes give highest rates for glycolaldehyde followed by D-glyceraldehyde, but TKeco shows 
about 20-40% higher activity, respectively, than TKyst. Aldehydes with shorter (methanal) or 
longer carbon backbones (equal or larger than tetroses) cause a parallel decrease in rates with 
both catalysts. Common sugars (pentoses, hexoses) yielded only low specific activities even at 
higher substrate concentration (200 mM instead of 50 mM), which is likely due to the 
minimal prevalence in solution of free aldehyde forms representing the true enzyme substrate.  
 
 
 
 
 
Figure 3.3. Reaction plates for TK assay. The assay solution contained 50 mM or 200 mM acceptor aldehyde, 4, 12 
or 20 µg TK, 2.4 mM ThDP, 9 mM MgCl2, 0.028 mM phenol red in 2 mM TEA buffer (pH 7.5). The reaction started 
after adding 50 mM LiHPA, total assay volume was 200 µL. Photographs were taken 30 min (left; good substrates) 
and 2 h (right; weak substrates) after reaction start, respectively. A. 50 mM methanal, B. 50 mM glycolaldehyde, C. 
50 mM D-glyceraldehyde, D. 50 mM D,L-glyceraldehyde, E. 50 mM D,L-2,4-dihydroxybutanal, F. 200 mM D-glucose, 
G. 200 mM propanal, H. 200 mM ethanal.  
 
 
 
 
 
 
 
 
 
Figure 3.4. Determination of TK acceptor specificity. The assay solution contained 50 mM or 200 mM acceptor, 4, 
12 or 32 µg TK, 2.4 mM ThDP, 9 mM MgCl2, 0.028 mM phenol red and 2 mM TEA (pH 7.5). The reaction started 
after adding 50 mM LiHPA, Total assay volume was 200 µL. The OD increase was measured at 560 nm by plate 
reader. 
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Wild-type TK enzymes have a strong preference for α-hydroxylated acceptors with strict 
stereoselectivity towards the (2R)-configuration, which is clearly revealed by the results for D-
glyceraldehyde versus racemic substrate. Using D,L-glyceraldehyde as an acceptor (at 
identical 50 mM concentration), both TKeco and TKyst show reduced activity, even smaller than 
50% as compared to pure D-glyceraldehyde. Notwithstanding the lower concentration of the 
reactive D-enantiomer, this result might illustrate that the L-configurated isomer is acting as 
an inhibitor of TK. On the other hand, stereoselectivity of TKeco and TKyst towards hydroxyl 
configuration at C3/C4 positions is much less distinct than at C2, which is evident by the 
relatively similar rates for D-erythrose versus L-threose, and by the relatively small rate 
variation within the series of pentoses (D-ribose, L-lyxose, D-xylose and L-arabinose). Deletion 
of acceptor hydroxylation causes a strong drop in activity for both TKeco and TKyst enzymes; 
relative to glycolaldehyde the aliphatic structural analogs ethanal (2-hydroxyl deletion) and 
propanal (replacement of 2-OH for methyl) react more slowly by factors of 12% and 3% (even 
at fourfold concentration), respectively. The loss in activity upon 2-deoxygenation cannot be 
recovered by hydroxylation at more distant positions such as present in 3-hydroxpropanal, 
(R)-3,4-dihydroxybutanal, 4-hydroxybutanal, or 2-deoxy-D-ribose which all show rather low 
activity with wild-type TK enzymes. 
For variant TKD469E eco , previously identified to accept propanal with eightfold higher activity than 
wild-type TK,[105] it consistently also shows significantly higher activities towards other 2-
deoxygenated aldehydes (ethanal, propanal, 3-hydroxy-propanal, and 4-hydroxybutanal) than 
the corresponding wild-type enzyme. Although 2-deoxy-D-ribose was better accepted than D-
ribose when compared to wild-type, interestingly the variant showed lower activity towards 
(R)-3,4-dihydroxybutanal and also for all aldehydes bearing a 2-hydroxylation, which 
indicates its relatively narrow substrate limitation. Unfortunately, the unexpectedly low 
specific activity of TKH26Y eco rendered a direct comparison with this variant impossible.  
The new assay format has allowed to rapidly recording a quantitative multi-substrate activity 
profile of closely related TKyst, TKeco, and TK
D469E 
eco variants. For a better visualization of their 
substrate scope, the relative specific activity data was processed to gray scale values according 
to the Reymond method[107] to draw a functional fingerprint map of the three enzyme 
variants for a graphical representation (Figure 3.5). The specific activity of TKeco towards 50 
mM glycolaldehyde was used as 100% reference value. The resulting map indeed readily 
illustrates the similarities and differences in the enzymes’ relative substrate specificities. Thus, 
it clearly indicates the high catalytic conformity of the wild-type TK enzymes, while variant  
TKD469E eco acts rather differently. This feature is remarkable as TKyst shows only 42.2% identity to 
TKeco in its protein sequence, whereas variant TK
D469E 
eco is 99.8% identical to TKeco, except for the 
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single amino acid substitution. The fingerprint also clearly reveals that beyond the functional 
similarity TKeco displays somewhat higher activities towards glycolaldehyde and D-
glyceraldehyde than TKyst, whereas TK
D469E 
eco should be a preferred catalyst towards methanal 
and, in particular, 2-deoxygenated aldehydes (ethanal, propanal, 3-hydroxpropanal, and 4-
hydroxybutanal).  
 
Table 3.2. Determination of TK acceptor specificity  
Acceptor  Conc. (mM) TKyst 
(U/mg) 
TKeco 
(U/mg) 
TKD469E eco
 
(U/mg) 
methanal 50 7.06±0.75 7.77±0.28 8.41±0.37 
glycolaldehyde 50 19.0±1.1 22.6±1.2 6.72±0.32 
ethanal 200 2.23±0.11 2.79±0.11 8.38±0.32 
D-glyceraldehyde  50 10.6±0.2 14.8±0.8 1.69±0.05 
D,L-glyceraldehyde 50 4.47±0.00 4.50±0.35 0.497±0.080 
3-hydroxypropanal 200 0.211±0.005 0.227±0.011 0.993±0.109 
propanal 200 0.503±0.093 0.370±0.020 4.90±0.16 
D-erythrose 50 5.47±0.33 5.08±0.58 0.393±0.080 
L-threose 50 6.12±0.18 6.84±0.32 1.21±0.06 
D,L-2,4-dihydroxybutanal 50 0.193±0.005 0.631±0.007 0.147±0.011 
(R)-3,4-dihydroxybutanal 200 1.02±0.07 0.867±0.060 0.353±0.001 
4-hydroxybutanal 200 0.034±0.001 0.019±0.004 0.543±0.045 
D-ribose 200 0.227±0.007 0.275±0.020 0.011±0.006 
L-lyxose 200 0.109±0.001 0.111±0.014 n.d.* 
D-xylose 200 0.060±0.013 0.068±0.008 n.d. 
L-arabinose 200 0.045±0.007 0.046±0.002 n.d. 
2-deoxy-D-ribose 200 0.007±0.002 n.d. 0.027±0.004 
D-allose 200 0.022±0.003 0.021±0.003 0.019±0.005 
D-gulose 200 0.112±0.010 0.086±0.006 0.022±0.003 
L-mannose 200 0.023±0.003 0.015±0.002 0.015±0.001 
D-glucose 200 0.009±0.001 0.005±0.001 0.011±0.006 
*n.d. = not detectable 
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Figure 3.5. Fingerprint comparison for TKyst, TKeco, and TKD469E eco . The relative specific activity data was converted to 
gray scale value.[107] The specific activity of TKeco towards 50 mM glycolaldehyde was used as 100% reference. A. 
50 mM methanal, B. 50 mM glycolaldehyde, C. 50 mM D-glyceraldehyde, D. 50 mM D,L-glyceraldehyde, E. 50 mM 
D-erythrose, F. 50 mM L-threose, G. 50 mM D,L-2,4-dihydroxybutanal, H. 200 mM D-ribose, I. 200 mM ethanal, J. 
200 mM 3-hydroxypropanal, K. 200 mM propanal, L. 200 mM (R)-3,4-dihydroxybutanal, M. 200 mM 4-
hydroxybutanal. 
 
Although the number of substrates included in the fingerprint analysis (considering factors 
such as chain length, hydroxylation pattern, and sense of chirality) and the number of 
enzymes available in this study are rather limited, it appears that this approach should prove 
a valuable tool to discriminate TK enzyme variants that might become available from various 
other sources or from experiments in directed evolution. While in this first attempt it has been 
only considered the influence of chirality inherent to the substrate, it is noted that the level of 
chiral induction at C3 in the product may further be indicated by color-coding for (R) or (S) 
configuration[107] once this is determined. 
 
3.3. Conclusion 
 
Using HPA as the donor component in TK reactions causes a defined pH increase, the rate of 
which has been shown to be directly proportional to the activity of TK. The proton 
consumption can be revealed in the presence of the pH indicator phenol red accurately with 
high specificity and sensitivity, which allows using this system for quantitative measurements 
covering a broad range of TK activity. TEA buffer at low 2 mM concentration proved sufficient 
to avoid an undesired pH interference of assay components.  
It has been demonstrated that this new assay format is applicable to the reliable 
determination of kinetic constants using three different kinds of TK, including wild-type and 
mutated protein variants. The method is also useful for a rapid quantitative multi-substrate 
screening to chart and distinguish the distinct acceptor specificities of enzyme variants, 
resulting in a functional fingerprint map of their substrate tolerance that readily illustrates the 
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similarities and differences in the enzymes’ relative specificities. This pH based assay should 
prove as a very useful tool in the screening of novel TK enzymes for their substrate tolerance 
and for their modification by directed evolution because of its simplicity, speed, high 
sensitivity, and low costs.  
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4. Directed Evolution of Thermostable Transketolase from Geobacillus 
stearothermophilus 
 
 
4.1. Introduction 
 
The TK from Geobacillus stearothermophilus (TKgst) is a novel thermostable enzyme which has 
been cloned and identified recently within a French collaboration.[65] This thermophilic TK 
shows impressive high activity and stability at elevated temperatures. It has revealed that it 
has an optimum temperature range around 60–70°C and retains almost 100% activity for one 
week at 50°C and for 3 days at 65°C, which allows carrying out an easy, one-step purification 
by simple heat shock treatment of crude cell extracts at 70°C. When comparing its 
performance under different temperatures, the reaction rate of TKgst with glycolaldehyde 
showed an 8–14 fold increase at 70°C compared to 20°C, and a four-fold higher activity at 
50°C when compared to TKeco under the same conditions. When tested at 50°C with other 
aldehyde acceptors, the TKgst activity was approximately 3 times higher than that observed at 
20°C.[65] 
High thermostability is a significant and useful feature for an enzyme to expand its potential 
for preparative applications and future biocatalyst development. Processes at elevated 
temperatures could offer opportunities to extended TK biocatalysis applications, improving 
substrate solubility of hydrophobic aldehyde acceptors and enzyme tolerance towards non-
conventional substrates. A number of applications of this new TKgst in biocatalysis have been 
performed with Li-HPA as donor and glycolaldehyde, D-glyceraldehyde and butyraldehyde as 
acceptors, from which the corresponding products L-erythrulose, D-xylulose and 1,3-
dihydroxyhexan-2-one were obtained, respectively, leading to identical chiral induction (3S-
configuration) of products for α-hydroxylated acceptors and improved ee values for products 
from non-hydroxylated substrates.[65] 
As a key enzyme involved in carboligation, TK has been proved as an efficient biocatalyst for 
carbon chain extension and introduction of a chiral hydroxylation site. Upon conversion of 
non-hydroxylated substrates, the TK catalytic reaction can form deoxyketose-type products, 
which are regarded as valuable intermediates for the pharmaceutical industry.[108] However, 
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as discussed in Chapter 3, in comparison with the α-hydroxylated substrates, non-α-
hydroxylated aldehydes cannot be well accepted by wild-type TK. TK’s specific activity 
towards non-α-hydroxylated substrates is usually about 40 folds lower than for the 
corresponding α-hydroxylated derivatives.[108] Probably, this is because remoral of the α-
hydroxy group reduces the hydrogen bonding contacts between TK and acceptors, leading to 
higher KM values, more freedom of substrate motion and lower activation of substrate in the 
TK’s active pocket, and consequently lower catalytic efficiency of TK. Thus, an improved 
structural adjustment at active site by mutagenesis may help to improve binding and 
activation of non-α-hydroxylated substrates. Recently, Hailes et al. have constructed single site 
saturation mutagenesis libraries on 10 structurally defined position in the active site and 10 
phylogenetic ones for TKeco to improve its acceptance towards non-phosphorylated 
substrates[58] and in particular for the non-α-hydroxylated propanal.[59] Among these 20 
mutation positions, D469 showed the highest plasticity in comparison with other ones. A 
change of Asp469 to Thr, Tyr, Ala and Glu gave 4.3 to 8 fold activity improvement towards 
propanal.[59] It should be mentioned that mutagenesis also modified —  occasionally 
enhanced or even reversed — TKeco’s stereoselectivity, especially providing mutant D469E 
with selectivity for 90% (S)-configuration and variant H26Y for 88% (R)-configuration.[61]  
TKgst has 50.2% identity with TKeco and almost an identical active site constitution. Because of 
its high thermostability and better stereoselective performance than TKeco, it seems plausible 
that TKgst and its potential descendents could become ideal biocatalysts for the synthesis of 
deoxyketose-type products. In this chapter, the structure of TKgst has been simulated and 
aligned with those of TKeco, TKyst and TKban by computational methods to analyze the 
contributions for substrate binding and catalysis. According to this structure alignment, two 
critical amino acid residues were then chosen for building single site and double site 
saturation mutagenesis libraries in the quest for improved TKgst activity towards non-α-
hydroxylated acceptors, as evaluated by using a pH-based high throughput screening method. 
 
1                                                                              80 
 TKeco    (1) ----------------MSSRKELANAIRALSMDAVQKAKSGHPGAPMGMADIAEVLWRDFLKHNPQNPSWADRDRFVLSN 
 TKyst    (1) ------------MAQFSDIDKLAVSTLRLLSVDQVESAQSGHPGAPLGLAPVAHVIFKQLRCN-PNNEHWINRDRFVLSN 
 TKban    (1) MYKTFTNISEGKNSMSHSIEQLSINTIRTLSIDAIEKANSGHPGMPMGAAPMAYTLWTQFMKHNPNNPTWFNRDRFVLSA 
 TKgst    (1) --------------MAHSIEELAITTIRTLSIDAIEKAKSGHPGMPMGAAPMAYTLWTKFMNHNPANPNWFNRDRFVLSA 
 
81                                                                            160 
 TKeco   (65) GHGSMLIYSLLHLTGYDLPMEELKNFRQLHSKTPGHPESGVTPLGVETTTGPLGQGIANAVGMAIAEKTLAAQFNRPGHD 
 TKyst   (68) GHSCALLYSMLHLLGYDYSIEDLRQFRQVNSRTPGHPEF-HSAG-VEITSGPLGQGISNAVGMAIAQANFAATYNEDGFP 
 TKban   (81) GHGSMLLYSLLHLSGYDVTMDDLKNFRQWGSKTPGHPEYGHTAG-VDATTGPLGQGIATAVGMAMAERHLAAKYNRDAYN 
 TKgst   (67) GHGSMLLYSLLHLSGYDVSMDDLKQFRQWGSKTPGHPEYGHTPG-VEATTGPLGQGIAMAVGMAMAERHLAATYNRDGFE 
 
161                                                                           240 
 TKeco  (145) IVDHYTYAFMGDGCMMEGISHEVCSLAGTLKLGKLIAFYDDNGISIDGHVEGWFTDDTAMRFEAYGWHVIRDIDG-HDAA 
 TKyst  (146) ISDSYTFAIVGDGCLQEGVSSETSSLAGHLQLGNLITFYDSNSISIDGKTSYSFDEDVLKRYEAYGWEVMEVDKGDDDME 
 TKban  (160) IVDHYTYAICGDGDLMEGVSAEASSLAAHLQLGRLVVLYDSNDISLDGDLNRSFSESVEDRYKAYGWQVIRVEDG-NDIE 
 TKgst  (146) IINHYTYAICGDGDLMEGVASEAASLAGHLKLGRLIVLYDSNDISLDGELNLSFSENVAQRFQAYGWQYLRVEDG-NNIE 
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241                                                                           320 
 TKeco  (224) SIKRAVEEARAVTDKPSLLMCKTIIGFGSPNKAGTHDSHGAPLGDAEIALTREQLGWKYAP-FEIPSEIYAQW--DAKEA 
 TKyst  (226) SISSALEKAKLSKDKPTIIKVTTTIGFGS-LQQGTAGVHGSALKADDVKQLKKRWGFDPNKSFVVPQEVYDYYKKTVVEP 
 TKban  (239) AIAKAIEEAKADEKRPTLIEVRTTIGFGSPNKSGKSASHGSPLGVEETKLTKEAYAWTAEQDFHVAEEVYENFRKTVQDV 
 TKgst  (225) EIAKALEEARADLSRPTLIEVKTTIGYGAPNKAGTSGVHGAPLGAQEAKLTKEAYRWTFAEDFYVPEEVYAHFRATVQEP 
 
321                                                                           400 
 TKeco  (301) GQAKESAWNEKFAAYAKAYPQEAAEFTRRMKGEMPSDFDAKAKEFIAKLQANPAKIASRKASQNAIEAFGPLLPEFLGGS 
 TKyst  (305) GQKLNEEWDRMFEEYKTKFPEKGKELQRRLNGELPEGWEKHLPKFTPD----DDALATRKTSQQVLTNMVQVLPELIGGS 
 TKban  (319) GETAQAEWNTMLGEYAQAYPELANELQAAMNGLLPEGWEQNLPTYELG-----SKAATRNSSGAVINAIAESVPSFFGGS 
 TKgst  (305) GAKKEAKWNEQLAAYEQAHPELAAQLKRAIEGKLPDGWEASLPVYEAG-----KSLATRSSSGEVINAIAKAVPQLFGGS 
 
401                                                                           480 
 TKeco  (381) ADLAPSNLTLWSGSK------AINEDAAGNYIHYGVREFGMTAIANGISLHGG-FLPYTSTFLMFVEYARNAVRMAALMK 
 TKyst  (381) ADLTPSNLTRWEGAVDFQPPITQLGNYAGRYIRYGVREHGMGAIMNGISAFGANYKPYGGTFLNFVSYAAGAVRLAALSG 
 TKban  (394) ADLAGSNKTYMNNEKD-----FTRDDYSGKNIWYGVREFAMGAAMNGIALHGG-LKTYGGTFFVFSDYLRPAIRLAALMQ 
 TKgst  (380) ADLASSNKTLIKGGGN-----FFPGSYEGRNVWFGVREFAMGAALNGMALHGG-LKVFGGTFFVFSDYLRPAIRLAALMG 
 
481                                                                           560 
 TKeco  (454) QRQVMVYTHDSIGLGEDGPTHQPVEQVASLRVTPNMSTWRPCDQVESAVAWKYGVERQDGPTALILSRQNLAQQE-RTEE 
 TKyst  (461) NPVIWVATHDSIGLGEDGPTHQPIETLAHLRAIPNMHVWRPADGNETSAAYYSAIKSGRTPSVVALSRQNLPQLE---HS 
 TKban  (468) LPVTYVFTHDSIAVGEDGPTHEPIEQLAALRAMPNVSVIRPADGNESVAAWRLALESTNKPTALVLTRQDLPTLEGAKDD 
 TKgst  (454) LPVIYVLTHDSIAVGEDGPTHEPIEQLASLRAMPNLSVIRPADANETAAAWRLALESTDKPTALVLTRQDVPTLAATAEL 
 
561                                                                           640 
 TKeco  (533) QLANIARGGYVLKDCAG-QPELIFIATGSEVELAVAAYEKLTAEG-VKARVVSMSSTDAFDKQDAAYRESVLPKAVTARV 
 TKyst  (538) SFEKALKGGYVIHDVEN--PDIILVSTGSEVSISIDAAKKLYDTKKIKARVVSLPDFYTFDRQSEEYRFSVLPDGVP-IM 
 TKban  (548) TYEKVAKGAYVVSASKKETADVILLATGSEVSLAVEAQKALAVDG-VDASVVSMPSMDRFEAQTAEYKESVLPKAVTKRF 
 TKgst  (534) AYEGVKKGAYVVSPAKNGAPEALLLATGSEVGLAVKAQEALAAEG-IHVSVISMPSWDRFEAQPKSYRDEVLPPAVTKRL 
 
641                                                                 710 
 TKeco  (611) AVEAGIADYWYKYVGLNGAIVGMTTFGESAPAELLFEEFGFTVDNVVAKAKELL---------------- 
 TKyst  (615) SFEVLATSSWGKYAHQS---FGLDEFGRSGKGPEIYKLFDFTADGVASRAEKTINYYKGKQLLSPMGRAF 
 TKban  (627) AIEMGATFGWHRYVGLEGDVLGIDTFGASAPGEKIMEEYGFTVENVVRKVKEML---------------- 
 TKgst  (613) AIEMGASLGWERYVGAEGDILAIDRFGASAPGEKIMAEYGFTVDNVVRRTKALLGK-------------- 
 
Sequence 4.1. Protein sequence alignment of TK from E. coli, S. cerevisiae, B. anthracis and G. stearothermophilus. 
Yellow: identical; blue: conservative; green: weakly similar. 
  
 
4.2. Results and discussion 
 
4.2.1. Sequence and structure analysis of TKgst 
 
TKgst has a highly similar protein sequence to TKs from E. coli, S. cerevisiae and B. anthracis, 
for which protein crystal structures have been determined.[51, 52, 109-112] Among them, 
TKgst and TKban have the highest similarity to each other due to the close genetic relationship 
between Geobacillus sp. and Bacillus sp.. Thus, the crystal structure of TKban was chosen as the 
template for the simulation of the 3D structure of TKgst. The computational simulation was 
created by using the SWISS-Model web tool,[113, 114] which also recommended TKban as an 
optimum template from alignment of protein sequence data and a PDB database search. The 
simulated 3D structure is shown in Figure 4.1a, from which one can appreciate its high 
similarity to that of TKban, and even TKeco and TKyst. Focusing on their active sites, all these 
four TKs share the same ‘boot’ shape active pocket structure (Figure 4.1b and 4.2). The “feet 
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space” in this “boot” is for the binding of the cofactor ThDP, which is surrounded by 11 amino 
acid residues (Ile249, His68, Gly116, Pro117, Leu118, Tyr441, Glu162, Gly158, Asp157, 
Gly156 and Asn187). The “bootleg” is constituted by nine amino acid residues (His462, 
Arg520, Asp470, His28, Gly264, His263, Leu192, Leu382 and Ser385), forming a channel for 
substrate entrance to the catalytic core. Therefore, the modification of the amino acid residue 
components forming the “bootleg” may change the TK’s acceptance towards acceptors. 
 
a)                                                                        b) 
 
 
 
 
 
 
 
Figure 4.1. Simulated structure of TKgst dimer. a) Overall structure of TKgst. b) The “boot” shaped active pocket of 
TKgst. E4P: D-erythrose 4-phosphate; ThDP: thiamine pyrophosphate. 
 
a)                                                                                      b) 
 
 
 
 
 
 
 
Figure 4.2. Active site alignment of TKgst with those of TKeco, TKyst and TKban. a) ThDP binding pocket. b) E4P 
binding pocket. Red: TKyst; Blue: TKeco; Yellow: TKban; Green: TKgst. E4P: D-erythrose 4-phosphate; ThDP: thiamine 
pyrophosphate. 
E4P 
ThDP
ThDP 
E4P 
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Figure 4.3. Model of acceptor binding pocket of TKgst, using E4P substrate conformation determined in TKyst. E4P: 
D-erythrose 4-phosphate. Residue numbering for TKgst. 
 
The earlier saturation mutagenesis study of TKeco towards non-α-hydroxylated acceptors had 
been performed by Hailes et al. with propanal as a typical substrate and using a colorimetric 
screening method.[59, 61, 115] This study was focused on both the ThDP binding and 
acceptor pockets. As a result of the screening, several positive mutants have been found on 
Asp469, Ala29, Asp259 and His26 positions, among which D469E was the top variant with an 
eight fold increased activity towards propanal as compared to the wild-type.[59, 61] D469 is 
the amino acid residue that directly contributes a hydrogen bond to the α-hydroxy group of an 
α-hydroxylated acceptor. The replacement of Asp469 by other amino acid residues with longer 
side chains such as Glu may narrow the acceptor access tunal, and further limit the mobility of 
bound substrates, and thus improve the catalytic efficiency with non-α-hydroxylated acceptors 
such as propanal (Figure 4.3). TKgst also has the equivalent Asp at position 470. Thus, it is 
considered that saturation mutagenesis on this position could produce similar results to those 
obtained by Hailes et al.. Therefore, Asp470 was chosen as one mutantion site.  
On the other hand, Leu382 is located at a position almost opposite to Asp470 (Figure 4.3). 
Although it seems to have no specific contribution to substrate binding and activation in the 
wild-type structure, modification of this position may complement an effect of Asp470 
mutagenesis. Furthermore, variation at the Leu382 position may also provide an opportunity 
for reversing TK’s enantioselectivity, for example to accept L-glyceraldehyde (which rescently 
has been ifentified to be an inhibitor to TKs[108]) and forming the products containing the 
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non-natural, reversed configuration. According to the above structure analysis, Asp470 and 
Leu382 were selected as the most plausible mutation positions for single and coupled site 
mutagenesis library construction.  
 
4.2.2.  Building of TKgst mutagenesis libraries 
 
Saturation mutagenesis is an efficient mutagenesis strategy based on the structure and 
interaction analysis between enzyme and substrate, which has been successfully used to 
improve the properties of an enzyme, including stability, substrate tolerance and 
stereoselectivity.[26] This method was also chosen here to construct three libraries to induce 
mutations on Leu382 or/and Asp470 sites, including individual two single-site libraries on 
each site and a double-site library corering both positions with NNS codon strategies. 
For the single-site libraries at each Asp470 and Leu382, the gene codons at the mutation site 
were designed as NNS in order to reduce the library size to 95 colonies, while maintaining a 
95% coverage of all 20 amino acids,[26] which would readily be compatible with a 96-well 
plate formate. For the coupled Asp470 and Leu382 double site library, there are two well-
known construction strategies. One is named ISM (Iterative Saturation Mutagenesis),[116] in 
which the most active mutants are identified at the Asp470 or Leu382 positions in a first 
round of screening, followed by raudomizing the second site and using the first positive 
mutants as templates. This is a relative simple but efficient method, which has the advantage 
of small library size, especially when a few mutant sites need to be induced. However, 
unfortunately potentially interesting mutants might be missed with this method, because one 
or more mutant sites are fixed at an early stage by certain residues in these libraries. This will 
limit the diversity of mutants, because it ignores that the enzyme property could be improved 
by a cooperative interaction between any two or more amino acid residues. The other strategy 
performs a saturation mutagenesis on both positions simultaneously using an NNS codon 
(Table 4.1) on both Leu382 and Asp470 sites, at least 3,066 colonies must be included in this 
library to achieve a statistical 95% coverage with 20 residues.[26] Although the total size of 
this library is much larger than that of a single site one, it is still feasible to handle the library 
on 31 96-well plates. Therefore, NNS degeneracy was also chosen for the construction of the 
double-site library.  
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Table 4.1. Codon degeneracy of saturation mutagenesis.[26] 
Codon 
degeneracy 
No. of 
codons 
No. of 
AA 
No. of 
stops 
AA encoded 
95% coverage for 2 
pos. 
95% coverage for 3 
pos. 
NNK/NNS 32 20 1 All 20 3066 98163 
DBK 18 12 0 ARCGILMFSTWV 969 17470 
NDK 12 12 0 RNDCGHILFSYV 430 5175 
NRT 8 8 0 RNDCGHSY 190 1532 
 
 
For the construction of these three libraries the commercial QuikChange method was used, 
which is an ideal one-step mutant induction strategy that does not require any ligation 
process (Figure 4.4).[117, 118] Two pairs of primers were designed including an NNS codon 
for single site libraries. The PCR was found to be a difficult step, in which the annealing 
temperature had to be optimized up to 68 or 72 °C instead of recommended 60 °C to achieve 
suffricient PCR amplification. In the standard QuikChange method, the DpnI treated PCR 
product is used directly to transform the expression host cells, followed by the screening on 
selection plates. Finally, the positive colonies are picked as library members, from which a few 
recombinants are chosen for sequencing to evaluate the degree of randomization of the 
mutations.[117, 118] However, the generated PCR products are self-annealing plasmids only 
with two remaining nicks because of the absence of ligase. Therefore, their transformation 
efficiency is much lower than that of the corresponding continuous ones, which may create an 
insufficient number of positive colonies on selection plates. On the other hand, choosing only 
a few random samples for evaluation of the diversity of a mutagenesis library may not 
factually reflect the statistical degree of true mutation randomness for the whole library. In 
addition, sequencing multiple samples is quite costly. 
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Figure 4.4. Principle of the QuikChange mutagenesis method. (Copied from the manual of the QickChange 
mutagenesis kit from Agilent, USA) 
 
In order to deal with these problems, the process after DpnI digestion was modified. The PCR 
product was transformed into competent XL1 cells followed by liquid cultivation in selection 
LB medium instead of spreading on plates. The mixture of cells was harvested after overnight 
cultivation and their internal plasmids were extracted as a mixture sample. Owing to the same 
transformation rate and change of each mutant, this mixed plasmid sample contained all the 
variants with the same proportion as produced during the mutagenic PCR. Thus, this sample 
was sent for sequencing to determine the base composition on each position. Figure 4.5 shows 
the obtained sequencing results. The original codon TTG (Leu382) and GAC (Asp470) have 
been successfully replaced by NNS, in which N was shown as A/T/G/C overlapping peaks and 
S as G/C overlapping peaks. Although the A/T/G/C peaks cannot be quantitatively compared 
between each position, their peak heights or peak areas have a quantitative relationship for 
the specific site. The highest peak indicates that its represented nucleotide residue dominates 
this position. Zheng et al also used this method to evaluate their improved mutagenesis 
method.[119] By calculating the heights of overlapping peaks, A/T/G/C were found to be 
present with a similar coverage of around 20-25% for N and G/C 50% for S, which are close 
to the ideal value of 25% and 50%. This result proved that the nucleotide residue randomness 
at the two mutated positions was excellent for library building. After this evaluation, the 
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Leu382
1 2 3 
Height % Area% Height % Area% Height % Area%
A 24 25 26 30 3 1 
C 20 19 22 15 33 37 
G 17 16 23 23 63 62 
T 39 40 30 32 1 0 
 
Asp470
1 2 3 
Height % Area% Height % Area% Height % Area%
A 22  18 42  41  1  0  
C 19  20 20  19  56  58 
G 28  27 25  26  38  36 
T 31  35 13  14  6  5  
 
Asp470
Leu382
plasmid mixture was transformed into competent BL21(DE3) cells. Because the plasmids had 
been repaired during the plasmid amplification, the efficiency of the second transformation 
was definitively sufficient for the single site library building on a single plate. Finally, 96 
colonies for each single site library were picked. 
a)                                    b)                                 c)                                  
 
 
 
 
 
 
 
Figure 4.5. Evaluation of single site libraries. a) PCR product identification by agar gel. Left for Lib-Leu382; right for 
Lib-Asp470. b) Sequencing results of the mixed plasmid samples. The original codon TTG (Leu382) and GAC (Asp470) 
have been successfully replaced by NNS, in which N was shown as A/T/G/C overlapping peaks and S as G/C 
overlapping peaks. c) Calculation of peak heights or peak areas from the sequencing results. 
 
The double site library construction was attempted in two ways. The first used the 
QuikChange Multi-mutagenesis Kit with a modified QuikChange method that uses two single 
primers for each mutation site and a thermophile ligase for the cyclization of single nucleotide 
chain. The second method performs independent single site mutagenesis sequentially to 
achieve the double site modification (Figure 4.6a). The former is easy to be operated and also 
timesaving. However, because the PCR products from each amplification round cannot be 
used as templates for the second round, very little PCR products can be obtained as compared 
to a normal PCR. Although the PCR conditions were optimized many times, probably because 
of the latter reason, PCR products could not be achieved in sufficient quantities for further 
steps. Thus, the second method was used to perform single site mutagenesis consecutively, in 
which the evaluated plasmid mixture from the first round of mutation was used as the 
template for the second round of PCR (Figure 4.6b). The evaluation of these two rounds of 
mutagenesis by DNA sequencing is presented in Figure 4.7. The nucleotide randomness at 
each mutation site was also excellent for library building. Finally, 3,456 colonies (36 plates) 
were chosen for the double site library. 
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a)                                                                 b) 
 
 
 
 
 
 
 
 
Figure 4.6. Principle of double site library construction. (Modified based on the copy from the manual of the 
QickChange mutagenesis kit from Agilent, USA) 
 
 
a)                            b)                                    c) 
 
 
 
 
 
 
 
 
Figure 4.7. Evaluation of double site library. a) PCR product identification by agar gel. b) Sequencing results of the 
mixed plasmid samples. The original codon TTG (Leu382) and GAC (Asp470) have been successfully replaced by NNS, 
in which N was shown as A/T/G/C overlapping peaks and S as G/C overlapping peaks. c) Calculation of peak heights 
or peak areas from the sequencing results. 
 
 
××
××
××××
××
××
Asp470 Leu382 
Leu382 
Asp470 
Leu382
1 2 3 
Height % Area% Height % Area% Height % Area%
A 26  26 30  32  0  0  
C 16  12 16  15  43  43 
G 22  25 27  27  50  52 
T 36  37 27  26  7  5  
 
Asp470
1 2 3 
Height % Area% Height % Area% Height % Area%
A 25  21 40  42  2  0  
C 22  22 19  18  58  63 
G 26  28 20  19  35  30 
T 26  29 20  21  6  6  
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4.2.3. Development of a high-throughput screening method for TK mutagenesis 
library 
 
Tetrazolium-based colorimetric[82] and HPLC assays[80] have been applied for the screening 
of TKeco mutagenesis libraries. However, the former can only be used for non-α-hydroxylated 
aldehyde acceptors, and both methods are rather laborious and time-consuming. Thus, the 
pH-based assay was further evaluated for its suitability for the high-throughput screening of 
TK libraries. Assays for HTS not only require small sample volume, high throughput, and 
robustness, but also adequate sensitivity, reproducibility, and accuracy in order to 
discriminate among a large number of substrates that span the entire range of activity.  
The culture and lysis methods were optimized for recombinant cells on 96-well plates, and 
adapted to the pH-based assay for the screening in microtiter plate format. For proof-of-
principle, only recombinant cells expressing wild-type TKyst and TKeco were used as samples, 
for which BL21(DE3) host cells served as “negative” control; background activity from the 
native TK gene of the host was deemed too low to interfere with the measurements. In view of 
the requirement for very low buffer concentration in the assay system, cell lysis had to be 
effected in the absence of high concentration of buffering components. For this purpose, a 
recently published method was adopted by using 1/10 BugBuster solution with inclusion of 
0.5 mg/mL lysozyme and 4 U/mL Benzonase endonuclease as the resuspension buffer.[89] By 
shaking at room temperature for 0.5-1 h, practically all E. coli host cells became disintegrated 
as judged by microscopic examination. A 40 μL sample of the supernatant was applied for 
activity measurement. Low concentrations of glycolaldehyde (5 mM for TKyst, 2.5 mM for 
TKeco) were chosen as a rate-limiting factor.  
For an evaluation and validation of high-throughput screening assays, Zhang et al. defined a 
screening window coefficient called Z-factor,[120] a dimensionless statistical parameter that 
is significant for both the assay signal dynamic range and the data variation associated with 
the signal measurements, which therefore is suitable for assay quality assessment. The assay 
method is judged to be excellent when 1.0 > Z ≥ 0.5 (an ideal method is characterized by a Z-
factor of 1). To evaluate our screening method, 48 parallel samples (one half of a 96-well 
plate) were used for each cell type to compare the differences within the same sample dataset 
as well as between that of the diverse recombinants, and calculated the Z-factor to assess the 
high-throughput application of our screening method as listed in Table 4.2. Soluble 
expression of TKyst in E. coli is compromised by formation of inclusion bodies and thus the 
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enzyme reaches a much lower soluble concentration level than attainable for TKeco, which is 
why its activity towards 5 mM glycolaldehyde (2.3 mU) in crude extracts already reaches the 
LOD of this method (2.5 mU). However, the Z-factor value (0.52) is still above 0.5, which 
demonstrates that the pH-based assay has enough precision for its use towards a high-
throughput purpose. In comparison, the application of the assay to the screening of TKeco 
variants at even lower substrate concentration is far superior.  
 
Table 4.2. Evaluation of pH-based screening method
 TKyst TKeco 
glycolaldehyde (mM) 5.0 2.5 
average activity (mU) 2.3 38.3 
relative standard deviation 14% 7% 
Z-factor 0.52 0.80 
 
 
4.2.4. Screening, identification and docking of positive TKgst variants towards 
propanal 
 
4.2.4.1. Screening of positive TKgst variants towards propanal 
 
The screening of TKgst mutagenesis libraries was carried out on 96-well plates with an 
optimized pH-based high throughput assay method, in which 40 μl lysate sample was used, 
and with the assistance of a multichannel pipetting work station, Biomek 2000 from Beckman 
(USA). The increasing OD560 during the initial 10 min was recorded by a Vmax plate reader 
and further converted into the absolute reaction rate to compare the activity discrepancy 
between each well. About 15% (192) top positive clones were picked into new plates for a 
second round of rescreening. Their plasmids were extracted for sequencing. Although the 
double site library includes the two single site libraries, the screening of two single site 
libraries was deemed appropriate to help in evaluating the assay method firstly because of 
their small size, and also to illuminate the particular effects of the individual single site 
mutation. The top 40 mutants from this second round of screening with propanal were finally 
collected for purification and independent activity identification.   
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4.2.4.2. Purification and activity identification of positive TKgst variants towards 
propanal, butanal and methoxyethanal, including their thermostability 
determination 
 
The recombinant TKgst mutants are His-tag labeled, so they can be easily purified by Ni- 
affinity chromatography. However, the simultaneous purification of 40 samples by affinity 
chromatography is not convenient to operate. The ultrafiltration for removing high imidazole 
concentrations for the pH assay is a time-consuming step. Fortunately, the TKgst has a high 
thermostability, and indeed a one-step heating method could be simply performed to obtain 
high purity TKgst samples.[65] Although any change of its protein sequence may enhance its 
flexibility under high temperatures and thus destabilize its structure, its high thermostability 
is expected to remain largely during the mutagenesis of TKgst. Therefore, the one-step heating 
method was also carried out for the purification of these 40 variants. Their protein 
concentration and purity were determined by the Bradford method and SDS-PAGE, 
respectively, followed by an activity determination towards propanal, butanal, 
methoxyethanal, and glycolaldehyde (Table 4.3). 
 
Table 4.3. Screening results for mutant libraries of TKgst* 
mutant position 
propanal butanal methoxyethanal  glycolaldehyde 
thermo- 
stability Leu382 Asp470 
AA codon AA codon 200 mg, U/mg 200 mM, U/mg 200 mM, U/mg 10 mM, U/mg Tm, °C 
Leu TTG Ile ATC 1.3 1.4 1.9 0.65 74 
Leu CTC Leu CTC 0.97 1.0 1.6 0.37 74 
Phe TTC Asp GAC 0.91 0.86 1.0 0.70 72 
Leu TTG Thr ACG 0.71 0.72 1.2 0.64 73 
Asn AAC Phe TTC 0.70 0.72 0.93 0.20 71 
Phe TTC Thr ACG 0.65 0.75 1.0 0.45 73 
Leu TTG Tyr TAC 0.61 0.67 0.74 0.19 75 
Glu GAG Ser TCG 0.58 0.63 0.66 0.17 72 
Leu TTG Glu GAG 0.55 0.54 0.79 0.24 73 
Ile ATC Val GTC 0.54 0.52 1.1 0.46 74 
Val GTC Leu CTG 0.53 0.52 0.70 0.35 74 
Asn AAC Trp TGG 0.44 0.52 0.65 0.25 70 
Leu TTG Ser TCG 0.44 0.43 0.56 0.24 72 
Asn AAC Val GTC 0.43 0.42 0.62 0.38 71 
Ala GCG Ile ATC 0.39 0.40 0.57 0.28 70 
Phe TTC Ser TCC 0.36 0.38 0.40 0.15 70 
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Phe TCC Asn AAC 0.34 0.39 0.58 0.48 71 
Phe TTC Pro CCG 0.33 0.36 0.45 0.21 71 
Leu TTG Glu GAG 0.31 0.30 0.33 0.09 71 
Leu TTG Trp TGG 0.31 0.30 0.38 0.14 69 
Ile ATC Leu CTG 0.28 0.30 0.31 0.07 70 
Ile ATC Glu GAG 0.28 0.25 0.28 0.25 71 
Asn AAC Ser TCC 0.27 0.30 0.37 0.10 71 
Met ATG Val GTC 0.27 0.28 0.46 0.10 69 
Gln CAG Ile ATC 0.26 0.30 0.45 0.14 69 
Asn AAC Ser TCC 0.23 0.23 0.20 0.06 69 
Ala GCC Val GTG 0.23 0.25 0.41 0.13 69 
Met ATG Leu TTG 0.23 0.24 0.35 0.13 69 
Phe TTC Val GTG 0.20 0.22 0.45 0.29 68 
Ile ATC Ser TCC 0.18 0.21 0.28 0.03 70 
Gly GGG Gly GGC 0.17 0.21 0.22 0.03 71 
Ser TCG Thr ACC 0.16 0.16 0.21 0.04 71 
Thr ACG Leu CTC 0.16 0.15 0.18 0.04 69 
Gln CAG Ser TCC 0.16 0.18 0.24 0.12 69 
Leu TTG Thr ACG 0.15 0.18 0.32 0.10 69 
Ser TCC Ser AGC 0.14 0.16 0.17 0.04 71 
Gly GGG Asp GAC 0.09 0.10 0.16 0.25 72 
Leu** TTG Asp GAC 0.08 0.11 0.22 0.41 71 
* Same amino acids are marked with same color. 
** The last line is for the wild-type TKgst. 
 
From the activity determination of all 40 variants towards propanal, it became apparent that 
the activity variation corresponding to mutation in Asp470 position was realized by similar 
exchanges as those that had been found in TKeco.  The exchanges D470E, D470T and D470W 
were also found in the top list of TKgst. Remarkably, however, besides them novel variants 
D470I, D470L and D470S were identified in the screening. All of them presented an up to 17 
fold higher activity than the wild-type. Mutation of the Leu382 position was found to be much 
more conservative and gave much less contribution to the activity improvement as compared 
to that of the Asp470 site. Only L382F showed a roughly 10 fold activity improvement. The 
double site library could offer almost all amino acid residue combinations at both positions of 
Leu382 and Asp470. The most notable combination is that when both sites contain non-polar 
residues, for example D470I, D470L, L382I/D470V, L382V/D470L and L382A/D470L (Figure 
4.8). In this case, the 382 and 470 residues can jointly form a hydrophobic pocket for binding 
the alkyl moiety of propanal (Figure 4.9). When either position is a polar residue, usually one 
of these two positions contains a residue with a large side group, for example Phe, Thr, Tyr 
and Pro, which probably can narrow the tunnel of the active site entrance and limit the 
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mobility of propanal during the carboligation reaction. Interestingly, no basic amino acid 
residues were found at either of these two positions in any positive variant.   
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8. Positive variants from the screening of the TKgst libraries against simple aliphatic aldehydes. 
 
 
 
 
 
 
 
 
 
Figure 4.9. Docking of propanal as substrate analog for TKD469I gst . Asp470Ile and Leu382 form a non-polar surface to 
bind the aliphatic chain of propanal with higher affinity. 
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The specific activity of the variants towards the related aliphatic substrates butanal and 
methoxyethanal was also determined. The top mutants showed similar activity towards 
butanal in comparison with that of propanal. The methoxy group has an electronwithdrawing 
effect, which enhaces the electrophilicity of the carbonyl group and makes it more reactive 
against a nucleophilic attack. Therefore, the activity of the variants towards methoxyethanal is 
universally higher than that obserred with propanal and butanal. Surprisingly, the top four 
variants even improved or retained their activity towards glycolaldehyde. That means that the 
α-hydoxy group of glycoladehyde might have a different binding position which does not 
affect the catalytic efficiency of TK. 
 
4.2.4.3. Thermostability determination of positive TKgst variants  
 
The positive variants found in the screening of TKgst libraries were expected to have a 
somewhat modified thermostability relative to the wild-type. To evaluate the effect of the 
individual mutagenesis events on the overall protein stability, the thermostability of all 40 
variants were determined by a thermofluor-based high-throughput method,[121, 122] in 
which the hydrophobic fluoroprobe SYPRO orange is used as dye. During the denaturation of 
the protein at high temperature, its hydrophobic interior will become exposed to the probe in 
an aqueous solution, leading to a sharp decrease in quenching of the dye, so that a readily 
detected fluorescence emission can be studied in a RT-PCR experiment as a function of 
temperature.[122] This thermofluor-based assay showed that interestingly all of the positive 
variants indeed had an increased Tm compared to the wild-type, and none of them had 
significantly lost the high thermostability. The melting temperature of the top hit reached 
74 °C. 
 
4.3. Conclusion 
 
In this chapter, the saturation mutagenesis libraries of the thermostable TKgst at Leu382 and 
Asp470 have been constituted in a first attempt to improve its activity towards non-α-
hydroxylated aldehydes. Leu382 and Asp470 are the corresponding residues for binding the 
hydroxymethylene group of α-hydroxylated aldehydes. The mutation of these two positions 
contained several positive variants from both single-site libraries and the double-site library. 
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D469I was identified as the top mutant with 17, 13 and 8.6 fold activity improvement 
towards propanal, butanal and methoxyethanal, respectively, in comparison to the wild-type, 
but still keeps high thermostability with a Tm of 74 °C.     
  
 Seite 44 
  
   Seite 45 
 
 
 
 
 
 
 
 
Part II. Chemoenzymatic Synthesis of neo-Sialoconjugates 
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5. Introduction for Part II 
 
 
Carbohydrates not only serve as intermediates in storing and generating energy, but also as 
signaling effectors, recognition markers, and structural components in vivo.[35] They are 
abundant on the surface of cells in the form of glycoproteins, glycolipids or free glycans, 
involved in the interaction between cells, and cells and proteins. Therefore, the biosynthesis 
and functions of glycoconjugates are studied with increasing attention because of their 
growing role in medicine and biotechnology.[35] In particular, sialic acids and 
sialoconjugates are a type of saccharides that play a key role in glycobiology.   
 
5.1. Sialic acids and sialoconjugates 
 
Sialic acids are a family of mostly 9-carbon sugars containing more than 50 natural members, 
which occur broadly in eucaryotes and prokaryotes, as well as in some viruses.[123] The 
parent sialic acid is neuraminic acid (Neu),[124] in which C4, C5, C7, C8 and C9 positions 
can be substituted or modified by hydroxyl, acetyl, amino, glycolyl, acetimidoyl, or even 
phosphate and sulfate groups (Scheme 5.1a).[35, 123] Therefore, the structures of sialic acids 
show quite high diversity. Among them, N-acetylneuraminic acid (Neu5Ac), N-
glycolylneuraminic acid (Neu5Gc) and deaminoneuraminic acid (Kdn) are the most abundant 
sialic acid in higher organisms (Scheme 5.1b).[124] Besides, some related nonulosonic acids, 
such as legionaminic acid and pseudaminic acid, are also common in bacteria.[124] (Scheme 
5.1c) 
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Scheme 5.1. Typical structures of sialic acid. a) Natural occurrence of modified sialic acid.[35] b) Structures of most 
common sialic acids: Neu5Ac, Neu5Gc and Kdn. C) Structures of bacterial sialic acids: legionaminic acid and 
pseudaminic acid. 
 
Sialic acids are mainly present at the terminus of the free or buoconjugates glycan of 
glycosphingolipids and glycoproteins on the surface of cells, where they are involved in very 
important biological functions by their interation with different Sia-recognizing proteins in 
cellular adhesion and recognition, blood components and clotting, immunology and infection, 
transmission of nerve impulses, hormonal regulation, and many more.[123] Bacteria, 
especially pathogenic bacteria, also produce sialylated lipooligosaccharides or capsular 
polysaccharides to make against the immune response pathway of their host.[124] Therefore, 
both eukaryotes and prokaryotes process their own metabolism pathway to sialic acids. 
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Figure 5.1. Structure model of glycans on the cell surface. (Copied from ref. [125]) 
 
The diversity of natural sialic acid linkages and sialylated glycans is also abundant. The sialyl-
associated monosaccharides are commonly galactose (Gal), N-acetylgalactosamine (GalNAc), 
N-acetylglucosamine (GlcNAc) and also sialic acid.[123] Sialic acids can be transferred to the 
Gal moiety with α-2,3-, 2,4- and 2,6-linkage, to a GalNAc moiety with α-2,6-linkage, to a 
GlcNAc moiety with α-2,4- and 2,6-linkage, and to a sialic acid moiety with α-2,8- and 2,9-
linkage, even forming polysialic acids.[123] Notably, Sialyl LewisX (SLX, Siaα2-3Galβ1-
4(Fucα1-3)GlcNAcβOR) is an important sialylated epitope involved in inflammation and 
cancer metastasis.[123] The structure change of sialylated glycans is related to many 
physiological responses. For example, the shorter O-linked GalNAc and βGal-(1-3)-αGalNAc 
epitope is often aberrantly highly produced on the surface of cancer cells and are capped by 
sialic acid residues, while can be utilized for tumor typing in diagnostics.[126-128] Owing to 
these important roles of sialic acid in the cellular activity, the systematic study of the structure 
of sialosides and corresponding cellular responses have a significant value for the 
understanding of the mechanism of carbohydrate-protein interactions in physiological events 
for diagnostic and therapeutic targets. Therefore, it is of high importance to be able to 
synthesize uniform sialoconjugates in vitro for research on sialic acid in glycobiology and for 
medicinal purposes.  
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Scheme 5.2. Structures of Sialyl LewisX and Sialyl T/Tn antigen.  
 
5.2. Biosynthetic metabolism of sialic acid and sialosides in vivo 
 
Although sialic acids are partly shared by eukaryotes and prokaryotes, the biosynthesis of 
sialic acid in eukaryotes and bacteria is quite different because of the difference of cell 
structure and metabolism. In eukaryotes, the biosynthesis of sialic acid starts from UDP-
GlcNAc. A bifunctional hydrolyzing UDP-GlcNAc 2-epimerase/ManNAc-6-kinase (GNE) 
converts UDP-GlcNAc to ManNAc, followed by the phosphorylation of ManNAc to give 
ManNAc-6-P. ManNAc-6-P is then converted to Neu5Ac-9-phosphate by Neu5Ac-9-phosphate 
synthase (NANS) and dephosphorylated by Neu5Ac-9-phosphate phosphatase (NANP).[129] 
Correspondingly, in some bacterial pathogens, UDP-GlcNAc is converted to ManNAc by 
hydrolyzing UDP-GlcNAc 2-epimerase (NeuC). However, in the following step, ManNAc is 
used directly by Neu5Ac synthase (NeuS) to form Neu5Ac in the presence of 
phosphoenolpyruvate (PEP). Moreover, some bacteria can also scavenge sialic acid from host 
sialosides or utilize free sialic acids directly from their host.[129] In both eukaryotes and 
bacteria, the CMP-activation of sialic acid is catalyzed by CMP-Neu5Ac synthetase (CSS). The 
CMP-activated sialic acid can be accepted by sialyltransferase (SiaT), which transfers the sialic 
acid moiety to the Gal, GalNAc, GlcNAc or sialic acid terminus of glycans.  
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Scheme 5.3. Biosynthetic pathway of sialic acid (a) in eukaryotes and (b) in prokaryotes. GNE: hydrolyzing UDP-
GlcNAc 2-epimerase/ManNAc-6-kinase, NANS: Neu5Ac-9-P synthetase, NANP: Neu5Ac-9-P phosphatase, CSS: CMP-
sialic acid synthetase, SiaT: sialyltransferase, NeuC hydrolyzing UDP-GlcNAc 2-epimerase, NeuS: sialic acid synthase, 
NeuA: sialic acid aldolase. 
 
5.3. Chemoenzymatic synthetic route of sialic acid and sialoconjugates in vitro 
 
The synthetic pathway of sialosides in vitro begins with Man(NAc) or its chemically 
synthesized derivatives. In the presence of pyruvate, sialic acid aldolase catalyzes the 
reversible condensation of Man(NAc) and pyruvate producing the corresponding sialic acids. 
Because the chemical modification of Man(NAc) can be relative easily induced, a multitude of 
sialic acid derivatives can be obtained by this approach, whereby the natural sialic acids and 
their derivatives carrying with modifications at the C5, C7, C8 and C9 positions have been 
successfully synthesized.[130-137] 
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Scheme 5.4. Enzymatic synthesis of sialosides in vitro. NeuA: sialic acid aldolase, CSS: CMP-sialic acid synthetase, SiaT: 
sialyltransferase. 
 
Due to the difficulty of chemical sialylation,[124] enzymatical methods are mostly applied for 
the CMP-activation and sialylaction of glycans, respectively. The activation step is catalyzed 
by CMP-sialic acid synthetase (CSS, E.C. 2.7.7.43), which uses CTP as nucleotide donor and 
Mg2+ as cofactor.[138] Besides animals, CSS can also be found in many microorganisms, 
especially in the pathogenic ones, such as Clostridium thermocellum, Streptococcus agalactiae, 
Escherichia coli, Haemophilus ducreyi, Mannheimia haemolytica, Pasteurella haemolytica, 
Neisseria meningitides,[139] and newly found CSS from Pasteurella multocida.[140] The CSS 
from Neisseria meningitidis (CSSnme) is a typical enzyme which has been cloned[141], 
crystalized for structure determination and investigated for synthetic applications.[142] Its 
kinetic constants have been well determined by a pH-based assay method and interpreted by 
the acceptor binding alignment with CSS from Mus musculus (CSSmmu).[143] CSSnme has a 
relative broad acceptor tolerance towards 5’, 7’, 8’ and 9’ modified sialic acids.[141, 143] A 
series of Neu5Ac analogues with the modification on the acylamino group could be accepted 
by CSSnme, though their corresponding kcat/KM values were much lower than that of 
Neu5Ac.[143]   
Sialyltransferase (SiaT) catalyzes the transfer of CMP-activated sialic acid to a suitable 
terminal glycan moiety. Eukaryote species normally have multiple SiaTs. However, 
mammalian enzymes normally cannot be well expressed in prokaryotic expression systems, 
which limits their applications for the synthesis in vitro. Bacterial SiaT are often found in 
pathogenic bacteria, and most enzymes can be expressed in soluble form in an E. coli 
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expression system. Thus, these have been developed as efficient tools for sialoside synthesis. 
According to their target glycosidic bond types, bacterial SiaTs are mainly classified into α/β-
galactoside α-2,3-sialyltransferase (2,3SiaT, E.C. 2.4.99.4) and β-galactoside α-2,6-
sialyltransferase (2,6SiaT, E.C. 2.4.99.1). Up to the present, several bacterial SiaTs have been 
cloned from Campylobacter jejuni, Pasteurella multocida, Haemophilus sp., Neisseria sp., 
Photobacterium sp., and Vibrio sp., which are classified in the CAZy families 42, 52 and 80, 
respectively.[129] Some of them also seem to have sialidase and trans-sialidase activites.[144]  
The substrate specificities of some bacterial SiaTs have been determined either by employing 
radioactive [145] or fluorescent labeled CMP-Neu5Ac [146], or by direct analysis for formed 
product by HPLC.[147] Bacterial 2,3SiaT can accept both α- and β-galactosides, but 
apparently the 2,6SiaT can only transfer to β-galactosides. From the crystal structure 
determination of marine bacterial SiaTs, the active sites of 2,3SiaTpph and 2,6SiaTpsp have 
been identified, as well as their catalytic mechanism. [148-150] The synthesis of sialosides 
can be carried out as a one-pot multi-enzyme process, as demonstrated by a series of 
acceptors including galactosides, lactosides, and LacNAc, as well as Lex, T- and Tn-antigens, 
and oligosaccharide chains.[129] 
 
Table 5.1. Bacterial sialyltransferases characterized so far. 
SiaT resource  activity CAZy family ref. 
CstI Campylobacter jejuni  2,3SiaT 42 [151] 
CstII Campylobacter jejuni 2,3/8SiaT 42 [151] 
CstIII Campylobacter jejuni 2,3SiaT 42 [151] 
Lic3B Haemophilus influenzae 2,3/8SiaT 42 [152] 
LsgB Haemophilus influenzae 2,3SiaT 52 [153] 
HD2,3ST Haemophilus ducreyi 2,3SiaT 80 [154] 
Lst Neisseria meningtitidis 2,3/6SiaT 52 [155] 
Lst Neisseria gonorrhoeae 2,3/6SiaT 52 [155] 
PmST1 Pasteurella multocida 2,3/6SiaT 80 [147] 
PmST2 Pasteurella multocida 2,3SiaT 52 [156] 
PmST3 Pasteurella multocida 2,3SiaT 42 [157] 
Bst Photobacterium damselae 2,6SiaT 80 [145, 158]
 Seite 54 
Plst6 Photobacterium leiognathi JT-SHIZ-119 2,6SiaT 80 [159] 
Plst6 Photobacterium leiognathi JT-SHIZ-145 2,6SiaT 80 [160] 
PpST Photobacterium phosphoreum  2,3SiaT 80 [161] 
Pst3-224 Photobacterium sp. JT-ISH-224 2,3SiaT 80 [162] 
Pst6-224 Photobacterium sp. JT-ISH-224 2,6SiaT 80 [162] 
2,3ST Vibrio sp. JT-FAJ-16 2,3SiaT 80 [163] 
 
 
5.4. Sialoside-based carbohydrate microarray and dendrimers 
 
Due to the complex structure and multi-biofunction of oligosaccharides, the glycan and its 
acceptors become important targets for understanding many cell physiologies (e.g. cell 
adhesion, recognition, signaling, and pathogen infection), as well as developing novel 
medicines. The chemoenzymatic synthesis of sialoconjugates in vitro can help for the study of 
the immobilization of multi-structural carbohydrates on a chip surface. The presence of sialic 
acids in the form of microarray is a high-throughput technology for the rapid analysis of the 
binding properties of a variety of binding partners including antibodies, pathogens and 
cells.[164] Using several chemical immobilization methods, diverse sialic acids or their 
derivatives have been displayed as conjugates on the Gal moiety of glycan acceptors for the 
screening of SiaT epitope specificities,[165] identification of high affinity Siglec ligands,[166] 
revealing novel interactions of modified sialic acids with proteins and viruses,[167, 168] and 
analysis of biointerfaces for protein binding. 
In biological systems, multivalency is a valuable strategy to enhance the affinity and 
specificity of ligand-receptor interactions.[169] The synthesis of multiple ligand clusters, for 
example in form of dendrimers, can simulate the multivalency affinity, which is helpful for the 
study of biospecific recognition, inhibition and targeting.[170] Recently, in our group, a 
“clickable” hybrid nanocluster with cubic symmetry has been synthesized.[169] Owing to its 
multi-tentacle structure in three-dimensions, it could be an excellent scaffold for sialoside-
based dendrimer synthesis. To achieve this aim, the enzymatic synthesis of sialoconjugates 
needs to be optimized firstly. 
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5.5. Specific aim 
 
• The activity determination of SiaT is usually based on analysis of radioactive[145] or 
fluorescent labeled probes[146], or by HPLC separation for determining the quantity of 
formed product,[147] which are all tedious and non-continuous assays. Therefore, a simple 
sensitive and simple continuous method was highly desirable to be developed for the 
measurement of kinetic constants and mutagenesis library screening. 
• CSS has low activity towards structurally sererely modified sialic acids. Moreover, 
2,6SiaT cannot well accept α-galactosides. The newly developed screening method should be 
instrumental for protein engineering by random mutagenesis in order to extend their 
substrate range. 
• Besides natural sialic acids, the non-natural analogs with modifications at C5, C7, C8 
and C9 could be linked to a fluorescent lactose with an α-2,6-linkage.[171] The same typical 
sialic acids or other derivatives should also be transferred to the same fluorescent Lac with an 
α-2,3-linkage by 2,3SiaT, or to a fluorescent LacNAc acceptor with α-2,6-linkage by 2,6SiaT. 
• Many potential SiaT sequences can be found from the genome sequence information 
in the Genbank database using homology search. With this method, novel bacterial SiaTs 
should be cloned and identified by genetic engineering.    
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6. Chemoenzymatic Synthesis of N-Acetyl-D-lactosamine Precursors 
 
 
6.1. Introduction 
 
N-Acetyl-D-lactosamine (LacNAc) exists broadly at the termini of oligosaccharides, such as 
present in N- and O-linked glycoproteins and glycolipids that are found in Nature on the cell 
surface. Additionally, the galactosyl (Gal) and N-acetyl-glucosamine (GlcNAc) moieties can be 
modified forming diverse carbohydrate post-glycosylation modifications (PGMs).[172] In 
many organisms, a LacNAc moiety performs the role as an acceptor for sialylation.[123] 
Sialyltransferases transfer the CMP activated sialic acids (CMP-sialic acid) to a LacNAc or 
lactose (Lac) terminus of oligosaccharides producing α-2,3- or 2,6-sialoconjugates.[123] 
Therefore, the synthesis of LacNAc precursors is of high importance to study their enzymatic 
properties of SiaTs, especially the substrate specificity.  
The enzymatic synthesis of LacNAc in vitro is catalyzed by β-1,4-galactosyltransferase (E.C. 
2.4.1.22, GalT), which transfers an UDP activated galactose (UDP-Gal) to the GlcNAc moiety, 
forming a β-1,4-glycosidic bond, (Scheme 6.1) in analogy to the natural synthesis pathway of 
LacNAc in vivo.[173] GalT is present broadly in mammalian organisms. However, the activity 
of mammalian GalT requires α-lactalbumin for Glc based acceptors,[174] which is 
inconvenient for the synthesis of LacNAc and Lac precursors. Also, mammalian GalTs cannot 
be well expressed in soluble form in recombinant bacteria even after removal of their 
membrane insertion segments.[175] On the other hand, soluble bacterial GalT can be 
expressed well in E. coli and can perform the reaction without α-lactalbumin activation, which 
therefore becomes the ideal biocatalyst for the galactosylation in vitro. Up to now, several 
useful bacterial GalTs have been found in Neisseria meningitides (GalTnme)[175, 176], Neisseria 
gonorrhoeae (GalTngo)[176] and Helicobacter pylori (GalThpy)[176, 177], and the GalTs from 
these three organisms have been successfully cloned and expressed in E. coli.[175-178]     
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Scheme 6.1.  Enzymatic synthesis pathway for N-Acetyl-D-lactosamine and its derivatives 
 
GalT from Neisseria sp. accommodates a broad substrate range. It can accept not only natural 
Glc, GlcNAc and Fuc-1,3-GlcNAc as Gal acceptors to produce large-scale LacNAc and Lewisx 
tetrasaccharides, but also unnatural Glc and GlcNAc moieties carrying modification at C1, C2 
and C6.[179-184] GalT from Helicobacter pylori (GalThpy) has been shown to have only 3×10-4 
lower activity towards Glc than that towards GlcNAc.[177] It also is unable to accept any Glc 
derivatives and even GlcNAc with α-anomeric conjugation.[184] However, Namdjou et al. also 
reported that GalThpy has some activity towards 4-nitrophenyl labeled Glc (pNP-Glc),[185] 
and can also accept 4-nitrophenyl labeled mannose (pNP-Man) with very low activity.[185] 
Therefore, GalThpy has been used for thioglycoside and poly-LacNAc synthesis.[185, 186] 
UDP-Gal is essential for galactosyltransferation as the only acceptable donor for GalT. 
However, UDP-Gal is too expensive to be used for large scale synthesis (€473.5/100mg, 
Sigma-Aldrich, 2012). To deal with this problem, a practicable solution is using UDP-galactose 
4-epimerase (E.C. 5.1.3.2, GalE) to transform UDP-glucose (UDP-Glc) into UDP-Gal, because 
UDP-Glc (€71.8/100mg, Sigma-Aldrich, 2012) is much cheaper than UDP-Gal. Thus, this 
could be a relative economical pathway for LacNAc synthesis (Figure 6.1). The GalE enzyme 
from E. coli (GalEeco) has been cloned.[187] It can be added to the synthesis reaction as 
coupled enzyme or even in combination with UTP-glucose-1-phosphate uridylyltransferase 
(EC 2.7.7.9, GalU) for UDP-Glc preparation,[184] but also was expressed as fusion 
protein[188] or coexpressed with GalT for whole cell catalysis.[180-182, 189]  
As natural acceptor for sialyltransferases, LacNAc precursors have significant research value 
for the synthsis of neo-sialoconjugates in vitro. In this chapter, GalThpy and GalEeco have been 
cloned and expressed in E. coli, followed by the chemoenzymatic preparation of LacNAc and 
the fluorophore-labeled LacNAc and Lac precursors for a further synthesis of neo-
sialoconjugates. 
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6.2. Results and discussion 
 
6.2.1. Cloning, expression and characterization of β-1,4-galactosyltransferase from 
Helicobacter pylori 
 
The gene of β-1,4-galactosyltransferase from Helicobacter pylori (GalThpy) and cloning work 
have been reported.[177, 190] The amino acid sequence of GalThpy consists of 274 residuces 
with molecular mass of 31 kDa, but the enzyme has no significant similarity to the GalT from 
Neisseria sp. which have been researched widely.[177] Due to the pathogenicity of 
Helicobacter pylori, it was decided to use an artificial gene of GalThpy for its cloning in this 
work. The gene of GalThpy was synthesized commercially and cloned into Tuner BL21 host 
cells using the pET19b vector for protein over-expression (Figure 6.1a). The recombinant 
protein expression was induced by 0.1 mM IPTG at 28 Ԩ overnight. The SDS-PAGE analysis 
displaying the expression level is shown in Figure 6.1b. It seems that in the crude cell extract 
all of recombinant GalThpy existed in the pellet. To improve the soluble expression level, the 
culture conditions including growth temperature (25Ԩ-37Ԩ), OD600 for induction value (0.3-
1.0) and concentration of IPTG (0.01-1 mM) were optimized, but no significant improvement 
could be observed. However, fortunately, quite strong GalT activity could be found both in the 
crude extract and supernatant of the recombinant cells (Figure 6.1c), even if GalThpy could 
hardly be detected in SDS-PAGE gels.  
a)                                                                          b)                                       c) 
 
 
 
 
 
Figure 6.1. Cloning, expression and activity determination of GalT from Helicobacter pylori. a) Plasmid map of the 
expression plamid pET19b-GalThpy. b) Expression level of the recombinant GalThpy displayed by SDS-PAGE. 1: 
Supernatant of crude cell extract. 2: Crude cell extract. 3: Marker c) Activity determination of GalThpy by 
fluorescence labeled acceptor (Glc-D-T-P-Acr, see structure in scheme 6.2). The reaction was carried out in 100 µl 
scale with 20 mM Tris-HCl (pH 7.5) and 5 mM MnCl2. The reaction system contains 3 mM Glc-D-T-P-Acr, 5 mM UDP-
Gal and 50 µl enzyme sample.1: Fluorescence labeled acceptor Glc-D-T-P-Acr. 2: Supernatant of crude cell extract. 3: 
Crude cell extract. 
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The low soluble expression of the protein of interest in the E. coli system is mainly caused by 
two reasons. One is that the over-expressed protein cannot be folded in a correct way during 
its expression, and consequently most of the expressed protein agglomerates in the form of 
inclusion bodies. The other reason may be due to a hydrophobic trans-membrane anchoring 
of the recombinant protein, which causes this kind of protein to coprecipitate with the 
membrane fragments during the cell lysis. Similar difficulty in the GalThpy’s soluble expression 
was also reported in the literature.[177, 184, 190] Lau et al. tried to express GalThpy as a 
fusion protein with an N-terminal maltose binding protein (MBP)-tag and C-His6-tag.[184] In 
this work, two alternative ways, chaperone co-expression and gene modification, were used 
for its expression optimization.   
In vivo, the protein folding has been shown to be an energy-dependent process mediated by 
molecular chaperones and foldases.[191] The former binds partially folded proteins and 
maintains them in a soluble or translocation-competent conformation, while the latter can 
accelerate the rate-limiting steps along the folding pathway, for example the isomerization of 
peptidyl-prolyl bonds and the formation and reshuffling of disulfide bridges.[191] As useful 
tools for protein expression, the chaperonins DnaK-DnaJ-GrpE, GroEL-GroES and Tf in E. coli 
have been well identified and successfully applied for heterologous protein expression, 
promoting the soluble expression level observably.[192, 193] Therefore, in order to improve 
the soluble expression level of GalThpy in E. coli cells, it was coexpressed with the chaperonins 
GroEL-GroES and DnaK-DnaJ-GrpE, respectively. All of these chaperones have a high 
expression level in E. coli. Unfortunately, no significantly increased soluble expression of 
recombinant GalThpy was found in SDS-PAGE gel (Figure 6.2). 
 
      a)                                                                   b) 
 
 
 
 
 
 
Figure 6.2. Coexpression of GalT from Helicobacter pylori  with chaperonins a) GroEL-GroES b) DnaK-DnaJ-GrpE. 1: 
Crude cell extract. 2: Supernatant of crude cell extract. 3: Marker. 
GalThpy------- GalThpy-------
1       2       3                                                   1      2     3 
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The failing of the chaperone co-expression but nevertheless high GalT activity identified both 
in supernatant and pellet of the recombinant cell lysate indicated that GalThpy might be a 
membrane protein. To analyze whether GalThpy contains a transmembrane fragment, the 
protein sequence of GalThpy was aligned to that of fucosyltransferase from Helicobacter pylori 
(FucThpy), for which it has been verified that it carries a transmembrane fragment at the C-
terminus.[194] The alignment result for these two protein sequences is shown in Sequence 
6.1. The transmembrane fragment of proteins has a typical characteristic: Lys and Arg are 
repeated with a fixed interval that can fold into a putative amphipathic α-helix structure in the 
protein’s tertiary structure which functions as a membrane anchor. In the FucT case, the 
deletion of its transmembrane fragment increased both expression level and solubility of 
FucThpy, without significant loss of the activity.[194, 195] At the C-terminus, GalThpy also 
contains a relatively high percentage of Lys and Arg. Thus, this 27 residues transmembrane-
like fragment of GalThpy was deleted to improve the solubility of GalThpy in E. coli. To avoid a 
negative influence of the His-tag, two different pET vectors (pET19b and pET21a) were used 
for the cloning, which add His-tag on either the C- or N-terminus of GalThpy, respectively. 
However, neither of the expressed modified GalThpy variants became sufficiently soluble. As a 
result, the crude extract of recombinant cells containing unpurified GalThpy was used for the 
subsequent synthesis work. 
 
   1                                                                         75 
C-FucThpy    (1) --------------------------------------------------------------------------- 
  GalThpy    (1) MLRVFIISLNQKVCDTFGLVFRDTTTLLNNINATHHQAQIFDAIYSKTFEGGLHPLVKKHLHPYFITQNIKDMGI 
   76                                                                      
      150 
C-FucThpy    (1) --------------------------------------------------------------------------- 
  GalThpy   (76) TTNLISEVSKFYYALKYHAKFMSLGELGCYASHYSLWEKCIELNEAICILEDDITLKEDFKEGLDFLEKHIQELG 
   151                                                            
               225 
C-FucThpy    (1) --------------------------------------------------------------------------- 
  GalThpy  (151) YVRLMHLLYDPNVKSEPLNHKNHEIQERVGIIKAYSHGVGTQGYVITPKIAKVFKKHSRKWVVPVDTIMDATFIH 
   226                                                      275 
C-FucThpy    (1) --------------------FKIYRKAYQKSLPLLRTIRRWVKK------ 
  GalThpy  (226) GVKNLVLQPFVIADDEQISTIARKEEPYSPKIALMRELHFKYLKYWQFV- 
 
 
Sequence 6.1. Alignment of the protein sequence of GalThpy with the C-terminus of FucThpy. Lys and Arg residues 
are marked with acid blue. The transmembrane-like fragment, which contains 27 amino acid residues, is marked 
with red color. 
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a)                                       b)                                                             c) 
 
 
 
 
 
 
Figure 6.3. Deletion of the transmembrane-like fragment at the C-terminus of GalThpy. a) Identificaiton of PCR 
product for the deletion. 1: Marker. 2: PCR product of pET19b-d27GalThpy. 3: PCR product of pET21a-d27GalThpy. b) 
Restriction identification of the plasmids (Nde I and BamH I). 1: pET21a-d27GalThpy. 2: pET21a-GalThpy. 3: Marker. 4:  
pET19b-GalThpy. 5: pET19b-d27GalThpy. c) Idendification of expression level by SDS-PAGE. 1: d27GalThpy-C-His, crude 
cell extract. 2: d27GalThpy-C-His, supernatant of crude cell extract. 3: d27GalThpy-N-His, crude cell extract. 4: 
d27GalThpy-N-His, supernatant of crude cell extract. 5: Marker. 
 
 
6.2.2. Cloning, expression and characterization of UDP-galactose 4-epimerase from 
Escherichia coli  
 
UDP-galactose 4-epimerase (E.C. 5.1.3.2, GalE) catalyzes the interconversion of UDP-Glc and 
UDP-Gal in vivo. The GalE from E. coli (GalEeco) is a homodimer (79kDa), in which each 
subunit contains 338 amino acid residues [187]. The gene of GalEeco was obtained from the 
chromosomal DNA of E. coli strain K-12 using PCR, cloned into pET19b vector and expressed 
in Tuner BL21 cells. The expressed recombinant GalEeco contains a His6-tag at the C-terminus. 
Because this GalE was homologously cloned from E. coli, a high soluble expression level could 
be achieved (Figure 6.4). The recombinant enzyme was purified by Ni-affinity 
chromatography. 
 
 
 
 
1       2       3                 1        2        3        4        5               1     2     3     4     5
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  a)                                                                                 b)  
 
 
 
 
 
 
Figure 6.4. Cloning and expression of GalE from E. coli. a) Plasmid map of the expression plamid pET19b-GalEeco. b) 
Expression level of the recombinant GalEeco displayed by SDS-PAGE. 1: Marker. 2: Crude cell extract. 3: Supernatant 
of crude cell extract. 4: Purified GalEeco by Ni-affinity chromatography. 5: Marker. 
 
6.2.3. Chemoenzymatic synthesis of N-acetyl-D-lactosamine precursors 
 
Using recombinant GalEeco and GalThpy, the synthesis of LacNAc and its fluorophore-labeled 
derivative was carried out as one-pot reactions, in which UDP-Glc was converted into UDP-Gal 
which is subsequently consumed as glycosyl donor, while GlcNAc or fluorophor-labeled 
GlcNAc played as acceptors. Although GalEeco catalyzes a fully reversible reaction with only 25% 
final conversion of UDP-Glc to UDP-Gal,[187] the galactosylation consumed UDP-Gal and 
promoted the continuous further production of UDP-Gal. GalThpy has a relative high activity 
with GlcNAc and its derivatives. The total conversion of LacNAc and LacNAc-D-T-P-Acr thus 
reached virtually 100% as judged from the TLC monitoring of the reaction. The final isolated 
yields of these two compounds at the 100 mg scale were as high as 88% and 92%, 
respectively (Scheme 6.2). The product LacNAc-D-T-P-Acr was subsequently used as acceptors 
for the synthesis of neo-sialoconjugates in Chapter 10.  
 
 
 
 
 
pET19b-GalEeco
67 26 bp
lac I
bla (Ap) sequence
lac operator
galeeco
T7 promoter
His tag
enterokinase
ColE1 pBR322 orig
T7 terminator
BamHI (1)
NdeI (57 08)
1     2     3       4     5 
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Scheme 6.2. Chemoenzymatic synthesis of N-Acetyl-D-lactosamine and lactosamine precursors 
 
GlcNAc-α-ethynyl, GlcNAc-β-ethynyl, Glc-β-ethynyl glycosides and free Glc were also tested as 
acceptors to confirm the results reported by Lau et al., who found that GalThpy could not 
accept any Glc and α-GlcNAc derivatives.[173] However, in our TLC determination, GlcNAc-α-
ethynyl glycoside was also well accepted by GalThpy. Interestingly, the recombinant GalThpy 
could also use Glc-β-ethynyl glycoside and Glc as an acceptor, though its activity was lower 
than that towards GlcNAc and its derivatives (Figure 6.5). Lau et al.’s recombinant GalThpy 
was expressed in the fusion form with MBP and His6 tags at N and C terminus, respectively, in 
order to improve its soluble expression.[173] Conversely, the recombinant GalThpy described 
here contained only a His6-tag at the N terminus. There is the possibility that the fusion tag at 
the C-terminus or at both N- and C-termini affects the specificity of GalThpy. It is a pity that the 
crystal structure of GalThpy has not been determined yet, and also that there is no similar 
enzyme with high homology toward GalThpy that could be used as template for a 3D structure 
simulation. Therefore, up to now, it is still difficult to evaluate an effect of the MBP tag on the 
tertiary structure of GalThpy. To confirm the Lac derivative product catalyzed by GalThpy, Lac-
D-T-P-Acr was synthesized from Glc-D-T-P-Acr (50 mg scale, yield 85%), which reaction 
performed with significantly lower rate than that using GlcNAc-D-T-P-Acr as acceptor. 
Although the chemical preparation of Lac-D-T-P-Acr from Lac as starting material is much 
more economic,[196] the enzymatic galacosylation offers an alternative route for its synthesis.  
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Figure 6.5. TLC identification of the specificity of GalThpy. 1: Product from GlcNAc-α-ethynyl glycoside. 2: GlcNAc-α-
ethynyl glycoside. 3: Product from GlcNAc-β-ethynyl glycoside. 4: GlcNAc-β-ethynyl. 5: Product from Glc-β-ethynyl 
glycoside. 6: Glc-β-ethynyl glycosides. 7: Product from Glc. 8: Glc. 
 
6.3. Conclusion 
 
The LacNAc moiety at the terminus of oligosaccharides is an important natural substrate of 
SiaT. Synthesis of LacNAc and its derivatives in vitro can extend the diversity of acceptors for 
the synthesis of neo-sialoconjugates. In this chapter, the β-1,4-galactosyltransferase from 
Helicobacter pylori has been cloned and over-expressed in an E. coli expression system using a 
synthetic gene sequence. The expression of GalThpy has been optimized with the aid of 
chaperone co-expression and gene truncation. Although the expressed recombinant GalThpy 
remained largely insoluble, high GalT activity could nevertheless be identified in the crude 
extract of recombinant cells. The GalE from E. coli was also cloned for the interconversion of 
UDP-Glc to UDP-Gal to reduce the substrate cost of the galactosyltransfer reaction. Finally, 
free LacNAc and LacNAc-D-T-P-Acr, as well as Lac-D-T-P-Acr have been synthesized from 
UDP-Glc donor and using GalNAc, GalNAc-D-T-P-Acr and Gal-D-T-P-Acr as acceptor substrates, 
with isolated yields of 88%, 92% and 85%, respectively, on a 100 mg scale each for further 
preparative utilization.   
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7. Cloning, Expression and Characterization of α-2,3- and α-2,6-Sialyltransferases 
from Photobacterium sp. 
 
 
7.1. Introduction 
 
Bacterial α-2,3/2,6-sialyltransferases (2,3/6SiaTs) are classified into the GT80 family 
(www.cazy.org) which currently contains 15 different SiaT sequences from Alistipes shahii 
(GenBank accession number: CBK63974.1), Haemophilus ducreyi (GenBank accession number: 
AAP95068.1), Pasteurella multocida (GenBank accession number: AET16017.1,[197] 
AAY89061.1,[147] AFI46264.1, AFF24354.1[198] and AAK02272.1[199]), Photobacterium sp. 
(GenBank accession number: BAA25316.1,[145] BAI49484.1,[200] BAF91416.1,[160] 
BAF63530.1,[161] BAF92025.1[162] and BAF92026.1[162]), Shewanella piezotolerans 
(GenBank accession number: ACJ31674.1[201]), and Vibrio sp. (GenBank accession number: 
BAF91160.1[163]), respectively. Among theese, the enzymatic properties of a multifunctional 
SiaT from Pasteurella multocida (2,3/6SiaTpmu) has been studied intensively, and the enzyme 
has been  applied for the synthesis of sialoside libraries.[137, 147, 150, 202-204] Recently, 
the discovery of 2,3- and 2,6SiaTs in marine bacteria from Photobacterium sp. with high 
sialyltransfer activity has immensely expanded the membership size of the bacterial SiaT 
family.[145, 158, 160-163, 200] Some of these enzymes have unique properties. For example, 
the 2,6SiaT from Photobacterium leiognathi JT-SHIZ-145 (2,6SiaTple) has an optimum at pH 8 
instead of 6 to 6.5 reported for other SiaTs;[160] an alkaline optimum is more favorable for 
sialoconjugate synthesis, because CMP-activated sialic acids are un stable under acidic 
conditions. The synthetic potential of the SiaTs from Photobacterium sp. has also been proved. 
Especially, a 2,6SiaT from Photobacterium damselae JT0160 (2,6SiaTpda) has been successfully 
applied to the synthesis of natural and non-natural sialosides.[144, 202, 205] As a result, 
2,3SiaT and 2,6SiaT from Photobacterium sp. became the preferred candidates in this thesis 
for the purpose of synthesis of neo-2,3- and 2,6-sialocojugates.  
For synthetic applications, an accurate study of the substrate specificity and kinetics of SiaT is 
quite significant. Because of the difficulty of the oligosaccharide detection and quantification, 
the assay methods used for SiaT activity monitoring employ radioactive [145] or fluorescently 
labeled CMP-Neu5Ac[146], or determine the formation of product directly by HPLC.[147] 
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However, none of these methods is easy to be performed. The radio-labeled compound is 
expensive and harmful to health, and requires a special detector. The modification of either 
donor or acceptor may change the activity of SiaT or limit the variety of accessible substrates, 
which will narrow the scope for the substrate specificity determination of SiaT. Therefore, a 
sensitive, simple and rapid screening assay method is still required for the activity 
determination towards a broader substrate variation. 
In this chapter, the 2,3-SiaT from Photobacterium phosphoreum JT-ISH-467 (2,3SiaTpph) and 
2,6-SiaT from Photobacterium leiognathi JT-SHIZ-145 (2,6SiaTple) were cloned, over-expressed 
in E. coli and purified by affinity chromatography. Their substrate tolerance was determined 
with a novel pH-based assay method. 
 
7.2. Results and discussion 
 
7.2.1. Cloning, expression and characterization of α/β-galactoside α-2,3-
sialyltransferase from  Photobacterium phosphoreum 
 
The α/β-galactoside α-2,3-sialyltransferase from Photobacterium phosphoreum (2,3SiaTpph) is a 
novel 2,3SiaT that was reported in 2007,[161] for which recently also a protein crystal 
structure has been determined [148]. Therefore, it can be used as a standard enzyme and 
structure template for the research of other 2,3SiaTs in the same family. The sequence of 
2,3SiaTpph has 409 amino acid residues, among which the first 24 residues at its N-terminus 
have been identified as a signal sequence.[159] The gene of Δ24-2,3SiaTpph was synthesized 
commercially and ligated into the pET19b vector (Figure 7.1), then transformed into 
BL21(DE3) host cells for over-expression. The SDS-PAGE analysis shows that truncated the 
recombinant 2,3SiaTpph is well expressed in the soluble form by the E. coli expression system 
(Figure 7.2a). However, activity identification using the fluorolabeled lactose (Lac-D-T-P-Acr) 
as acceptor revealed that besides high 2,3SiaT activity from the protein of interest, the crude 
extract sample also contained β-galactosidase activity (Figure 7.1b). Since 2,3SiaTpph should 
not have any hydrolytic activity, the observed galactosidase activity probably came from the 
host strain BL21(DE3). Therefore, the expression host was changed into BL21Tuner, in which 
galactosidase activity was indeed practically absent upon host cell screening. The recombinant 
enzyme was purified using Ni-affinity chromatography (Figure 7.1c).  
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Figure 7.1. Plasmid map of the expression plamid pET19b-SiaTpph.  
 
 a)                                                 b)                                           c) 
 
 
 
 
 
 
Figure 7.2. Cloning, expression and activity determination of 2,3SiaT from Photobacterium phosphoreum. a) 
Expression level of the recombinant SiaTpph in BL21(DE3) displayed by SDS-PAGE. 1: Marker. 2: Crude cell extract. 3: 
Supernatant of crude cell extract. b) Activity determination of 2,3SiaTpph by fluorescent labeled acceptor (Lac-D-T-P-
Acr). The reaction was carried out in 100 µl scale with 20 mM Tris-HCl (pH 8). The reaction system contains 3 mM 
Lac-D-T-P-Acr (see scheme 6.2), 5 mM CMP-Neu5Ac and 50 µl enzyme sample.1: Fluorescence labeled acceptor Lac-
D-T-P-Acr. 2: 2,6-Sialylation reference. 3: Rection with supernatant of crude cell extract. c) Purified 2,3SiaTpph by Ni-
affinity chromatography. 1: Marker. 2: Purified 2,3SiaTpph. 
 
7.2.2. Cloning, expression and characterization of β-galactoside α-2,6-
sialyltransferase from  Photobacterium leiognathi JT-SHIZ-145 
 
The β-galactoside α-2,6-sialyltransferase from Photobacterium leiognathi JT-SHIZ-145 
(2,6SiaTple), which was isolated from the gut of a Japanese barracuda, is produced from an 
pET19b-SiaTpph
6870 bp
lac I
bla (Ap) sequence
lac operator
23SiaTpphT7 promoter
His tag
enterokinase
ColE1 pBR322 origin
T7 terminator
BamHI (1164)
NdeI (1)
-----Gal-D-T-P-Acr
-----Lac-D-T-P-Acr 
 
-----2,3 product 
-----2,6 product 
 1      2      3                       1  2  3                                  1       2   
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open reading frame of 1,494 base pairs encoding a predicted protein of 497 amino acid 
residues.[160] The deduced amino acid sequence of 2,6SiaTple showed 68.2% homology to 
2,6SiaTpdm. In the previous study, the optimum pH of SiaTple was determined at 8. Its transfer 
ability for mono- and di-saccharides and glycoproteins as sialyl acceptors, and the kinetic 
parameters of a truncated version of the sialyltransferase have been studied previously.[160]  
In the present study, the DNA sequence of the 2,6SiaTple gene was optimized for expression in 
E. coli and synthesized commercially. For the 2,6SiaTpdm, it was reported that the first 15 
amino acid residues at the N-terminus is a signal sequence and unrelated to its activity. [159] 
A similar sequence was also found in the N-terminus of 2,6SiaTple[160] and thus, the first 15 
amino acid residues of 2,6SiaTple were similarly deleted. The truncated 2,6SiaTple gene 
fragment was ligated into the pET19b vector to construct the expression plasmid, which was 
then transformed into BL21 Tuner competent cells. The map and identification of the 
expression plasmid (pET19b-SiaTple) are shown in Figure 7.3. The 2,6SiaTple could also be 
expressed well in soluble form in the E. coli system (Figure 7.4a). The purity of the 
recombinant 2,6SiaTple purified by Ni-affinity chromatography is displayed in Figure 7.4b. The 
recombinant 2,6SiaTple contains a His6-tag at the N-terminus, which gives higher activity than 
when produced with a C-terminal His-tag.[159] For a rapid activity test of the recombinant 
2,6SiaTple also the fluorescence labeled lactose (Lac-D-T-P-Acr) was used as the acceptor 
together with the lysis supernatant of the recombinant strain as biocatalyst. The TCL result 
indicated a high activity of recombinant 2,6SiaTple (Figure 7.4c). 
 
                                                         
 
 
 
 
 
 
 
Figure 7.3. Plasmid map of the expression plamid pET19b-SiaTple.  
 
pET19b-SiaTple
7 161 bp
lac operator
bla (Ap) sequence
lac I
2,6SiaTple
T7 promoter
enterokinase
His tag
ColE1 pBR322 origin
T7 terminator
BamHI (1841)
NdeI (387 )
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 a)                                        b)                                       c) 
 
 
 
 
 
 
Figure. 7.4. Expression, purification and activity identification of the recombinant 2,6SiaTple. a) Expression level of 
2,6SiaTple in Tuner BL21. b) Purified recombinant 2,6SiaTple. c) Activity determination of 2,6SiaTple by fluorescent 
labeled acceptor (Lac-D-T-P-Acr). The reaction was carried out in 100 µl scale with 20 mM Tris-HCl (pH 8). The 
reaction system contains 3 mM Lac-D-T-P-Acr (see scheme 6.2), 5 mM CMP-Neu5Ac and 50 µl enzyme sample. 1: 
Fluorescence labeled acceptor Lac-D-T-P-Acr. 2: Rection with supernatant of crude cell extract. 3: 2,3-Sialylation 
reference. 
 
7.2.3. Identification of regioselectivities of 2,3SiaTpph and 2,6SiaTple by synthesis of 
Neu5Ac-2,3-Lac-D-T-P-Acr and Neu5Ac-2,6-Lac-D-T-P-Acr 
 
The high sialyltransfer activities of 2,3SiaTpph and 2,6SiaTple have been proved from the rapid 
activity test using Lac-D-T-P-Acr as acceptor. In order to confirm the α-2,3- or α-2,6-linkage in 
each product, the sialylation of Lac-D-T-P-Acr was performed in a 20 mg scale. Both of the 
2,3- and 2,6-sialylated products were isolated and analyzed by NMR spectrum. The structure 
variance between the products Neu5Ac-2,3-Lac-D-T-P-Acr and Neu5Ac-2,6-Lac-D-T-P-Acr is 
the different sialylation positions. In Neu5Ac-2,3-Lac-D-T-P-Acr, the sialylation at OH3’’ 
position is accompanied by a large deshielding for the corresponding glyconic hydrogen.[206] 
Therefore, the corresponding peaks if H3’’ in 1H spectrum shift from around 3.6 ppm in 
Neu5Ac-2,6-Lac-D-T-P-Acr  to 4.1 ppm in Neu5Ac-2,3-Lac-D-T-P-Acr (Figure 7.5).  This large 
deshielding (around 0.5-0.6 ppm) can be a main reference to distinguish 2,3-sialosides and 
2,6-sialosides. 
 
 
 
-----Gal-D-T-P-Acr
-----Lac-D-T-P-Acr 
 
-----2,3 product 
-----2,6 product 
1  2  3        
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Figure 7.5. NMR spectrum (gs-HSQC) comparison of Neu5Ac-2,3-Lac-D-T-P-Acr and Neu5Ac-2,6-Lac-D-T-P-Acr. In 
Neu5Ac-2,3-Lac-D-T-P-Acr, the sialylation at OH3’’ position is accompanied by a large deshielding for the 
corresponding glyconic hydrogen. The corresponding peaks if H3’’ in 1H spectrum shift from around 3.6 ppm in 
Neu5Ac-2,6-Lac-D-T-P-Acr  to 4.1 ppm in Neu5Ac-2,3-Lac-D-T-P-Acr. 
 
7.2.4.  Development of a pH-based assay for sialyltransferases 
 
For the specificity determination with a number of potential substrates, a fast and sensitive 
method is required. Recently, the principle pH-based assay has been introduced successfully 
for the activity determination of glycosyltransferases, such as GalT and GalNAcT.[207, 208] In 
principle, any enzymatic reaction using substrate/product pairs that have sufficiently different 
pKa values and that therefore cause changes in pH upon conversion can be evaluated 
qualitatively and quantitatively by adding a suitable pH indicator and monitoring OD 
variations during the reaction in the absence of a buffer system. During the sialyltrasfer, the 
production of a proton upon CMP release decreases the pH value of the reaction system. This 
pH change could also be well revealed by adding a pH indicator. According to this principle, a 
pH-based method was developed, in which phenol red (pKa 8.0) was used as the pH indicator. 
Its color exhibits a gradual transition from yellow to red over the pH range 6.8 to 8.2, which 
includes the pH optimum of the enzymatic reaction system (pH 8.0). As discussed in detail in 
 
 
2,3-product 
2,6-product 
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Chapter 3, a low concentration (1 mM to 3 mM) is necessary for high sensitivity of the pH 
based assay and a buffer with a pKa as close as possible to the pKa of the indicator gives the 
results.[209] Tris has a pKa at 8.1 and shows chemical reactivity with any other component 
present in the sialylation system, which is perfect for its application in this measurement 
method. Thus, 2 mM Tris-HCl (pH 8.0) was used to slightly buffer the assay.  
 
 
 
 
 
 
Scheme 7.1.  Principle of the pH-based assay for sialyltransferase analysis 
 
The proton used for quantification is released during the sialylation reaction. Therefore, a 
standard curve was established for the linear relationship between proton concentration and 
absorbance of phenol red at 560 nm using 0 mM to 0.5 mM HCl (Figure 7.6a). Because of the 
relatively higher acidity of phosphate, the effect of stoichiometric released protons on the pH 
value is much higher than that of bicarbonate released in the TK assay. Therefore, the LOD 
and LOQ of this standard curve can reach 0.014 mM and 0.041 mM. Using a few substrates as 
acceptors for the primary test, the time curves of absorbance (Figure 7.6b) clearly revealed 
the different activities of SiaT towards the varying acceptors, including α- and β-configurated 
galactose derivatives. Absorbance data for the first 60 s were recorded and converted into 
concentration of protons according to the standard curve. A typical time curve of 
concentration of proton using lactose as acceptor is shown in Figure 7.6c. The slope of this 
curve was used to calculate the specific activity of SiaT according to the Formula 7.1. One unit 
was defined as the amount of enzyme required to produce 1 μmol of protons per minute. 
 
ݏ݌݂݁ܿ݅݅ܿ	ܽܿݐ݅ݒ݅ݐݕ	܃/ܕ܏ ൌ ݏ݈݋݌݁	ܕۻ/ܛ ൈ 10
ଷ ൈ 60ܛ ൈ 200 ൈ 10ି଺ۺ
ܽ݉݋ݑ݊ݐ	݋݂	݁݊ݖݕ݉݁	ܕ܏ 	ሺFormula	7.1ሻ 
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Variation of the amount of SiaT for an equal increment of OD change confirmed the linear 
relationship between activity and amount of enzyme (Figure 7.6d), which demonstrates that 
this method can be used for the quantitative determination of the absolute and relative 
specific activity of different SiaT. The observable LOD and LOQ values are 0.6 mU and 1.9 mU, 
respectively. 
 
a)                                                                      b) 
 
 
 
 
 
 
 
c)                                                                       d) 
 
 
 
 
 
 
 
 
Figure 7.6. Development of the assay method. Samples contained 0.028 mM phenol red in 200 µL of 2 mM Tris 
buffer (pH 8.0) as well as enzyme and acceptor as specified. After addition of 0.5 mM CMP-Neu5Ac, absorbance 
was measured at 560 nm using a plate reader. a) Standard curve; reaction mixtures contained 2 µg 2,6SiaTple and 
varying amounts of HCl (0–0.5 mM). b) Time curve of absorbance change using different acceptor substrates. Assay 
solutions contained 2 µg 2,6SiaTple and various acceptors and control without enzyme. c) Time curve for absolute 
data. Absorbance data from (b) for lactose was converted into equivalent H+ concentration according to the 
calibration curve. The slope of the resultant curve was used for calculating the specific activity. d) Dependence of 
rate on amount of enzyme; reaction mixtures contained lactose and varying amounts of 0 - 4 µg 2,6SiaTple. 
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7.2.5.  Determination of kinetic constants of SiaT 
 
The pH-based assay for SiaT is an exceptionally sensitive method, because the release of the 
proton affects the pH of the reaction system directly. Its continuous determination starting 
with the initial reaction rate makes itself to be very suitable for the measurement of the 
kinetic constants for SiaT with high definition. Using this method, the kinetic constants of 
both 2,3SiaTpph and 2,6SiaTple were determined and listed in Table 7.1. Both the 2,3SiaTpph 
and 2,6SiaTple have very similar Km and kcat values towards the donor CMP-Neu5Ac and the 
acceptor Lac. That means there is no significant difference between the behavior of 2,3SiaTpph 
or 2,6SiaTple towards some natural substrates. However, 2,3SiaTpph and 2,6SiaTple have totally 
different performance towards the galactosides with C1 modification in both α- and β-
configurations,. 2,3SiaTpph binds methyl-α-D-galactopyranoside with a higher affinity methyl-
β-D-galactopyranoside (the KM value of the latter is ca. 1.6 fold higher). The affinity of 
2,3SiaTpph towards free Gal and Lac are very similar to that for methyl-β-D-galactopyranoside. 
On the other hand, the substrate selectivity of 2,6SiaTple is ver different. While it shows 
practically identical affinity for the Lac disaccharide, the binding constant for Me-β-Gal is 
around 2.6 fold higher, which indicates that the second monosaccharide unit in the Lac 
acceptor has specific binding interaction with the active pocket of 2,6SiaTple. However, 
2,6SiaTple cannot accept α-galactosides as indicated by the fact that the Km value for methyl-α-
D-galactopyranoside is too high to be measured. With α,β-anomeric, free Gal as acceptor, the 
Km value further increases to 234 mM, which is 12 fold higher than that for methyl-β-D-
galactopyranoside, and 320 fold higher than that for Lac.  
Table 7.1. Kinetic constants of 2,3SiaTpph and 2,6SiaTple using the pH-based assay method 
 2,3SiaTpph 2,6SiaTple 
 
KM 
(mM) 
kcat 
(s-1) 
kcat/KM 
(s-1·mM-1) 
KM 
(mM) 
kcat 
(s-1) 
kcat/KM 
(s-1·mM-1) 
CMP-Neu5Ac 0.20±0.04 1.13±0.07 5.7 0.091±0.016 1.09±0.04 12 
Galactose (1)* 0.72±0.07 1.41±0.02 2.0 234±40 1.11±0.13 0.0048 
methyl-α-D-galactopyranoside (2) 0.39±0.02 1.51±0.01 3.9 n.d.** n.d. n.d. 
methyl-β-D-galactopyranoside (3) 0.63±0.04 1.49±0.02 2.4 19.1±1.3 1.41±0.04 0.074 
Lactose (11) 0.70±0.05 1.37±0.02 2.0 0.73±0.09 1.36±0.02 1.9 
*  See structures in Figure 7.8  
**n.d. = not detectable 
 Seite 74 
 
The kinetic constants of 2,3SiaTpph and 2,6SiaTple at pH 6.0 and pH 8.0, respectively, have 
been reported by using a radioactive detection method with 14C labeled CMP-Neu5Ac as 
donor.[160, 161] The reported Km value for CMP-Neu5Ac is 0.05 mM for 2,3SiaTpph and 0.2 
mM for 2,6SiaTple which is similar to the value of 0.2 mM and 0.09 mM determined here. For 
the acceptors, the reported Km values of 2,3SiaTpph for Lac (Figure 7.8, 11), methyl-α-D-
galactopyranoside (Figure 7.8, 2) and methyl-β-D-galactopyranoside (Figure 7.8, 3) are 1.7 
mM, 0.54 mM and 1.3 mM, respectively, which are all around 2 fold higher than those 
determined by the continuous pH-based assay, although the relative proportion between these 
data is consistent. The reported Km value of 2,6SiaTple for Lac and methyl-β-D-
galactopyranoside are 12.7 mM and 14.8 mM, respectively. The former is very different 
compared to the data (0.73 mM) obtained here, and is about 16 fold higher, while the latter 
value is similar to that (19 mM) determined here. Since the pH-based assay is the only 
continuous method of the three known assay methods and the kinetic constants were 
measured at different reaction conditions, the data discrepancy is plausible. The difference 
between the two Km values of 2,SiaTple for Lac is huge. However, the corresponding apparent 
Km value of 2,6SiaT from Photobacterium sp. JT-ISH-224 (2,6SiaTpsp) is 31 mM for Lac and 99 
mM for methyl-β-D-galactopyranoside; and the Km value of 2,6SiaTpda is 6.82 mM for Lac and 
174 mM for methyl-β-D-galactopyranoside (Table 7.2). Both of these two homologous 
2,6SiaTs have obvious Km value difference between that for Lac and for methyl-β-D-
galactopyranoside. Therefore, the Km value of 2,6SiaTple determined here for Lac and methyl-
β-D-galactopyranoside is reasonable. From the structure analysis, the unknown three-
dimensional structure of 2,6SiaTple can be simulated computationally based on another 
2,6SiaT from Photobacterium sp. JT-ISH-224 (2,6SiaTpsp) as a template, which has high 
homology to 2,6SiaTple and for which an X-ray protein crystal structure has been 
determined.[148, 149, 210] The acceptor binding position could be identified by structure 
alignment (Figure 7.7). Asn157 is the corresponding amino acid residue for binding the OH7 
of Lac, which could contribute to the orientation of Lac in a correct position. However, 
methyl-β-D-galactopyranoside has no binding contribution from such a Glc moiety, which 
could give methyl-β-D-galactopyranoside more flexibility in the active pocket of 2,6SiaTple.    
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  Table 7.2. Comparison of KM values (mM) of 2,3SiaTpph and 2,6SiaTple with the reported data 
 2,3SiaTpph 2,6SiaTple 2,6SiaTpsp 2,6SiaTpda 
 pH assay 
adioactive 
method[161] pH assay 
adioactive 
method[160] 
adioactive 
method[162] 
adioactive 
method[158] 
CMP-Neu5Ac 0.20 0.05 0.091 0.2 - 0.32 
Galactose 0.72 - 234 - - - 
methyl-α-D-galactopyranoside 0.39 0.54 n.d.* - - - 
methyl-β-D-galactopyranoside 0.63 1.3 19.1 14.8 99 174 
Lactose 0.70 1.7 0.73 12.7 31 6.82 
**n.d. = not detectable 
 
 
 
 
 
 
 
 
 
Figure 7.7. Lactose acceptor binding position simulated for 2,6SiaTple by structure alighment with the X-ray 
structure of 2,6SiaTpsp (PDB code 2Z4T). 
 
7.2.6. Sialyltransferase screening for substrate tolerance  
 
Besides the determination of kinetic constants, the pH-based assay method can also be used to 
assess the substrate tolerance of SiaT. A group of 13 potential and known acceptors were 
chosen for the specificity determination, which includes α- and β-galactosides, 
configurationally and structurally related monosaccharide and their derivatives, as well as 
lactose and lactosides, and the compound 12 and 13 for the further fluorescent labeling by a 
“clickable” reaction (Figure 7.8). Apparently, 2,3SiaTpph has quite broad acceptor range, 
Lac
CMP
Trp347
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showing relatively high activity of 6-10 U/mg towards almost all 13 acceptors except for 
GlcNAc (around 2 U/mg), which comprises both configurational change at C4 and 
substitution at C2 of the natural Gal acceptor structure. Other monosaccharide than 
galactosides, for example Man, Glc and GalNAc, are well accepted by 2,3SiaTpph with only 
small decrease in activity as compared to Gal. This result illustrated that 2,3SiaTpph has an 
astonishing tolerance towards modifications at the C2 and C4 positions of the monosaccharide 
acceptors. On the other hand, 2,6SiaTple presents very different behavior when comparing to 
2,3SiaTpph. Its activity towards α-galactosides, Glc, Man, GalNAc and GlcNAc are only 5% or 
less of that towards β-galactosides and lactosides. Its relative small acceptor range reveals that 
the configuration of hydroxyl groups and the anomeric linkage at C1, C2 and C4 highly 
important for the interaction of the enzyme with the acceptor substrate. Additionally, the 
modification of C1 of Lac does not reduce the acceptance of 2,3SiaTpph and 2,6SiaTple. As a 
result, the fluorophor-labeling and possibly surface immobilization of Lac acceptor will likely 
not affect the activity of SiaT.   
 
 
 
 
 
 
 
 
 
Figure 7.8. Substrate tolerance screening of 2,3SiaTpph and 2,6SiaTple. Reaction contained 0.028 mM phenol red in 
200 µL of 2 mM Tris buffer (pH 8.0) as well as enzyme and 20 mM acceptor as specified. After addition of 1 mM 
CMP-Neu5Ac, absorbance was measured at 560 nm using a plate reader.  
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7.3. Conclusion 
 
SiaT is an essential catalyst for the regiospecific chemoenzymatic synthesis of neo-
sialoconjugates in vitro. 2,3SiaTpph and 2,6SiaTple have been cloned and expressed in the E. 
coli expression system. Both enzymes could be easily purified in soluble form by Ni-affinity 
chromatography with high purity and activity. In order to understand the substrate specificity 
of these two SiaTs, a pH-based assay method has been established for determination of their 
kinetic constants and substrate tolerance, using phenol red as pH indicator in a low buffer 
system, and. This pH assay method is rapid, highly sensitive, and can be operated in 
continuous mode. With this method, the kinetic constants and the acceptor substrate 
tolerance of 2,3SiaTpph and 2,6SiaTple has been determined. These two SiaTs have quite 
different acceptor specificity. While the 2,3SiaTpph can well accept both α- and β-galactosides, 
lactosides, Glc, Man and GalNAc, in striking contrast, the 2,6SiaTple has high activity only 
towards β-galactosides and lactosides. 
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8. Directed Evolution of Cytosine-5’-Monophosphate- N-Acetylneuraminate 
Synthetase from Neisseria meningitides for Improved Tolerance towards          
5’-Modified N-Acetylneuraminate analogues 
 
 
8.1. Introduction 
 
CMP-sialic acid synthetase (CSS, E.C. 2.7.7.43) catalyzes the CMP activation of sialic acid 
using CTP as donor and Mg2+ as cofactor,[138] which is a key step of the Leloir biosynthetic 
route of complex oligosaccharides followed by a sialyltransfer reaction to form the specific 
2,3-, 2,6- or 2,8-sialated products.[211] Besides its occurrence in higher vertebrates, CSS can 
also be found in several microorganisms, notably human pathogens, such as Clostridium 
thermocellum, Streptococcus agalactiae, Escherichia coli, Haemophilus ducreyi, Mannheimia 
haemolytica, Pasteurella hemolytica and Neisseria meningitides,[139] in which it is involved in 
the synthesis of host-like oligosaccharides to protect themselves against an attack by the host 
immune system.[212, 213] The CSS from Neisseria meningitidis (CSSnme) is a well-studied 
enzyme that has been cloned[141] and its crystal structure analysed.[142] Recently, kinetic 
constants for several substrates analogs have been well determined by a new pH-based assay 
method and used to explain by acceptor binding with reference to the CSS from Mus musculus 
(CSSmmu).[143] CSSnme has a remarkably broad acceptor tolerance towards 5’, 7’, 8’ and 9’ 
modified sialic acids.[143, 210] A series of Neu5Ac analogues carrying modifications of the 
acylamino group could be accepted by CSSnme, although their corresponding kcat/KM values 
were found to be much lower than those for Neu5Ac.[143] In order to improve its activity 
towards 5’-modified Neu5Ac analogues by site-directed mutagenesis, in this chapter an 
improved realignment of available three-dimensional CSS protein structures of CSSmmu and 
CSSnme was attempted with interpretation for the dynamic motions within the active site.  
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8.2. Results and discussion 
 
8.2.1. Structure analysis of CSS 
 
The crystal structure of CSS from Neisseria meningitidis (CSSnme) has been determined with 
CDP as co-crystallized substrate in 2 conformations.[142] Its acceptor domain structure has 
been revealed by docking Neu5Ac to the active pocket with AutoDock,[142] which was a 
rational computationally simulated result based on the opened conformation of CSSnme 
towards the acceptor. However, the substrate access is a process of subtle interactions 
between both substrate and peptide, during which the positions of the corresponding residues 
or even the shape of the peptide might be changing dynamically. The closed conformation of 
the CSSmmu active site at least has slight changes in comparison with the opened one from 
CSSnme. Therefore, the docking to an opened conformation in CSSnme might give biased 
structure information of the real Neu5Ac binding position. Up to date, only the CMP-Neu5Ac 
binding position in another CSS from Mus musculus (CSSmmu) has been revealed by crystal 
structure determination of its product-liganded form.[214, 215] CSSmmu has 24.6% identity 
and 40.1% consensus homology with CSSnme (Sequence 8.1). Therefore, more detailed 
information on substrate binding interactions in the active site of CSSnme might be devired by 
a careful analysis of the three-dimensional structure alignment between CSSnme and CSSmmu. 
 
    1                                                                        75 
   CSSnme    (1) MEKQNIAVILARQNSKGLPLKNLRKMNGISLLGHTINAAISSKCFDRIIVSTDGGLIAEEAKNFGVEVVLRPAEL 
   CSSmmu    (1) –PPHLAALVLARGGSKGIPLKNIKRLAGVPLIGWVLRAALDAGVFQSVWVSTDHDEIENVAKQFGAQVHRRSSET 
 
    76                                                                      150 
   CSSnme   (76) ASDTASSISGVIHALETIGSNSGTVTLLQPTSPLRTGAHIREAFSLFDEKIKGSVVSACPMEHHPLKTLLQINNG 
   CSSmmu   (75) SKDSSTSLDAIVEFLNYHN-EVDIVGNIQATSPCLHPTDLQKVAEMIREEGYDSVFSVVRRHQFRWSEIQKGVR- 
 
    151                                                                     225 
   CSSnme  (151) EYAPMRHLSDLEQPRQQLPQAFRPNGAIYINDTASLIANNCFFIAPTKLYIMSHQDSIDIDTELDLQQAENILNH 
   CSSmmu  (148) EVTEPLNLNPAKRPRRQDWDGELYENGSFYFAKRHLIEMGYLQGGKMAYYEMRAEHSVDIDVDIDWPIAEQRVLR 
 
    226 
   CSSnme  (226) KES---- 
   CSSmmu  (223) FGYFGKE 
 
Sequence 8.1. Protein sequence alignment of CSSnme and CSSmmu 
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a)                                                                         b) 
 
 
 
 
 
 
c)                                                                         d) 
 
 
 
 
 
 
 
 
Figure 8.1. Overall structure of the active pocket of CSSnme (a and c) in comparison to that of CSSmmu (b and d). The 
active residues identified in CSSmmu Tyr216, Gln141 (in subunit 1, green) and Arg202 (in subunit 2, blue) are exactly 
corresponding to Tyr179, Gln104 (in subunit 1) and Arg165 (in subunit 2) in CSSnme. The distance measurement is 
marked as purple dotted lines. The motion trends of the secondary structures are marked as red arrow. 
 
Although CSSnme and CSSmmu are two heterologous isozymes, the three-dimensional structure 
alignment of their acceptor binding pockets showed that they are provided with a very similar 
catalytic site, which indicates they likely share the same catalytic mechanism. In both the 
dimeric enzymes, the active site is jointly constructed by both subunits.[141, 142] The active 
residues identified in CSSmmu Tyr216, Gln141 (in subunit 1) and Arg202 (in subunit 2) are 
exactly corresponding to Tyr179, Gln104 (in subunit 1) and Arg165 (in subunit 2) in CSSnme. 
(Figure 8.1a and 8.1b) Therefore, measuring the distances between these identical residues 
can be used to illustrate the structure difference between opened and closed conformation of 
Arg202
Gln141
Tyr216 
Subunit 1 
Subunit 2 
Subunit 1
Subunit 2
Arg165
Gln104 
Tyr179
Subunit 1 
Subunit 2 
Arg202 
Tyr216
Subunit 1
Subunit 2
Arg165 
Tyr179
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CSSnme and assist in the identification of the Neu5Ac binding position in CSSnme. As shown in 
Figure 8.1a, the distances between Arg202 to Tyr216 and Gln141 are 7.9Å and 5.4Å, 
respectively. However, corresponding distances in CSSnme are significantly enlarged 8.9Å and 
9.5Å, respectively. (Figure 8.1b) This comparison demonstrates that the crystal structure of 
CSSnme is indeed in an opened conformation to facilitate acceptor substrate access. After 
capture of Neu5Ac, owing to the interaction between the substrates and amino acid residues, 
the two subunits of CSSnme will perform a tighter interaction. The β-sheet 1 and the α-helix 1 
have to move jointly towards each other to close in on the Neu5Ac substrate (Figure 8.1d, red 
arrows). The side chains of Tyr179, Gln104 and Arg165 could form the arms surrounding the 
acceptor almost totally. (Figure 8.1c and 8.1d) These peptide movements will result in an 
adjustment of the position of all active residues for binding of the acceptor, which is 
indispensable for any detailed analysis of active residues. 
From the model alignment of CMP-Neu5Ac (ligand conformation from CSSmmu) in the CSSnme 
active pocket, the amino group of Arg165 would have 2.7 Å, 3.1 Å and 4.1 Å closest distances 
to COO-, 9-O and 7-O of the Neu5Ac moiety, respectively (Figure 8.2b). It seems to have the 
broad possibility to form hydrogen bonds with all of these groups.[143] However, when the 
active pocket is closed, Arg165 will more towards the β-sheet 1 from the other subunit as seen 
from the location of the corresponding Arg202 in CSSmmu (Figure 8.2a). Since Arg165 is the 
essential[215] and the only basic residue nearby, it will keep its hydrogen bond with COO-, 
but will certainly dislocate from 9-O and 7-O, keeping about a 5 Å distance to those as 
indicated by the situation of corresponding Asp202 in CSSmmu (Figure 8.2a). Therefore, 
Arg165 may mostly form an ionic bond to COO- instead of hydrogen bouding to 9-O and 7-O. 
For 4-O, Ser82 is the only residue at a satisfactory distance (3.7 Å) and orientation to form a 
hydrogen bond (Figure 8.2d). Gln can act both as an acidic or basic group because of its 
amide moiety. In CSSmmu, Gln141 binds with both 5-NH and 8-O perfectly with the distance of 
2.7 Å and 3.1 Å (Figure 8.2e). The corresponding residue Gln104 in the opened CSSnme 
conformation is somewhat farther away from 5-NH and 8-O. (Figure 8.2f) However, as 
described above, Gln104 has a clear trend towards Neu5Ac during the acceptor binding. 
(Figure 5.2d, red arrow) Therefore, Gln104 is still the most plausible functional residue for 
binding of both 5-NH and 8-O in CSSnme. Lys142 in CSSnme has only a 2.7 Å distance to 7-O. 
Since it locates on a rather flexible loop, it can be identified as the corresponding residue to 
binding of 7-O (Figure 8.2h). For 9-O, there is no suggested binding contact in CSSmmu[142] 
(Figure 8.2i). However, the kinetic study of CSSnme has shown that 9-O has a positive binding 
contribution.[143] Indeed, when β-sheet 1 approaches the Neu5Ac moiety, the extensible side 
chain of Arg173 can reach out to 9-O in a reasonable distance from 5.9 Å to an approximated 
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of around 3-4 Å (Figure 8.2j). In CSSmmu, the binding residue to the C=O group of the N-acyl 
moiety is Arg199 (Figure 8.2k). However, only Glu162 is located at the corresponding 
position in the subunit 2 of CSSnme with a distance of 5.8 Å to the carbonyl group (Figure 8.2l). 
When the α-helix 1 changes its position towards the closed conformation, the distance 
between Glu162 and =O will also be shortened. Although the side chain of Glu is shorter than 
that of Arg, it could still reach the effective distance to C=O. Thus, it should be the 
corresponding binding contact for the N-acyl group. For binding of the non-polar CH3 of the 
amide moiety, the aromatic aide chain of Phe192, Phe193 and Tyr179 could jointly form a 
hydrophobic pocket[143] (Figure 8.2n). 
a)                                                                     b) 
 
 
 
 
 
c)                                                                     d) 
 
 
 
 
 
e)                                                                     f) 
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Ser82 Ser120 
Gln141 
Gln104 
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g)                                                                     h) 
 
 
 
< 
 
i)                                                                      j)  
 
 
 
 
 
 
 
k)                                                                     l) 
 
 
 
 
 
 
 
 
 
Lys142
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α-helix 1 
β-sheet 1 
Arg173
Tyr179 
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m)                                                                       n) 
 
 
 
 
 
 
 
Figure 8.2.  Active pocket analysis from structure alignment. Left: CSSmmu, right: CSSnme. Distance measurements are 
marked by purple dotted lines. The motion trends of the secondary structures are marked by purple arrows. Green: 
subunit 1. Blue: subunit 2. (See description in details in 8.2.1) 
 
When compared to the substrate docking results,[142] the suggested residues in contact with 
COO-, 4-O, 5-NH, 7-O and 8-O are identical. (Table 8.1) Two more residues, Asp209 and 
Thr106, were also considered from the docking result for 8-O. However, Asp209 has been 
involved in the co-binding to Mg2+ together with Asp211.[216] Thr106 has an estimated 5.2 
Å distance to 8-O in the open conformation of CSSnme. It could get nearer to 8-O during the 
closing movement, though there remains a 4.3 Å distance in CSSmmu. As a result, Gln104 most 
likely forms the contact to 8-O. Try179 was suggested to have a hydrogen bonding interaction 
with 9-O.[142] According to the X-ray structure of the CSSmmu, the corresponding Tyr216 has 
has a large 5.0 Å distance to 9-O. The only possibility for a binding interaction would be that 
the carbon-oxygen bond of 9-O rotates to a cis position with 8-O (Figure 8.2j), which, 
however, is not its energy minimium orientation. Thus, Tyr179 in CSSnme might be less 
probable for making a hydrogen bond interaction with 9-O. Compared to another structure 
alignment result,[143] Arg165 probably has no immediate contacts to 7-O and 9-O because of 
its shifted position described above (Figure 8.2a and b). Asn175, Gly176 and Tyr179 are 
located on the same rotating β-sheet. The side chains of Asn175 and Gly176 reache out to the 
other side against Neu5Ac (Figure 8.3). Thus, they are not at the appropriate location to 
contacting 8-O. Try179 has indeed a trend to move towards 8-O, but owing to its rigid 
location on a β-sheet, it might not have enough flexiblility to shorten the distance from 5.2 Å 
to less than 4 Å (Figure 8.3). Therefore, in comparison its corresponding Tyr216 in CSSmmu 
still keep 4.3 Å away from 8-O. 
Phe192
Phe193
Tyr179 
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Figure 8.3.  Location of Asn175, Gly176 and Tyr179 in the active site of the open form of CSSnme. The motion trends 
of the secondary structures are marked by purple arrows. Green: subunit 1. Blue: subunit 2. 
 
Table 8.1. Specific interactions suggested between residues of N. meningitides CSS to CMP-Neu5Ac  
Atom or group 
in Neu5Ac 
Contacting residue in 
murine CSS[214, 
215]  
Contacting residue 
suggested by 
docking[142] 
Potential additional or alternative contacts 
from structure alignment 
ref.[171] in this work 
COO- Arg202 Arg165  Arg165 
4-O  Ser82  Ser82 
5-NH Gln141 Gln104  Gln104 
7-O  Lys142 Arg165 Lys142 
8-O Gln141 
Gln104, Asp209, 
Thr106 
Asn175, Gly176, 
Tyr179 
Gln104 
9-O  Tyr179 Arg165, Arg173 Arg173 
=O (N-acyl) Arg199   Gln162 
CH3 
Ile124, Tyr216, 
Leu228 
Phe192, Phe193 Tyr179 
Phe192, Phe193, 
Tyr179 
 
 
Tyr179
Asn175
Gly176
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In summary, according to the structure alignment results described above, it is suggested that 
Arg165, Ser82, Gln104, Lys142, Gln104, Arg173 and Gln162 are the amino acid residues 
most likely offering hydrogen bonding interaction to COO-, 4-O, 5-NH, 7-O, 8-O, 9-O and 
C=O (N-acyl) of the Neu5Ac moiety, respectively. Phe192, Phe193 and Tyr179 potentially 
form a hydrophobic pocket to accept the non-polar CH3 group (Table 8.1).    
 
8.2.2. Building and screening of single site mutagenesis libraries for Phe192 and 
Phe193  
 
From the kinetic constant study of CSSnme, 5’-modified Neu5Ac analogues are not well 
accepted as indicated by 10-100 folds increased KM values and 30-1700 fold decreased kcat/KM 
values in comparison with natural substrate Neu5Ac.[143] According to the structure 
alignment of CSSnme, Phe192 and Phe193 are directly contacting the acylamino moiety of 
Neu5Ac (Figure 8.4). Apparently, the phenyl groups of Phe192 and Phe193 block the access 
of modified groups to the pocket. A study of mutants from an Ala scan of CSSnme had shown 
that Phe192Ala causes a remarkable activity improvement towards Neu5Ac-OBz. Therefore, in 
order to improve the acceptance of CSSnme towards 5’-modified Neu5Ac analogs, focussed 
mutagenesis libraries were planned targeting on these two positions to obtain improved 
mutants offering less steric hindrance or a more polar pocket. Two individual single site 
libraries at positions Phe192 and Phe193 were constructed firstly to reveal their independent 
effect against modified groups, to be followed by a combined double site library for both 
Phe192 and Phe193 to illustrate their cooperative action.   
For the single-site libraries, the gene codons on the mutation site were designed as NNK 
covering the entire set of all 20 amino acids for reducing the library size to a lower limit of at 
least 95 colonies, while still guaranteeing a statistical library coverage of 95%,[26] which 
could easily be performed on a single 96-well plate. The QuikChange method was used for the 
construction of the mutagenesis libraries, which has been used widely in saturation 
mutagenesis. The common protocol uses a PCR to produce mutant plasmids followed by DpnI 
digestion, transformation and isolation of positive mutants on selection plates. A total of 96 
colonies were picked randomly for each single site library (named Lib-F192k and Lib-F193k, 
respectively). 
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Figure 8.4. Mutation sites of CSSnme. Phe192 and Phe193 are directly contacting the acylamino moiety of Neu5Ac. 
Apparently, the phenyl groups of Phe192 and Phe193 block the access of modified groups to the pocket. 
 
8.2.3. Building and screening of a Phe192-Phe193 double site mutagenesis library 
 
For building the double site library (Phe192 and Phe193), there were two well-used strategic 
alternatives. One is named Iterative Saturation Mutagenesis (ISM),[217] in which the most 
active single-site mutants at either position (Phe192 or Phe193) are identified first, followed 
by performing a second single site mutagenesis on the other Phe site using these positive 
mutants as templates. This is a relative simple and efficient method with the advantage of 
small library size, especially when only a few mutant sites need to be induced. However, a 
few potentially interesting mutants might unfortunately be missed with this method, because 
the first (or more) mutant site is fixed early on in these libraries. This will limit the diversity 
of mutations, and limits the opportunity to find cooperative interactions between any two (or 
more) amino acid residues. The other strategy is to perform saturation mutagenesis on both 
positions simultaneously. When using the NNK codon on both Phe sites, at least 3,066 
colonies should be included in this library for a statistical 95% coverage of the library for all 
20 residues,[26] so that the total required library size becomes much larger than that of 
sequential  single-site ones. However, if we use NRT or NDT degeneracy, the library size could 
be reduced to 190 or 430 colonies at 95% library coverage with a restriction to only 8 or 12 
amino acid residues, respectively. However, this would still include the typical residues 
containing polar, nonpolar (unavailable with NRT degeneracy), charged and aromatic 
Phe192
Phe193
Tyr179
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building blocks in the library.[26] Thus, two double-site libraries were built with either NRT 
or NDT degeneracies to compare their forward mutation efficiency for our experimental 
subject and to obtain as many positive hits as possible. Because the mutation sites are 
adjacent, the QuikChange method was also used for the construction of the mutagenesis 
libraries. A total of 192 and 432 colonies were chosen randomly for two double-site libraries 
(named Lib-F1923r and Lib-F1923d), respectively.  
 
8.2.4. Screening and docking of CSS mutants 
 
For the screening of the CSS mutagenesis libraries, a high-throughput method is required. 
Previously, a pH-based assay method has been well established for CSS activity determination, 
in which cresol red was used as pH indicator in 2 mM Tris as a low concentration buffer 
system.[143] With this assay method, the kinetic constants and substrate tolerance of CSSnme 
have been successfully measured towards various sialic acids and their derivatives. Because of 
its high throughput, sensitivity and economy, this pH-based assay also promised to be a 
suitable screening method for evaluation of the CSS mutagenesis libraries. To avoid inducing 
additional buffer components, a culture and lysis method described in the literature was used, 
which performed well in another pH-base screening system.[208] The cells were cultured and 
induced in LB medium without any additional buffer. The harvested cells were lysed by 
addition of 1/10 (V/V) BugBuster solution containing lysozyme and Benzonase.[208] The 
supernatant of the lysate was used directly as enzyme sample for the activity screening. The 
OD change was read and recorded by a plate reader at 574 nm. After the first round of 
screening, 16, 24 or 32 positive samples in each single-site and double-site libraries, 
respectively, were chosen for the rescreening. Finally, a total of 40 most active mutants from 
these four libraries were picked for the genetic identification. The screening and sequencing 
results are listed in Table 8.2. 
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Table 8.2. Screening and sequencing results for mutagenesis libraries 
Library 
Neu5Ac-OBz Neu5Hex Neu5PenN3 
Mutant 
(192/193) 
Relative 
activity 
Mutant 
(192/193) 
Relative 
activity 
Mutant 
(192/193) 
Relative 
activity 
Phe192k S/F 12.8 S/F 4.6 S/F 4.0 
 A/F 12.4 C/F 4.2 T/F 3.7 
 C/F 12.2 A/F 3.9 A/F 3.4 
 N/F 11.3 N/F 3.6 N/F 3.2 
 T/F 10.9 P/F 3.2 P/F 2.9 
 P/F 7.3 T/F 2.9 C/F 2.8 
Phe193k F/Y 3.9 F/Y 2.4 F/Y 2.1 
 F/I 3.2 F/I 1.8 F/I 1.8 
Phe1923r C/Y 14.1 C/Y 3.9 S/Y 3.8 
 S/Y 12.0 S/Y 3.5 S/H 2.9 
 S/H 10.7 S/H 3.0 C/Y 2.8 
 P/F 7.3     
Phe1923d C/F 13.3 C/F 4.6 I/Y 3.6 
 S/H 10.3 S/I 3.5 S/H 3.0 
 C/Y 10.0 G/I 3.2 S/I 3.0 
 S/I 10.0 G/Y 3.0 G/I 2.8 
 S/V 7.0 S/H 2.9 C/F 2.7 
     G/Y 2.5 
*The activity of wild-type is calculated as 1. 
 
The single site mutation results for F192A and P193A revealed that the Phe192 site has more 
influence in binding of the substrate’s acyl moiety than Phe193. This hypothesis is proved by 
the far better screening results of library Lib-F192k than those of Lib-F193k. Comparing the 
forward mutation efficiency between these two single-site libraries, much more and also 
higher active mutants can be found for Phe192, offering at least 2-3 fold higher activity than 
top mutants from Lib-F193k. The positive hits in Lib-F192k (Ser, Ala, Cys, Asn, Thr and Pro) 
are all those with amino acid residues that have shorter side chains and offer more space for 
the modified acyl groups than Phe. The top one F192S, which has an additional hydroxyl 
group, has a slightly higher activity than F192A. This particular hydroxyl group possibly forms 
an additional hydrogen bond to the modified acyl group of sialic acids, which is conducive to 
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the binding of substrate to enzyme. However, the most advanced mutants in the Lib-F193k 
library contained Tyr and Ile instead of Ala. Tyr has one more hydroxyl on the benzene ring 
than Phe, while Ile is a hydrophobic amino acid with a C4 side chian which is similar to but 
shorter than that of Phe, and much more voluminous than that of Ala. This result might reveal 
that the suitable side group volume and hydrophobicity or/and stable hydrogen bond at 
Phe193 are more important than an additional space and flexibility for the activity of CSS 
towards substrates modified at the acyl group. 
From the double site libraries, more coevolution mutants were observed. The NDK degeneracy 
offers four more hydrophobic amino acid residues than the one based on NRK. Thus, the 
positive mutants in Lib-F1923d present more diversity than those in Lib-F1923r. On the 
Phe192 position, we obtained Cys, Ser, Pro and also Gly and Ile, which can fit the 
requirement of more room for the modified acyl group. Meanwhile, on the Phe193 site, His 
and Val were newly found, the side-chains of which are similar to Tyr and Ile. Although there 
are more variations obtained in the double site libraries, there seems to be no major activity 
improvement as compared to the Lib-F192k hits. In consideration of the relative inaccuracy of 
measurements when using crude extract samples, the seven top mutants (Cys/Phe, Cys/Tyr, 
Ser/Phe, Ser/Tyr, Gly/Tyr, Ala/Phe and Ser/His) were chosen and purified by Ni-affinity 
chromatography, and their performance as pure enzymes will be compared in ongoing studies. 
 
8.2.5. Verification by synthesis of neo-sialoconjugates 
 
In order to validate the real improved activity towards 5’ modified Neu5Ac, the in situ CMP 
activation of Neu5Ac analogues was applied by using three selected CSS variants, CSSnme-
F192C/F193Y, CSSnme-F192S, and CSSnme-F192S/F193Y, for the preparative synthesis of new 
neo-sialoconjugate products, in which the mutant CSS catalysis was coupled with the 
2,6SiaTple conversion, which causes overall one-pot activation and transfer of the sialate 
moiety to Lac-D-T-P-Acr. (Scheme 8.1) 
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Scheme 8.1. Preparative synthesis of new neo-sialoconjugate products by using optimized mutants CSSnme-
F192C/F193Y, CSSnme-PF192S, and CSSnme-F192S/F193Y, in a one-pot, coupled system with 2,6SiaTple. 1: Neu5Ac-OBz. 
2: Neu5Hex. 3: Neu5PenN3. 
 
 
From the kinetic study of CSSnme, the wild-type has only low kcat/KM values of 0.2 and 0.7 
towards Neu5Ac-OBz and Neu5PenN3, respectively.[143] Variants CSSnme-F192C/F193Y, 
CSSnme-F192S, and CSSnme-F192S/F193Y were found as the top variants with 14.1 fold, 4.6 
fold and 4.0 fold activity improvement towards Neu5Ac-OBz, Neu5Hex and Neu5PenN3, 
respectively. During the synthesis of neo-sialoconjugate products, the activition step of 
Neu5Ac-OBz, Neu5Hex and Neu5PenN3 could be completed in one hour. The coupled 
sialyltransfer reaction also confirmed that indeed the CMP-sialic acid derivatives were formed 
correctly because they were well accepted as donor by 2,6SiaTple. The yields of the final 
products were 50%, 64% and 70%, repectively. 
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8.3. Conclusion 
 
CSSnme shows much less activity towards 5’-modified Neu5Ac analogues. From the active site 
alignment for the acceptor binding of CSSnme, Phe192 and Phe193 have been identified as the 
corresponding residues for the acylamino group of Neu5Ac. Therefore, four saturation 
mutagenesis libraries were constructed at positions of Phe192 and Phe193 (single and 
combined mutating) to improve its activity towards three representative substrates Neu5Ac-
OBz, Neu5Hex and Neu5PenN3. Using a pH-based high-throughput screening method, a series 
of positive variants were ifentified by screening. Among them, CSSnme-F192C/F193Y, CSSnme-
F192S, and CSSnme-F192S/F193Y were the top candidates with 14.1-fold, 4.6-fold and 4.0-
fold activity improvements towards Neu5Ac-OBz, Neu5Hex and Neu5PenN3, respectively. In 
order to validate the real improved activity towards 5’-modified Neu5Ac, the in situ CMP 
activation of Neu5Ac analogues was applied by using these three CSS variants for a 
preparative synthesis of new neo-sialoconjugate products when coupled with 2,6SiaTple 
catalysis to obtain final product yields of 50%, 64% and 70%, respectively. 
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9. Directed Evolution of 2,6-Sialyltransferase from Photobacterium leiognathi JH-
SHIZ-145 towards the Use of α-Galactosides as Glycosyl Acceptors 
 
 
9.1. Introduction 
 
2,6SiaTple is a typical and efficient 2,6-sialyltransferase having an optimum pH at around 
8.0.[160] In Chapter 4, the substrate tolerance and kinetic constants of 2,3SiaTpph and 
2,6SiaTple were evaluated based on a pH-based assay method and compared to literature 
results obtained by the HPLC methods.[160, 161] According to their specificity data, 
2,3SiaTpph and 2,6SiaTple showed different behavior towards α- and β-galactosides. Both α- 
and β-galactosides are well accepted by 2,3SiaTpph, while only β-configurated galactosides are 
acceptable by 2,6SiaTple. Although these two enzymes belong to the same sialyltransferase 
family (GT80) in CAZy database (carbohydrate-active enzymes),[218] the structural 
difference between their active sites dominates their different substrate specificities. 
Fortunately, both the crystal structures of 2,3SiaTpph and another 2,6SiaT from 
Photobacterium sp. JT-ISH-224 (2,6SiaTpsp) similar to 2,6SiaTple have already been 
determined.[148, 149, 210] Because of the high homology between 2,6SiaTple and 2,6SiaTpsp 
(53.8% identity and 67.8% consensus), the three-dimensional structure of 2,6SiaTple can be 
well simulated computationally based on the 2,6SiaTpsp structure as a template. The active 
domain comparison between 2,3SiaTpph and 2,6SiaTple can provide the feasibility to reveal the 
structure difference between each other, to allow a possible site-directed mutagenesis towards 
an extension of substrate tolerance. As an 2,6-sialyltransferase, 2,6SiaTple has shown an 
efficient catalytic specificity towards lactose derivatives.[171] For broader preparative-scale 
applications, it would be desirable if the enzyme could also accept α-galactosides as substrates. 
Thus, in this chapter, three-dimensional structures of 2,3SiaTpph and 2,6SiaTple are aligned, 
especially for their active-site pockets. Based on this structural analysis, three site mutagenesis 
libraries of 2,6SiaTple were built in an attempt improving its activity towards α-galactosides. 
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9.2. Results and discussion 
 
9.2.1. Active domain analysis of 2,3SiaTpph and 2,6SiaTple 
 
The crystal structure of 2,3SiaTpph has been published liganded by CMP as co-crystallized 
substrate.[149, 210] The lactose binding site has not been determined by bound substrate, 
but was well simulated based on the crystal structure analysis of an 2,3/6SiaT from 
Pasteurella multocida (2,3/6SiaTpmu).[148] The crystal structure of 2,6SiaTpsp has been 
determined both in the presence of CMP and lactose as substrates. With respect to the high 
homology between 2,6SiaTple and 2,6SiaTpsp, the tertiary structure of 2,6SiaTple was simulated 
using the web tool “SWISS-Model” based on 2,6SiaTpsp as a template.[113, 114] This 
computer simulated structure was utilized for the active site comparison of 2,3SiaTpph and 
2,6SiaTple. 
 
    1                                                                        75 
  SiaTpph    (1) -------------------------------------------------------------------------MF 
  SiaTple    (1) MKRIFCLVSAILLSACNDNQNTVDVVVSTVNDNVIENNTYQVKPIDTPTTFDSYSWIQTCGTPILKDDEKYSLSF 
 
    76                                                                      150 
  SiaTpph    (3) VFCKKIFFLIFISLMILGGCNSDSKHNNSDGNITKNKTIEVYVDRATLPTIQQMTQIIN---ENSNNKKLISWSR 
  SiaTple   (76) DFVAPELDQDEKFCFEFTGDVDGKRYVTQTNLTVVAPTLEVYVDHASLPSLQQLMKIIQQKNEYSQNERFISWGR 
 
    151                                                                     225 
  SiaTpph   (75) YPINDETLLESINGSFFKNR-----PELIKSLDSMILTNEIKKVIINGNTLWAVD-VVNIIKSIEALGKKTEIEL 
  SiaTple  (151) IRLTEDN-AEKLNAHIYPLAGNNTSQELVDAVIDYADSKNRLNLELNTNTGHSFRNIAPILRATSSKNNILISNI 
 
    226                                                                     300 
  SiaTpph  (144) NFYDDGSAEYVRLYDFSRLPESEQEYKISLSKDNIQSSINGTQP-FDNSIENIYGFSQLYPTTYHMLRADIFETN 
  SiaTple  (225) NLYDDGSAEYVSLYNWKDTDNKSQ--KLSDSFLVLKDYLNGISSEKPNGIYSIYNWHQLYHSSYYFLRKDYLTVE 
 
    301                                                                     375 
  SiaTpph  (218) LPLTSLKRVISNNIKQMKWDYFTTFNSQQKNKFYNFTGFNPEKIKEQYKASPHENFIFIGTNSGT------ATAE 
  SiaTple  (298) TKLHDLREYLGGSLKQMSWDTFSQLSKGDKELFLNIVGFDQEKLQQEYQQSELPNFVFTGTTTWAGGETKEYYAQ 
 
    376                                                                     450 
  SiaTpph  (287) QQIDILTEAKKPDSPIITNSIQGLDLFFKGHP-SATYNQQIIDAHN-MIEIYNKIPFEALIMTDALPDAVGGMGS 
  SiaTple  (373) QQVNVVNNAINETSPYYLG--REHDLFFKGHPRGGIINDIILGSFNNMIDIPAKVSFEVLMMTGMLPDTVGGIAS 
 
    451                                                 505 
  SiaTpph  (360) SVFFSLPNTVENKFIFYKSDTDIENN-----ALIQVMIELNIVNRNDVKLISDLQ 
  SiaTple  (446) SLYFSIPAEKVSFIVFTSSDTITDREDALKSPLVQVMMTLGIVKEKDVLFWC--- 
 
Sequence 9.1. Protein sequence alignment of 2,3SiaTpph and 2,6SiaTple.  
 
Being two functionally different sialyltransferases, understandably the protein sequences of 
2,3SiaTpph and 2,6SiaTple show only low 26.1% identity and 38.4% consensus. (Sequence 9.1) 
However, according to the three-dimensional structure alignment, the overall folding patterns 
of these two proteins present high similarity. (Figure 9.1a) Both of them have shell-shaped 
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tertiary structures (glycosyltransferase-B, GT-B) stabilized by a core of multi-β-pleated sheets. 
The active sites are located at the bottom of the shell, close to the centers of the proteins. 
Their active pockets are made up from the same protein domains responsible for CMP and 
sialyl acceptor binding, respectively. CMP is captured by a trap in closed by Thr49, Gly227, 
Lys315, His317, Pro318, Phe341, Glu342, Ser360 and Val361 in 2,3SiaTpph,[148] and Ser108, 
Leu109, Thr342, Lys385, Gly386, His 387, Pro388, Ser412, Phe413, Glu414, Ser431, and 
Ser432 in 2,6SiaTple. Meanwhile, acceptor binding domains are Arg74, Trp121, Asp148 and 
Ser150 in 2,3SiaTpph,[148] and His106, Asn157, His187 and Asp215 in 2,6SiaTple(Table 9.1).  
Table 9.1. Corresponding residues of 2,3SiaTpph and 2,6SiaTple for CMP and acceptor binding 
 2,3SiaTpph 2,6SiaTple 
CMP 
Thr49, Gly227, Lys315, His317, Pro318, 
Phe341, Glu342, Ser360, Val361 
Ser108, Leu109, Thr342, Lys385, Gly386, His 387, 
Pro388, Ser412, Phe413, Glu414, Ser431, Ser432 
acceptor Arg74, Trp121, Asp148, Ser150 His106, Asn157, His187, Asp215 
 
In both 2,3- and 2,6-SiaT, His and Asp are the key residues for the catalytic performance, in 
which the former acts as a catalytic acid that protonates the phosphate oxygen of CMP-sialic 
acid, while the latter acts as a catalytic base that deprotonates the 6-hydroxyl of the terminal 
Gal moiety.[148, 149] Except for this similarity, the acceptor binding domains are quite 
different and cause the galactopyranose moiety’s retroflexion when the acceptor is entering 
into the active channel, exposing either the OH3 or OH6 of the galactopyranose moiety to the 
catalytic center in order to create and producing the products with two different regioisomeric  
constitutions (2,3- or 2,6-). Focusing on the entrance channel for the acceptor, 2,6SiaTple 
exposes Trp347 on the loop1 in Figure 9.1b. Its side chain offers a huge π-electron surface 
forming a wall of the channel across the catalytic His106, Asn157, His187 and Asp215. 
(Figure 9.2a) Therefore, into this narrow channel β-galactosides can enter quite freely owing 
to their rather flat β-glycosidic face (Figure 9.2b). However, α-galactosides may be blocked by 
Trp347 during their approach to the active center, because the α-glycosidic bond is 
perpendicular to the galactopyranose ring, which results in an increased steric bulkiness of the 
acceptor molecule. This structural feature is able to explain the low activity of 2,6SiaTple 
towards α-galactosides. On the contrary, loop 1 in 2,3SiaTpph is relative small. The lack of a 
corresponding residue for Trp347 in 2,6SiaTple offers more space for approaching acceptors. 
Both α- and β-galactosides fit quite well in positions close to the CMP location. Thus, only 
little activity difference of 2,3SiaTple was determined when methyl-α- and β-D-
galactopyranosides were tested as acceptors. 
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a)                                                               b) 
 
 
 
 
 
Figure 9.1.Three-dimensional structure alignment of 2,3SiaTpph and 2,6SiaTple. a) Overall structures alignment of 
2,3SiaTpph (PDB ID 2ZWI) and 2,6SiaTple. b) Active domain alignment of 2,3SiaTpph and 2,6SiaTple. Red-green-yellow 
stands for 2,3SiaTpph, flesh red-acid blue-pink stands for 2,6SiaTple. 
 
a)                                                                      b) 
 
 
 
 
 
 
c)                                                                     d) 
 
 
 
 
 
 
Figure 9.2. Structure analysis of active domain. a) Surface of loop1 in 2,6SiaTple. b) Amino acid residues of loop1 
(pink) in 2,6SiaTple. c) Surface of loop1 in W347A of 2,6SiaTple. d) Amino acid residues of loop1 in W347A of 
2,6SiaTple. 
W347 
CMP 
Lac 
W347
CMP
Lac
W347A
CMP
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Lac 
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Lac 
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In order to improve the tolerance of 2,6SiaTple for α-galactoside, the modification has to 
consider the most discriminating Trp347 as well as its spatical neighbors located on the same 
loop, including Thr344, Thr345, Thr346, Trp347, Ala348 and Gly349. Building a random 
mutagenesis library covering the whole loop would be an ideal way to test all amino acid 
combinations for activity. However, too many variants would have to be picked, which makes 
the screening a formidable task. Thus, the Trp347 site was firstly focused on to see whether it 
can be exchanged for other residues (named Lib-W347). Furthermore, replacing Trp347 into 
non-polar hydrophobic amino acid residues such as Ala or Gly could potentially eliminate the 
block for an entrance of α-galactosides (Figure 9.2a and b). Unfortunately, the W347A variant 
has been reported to loosing SiaT activity almost completely.[149] Therefore, if Trp347 needs 
to be changed into Ala or Gly, a similar residue would be required to activity recover 
somewhere else on the loop. Upon inspection of this loop, Thr344, Thr345 and Thr346 are 
oriented towards CMP and the galactopyranose ring of the acceptor, which makes them 
potential candidate sites for activity recovering mutagenesis. However, the side chain 
orientations of Thr344 and Thr346 point away from the reaction center between the 
phosphate group of CMP and the galactopyranose moiety of the acceptor, and only the side 
chain of Thr345 is directed to CMP. Therefore, Thr345 was chosen on rational consideration 
as the most promising mutagenesis site. On the other hand, Gly can sustain a larger turn 
angle then Ala in the tertiary structure of the protein. According to the analysis above, both 
Trp347Ala and Trp347Gly site mutation were tried to be induced into 2,6SiaTple first, 
followed by a building of saturation mutagenesis library at Thr345 (named Lib-W347A-T345 
and Lib-W347G-T345). In summary, it was planned to construct three mutagenesis libraries 
with different randomization sites, which are Lib-W347, Lib-W347A-T345 and Lib-W347G-
T345. 
 
9.2.2. Building and screening of 2,6SiaTple mutagenesis libraries 
 
For Lib-W347A-T345 and Lib-W347G-T345, single site mutations W347A (GGG) and W347G 
(GCG) were firstly introduced into 2,6SiaTple. The gene identification shows that the wild-type 
codon TGG (Trp) has been successfully replaced by GGG (Ala) and GCG (Gly), respectively 
(Figure 9.3a). For Lib-W347, primers with NNS codon degeneracy at W347 site were designed 
for PCR. For Lib-W347A-T345 and Lib-W347G-T345, similar NNS codon degeneracy primers 
 Seite 98 
were also designed based on the mutate sequence as templates. The mutation frequency of all 
three libraries was evaluated by sequencing of mixed plasmids presented in Figure 9.3.  
a)                                                 b)                                              c) 
 
 
 
Figure 9.3.Evaluation of 2,6SiaTple mutagenesis libraries. a) Lib-W347. b) Lib-W347A-T345, c) Lib-W347G-T345. The 
original codon on W347 or T345 has been successfully replaced by NNS, in which N was shown as A/T/G/C 
overlapping peaks and S as G/C overlapping peaks. 
 
In Chapters 4 and 8, pH-Based high throughput assay methods have been successfully applied 
already for screening of TK and CSS mutant libraries where serveral promising mutants with 
extended substrate tolerance could be identified. Similar to those, as well as to studies 
involving the modification of acceptors for sialyltransferase, the release of protons during the 
reaction can also be determined spectrophotometrically by assistance of a pH indicator. 
According to this assay principle, the substrate tolerance and kinetic constants of 2,3SiaTpph 
and 2,6SiaTple where already determined in Chapter 7. Because of its high sensitivity and 
high-throughput nature, this assay can also be utilized for the screening of SiaT libraries. The 
screening reaction system was basically the same as that for determination of SiaT substrate 
tolerance. Phenol red at (2.82 mM concentratrion) was used as pH indicator, and 2 mM Tris-
HCl buffer (8.0) with 0.5 M NaCl was chosen as buffer system. Substrates 0.5 mM CMP-
Neu5Ac and 50 mM methyl-α-D-galactopyranoside were added as donor and acceptor, 
respectively. The cultivation and lysis methods for cells expressing the SiaT variant followed 
the same protocals as described in Chapter 4/8 for TK/CSS mutagenesis libraries. As the 
enzyme sample, 40 μl each of crude extract was used. 
All of the 6 plates in the three libraries were screened for twice. Unfortunately, Lib-W347A-
T345 and Lib-W347G-T345 gave no positive mutants at all. That means the activity in the 
2,6SiaTple-W347A and –W347G variants cannot be recovered by any site-mutation at the T345 
position. Interestingly, four colonies in Lib-W347 presented positive assay results. However, 
sequencing upon all hits were confirmed still to be wild-type. This disappointing screening 
result reveals that W347 plays an extremely crucial role in the 2,6-sialyltransfer reaction, 
which cannot be replaced by any other amino acid residues at the same position or be rebuilt 
at the corresponding alternative Thr345 site.  
W347GT345 W347AT345W347 T345 
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9.2.3. Re-analysis of active site of 2,6SiaTple 
 
Although there was no anticipated positive result coming out from the library screening, it 
still provided certain information about the catalytic mechanism of 2,6-SiaT and the function 
of Trp347 in the catalytic center. Kakuta et al. have interpreted the proposed catalytic 
mechanism of 2,6SiaT.[149] It is considered that in 2,6SiaTple Asp215 deprotonates the OH6 
of the galactopyranose moiety of the acceptor, thereby increasing its nucleophilic character for 
the attack on C2 of the NeuAc moiety. On the other hand, His387 protonates the phosphate 
oxygen of CMP-NeuAc stabilizing the oxocarbenium-ion-like transition state, followed by the 
release of CMP and the formation of the product.[149] Trp347 seems not to be involved in 
the generation of the transition state. On the other hand, 2,3SiaT shares the same catalytic 
mechanism with 2,6SiaT,[148] but has no residue corresponding to Trp. This might indicate 
that the Trp moiety is not required for the sialyltransfer reaction but, irrespective of the 
results from site-directed mutagenesis[148, 150] or from the randomized mutagenesis 
libraries constructed here, Trp shows a unique function in 2,6SiaT. Ni et al. have proved that 
Trp270 in 2,3/6SiaTpmu interacts with the galactopyranose ring by hydrophobic stacking.[150] 
The KM change of W270F and W270A further showed that Trp270 binds to both donor and 
acceptor.[150] Therefore, it is concluded that Trp347 in 2,6SiaTple also very likely not only 
engages in hydrophobic stacking interaction with the acceptor galactopyranose ring, but also 
contributes to the binding both of donor and acceptor by acting as a bridge between them. 
This bridge seems to stabilize both the Neu5Ac moiety release from CMP-Neu5Ac and the 
attack of O6 of galactopyranose moiety to C2 of the Neu5Ac unit. Moreover, the retroflexion 
of the galactopyranose moiety causes the distinct regiospecific product formation 
characteristic for by 2,3- and 2,6-SiaTs. Thus, we also think that the presence of Trp347 in the 
2,6SiaTple helps to adjust the correct conformation of lactose to favor the formation of a 2,6-
sialated product.  
 
9.3. Conclusion 
 
Different from 2,3SiaTpph, 2,6SiaTple can only accept β-galactosides well. From the structure 
alignment between these two SiaTs, Trp347 was found as the crucial residue which blocks the 
entrance for α-galactosides to the active center. Therefore, three mutagenesis libraries were 
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constructed to improve the activity of 2,6SiaTple towards α-galactosides to replace or relocate 
Trp347. An optimized pH-based assay was developed as a high-throughput screening method 
using methyl-α-D-galactopyranoside as an acceptor. However, no positive mutant could be 
detected during the screening, which indicates that Trp347 seems to be irreplaceable in 
2,6SiaTple. It is presumed that Trp347 contributes to the binding between donor and acceptor 
and helps to stabilize the correct acceptor conformation to form the 2,6-sialated product. 
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10. Chemoenzymatic Synthesis of neo-2,3- and 2,6-Sialoconjugates 
 
 
10.1. Introduction 
 
The synthesis of neo-sialoconjugates in vitro is a chemoenzymatic pathway, which contains 
four steps: chemical synthesis of Man(NAc) derivatives, followed by enzymatic aldolization, 
CMP-activation and sialylation. The aldolase catalyzed carboligation produces sialic acids by 
starting from Man(NAc) or analogs and pyruvate. The CMP-activation of sialic acids is 
catalyzed by CMP-sialate synthetase forming the donor required for the finial sialyltransfer 
step which is catalyzed by a 2,3SiaT or 2,6SiaT to produce the target 2,3- or 2,6-
sialoconjugates (Scheme 10.1).[130, 171] Ideally, the three enzymatic steps can be carried 
out together in a one-pot approach.[202]  
 
 
 
 
 
 
 
 
 
Scheme 10.1. The enzyme-catalyzed synthetic route to sialcoconjugates  
 
The diversity of the synthesized sialoconjugates is determined by the regioselectivity of the 
chosen SiaT enzyme and by the potential diversity of the employed starting donor and 
acceptor in the sialyltrasfer. Although the natural acceptors of sialylation are mostly limited to 
a Gal or GalNAc moiety, the structure of artificial galactosides can be diverse, for example, the 
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C2 modified Gal or GalNAc, C1 modified lactose and LacNAc, and even modified, labeled or 
complex immobilized oligosaccharides such as LewisX in the potential research on medical 
purposes.[127, 147, 202, 204, 219-223] In addition, the extremely broad acceptor specificity 
of 2,3SiaT from Photobacterium sp. even allows sialyltransfer to related acceptors like α-Glc, β-
Man and inositol, thereby producing unique sialyloligosaccharides.[224, 225] 
Up to present, besides natural sialic acids, many non-natural analogs with modification at C5, 
C7, C8 and C9 have been linked to a fluorescent Lac with α-2,6-sialyl linkage.[171] In this 
chapter, six typical sialic acids and their derivatives were transferred to the same fluorescent 
Lac acceptor with an α-2,3-linkage by 2,3SiaTpph, and a fluorescent LacNAc acceptor with an 
α-2,6-linkage by 2,6SiaTple, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.1. Chemoenzymatic synthetic route for the synthesis of fluorescent sialoconjugates 
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10.2. Results and discussion 
 
10.2.1. Enzymatic synthesis and CMP activation of sialic acid derivatives 
 
The largest group of structureal variations in sialic acid is mainly due to modification of C5 
and C9 of Neu5Ac. For the present synthesis study, Neu5Ac, Neu5Gc, KDN, epi-KDN, Neu5Ac-
9-N3 and Neu5NPhAc were chosen as typical sialic acid donors. Besides Neu5Ac, Neu5Gc and 
KDN are also the most common sialic acids in nature. Neu5Gc has an additional hydroxyl 
group at the acetamide group of Neu5Ac. Accordingly, Neu5NPhAc contains a phenyl group at 
the same position, which is non-polar, much larger than the hydroxyl group and which can be 
specifically removed by Penicillin G acylase (PGA). Kdn has a hydroxyl group instead of the 
acetamide group of Neu5Ac. Oppositely, epi-Kdn contains the same hydroxyl in the epimeric 
trans configuration. In addition, Neu5Ac-9-N3 brings in a modification on C9 of Neu5Ac. 
Based on these six sialic acids, the donor specificity of SiaT can be tested for various structural 
variations along the chain of sialic acid, as well as the configuration of C5. The synthesis of 
these sialic acids starts from the corresponding Man(NAc) derivatives and pyruvate, and are 
catalyzed by N-acetylneuraminic acid aldolase (NeuA) from E. coli (Scheme 10.2). This 
aldolization reaction is a reversible reaction, which leads to a product yield around 50-60%. 
Therefore, excessive pyruvate was added to the reaction mixture in order to increase the 
product fraction at equilibrium. 
 
 
 
 
 
Scheme 10.2. Examplary synthesis of Neu5NPhAc and its CMP-activation.  
 
The CMP activation of sialic acid can be carried out easily together with the sialylation in a 
one pot reaction system.[171] Alternatively, it can also be performed separately as a single 
step in the synthesis process. For the determination of kinetic constants of SiaT, CMP-Neu5Ac 
was synthesized and isolated as a purified compound. The activation of Neu5Ac could be 
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completed with 100% conversion. Because of the relative instability of CMP-Neu5Ac in acidic 
solution, the purification of CMP-Neu5Ac on a Bio-gel column was performed with dilute 
aqueous ammonia (pH 9.0) as mobile phase to reach a final yield of 90%. On the other hand, 
large hydrophobic the phenyl modification in Neu5NPhAc leads to a significantly lower 
acceptance by CSSnme. In chapter 8, the mutation of CSSnme at Phe192 or/and Phe193 is 
shown to lead to variants having improved activity towards 5’ modified sialic acids. Therefore, 
the CMP-activation of Neu5NPhAc was carried out preferentially by CSSnme-F192A instead of 
the wild-type CSSnme, which was used for the other sialic acids in a one-pot reaction by 
coupling with SiaT. 
 
10.2.2. Enzymatic synthesis of neo-2,3-sialoconjugates  
 
The preparative regioselective synthesis of neo-sialoconjugates by using 2,3SiaTpph and 
2,6SiaTple was carried out by a one-pot two-enzyme approach, in which CSSnme and the 
correspongding SiaT were involved. Additionally, inorganic pyrophosphatase from baker’s 
yeast was added into the CMP-activation step to eliminate the product inhibition of 
pyrophosphate (PPi) for CSSnme. When the CMP-activation was completed, alkaline 
phosphatase from bovine intestinal mucosa was involved in the sialyltransfer step to eliminate 
the inhibition of released CMP for SiaT. With these two auliliary enzymes, CMP-activation and 
sialyltransfer can be performed much faster and closer to complete. The 2,3SiaT from 
Photobacterium sp. has been demonitrated before to have an extremely broad substrate range, 
which was confirmed by the pH-based assay in chapter 7. Actually, 2,3SiaT from 
Photobacterium sp. is able to accept all of the positions having an equatorial hydroxyl group of 
a cis-diol structure stereoconfigurationally corresponding to the C3 and C4 unit of the Gal 
moiety.[224] Moreover, the fluorescant label on C7 of Lac did not decrease the activity of 
SiaT.[171] Here, the synthesis of neo-2,3-sialoconjugates also used the fluorlabeled Lac 
acceptor (Lac-D-T-P-Acr). During the sialyltransfer reaction, 2,3SiaTpph can accept all of the 
six CMP-activated sialic acids. TLC monitoring of the reaction showed that Neu5Ac, Neu5Gc, 
Kdn and Neu5Ac-9-N3 all could be quantitatively transferred into the Gal moiety of Lac-D-T-P-
Acr. The final isolated product yields were 84%, 77%, 86% and 82%, respectively. However, 
the transfer rates for epi-Kdn and Neu5NPhAc were sloer and reached only around 60% and 
50% conversion under non-optimized conditions. As a result, the total yields of epi-KDN-2,3-
Lac-D-T-P-Acr and Neu5NPhAc-2,3-Lac-D-T-P-Acr were only 58% and 48%. This result reveals 
that the structure and configuration of the C5 side chain is more critical to the activity of CSS 
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and 2,3SiaTpph compared with C9 substitution. The modification with trans configuration or a 
large hydrophobic amide group can obviously decrease the activity and conversion efficiency 
of 2,3SiaTpph.  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 10.3. Enzymatic synthesis of neo-2,3- and 2,6-sialoconjugates. 
 
10.2.3. Enzymatic synthesis of neo-2,6-sialoconjugates  
 
Compared with 2,3SiaTpph, the 2,6SiaTple has a much narrower acceptor range, because the 
Trp347 at the entrance of its active pocket blocks the access for all α-galactosides and 
provides the enzyme with a stricter β-selectivity for sialylation acceptors. Fortunately, 
however, 2,6SiaTple was found to tolerate a large donor range, which rendered the synthesis 
of the corresponding 2,6-sialylated Lac-D-T-P-Acr acceptor successful.[171] The structurally 
related LacNAc is the terminal moiety in the Lewisx structure, where it plays the role of the 
natural acceptor for SiaT. Thus, the acridone conjugate LacNAc was synthesized in chapter 8 
to be used for the neo-2,6-sialoconjugate synthesis. Using the same one-pot enzyme cascade 
as above, the six sialic acids were activated, then transferred by 2,6SiaTple into the Gal moiety 
of LacNAc-D-T-P-Acr, thereby forming the expected 2,6-LacNAc-sialoconjugates with product 
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yields from 51% to 86%. Different from 2,3SiaTpph, the 2,6SiaTple can accept well not only 
Neu5Ac, Neu5Gc, Kdn and Neu5Ac-9-N3, but also epi-Kdn with close to 100% conversion rate 
(by TLC control) and 86% final yield of its product. Only Neu5NPhAc could be transferred 
less effectively by 2,6SiaTple, showing a relative conversion rate of around 50% and a total 
yield of 51% Neu5NPhAc-2,6-LacNAc-D-T-P-Acr. On the whole, 2,6SiaTple seems to have a 
similarly broad donor specificity like 2,3SiaTpph, except for its apparent higher tolerance for an 
inverted configuration at the C5 position like for 2,3SiaTpph, the N-phenylacetyl modification 
in Neu5NPhAc decreases the affinity and activity of 2,6SiaTple.  
 
10.3. Conclusion 
 
A series of neo-2,3- and 2,6-sialoconjugates were synthesized in a one-pot, two-enzyme 
approach using a combination of CSSnme with 2,3SiaTpph or 2,6SiaTple. Six typical sialic acids 
(Neu5Ac, Neu5Gc, Kdn, epi-Kdn, Neu5Ac-9-N3 and Neu5NPhAc) with structural modifications 
at C5 and C9 were involved as donors for a transfer to Lac-D-T-P-Acr and LacNAc-D-T-P-Acr 
with α-2,3- and α-2,6-configuration, respectively. Both 2,3SiaTpph and 2,6SiaTple showed quite 
similar donor specificity towards these six sialic acids. Both of them have high activity towards 
CMP activated Neu5Ac, Neu5Gc, Kdn and Neu5Ac-9-N3, but limited tolerance for the bulky 
Neu5NPhAc. As a clear distinction, the 2,6SiaTple can accept epi-Kdn better than 2,3SiaTpph. 
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11. Cloning, Expression and Characterization of a Potential 2,3-Sialyltransferase 
from Shewanella piezotolerans 
 
 
11.1. Introduction 
 
Finding novel and superior biocatalysts is a top priority in biocatalysis. While more and more 
genome sequence data is being added into gene databases, sequence alignment has become 
an effective tool to search for potential functional proteins from Genbank. Meanwhile, gene 
synthesis technique has been highly developed, so that gene sequences coding for desired 
enzymes can be artificially synthesized at relatively low cost. This technique can be applied 
widely in cloning, expression and further characterization of potential proteins without the 
need for growing of the resource organism, which is especially important for difficult to 
culture microorganisms. Recently, a new potential sialyltransferase from Shewanella 
piezotolerans (SiaT0160, SiaTspi) has been identified from genome sequencing[201] (Genbank 
Access No. CP000472) and assigned to the GT80 family (www.cazy.org) because of its high 
homology with α-2,3SiaTs in the same family. However, cloning, expression and activity assay 
for this SiaTspi have not been reported yet. In this chapter, an artificial gene of this protein is 
cloned, modified and expressed in E. coli and a Yarrowia expression system. The primary 
2,3SiaT function of this enzyme is characterized. 
 
11.2. Results and discussion 
 
11.2.1. Sequence and structure analysis of SiaTspi 
 
11.2.1.1. Protein sequence analysis of SiaTspi 
 
S. piezotolerans is a marine microorganism living in the deepsea.[226] The genomic DNA 
sequence of S. piezotolerans has been sequenced[201] and indexed in Genbank (Access No. 
CP000472). Among its whole genome sequence, an open reading frame has been identified 
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for which the corresponding protein expression product has high homology with α/β-2,3 and 
α-2,6SiaTs belonging to the GT 80 family (www.cazy.org) (Sequence 11.1). From the protein 
sequence alignment, it is shown that the protein is more similar to 2,3SiaT than to 2,6SiaT. 
For example, it has 27.9% identity and 42.9% consensus with 2,3SiaTpph, but only 19.3% 
identity and 31.4% consensus with 2,6SiaTple. From the sequence feature, it is equipped with 
both the typical CMP and lactose binding domains, which are also very similar to those of 
2,3SiaTpph. Thus, it is assumed that SiaTspi possibly has a 2,3SiaT function. 
 
    1                                                                        75 
  SiaTple    (1) MKRIFCLVSAILLSACNDNQNTVDVVVSTVNDNVIENNTYQVKPIDTPTTFDSYSWIQTCGTPILKDDEKYSLSF 
  SiaTpph    (1) -------------------------------------------------------------------------MF 
  SiaTspi    (1) --------------------------------------------------------------------------- 
SiaTspi-U     (1) --------------------------------------------------------------------------- 
    
    76                                                                      150 
  SiaTple   (76) DFVAPELDQDEKFCFEFTGDVDGKRYVTQTNLTVVAPTLEVYVDHASLPSLQQLMKIIQQKNEYSQNERFISWGR 
  SiaTpph    (3) VFCKKIFFLIFISLMILGGCNSDSKHNNSDGNITKNKTIEVYVDRATLPTIQQMTQIINEN---SNNKKLISWSR 
  SiaTspi    (1) -------------------------------------------------------MLVNNQ---SHNPKLICWQR 
SiaTspi-U     (1) -----------------------MVASSSSNAQQSPYALEIYIDKATLPSVQQAAMLVNNQ---SHNPKLICWQR 
    
    151                                                                     225 
  SiaTple  (151) IRLTEDNAEKLNAHIYPLAGNNTSQELVDAVIDYADSKNRLNLELNTNTGHSFRNIAPILRATSSKNNILISNIN 
  SiaTpph   (75) YPINDETLLESINGSFFKN----RPELIKSLDSMILTNEIKKVIINGNT-LWAVDVVNIIKSIEALGKKTEIELN 
  SiaTspi   (18) HPVNDEALLQGINAASFVS----IASLCQHAATLLAGHPHSHITIYGNT-YWSKDLARLIRYLTRISGVEIKKLE 
SiaTspi-U    (50) HPVNDEALLQGINAASFVS----IASLCQHAATLLAGHPHSHITIYGNT-YWSKDLARLIRYLTRISGVEIKKLE 
    
    226                                                                     300 
  SiaTple  (226) LYDDGSAEYVSLYNWKDTDNKSQ--KLSDSFLVLKDYLNG-----------ISSEKPNGIYSIYNWHQLYHSSYY 
  SiaTpph  (145) FYDDGSAEYVRLYDFSRLPESEQEYKISLSKDNIQSSING------------TQPFDNSIENIYGFSQLYPTTYH 
  SiaTspi   (88) LIDDGSSEYQKMFYWQRLSSEEQTRDLATGLKNLKSYLSGNDNKLLRLLTGHSNKLPRRLSSFMNWHQLFPTTYH 
SiaTspi-U   (120) LIDDGSSEYQKMFYWQRLSSEEQTRDLATGLKNLKSYLSGNDNKLLRLLTGHSNKLPRRLSSFMNWHQLFPTTYH 
    
    301                                                                     375 
  SiaTple  (288) FLRKDYLTVETKLHDLREYLGGSLKQMSWDTFSQ--LSKGDKELFLNIVGFDQEKLQQEYQQSE-LPNFVFTGTT 
  SiaTpph  (208) MLRADIFETNLPLTSLKRVISNNIKQMKWDYFTT--FNSQQKNKFYNFTGFNPEKIKEQYKASP-HENFIFIGTN 
  SiaTspi  (163) MLRMDYLDK-PELHQLKQYLGNNAQQIRWNYIADNLFDDEQQSLFYQLLGISLAEQKQLRAGRQQLHDFMFIGVD 
SiaTspi-U   (195) MLRMDYLDK-PELHQLKQYLGNNAQQIRWNYIADNLFDDEQQSLFYQLLGISLAEQKQLRAGRQQLHDFMFIGVD 
    
    376                                                                     450 
  SiaTple  (360) TWAGGETKEYYAQQQVNVVNNAINETSP--YYLGREHDLFFKGHPRGGIINDIILGSFNNMIDIPAKVSFEVLMM 
  SiaTpph  (280) SGT------ATAEQQIDILTEAKKPDSPIITNSIQGLDLFFKGHPSATYNQQIID--AHNMIEIYNKIPFEALIM 
  SiaTspi  (237) SSN------ASSKLQINVIADSRQESG--IIPTITAKKMLFKGHPFANFNQTIVD--AHQMGEMPAMIPFETLIM 
SiaTspi-U   (269) SSN------ASSKLQINVIADSRQESG--IIPTITAKKMLFKGHPFANFNQTIVD--AHQMGEMPAMIPFETLIM 
    
    451                                                                520 
  SiaTple  (433) TGMLPDTVGGIASSLYFSIPAEKVSFIVFTSSDTITDREDALKSPLVQVMMTLGIVKEKDVLFWC----- 
  SiaTpph  (347) TDALPDAVGGMGSSVFFSLPNTVENKFIFYK-----SDTDIENNALIQVMIELNIVNRNDVKLISDLQ-- 
  SiaTspi  (302) TGNLPQKVGGMASSLYFSLPNNYHIEYIVFSG----SKKDLEQHALLQIMLYLKVISPERVYFSEQFKSC 
SiaTspi-U   (334) TGNLPQKVGGMASSLYFSLPNNYHIEYIVFSG----SKKDLEQHALLQIMLYLKVISPERVYFSEQFKSC 
 
Sequence 11.1. Protein sequence alignment of SiaTspi and SiaTspi-U with 2,3SiaTpph and 2,6SiaTple. Red frames 
indicate upstream sequence and 12 amino acid insertion in the middle of SiaTspi. 
 
However, an interesting observation is that the gene of SiaTspi listed in the Genbank and the 
CAZy database contains only 1,101 bp encoding a predicted protein of 367 amino acid 
residues, which is significantly shorter than other SiaTs in the same family (usually around 
400 amino acid residues for 2,3SiaT and 500 amino acid residues for 2,6SiaT), while this 
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might be the result of evolution to adapt the organism to its preferred cold and pressurized 
habitat, it could also be due to a mistake generated by the automated sequence analysis 
software which might have misinterpreted the start codon ATG of the open reading frame. 
Using BLAST, indeed a missed sequence fragment of 96 bp can be identified. This sequence 
fragment codes for an additional series of amino acid residues that shows high similarity with 
the corresponding part of other SiaTs (Sequence 11.1, red frame 1).  When this sequence is 
joined to the SiaTspi, SiaTspi reaches the full sequence length typical for other 2,3SiaTs. Thus, it 
is inferred that this sequence might be an essential functional part of SiaTspi. On the other 
hand, a corresponding 24 amino acid sequence at the N-terminus of 2,3SiaTpph has been 
identified as a common signal peptide sequence, which does not contribute to the 
sialyltransfer function of the enzyme.[161]  
As an organism living in the deepsea, S. piezotolerans has to adapt its metabolism and 
constituents to the cold and pressurized environment. Therefore, the SiaTspi might be likely a 
cold-adapted enzyme. Normally, cold-adapted enzymes have remarkable sequence signatures. 
For example, they contain lower numbers of polar (Ser, Thr, Asn, Glu and so on) and 
aromatic (Tyr, Phe and Trp) amino acid residues to reduce the number of stabilizing 
hydrogen bonds and aromatic π- and hydrophobic interactions.[227, 228] The number of Pro 
residues is also reduced because of the rigidity of its imino group.[227] Gly stacking may be 
found near the active site because its absent side chain offers varied dihedral angle in protein 
conformation, which is beneficial for the flexibility of the enzyme.[227] Because the 
guanidinium group of Arg which can form at least one salt bridge in the tertiary structure, a 
lower number of Arg residues or a reduced ratio of Arg/(Arg+Lys) is often can be observed in 
thermolabile enzymes.[227]  
To find out whether SiaTspi fits the features of a cold-adapted enzyme, its amino acid residue 
composition and secondary structure were analyzed using the 2,3SiaTpph from a mesophilic 
source as reference. The analysis data is listed in Table 11.1. Compared to 2,3SiaTpph, the 
percentage of polar amino acid residues is obviously reduced. On the other hand, the total 
number of aromatic residues is almost the same as in 2,3SiaTpph, and both of them contain the 
same number of Pro residues. The Gly content in SiaTspi is slightly higher than that found in 
2,3SiaTpph. All these data show that SiaTspi may have a lower thermostability than 2,3SiaTpph. 
However, the doubled number of Arg and ratio Arg/(Lys+Arg) suggests the opposite 
conclusion. Considering the relative low optimum temperature of 2,3SiaTpph (30°C),[161] the 
analysis for which partly fits the property of a cold-adapted enzyme itself,[229] the SiaTspi 
could thus also be considered as a cold-adapted enzyme.  
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Table 11.1. Amino acid residue composition and secondary structure analysis of SiaTspi and 2,3SiaTpph  
 SiaTspi SiaTspi-U dSiaTspi-U 2,3SiaTpph 
Total residues 367 399 387 409 
Ser 9.68% 9.52% 9.82% 8.31% 
Thr 3.72% 3.76% 3.26% 6.36% 
Asn 5.71% 5.76% 5.43% 10.02% 
Glu 4.42% 4.26% 4.39% 6.11% 
Tyr 4.47% 4.51% 4.65% 3.64% 
Phe 3.97% 4.01% 4.13% 6.36% 
Trp 1.24% 1.25% 1.29% 0.73% 
Pro 3.54% 3.76% 3.88% 3.67% 
Gly 5.18% 4.76% 4.65% 4.16% 
Arg 3.72% 3.76% 3.62% 1.96% 
Arg/(Lys+Arg) 41.7% 40.5% 40.0% 20.5% 
Disulfide linkage none none none none 
 
 
11.2.1.2. Analysis of the three-dimensional structure of SiaTspi 
 
The crystal structure of 2,3SiaTpph has been determined containing CMP as co-crystallized 
substrate part.[148] Using this crystal structure as a template, the tertiary structure of SiaTspi 
with and without the identified additional upstream sequence has been simulated using the 
web-tool SWISS Model,[113, 114] to evaluate its active site and analyze the potential 
function of its upstream sequence. SWISS Model uses protein sequence alignment and known 
crystal structure databases (e.g. PDB) to calculate a model of the unknown protein 
structure.[113, 114] Because of the high homology between SiaTspi or SiaTspi-U and SiaTpph, 
the latter was chosen as the template for automatic structure simulation of SiaTspi by SWISS 
Model. Figure 11.1 shows a comparison of the structures of 2,3SiaTpph, SiaTspi and SiaTspi-U. A 
high similarity can found from the structure overlay. In the 2,3SiaTpph structure, 7 parallel β-
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sheets form a stable support motif. In comparison, however, in SiaTspi one large β-sheet and 
one α-helix are missing at the N-terminus when its upstream sequence is missing. This void 
may lend more flexibility to SiaTspi when needed to adapt to a cold environment under high 
pressure. If the upstream sequence is added to SiaTspi, these missing structures are fully 
reconstructed. Because the active site of 2,3SiaT is located in the center of the protein 
structure, this upstream sequence part could play an important role in the activity and 
stability of this potential 2,3SiaT. Therefore, it is believed the upstream sequence contributes 
to the activity of SiaTspi, at least within a normal environment. On the other hand, when 
compared to other SiaTs, SiaTspi contains an additional 12 amino acid residue insert in the 
middle of its protein sequence. These 12 residues are interpreted to create a double β-sheet 
structure on one site of SiaTspi, which may give more stability for SiaTspi. Although there is no 
obvious change to the overall tertiary folding pattern induced by these two β-sheets, this 
might affect the activity of SiaTspi. To investigate these conjectures, the 3 gene variants of (1) 
SiaTspi, (2) SiaTspi with upstream sequence (SiaTspi-U) and (3) SiaTspi-U with deletion of the 12 
residue sequence (dSiaTspi-U) were constructed and cloned into E. coli BL21 cells using 
pET21a and pET19b as expression vectors. The expression of these three recombinant 
enzymes (with His-Tag at either N or C terminus) is described below (Figure 11.1).  
 
 
 
 
 
 
 
 
Figure 11.1． Amino acid sequence alignment and structure simulation of 2,3SiaTpph (PDB code 2ZWI), SiaTspi and 
SiaTspi-U by SWISS Model.[113, 114] Blue arrow: the missing upstream sequence forms two β-sheets. White arrow: 
the 12 amino acid insection forms two β-sheets. 
 
The structure simulation of the active pocket could possibly directly reveal the enzyme’s 
catalytic property. The active site of SiaTspi was aligned with those of 2,3SiaTpph and 
2,3/6SiaTpmu for an analysis of the CMP and lactose binding residues, respectively (Figure 
C-ter
C-ter C-ter
N-ter
N-ter
N-ter
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11.2). The CMP binding domain of SiaTspi is exactly matching that of 2,3SiaTpph. It is 
composed of Thr23, Gly265, Lys301, His303, Pro304, Ile325, Pro 326, Phe327, Glu328, 
Ser345 and Ser346, corresponding to Thr49, Gly277, Lys315, His317, Pro318, Ile339, Pro340, 
Phe341, Glu342, Ser359, and Ser360 in 2,3SiaTpph.[148] However, the lactose binding site is 
somewhat different between SiaTspi and 2,3SiaTpph. Both of them have the key catalytic Asp 
residue (Asp122 in SiaTspi and Asp148 in 2,3SiaTpph) and a galactopyranose moiety binding 
Trp residue (Trp95 in SiaTspi and Trp121 in 2,3SiaTpph), but SiaTspi contains Tyr94 instead of 
Leu120 in 2,3SiaTpph and an additional Arg176, which may serve for hydrogen bonding to a 
glucopyranose moiety. Moreover, both SiaTspi and 2,3SiaTpph share the same loop 1 on the 
CMP site without a Trp constituent, which may act as an irreplaceable role for 2,6SiaT activity. 
This could be taken as further evidence that SiaTspi is a potential 2,3SiaT. 
 
 
 
 
 
 
 
 
 
Figure 11.2. Active site alignment of SiaTspi (green) and 2,3SiaTpph (pink, PDB code 2ZWI).  
 
Table 11.2. Corresponding residues of SiaTspi and  2,3SiaTpph for CMP and acceptor binding 
 SiaTspi 2,3SiaTpph 
CMP 
Thr23, Gly265, Lys301, His303, Pro304, Ile325, 
Pro 326, Phe327, Glu328, Ser345, Ser346 
Thr49, Gly277, Lys315, His317, Pro318, Ile339, 
Pro340, Phe341, Glu342, Ser359, Ser360 
acceptor Asp122, Trp95 Asp148, Trp121 
 
 
CMP
Lac
Loop 1 
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11.2.2. Cloning, expression and characterization of SiaTspi, SiaTspi-U and dSiaTspi-U in 
E. coli expression system 
 
The natural habital of S. piezotolerans[226] is quite hard to be simulated in the lab. Therefore, 
artificial gene synthesis was chosen to obtain a more convenient access to the SiaTspi gene. 
The DNA sequence of the SiaTspi-U gene was optimized for expression in E. coli and 
synthesized commercially. Restriction sites NdeI and BamHI were added at the 5’ and 3’ 
terminus, respectively, to facilitate further cloning work. The shorter SiaTspi and dSiaTspi-U 
genes were obtained by PCR to delete the upstream sequence or the 12 amino acid residues in 
the middle of the SiaTspi-U gene, respectively. According to the three dimensional structure of 
SiaTspi, its N-terminus lacking the upstream sequence might be located in the active site. To 
avoid the loss of activity of SiaTspi, the SiaTspi gene was only ligated into pET21a vector to 
obtain the recombinant SiaTspi with a His-Tag at C-terminus. The SiaTspi-U and dSiaTspi-U 
genes were inserted into pET19b adding a His-Tag sequence to the N-terminus of SiaTspi-U 
and dSiaTspi-U. The maps of these three recombinant plasmids are shown in Figure 11.3.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 11.3. Maps of pET21a-SiaTspi, pET19b-SiaTspi-U and pET19b-dSiaTspi-U 
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The constructed plasmids were identified by restriction analysis and sequencing, then 
transformed into BL21 Tuner cells (Novagen) for expression. IPTG was added at different 
concentration (0.1-1 mM) into the culture during the expression phase to optimize the 
induction of recombinant proteins at 28°C. The harvested cells were lysed by ultrasonic 
treatment in an ice bath. Both the supernatant and the pellet of the crude extract were loaded 
on SDS-PAGE to determine the soluble expression levels. The expression levels within 0.1-1.0 
mM concentration of IPTG showed no obvious difference. At 0.1 mM IPTG, the three 
recombinant SiaTspi could be very well expressed, possibly owed to the codon optimization of 
SiaTspi gene for E. coli. However, unfortunately the expressed proteins were formed as 
inclusion bodies, and soluble recombinant enzyme was found in the supernatant by SDS-
PAGE. The rapid activity determination using Lac-D-T-P-Acr also showed that there was no 
activity in both crude cell extracts and the supernatant both at 4°C and 25°C. It is surmised 
that the expression was too fast partly because of the optimization of codon usage of SiaTspi 
for E. coli expression, and that the protein folding occurred in an incorrect fashion which led 
to inactive SiaTspi. Therefore, attempts were started to optimize the expression as described 
below. 
 
11.2.3. Optimization of soluble expression of SiaTspi, SiaTspi-U and dSiaTspi-U in E. coli 
 
11.2.3.1. Co-expession with chaperones 
 
The formation of inclusion bodies during the high-level expression of the protein of interest in 
E. coli is usually caused by misfolding of recombinant peptides. In vivo, it has been proved that 
the protein folding is an energy-dependent process mediated by molecular chaperones and 
foldases.[191] The former bind partially folded proteins and maintain them in a soluble or 
translocation-competent conformation, while the latter can accelerate the rate-limiting steps 
along the folding pathway, for example the isomerization of peptidyl-prolyl bonds and the 
formation and reshuffling of disulfide bridges.[191] As tools useful for protein expression, the 
chaperonins DnaK-DnaJ-GrpE, GroEL-GroES and Tf in E. coli have been well identified and 
successfully applied for heterologous protein expression, observably promoting the soluble 
expression level.[192, 193] Therefore, as a first attmpt to improve the soluble expression level 
in E. coli cells, SiaTspi, SiaTspi-U and dSiaTspi-U were coexpressed with combinations of the 
chaperonins DnaK-DnaJ-GrpE, GroEL-GroES and GroEL-GroES-Tf, respectively. When SiaTspi, 
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SiaTspi-U and dSiaTspi-U were coexpressed with GroEL-GroES, the soluble expression levels 
seem to be higher than without chaperonin (Figure 11.4), although the major part of 
recombinant SiaTspi was still produced in the form of inclusion bodies. To confirm their real 
activities, fluorescently-labeled lactose was used as acceptor in the presence of CMP-Neu5Ac 
to detect the potential SiaT activities of both crude extract and supernatant of the cell lysate. 
The results are shown in Figure 11.5. Without chaperons, SiaTspi, SiaTspi-U and dSiaTspi-U 
were inactive from both supernatant and crude extract. However, upon coexpression with 
chaperone GroES-GroEL, all samples of SiaTspi, SiaTspi-U and dSiaTspi-U clearly showed 
detectable 2,3SiaT activity at romm temperature (20°C) when compared to authentic 2,3- and 
2,6-sialated product references. In particular, dSiaTspi-U showed much higher 2,3SiaT activity 
than the others. These results reveal that the SiaTspi indeed has true 2,3SiaT activity and that 
the chaperons improve the soluble expression level and the correct folding of recombinant 
SiaTspi. On the other hand, the reorganized protein dSiaTspi-U showed obviously higher 
activity than SiaTspi and SiaTspi-U. It supports the structure analysis above that the missing 
upstream sequence is important for the activity of SiaTspi. The additional 12 residue sequence, 
which is suggested to form two additional β-sheets, may give more stability to SiaTspi in a 
deepsea habitat, but seems not to contribute to stability under normal pressure and 
temperature. Certainly, the relatice activity of SiaTspi, SiaTspi-U and dSiaTspi-U enzymes ought 
to be compared in a quantitative way. However, the soluble expression level of SiaTspi was still 
lower than anticipated, which made the further purification and characterization of SiaTspi 
impossible. Therefore, other optimization strategies needed be considered.  
a)                                                                              b) 
 
 
 
 
 
 
Figure 11.4. Expression level analysis of SiaTspi, SiaTspi-U and dSiaTspi-U. a) Expressed in BL21 Tuner. 1: Marker. 2: 
Supernatant of BL21 Tuner host cell. 3: Crude cell extract of SiaTspi.  4: Supernatant of cell extract of SiaTspi. 5: Crude 
cell extract of SiaTspi-U.  6: Supernatant of cell extract of SiaTspi-U. 7: Crude cell extract of dSiaTspi-U.  8: Supernatant 
of cell extract of dSiaTspi-U. 9: Marker. b) Coexpression with chaperonins GroEL-GroES. 1: Marker. 2: Crude cell 
extract of dSiaTspi-U.  3: Supernatant of cell extract of dSiaTspi-U. 4: Crude cell extract of SiaTspi-U.  5: Supernatant of 
cell extract of SiaTspi-U. 6: Crude cell extract of SiaTspi.  7: Supernatant of cell extract of SiaTspi. 
1    2      3      4      5      6     7     8     9                                1     2       3      4      5     6      7
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Figure 11.5. Activity determination of SiaTspi, SiaTspi-U and dSiaTspi-U using fluorescent-labeled lactose. In each TLC 
board from left to right: 1. Lac-D-T-P-Arc, 2. 2,6SiaTple, 3. 2,3SiaTpph, 4. dSiaTspiU, 5. SiaTspiU, 6. SiaTspi, 7. dSiaTspiU 
coexpressed with GroEL-GroES, 8. SiaTspiU coexpressed with GroEL-GroES, 9. SiaTspi coexpressed with GroEL-GroES. 
(The competing galactosidase activities shown in 3, 7, 8 and 9 were caused by different host strain BL21(DE3).) 
 
11.2.3.2. Expession of SiaTspi at low temperature 
 
S. piezotolerans is known to live in a low temperature environment under high pressure, 
where the enzymes from this microorganism likely have correct folding and optimal 
activity.[201, 226, 230-233] High pressure is hard to simulate in an average lab because of 
equipment limitations. Thus, optimization of expression at low temperature became the 
priority option. On the other hand, a low temperature culture will limit the expression at a 
relatively low rate, which could also avoid or reduce formation of inclusion bodies. Normal E. 
coli strains can grow at a relative wide range of temperatures from 10°C to 49°C.[234] 
Therefore, recombinant BL21(DE3) cells carrying both the expression plasmid for SiaTspi and 
the chaperonins GroEL-GroES were pre-cultured at 37°C until OD600 reached 0.5, and then 
were induced by addition of 0.1 mM IPTG at 16°C for expression. Because of the slow growth 
of E. coli at such a low temperature, the induction was maintained for 2 days in order to 
harvest sufficient cell mass for subsequent activity determination. The final identification of 
expression on SDS-PAGE shows that the overall expression level was much lower than that 
observed at 28°C, but it was pleasing to see that all of the expressed proteins of interest were 
soluble in the supernatant. As a result, low temperature seemed indeed promising for the 
soluble expression of recombinant SiaTspi. However, no sialyltransfer activity could be 
detected in the crude extract, which might be due to reduction of the chaperon’s activity at 
low temperature. It has been shown that at 12 °C the activity of the E. coli chaperonin GroEL-
1  2   3  4   5  6  7  8   9                            1  2   3  4  5  6  7   8  9 
---Gal-D-T-P-Acr--- 
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GroES retains only about 30% refolding activity, compared to its activity at the temperature 
optimum of 30°C.[235] Therefore, a special E. coli cell line named ArcticExpress DE3 (Agilent, 
USA) was applied for this particular hypothesis. 
 
 
 
 
 
 
 
Figure 11.6. Expression level of SiaTspi with chaperonin complex GroEL-GroES or Cpn10-Cpn60 at a low temperature. 
1: Marker. 2: Crude cell extract of SiaTspi. 3: Crude cell extract of SiaTspi-U. 4: Crude cell extract of dSiaTspi-U. 5: 
Marker. 6: Supernatant of cell extract of SiaTspi. 7: Supernatant of cell extract of SiaTspi-U. 8: Supernatant of cell 
extract of dSiaTspi-U. 9: Marker.  
 
ArcticExpress DE3 is an E. coli strain engineered to address the common bacterial gene 
expression hurdle of protein insolubility. These cells co-express the cold-adapted chaperonins 
Cpn10 and Cpn60 from the psychrophilic bacterium, Oleispira Antarctica, which have high 
sequence identity to the E. coli GroEL and GroES chaperonins (74% and 54%, 
respectively).[235] Both of proteins show high protein refolding activities even at low 
temperatures of 4–12°C,[235] improving protein processing and potentially increasing the 
yield of active protein, which seemed to be perfect for SiaTspi expression. Commercial 
ArcticExpress DE3 competent cells were transformed with pET21-SiaTspi, pET19-SiaTspiU and 
pET19-dSiaTspiU plasmids for low-temperature cultivation and protein expression. The 
recombinant cells were firstly cultured at 37°C overnight, followed by 1 mM IPTG induction 
for at least 24 h at 12 °C. After that, the cells were harvested by centrifugation at 4°C and 
soluble expression was determined by SDS-PAGE. The result (Figure 11.6) clearly shows the 
high soluble expression of the three SiaTspi varieties, similar to the results obtained with 
chaperonins GroEL-GroES. But it was still disappointing to find that no SiaT activity was 
detectable in the crude extract. Therefore, the expression of SiaTspi was tried to be carried out 
in a prokaryotic expression system, Yarrowia system, in the next section. 
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11.2.4. Cloning and expression of SiaTspi, SiaTspi-U and dSiaTspi-U in Yarrowia 
lipolytica expression system 
 
Yarrowia lipolytica is a GRAS (Generally Recognized as Safe) organism with significant 
capacities for high molecular weight protein secretion.[236, 237] It also has additional 
oxidative degradation function for alkanes, fatty acids, fats and oils.[236] Therefore, it has 
been well used for the preparation of biological intermediates and heterologous gene 
expression.[236] For its use as an expression host, Barth et al. have constructed several 
vectors containing the regulable ICL1 promoters (ICL1 encoding the isocitrate lyase), an rDNA 
sequence for homologous recombination, a resistance marker for E. coli selection, an ura3 
allele for Y. lipolytica selection and multiple cloning site for the heterologous gene insert.[236] 
This vector can insert multiplecopies of the gene of interest into the rDNA range of Y. 
lipolytica’s genome thereby, directly increasing the intracellular expression level of a target 
protein. 
For the expression of SiaTspi in Y. lipolytica, a modified p64 vector (named p64PT) was used, 
which is equipped with all of the features described above (Figure 11.7a and b). The genes for 
SiaTspi-U and dSiaTspi-U were inserted into the SphI site of the p64PT vector. For the 
transformation of the plasmids, the uracil auxotrophic strain H355-S4[238] was used 
employing a LiAc induced chemical method which has been proved as an efficient way for Y. 
lipolytica recombinant construction.[236] The transformants were selected from minimal 
medium plates, on which the native host cells cannot survive because of the ura3 allele 
deletion. The inserted genes were confirmed by PCR for their presence in Y. lipolytica 
recombinants. (Figure 11.7c) The copy number of the insert gene could be potentially 
determined by real-time PCR, but in the present case, it was preferred to evaluate its 
expression and activity first. 
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a)                                                                      b) 
 
 
            
 
 
 
 
                                                   c) 
 
 
 
 
 
 
Figure 11.7. Identification of Y. lipolytica recombinants by PCR. a) Map of p64P-SiaT-U. b) Map of p64P-dSiaT-U. c) 
PCR identification of SiaTspi in Y. lipolytica recombinants. 1: Marker. 2: dSiaTspi-U. 3: SiaTspi-U 
 
The fermentation of Y. lipolytica was started in minimal medium containing 2% glucose. 
When glucose was consumed, ethanol was added for induction at 1% final concentration. The 
OD600 of the culture remained stable during the 24 h induction period. For activity tracking, 
cell samples were taken each 2.5 h. Lysis of cells utilized glass beads with high-speed shaking. 
For a rapid identification of SiaT activity, Lac-D-T-P-Acr and CMP-Neu5Ac were used as 
acceptor and donor, respectively. On SDS-PAGE, no target protein band could be detected 
from all the samples during the induction relative to the host cell H355. The corresponding 
activity determination showed that all the samples collected during the induction had no SiaT 
activity at all. This might be due to the very low expression level of target protein in Yarrowia 
lipolytica, partly from the result of the optimized gene codons of SiaTspi for E. coli expression 
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instead of yeast. On the other hand, when considering the much lower number of gene copies 
in yeast as compared to the multicopy plasmid situation in E. coli, the expressed heterologous 
protein may not be observable by SDS-PAGE from crude extract samples. Thus, the possibility 
of inactive protein expression cannot be excluded.  
 
11.3. Conclusion 
 
SiaTspi is considered a potential SiaT from Shewanella piezotolerans. Its sequence BLAST and 
structure alignment with other 2,3SiaTs in GT80 family retrieved a functional upstream 
sequence which potentially gives two β-sheets in the 3D-structure of SiaTspi. The deletion of a 
12 amino acid insert also improved its 2,3SiaT activity when it was co-expressed with 
chaperonins as demonstrated by a catalyzed reaction using fluorescence labeled acceptor. 
However, its low soluble expression in the E. coli expression system rendered its further 
property analysis impossible. At low temperatures soluble, SiaTspi could be co-expressed with 
chaperonins at a low expression level, but activity could not be detected. Its expression was 
also attempted in the Y. lipolytica expression system with a multicopy vector p64PT. However, 
no obvious SiaTspi production or activity could be detected. Further work may focus on 
improvement of the expression level first, followed by optimization of active expression. As a 
potential cold-adapted enzyme, there are difficulties to express SiaTspi well under 
conventional conditions. Although it was impossible to gain further insight to the properties of 
SiaTspi except for the activity of its variant dSiaTspi-U, the experiments still allowed to estimate 
the value of methods for enzyme cloning from psychrophiles, for example the application of 
chaperonins and low temperature cultivation. Further work could be focused on the 
expression optimization in yeast, including the optimization of the gene sequence and the 
fermentation conditions. In addition, the use of Shewanella piezotolerans’s own chaperonins 
might also provide a good option for expression of SiaTspi in E. coli. 
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12. Summary 
 
 
12.1. Part I. Enzymatic Properties and Directed Evolution of Transketolase 
 
12.1.1. Transketolase assay for substrate fingerprinting 
 
Transketolase (TK; EC 2.2.1.1) catalyzes the stereospecific transfer of a two carbon ketol unit 
to the carbonyl terminus of a variety of aldehydes. The use of TK for carbon-carbon bond 
formation is receiving increased attention for asymmetric synthesis because of the highly 
stereocontrolled formation of an (S)-configurated chiral center with efficient concomitant 
chiral resolution for (2R)-hydroxyaldehydes. Especially when using hydroxypyruvate (HPA) as 
donor, the release of CO2 makes the synthetic reaction irreversible, and the released 
bicarbonate increases the pH of the reaction system. According to this principle, a novel 
continuous pH-based assay method has been developed for the high-throughput screening of 
TK, in the presence of HPA as donor and phenol red as a sensitive pH indicator. The assay is 
generic and can be used for the reliable colorimetric determination of specific enzyme activity 
and measurement of kinetic constants. Based on this method, the kinetic constants and 
acceptor specificity of TK from Escherichia coli (TKeco) and Saccharomyces cerevisiae (TKyst), as 
well as two TKeco variants (TK
D469E 
eco and TK
H26Y 
eco ), have been determined for a detailed comparison 
of the enzymes. From the quantitative data, the catalytic capabilities of wild-type TKeco and 
TKsce are quite similar with only very little variation. Wild-type TK enzymes have a strong 
preference for α-hydroxylated acceptors with strict stereoselectivity towards the (2R)-
configuration. The variant TKD469E eco  shows significantly higher activities towards 2-deoxygenated 
aldehydes than the corresponding wild-type enzyme. 
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Figure 12.1. The principle of a novel pH-based assay method for transketolase and its application in the 
determination of specific enzyme activity. 
 
 
12.1.2. Transketolase engineering for generic aldehyde tolerance 
 
The TK from Geobacillus stearothermophilus (TKgst) is a novel enzyme which has been cloned 
and identified recently to have an impressively high thermostability. Similar to other TKs, it 
also shows low activity towards non-α-hydroxylated aldehydes. In order to improve its activity, 
saturation mutagenesis libraries of TKgst at Leu382 and Asp470 have been constructed in a 
first attempt to improve activity towards aliphatic aldehydes; Leu382 and Asp470 are the 
corresponding residues for binding of the hydroxymethylene group of α-hydroxylated 
aldehydes. Library screening revealed several positive variants from both single-site libraries 
and the double-site library. Asp469Ile was identified as the top mutant with 17, 13 and 8.6 
fold activity improvement towards propanal, butanal and methoxyethanal, respectively, in 
comparison to the wild-type, but the protein still maintains high thermostability with a Tm of 
74 °C.     
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Figure 12.2. Docking of propanal as substrate analog for TKD469I gst . Asp470Ile and Leu382 form a non-polar surface to 
bind the aliphatic chain of propanal with higher affinity. 
 
12.2. Part II. Chemoenzymatic Synthesis of neo-Sialoconjugates 
 
12.2.1. Sialyltransferase assay for enzyme kinetics 
 
Sialic acids are a family of 9-carbon sugars which exist broadly at the termini of free or 
conjugated glycans on the surface of cells, playing significant roles in cell physiology. 
Therefore, it is significant to develop methods for the synthesis of specific sialoconjugate 
epitopes in vitro to facilitate research on carbohydrate-protein interactions in physiological 
events. α/β-Galactosyl α-2,3/2,6-sialyltransferases transfer sialic acid residues to the terminal 
galactose moiety of an oligosaccharide, and therefore becomes are useful enzymatic tools to 
synthesize sialoconjugates in vitro. For this purpose, bacterial α-2,3- and 2,6- sialyltransferases 
have been cloned from Photobacterium phosphoreum (2,3SiaTpph) and Photobacterium 
leiognathi JT-SHIZ-145 (2,6SiaTple), respectively. In order to understand the substrate 
specificity of these two SiaTs, a pH-based assay method was established to determine the 
kinetic constants and substrate tolerance of SiaT. This assay method using a low 
concentration buffer system, and phenol red as pH indicator, is rapid, sensitive and 
continuous. Using this method, the kinetic constants and substrate tolerance of 2,3SiaTpph and 
2,6SiaTple has been determined. These two SiaTs have quite different acceptor specificity. 
2,3SiaTpph can well accept α- and β-galactosides, lactosides, Glc, Man and GalNAc. However, 
2,6SiaTple has high activity only towards β-galactosides and lactosides.  
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Figure 12.3. The principle of a novel pH-based assay method for sialyltransferase and its application in the 
determination of specific enzyme activity, with various accepter substrates. 
 
12.2.2. Attempted β-SiaT engineering for α-substrate tolerance 
 
From the structure alignment between 2,3SiaTpph and 2,6SiaTple, Trp347 was found to be the 
responsible residue that is blocking the entrance to the active center for α-galactosides. 
Therefore, three mutagenesis libraries were constructed to improve 2,6SiaTple’s activity 
towards α-galactosides using the optimized pH-based assay as high-throughput screening 
method and methyl-α-D-galactopyranoside as acceptor. However, no positive mutant could be 
ifentified from the screening, which revealed that Trp347 cannot be simply substituted in 
2,6SiaTple. It is speculated that Trp347 contributes to the binding between donor and acceptor 
and helps to stabilize the correct acceptor conformation to form the 2,6-sialated product. 
 
12.2.3. CSS engineering for bulky substrates 
 
CMP-sialic acid synthetase (CSS, E.C. 2.7.7.43) catalyzes the CMP activation of sialic acid 
using CTP as donor and Mg2+ as cofactor. A series of Neu5Ac analogues with bulky 
modification on the acylamino group were showen to be accepted by CSS from Neisseria 
meningitidis (CSSnme), although their corresponding kcat/KM values were much lower than that 
of the natural substrate Neu5Ac. From an active site alignment for the acceptor binding of 
CSSnme, Phe192 and Phe193 were identified as the corresponding residues for binding of the 
acylamino group in Neu5Ac. Therefore, four saturation mutagenesis libraries were 
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constructed on positions of Phe192 and Phe193 to improve its activity towards bulky analogs 
Neu5Ac-OBz, Neu5Hex and Neu5PenN3. From a screening by a pH-based high-throughput 
screening method, CSSnme-F192C/F193Y, CSSnme-F192S, and CSSnme-F192S/F193Y were the 
top enzyme variants with 14.1 fold, 4.6 fold and 4.0 fold activity improvements towards 
Neu5Ac-OBz, Neu5Hex and Neu5PenN3, respectively. In order to validate the improved 
activity, the in situ CMP activation of the Neu5Ac analogues was applied by using these CSS 
variants in with 2,6SiaTple a preparative synthesis of new neo-sialoconjugates. The yields of 
the final products were 50%, 64% and 70%, repectively. 
 
12.2.4. Enzyme cloning for LacNAc synthesis 
 
The N-acetyl-D-lactosamine (LacNAc) moiety at the terminus of oligosaccharides is an 
important natural substrate of SiaT. Synthesis of LacNAc and its derivatives in vitro can 
extend the diversity of acceptors for the synthesis of neo-sialoconjugates. For this purpose, β-
1,4-galactosyltransferase from Helicobacter pylori (GalThpy) and UDP-galactose 4-epimerase 
from E. coli (GalEeco) were cloned and over-expressed in an E. coli expression system. Using 
these two recombinant enzymes, free LacNAc and LacNAc-D-T-P-Acr, as well as Lac-D-T-P-Acr 
were synthesized from UDP-Glc donor and the corresponding acceptor substrates, with 
isolated yields of 88%, 92% and 85%, respectively, on a 100 mg scale each for further 
preparative utilization.   
 
12.2.5. Preparative synthesis of neo-sialoconjugates 
 
Using 2,3SiaTpph and 2,6SiaTple, as well as novel CSSnme variants, the neo-2,3- and 2,6-
sialoconjugates were synthesized in a one-pot two-enzyme approach. Six typical sialic acids 
(Neu5Ac, Neu5Gc, KDN, epi-KDN, Neu5Ac-9-N3 and Neu5NPhAc) with modifications on C5 
and C9 were involved as donors for enzymatic coupling to fluorescent lactose (Lac-D-T-P-Acr) 
and N-acetyl-D-lactosamine (LacNAc-D-T-P-Acr) acceptors with α-2,3- and α-2,6-configuration, 
respectively. 2,3SiaTpph and 2,6SiaTple show quite similar donor specificity towards these six 
sialic acids. Both of them can well accept Neu5Ac, Neu5Gc, KDN and Neu5Ac-9-N3, but are 
less reactive with the bulky Neu5NPhAc substrate analog. Moreover, 2,6SiaTple can accept epi-
KDN better than 2,3SiaTpph. 
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Figure 12.4. Chemoenzymatic synthetic route for the fluorogenic sialoconjugates 
 
12.2.6. Characterization of a potential novel SiaT 
 
Recently, a novel potential sialyltransferase from Shewanella piezotolerans (SiaTspi) has been 
identified from the genomic S. piezotolerans sequence. However, cloning, expression and 
activity assay of SiaTspi have not been reported yet. Therefore, the artificial gene of this 
protein was cloned, modified and optimally expressed in the E. coli and a Yarrowia expression 
system. Its sequence BLAST and structure alignment with other 2,3SiaTs in CAZy GT80 family 
retrieved its functional upstream sequence. The deletion of a loop containing 12 amino acid 
residues also facilitated to identify its 2,3SiaT activity by using a reaction with fluorescent 
labeled acceptor, particularly when co-expressed with chaperonins. However, its low soluble 
expression in both E. coli and Y. lipolytica expression systems prevented its further 
characterization. 
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13. METHODS 
 
 
13.1. Material, Reagents, Instruments and Services 
 
Reagent/Instrument Resource/Formulation 
1. Molecular Cloning Kits   
   Wizard Plus SV Minipreps DNA 
purifcation System 
Promega USA 
   GeneJET Plasmid Miniprep Kit Fermentas Germany
   GeneJET Gel Extraction Kit Fermentas Germany
   Restriction endonucleases New England Biolab UK 
    Fermentas Germany
   Phusion High-Fidelity DNA Polymerase New England Biolab Germany
   T4 Ligase Fermentas Germany
   Chaperone Plasmid Set TaKaRa Japan
   QuikChange Lightning Site-Directed 
Mutagenesis Kit 
Agilent USA 
   QuikChange Lightning Multi Site Directed 
Mutagenesis Kit 
Agilent USA 
2. Biological Reagents  
   LB medium Tryptone 10 g 
 Yeast extract 5 g 
 NaCl 10 g 
 Seite 128 
 H2O to 1 L 
*Adjust pH to 7.2, autoclave. 
   Low salt LB medium Tryptone 10 g 
 Yeast extract 5 g 
 NaCl 5 g 
 H2O to 1 L 
*Adjust pH to 7.2, autoclave. 
   Terrific Broth medium Tryptone 12g 
 Yeast extract 24g 
 Glycerol 4 ml 
 H2O to 900 mL 
       *Autoclave, cool to 60°C or less before adding 100 ml of filter sterilized 10×TB 
phosphate (0.17 M KH2PO4 , 0.72 M K2HPO4). 
   SOB medium Tryptone 20 g 
 Yeast extract 5 g 
 NaCl 0.5 g 
 250 mM KCl 10 mL 
 H2O to 900 L 
*Adjust pH to 7.0 and add H2O to 990 mL. Autoclave, cool to room temperature and 
add 10 mL sterile solution of 1 M MgCl2 before use. 
   SOC medium  
       *SOB medium (1 liter) with the addition of 20 mL filter sterilzed 1 M glucose. 
   10×YNB-Reader (NH4)2SO4 30 g 
 KH2PO4 10 g 
 K2HPO4·3H2O 1.6 g 
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 MgSO4·7H2O 7 g 
 NaCl 5 g 
 Ca(NO3)2·4H2O 4 g 
 H2O to 1 L 
       *Sterilized by filtration. Store at 4ºC.
   Trace-metal stock solution H3BO3 50 mg
 CuSO4·5H2O 4 mg 
 KI 10 mg
 MnSO4·4H2O 40 mg
 Na2MoO4·2H2O 20 mg
 ZnSO4·7H2O 40 mg
 H2O to 100 ml
       *Sterilized by filtration. 
   Iron solution FeCl3 3 g 
 EtOH to 100 ml
       *Sterilized by filtration. Store at 4ºC.
   1000×vitamin solution Thiaminhydrochlorid 30 mg
 H2O to 100 ml
       *Sterilized by filtration. Store at 4ºC.
  
   Media containing agar (per liter) agar 20 g 
Antibiotics (final concentration) ampicillin 100 μg/mL
 chloramphenicol 37 μg/mL
 kanamycin 50 μg/mL
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 tetracycline 12 μg/mL 
Galactosides (final concentration) X-Gal 20 μg/mL 
 IPTG 0.1 mM 
3. Enzymes and Chemical Reagents  
The enzymes and chemical reagents used in this thesis were purchased from the following 
companies: VWR (Germany), Sigma-Aldrich (Germany), Fluka (Germany), Alfa Aesar 
(Germany), Acros (Germany), Biospherics (USA), Roth (Germany), Riedel-de Haen 
(Germany) and Applichem (Germany). 
4. Instruments  
GeneAmp PCR System 9700 Applied Biosystems USA 
FLUOstar OPTIMA plate reader BMG Labtech Germany 
Biomek Vmax Plate Reader Beckman USA 
Plate Reader  
UV Spectrophotometer UV-1800 Shimadzu Japan 
LKB Ultrospec Plus Spectrophotometer Pharmacia Switzerland
Biomek 2000 Beckman USA 
TitroLine alpha  
HPLC Shimadzu Japan 
GC-17A/AOC-20i Shimadzu Japan 
Centrifuge 5410, 5415D, 5415R, 5804, 
5810 and 5810R 
Eppendorf Germany 
Biofuge 28 RS Heraeus Germany 
Thermomixer comfort Eppendorf Germany 
Thermomixer 5436 Eppendorf Germany 
Titramax 1000 and Incubator 1000 Heidolph Germany 
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1H-NMR and 13C-HMR 500 MHz Varian Unity 500  
Step One RT Applied Biosys USA 
5. Services  
Gene synthesis Mr. Gene Germany
Primer synthesis Biomers Germany
Sequencing Eurofins MWG Germany
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13.2. Enzymatic Property Study of Transketolase Using pH-Based Assay 
 
13.2.1. Cloning of TKeco, TKyst, and TKD469E eco   
 
The gene fragments for wild type TKeco (Genbank Accession No. X68025) and TKyst (Genbank 
Accession No. X73224) were ligated into pET21a and pET47b vectors, respectively, and 
transformed into BL21 Tuner or BL21DE3 host strain for the overexpression recombinant TKs. 
The construction of D469E mutant of TK from E. coli (TKD469E eco ) used QuikChange kit from 
Agilent (USA). PCR primers 5'-C GGT CTG GGC GAA GAA GGC CCG AC-3' (forward primer) 
and 5'-G TCG GGC CTT CTT CGC CCA GAC CG-3’ (backward primer) were designed for this 
certain site-directed mutation.  
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
QuikSolution reagent:  1.5 μl 
QuikChange Lightning Enzyme: 1 μl 
ddH2O:    up to 50 μl 
 
95°C   2 min 
95°C   30 sec 
60°C   10 sec 
68°C   4 min   30 cycles 
68°C   10 min 
 The PCR product was identified by electrophoresis and digested by 2 μl DpnI for 5 min at 
37°C. Then 2 μl PCR products were transformed into Jm109 competent cells for plasmid 
amplification and cultured on Amp-agar plate overnight. The positive colonies on Amp-agar 
plate were picked and cultured in 5 mL Amp-LB medium overnight. The amplified plasmid 
was then extracted and sent for sequencing. After that, the positive mutant plasmid was 
transformed into BL21 Tuner competent cells (Novagen, Germany) for protein expression. 
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13.2.2. Expression and purification of TKs 
 
All of the recombinant cells were cultured in a 10 L fermenter using Amp- or Kan-TB medium 
(dependent on the resistance of its vector) at 37°C until OD600 reached 0.5. Then the cells 
were induced by 0.1 mM IPTG at 28°C for the expression. After 6 h, the cells were harvested 
by centrifugation and stored at -80°C. For the purification,  20 g cells were lysed by 0.5 
mg/mL lysozyme (Roth, Germany) in 200 mL 20 mM Tris (pH 7.5) containing 0.5 M NaCl, 
and ultrasonic to obtain crude extract of the cells. After 12,000 rpm centrifugation for 30 min, 
the supernatant (added 25 mM imidazole) was loaded on Ni- affinity columns (GE, USA) to 
purify the recombinant protein. After sample loading, the affinity columns were washed by 50 
mM imidazole buffer. Then, the target protein was washed out by 200 mM imidazole buffer. 
The buffer of purified TK was replaced by 2 mM TEA buffer (pH 7.5) using ultrafiltration. The 
purified enzymes were stored in 50% glycerol at -20°C. 
 
13.2.3. Development of a pH-based assay method for TK 
 
13.2.3.1. Calibration curve, limit of detection (LOD) and limit of quantification (LOQ) 
 
The standard curve of the assay method used a series of finial concentrations of NaHCO3 from 
0 mM to 1.0 mM in a 96-well plate. The mixture also contained 50 mM LiHPA, 2.4 mM ThDP, 
9 mM MgCl2, 40 μl TKyst (0.3 mg/mL), 2 μl 0.1% phenol red and 2 mM TEA (pH 7.5). Total 
volume was 200 μl. The relationship between concentration of HCO3- and absorbance was 
measured at 560 nm by Vmax plate reader (Beckman, USA) to obtain the standard curve y = 
ax + b. LOD was defined as LOD = 3.3Sb / ā, and LOQ was defined as LOD = 10Sb / ā, 
where Sb is the standard deviation of the control. 
 
13.2.3.2. Reaction system for the assay 
 
The assay reaction was carried out on 96-well flat bottom plate. The reaction mixture 
contained 40 μl TK (0.1, 0.3 or 0.8 mg/mL, dependent on the activity of TK), 50 mM or 200 
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mM acceptor (dependent on the activity of TK towards this acceptor), 2.4 mM ThDP, 9 mM 
Mg2+, 2 mM TEA (pH 7.5) and 2 μl phenol red (0.1% , 2.82 mM). 50 mM LiHPA was added 
to start the reaction. The total volume in each well was 200 μl. The absorbance increase was 
measured at 560 nm by plate reader at 20°C. 
 
13.2.3.3. Dependence of rate on amount of TK 
 
The specific activity measurement at varying enzyme concentrations used a series of amount 
of 0.3 mg/mL TKyst (from 0 μl to 40 μl). 50 mM D-glyceraldehyde was used as the acceptor. 
Absorbance data for the first 60 sec was recorded and converted into concentration of HCO3- 
according to the calibration curve for the activity calculation. 
 
13.2.4. Sbustrate tolerance screening and kinetic study of TKs 
 
13.2.4.1. Determination of acceptor specificity  
 
To screening the acceptor tolerance of TKs, the activities towards various acceptors were 
measured, including 50 mM formaldehyde, glycolaldehyde, D,L-glyceraldehyde, D-
glyceraldehyde, D-erythrose, L-threose and D,L-2,4-dihydroxy butanal, and 200 mM D-ribose, 
L-lyxose, D-xylose, L-arabinose, acetaldehyde, 3-hydroxpropanl, propionaldehyde, (R)-3,4-
dihydroxy butanal, D-2-deoxy-ribose, D-allose, D-gulose, L-gulose, L-mannose, and D-glucose. 
Suitable concentrations of TKs were added into the reaction according to the activities toward 
different acceptors (0.1 mg/mL for formaldehyde, 0.3 mg/mL for glycolaldehyde, D,L-
glyceraldehyde, D-glyceraldehyde, D-erythrose, L-threose and D,L-2,4-dihydroxy butanal, and 
0.8 mg/mL for D-ribose, L-lyxose, D-xylose, L-arabinose, acetaldehyde, 3-hydroxpropanl, 
propionaldehyde, (R)-3,4-dihydroxy butanal, 2-deoxy-D-ribose, D-allose, D-gulose, L-gulose, 
L-mannose and D-glucose). 
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13.2.4.2. Determination of kinetic constants 
 
The enzymatic kinetics towards both donor LiHPA and acceptor (glycolaldehyde, D,L-
glyceraldehyde, D-glyceraldehyde and D-erythrose) were determined at varying concentration 
of substrates. The reaction rate at each concentration was calculated according to the 
calculation curve and collected for non-linear fit to the Michaelis-Menten equation using 
Origin 8 software to obtain enzymatic kinetic values. 
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13.3.  Directed Evolution of Transketolase from Geobacillus stearothermophilus 
 
13.3.1.1. Building of Leu382 and Asp470 single-site mutagenesis libraries of TKgst 
 
For the construction of Leu382 and Asp470 single-site mutagenesis libraries of TKgst, the 
QuikChange kit from Agilent (USA) was used. PCR primers TKGSL382f 5'- TTT GGC GGT TCG 
GCG GAC NNS GCA AGC TCG AAT AAA ACG C-3' (forward primer) and TKGSL382b 5'-G CGT 
TTT ATT CGA GCT TGC SNN GTC CGC CGA ACC GCC AAA-3’ (backward primer) and 
TKGSD470f 5'-C AGC ATC GCC GTC GGC GAA NNS GGG CCG ACG CAC-3' (forward primer) 
and TKGSD470b 5'-GTG CGT CGG CCC SNN TTC GCC GAC GGC GAT GCT G-3’ (backward 
primer) were designed for Leu382 and Asp470 sites, respectively. The PCR used the artificial 
TKgst gene in vector pET47b (pET47b-TKgst) as template. 
PCR reaction for Leu382: 
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
QuikSolution reagent:  1.5 μl 
QuikChange Lightning Enzyme: 1 μl 
ddH2O:    up to 50 μl 
 
95°C   2 min 
95°C   30 sec 
72°C   10 sec 
68°C   4 min   30 cycles 
68°C   10 min 
PCR reaction for Asp470: 
PCR reaction: 
dsDNA template:   2 μl 
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Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
QuikSolution reagent:  1.5 μl 
QuikChange Lightning Enzyme: 1 μl 
ddH2O:    up to 50 μl 
 
95°C   2 min 
95°C   30 sec 
68°C   10 sec 
68°C   4 min   30 cycles 
68°C   10 min 
The PCR products were digested by 2 μl DpnI for 1 h at 37°C. Then 2 μl PCR products was 
transformed into BL21(DE3) competent cells and cultured on kanamycin agar plates 
overnight. 192 colonies were picked into 96-well plates containing 150 μl/well LB-kanamycin 
medium. After overnight culture, 30 μl glycerol was added into each well. The whole plates 
were sealed with plastic lids and stored at -80°C.  
 
13.3.1.2. Building of Leu382-Asp470 double-site mutagenesis library of TKgst 
 
For the construction of the Leu382-Asp470 double-site mutagenesis libraries of TKgst, the 
QuikChange kit from Agilent (USA) was used. PCR primers TKGSL382f 5'- TTT GGC GGT TCG 
GCG GAC NNS GCA AGC TCG AAT AAA ACG C-3' (forward primer) and TKGSL382b 5'-G CGT 
TTT ATT CGA GCT TGC SNN GTC CGC CGA ACC GCC AAA-3’ (backward primer) and 
TKGSD470f 5'-C AGC ATC GCC GTC GGC GAA NNS GGG CCG ACG CAC-3' (forward primer) 
and TKGSD470b 5'-GTG CGT CGG CCC SNN TTC GCC GAC GGC GAT GCT G-3’ (backward 
primer) were designed for Leu382 and Asp470 sites, respectively. The PCR used the plasmid 
mixture of the Asp470 library as template. 
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
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dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
QuikSolution reagent:  1.5 μl 
QuikChange Lightning Enzyme: 1 μl 
ddH2O:    up to 50 μl 
 
95°C   3 min 
95°C   30 sec 
72°C   10 sec 
68°C   4 min   30 cycles 
68°C   10 min 
The PCR product was digested by 2 μl DpnI for 1 h at 37°C. Then 2 μl PCR products was 
transformed into BL21(DE3) competent cells and cultured on kanamycin agar plates 
overnight. 3,456 colonies were picked into 96-well plates containing 150 μl/well LB-
kanamycin medium. After overnight culture, 30 μl glycerol was added into each well. The 
whole plates were sealed with plastic lids and stored at -80°C.  
 
13.3.1.3. Development of screening method for mutagenesis library 
 
TKeco and TKyst recombinant cells were used as samples for the development of a screening 
method for the mutagenesis library. BL21(DE3) host cell was used as control. 2 μl of each 
clone was transferred to individual wells in 96-well plates containing 150 μl/well LB growth 
media comprised with 30 μg/mL kanamycin. The plates were sealed with plastic lids to avoid 
evaporation, and then incubated at 30°C, 900 rpm overnight. After that, 5 μl was transferred 
from each well to 96-deepwell plates with plastic lids containing 400 μl/well of LB-kanamycin 
growth medium with 0.1 mM IPTG. The plates were then incubated at 30°C, 900 rpm 
overnight. Cells were harvested by centrifugation at 4000 rpm for 30min. The culture medium 
was removed and the cell pellets could be stored at -80°C.  
The cell pellets were resuspended in 150 μl resuspension buffer (1/10 BugBuster solution 
(Novagen, Germany), 0.5 mg/mL lysozyme (Roth, Germany) and 4U/mL Benzonase 
endonuclease (Novagen, Germany)) and incubated in a shaker for 0.5 to 1 hour at room 
temperature. Then, the cell lysate was centrifugated at 4000 rpm for 30min. 40 μl of the 
supernatant was transferred to a new 96-well plate. 140 μl of substrate solution (2 mM TEA 
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(pH7.5), 9 mM MgCl2, 2.4 mM ThDP, 2.82 mM phenol red and 2.5 mM (for TKeco) or 5 mM 
(for TKyst) glycolaldehyde) was added to each well. The reaction was initiated by the addition 
of 50 mM LiHPA. The OD increase was read by the plate-reader at 560 nm. 
For the evaluation and validation of this assay method, Z-factor was used as calculated using 
the data of the acceptor specificity measurement according to the formula Z = 1 - (3σs + 3σc) 
/ |μs + μc|, where σs is sample standard deviation, σc is control standard deviation, μs is 
sample average, and μc is control average. 48 samples (half 96-well plate) of each TK and host 
cells were used for Z-factor calculation. 
 
13.3.1.4. Screening of mutagenesis libraries of TKgst 
 
2 μl of each clone in libraries was transferred to individual wells in 96-well round bottom 
plates containing 150 μl/well LB growth media comprised 30 μg/mL kanamycin. The plates 
were sealed with plastic lids to avoid evaporation, and then incubated at 30°C, 1,000 rpm 
overnight. After that, 5 μl was transferred from each well to 96-deepwell plates with plastic 
lids containing 400 μl/well of LB-kanamycin growth medium containing 0.1 mM IPTG. The 
plates were then incubated at 30°C, 1,000 rpm overnight, until the amount of cells in each 
well reached the maximum. Cells were harvested by centrifugation at 4,000 rpm for 20 min. 
The culture medium was removed and the cell pellets could be stored at -80°C.  
The cell pellets were resuspended in 150 μl resuspension buffer (1/10 BugBuster solution 
(Novagen, Germany), 0.5 mg/mL lysozyme (Roth, Germany) and 4U/mL Benzonase 
endonuclease (Novagen, Germany)) and incubated in a shaker for 30 min at room 
temperature. Then, the cell lysate was centrifugated at 4,000 rpm for 30 min. 40 μl of the 
supernatant was transferred to a new 96-well flat bottom plate. 140 μl of substrate solution (2 
mM TEA (pH7.5), 9 mM MgCl2, 2.4 mM ThDP, 2.82 mM phenol red and 200 mM 
propionaldehyde or 100 mM L-glyceraldehyde was added to each well. The reaction was 
initiated by the addition of 50 mM LiHPA. The total volume in each well was 200 μl. The OD 
increase was read by the plate-reader at 560 nm. 
20 positive colonies with the highest activity were picked from each plate into a new plate for 
the second round screening and so on.  
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13.3.1.5. Expression and purification of positive mutants 
 
10 μl from each positive mutant was transferred into 1 mL Kan-LB medium and cultured at 
37°C 250 rpm overnight. Then, 100 μl each culture was transferred into 20 mL Kan-LB 
medium and cultured at 37°C 250 rpm until OD reached 0.5. 0.1 mM IPTG (final 
concentration) was added for the expression induction at 28°C overnight. After that, the cells 
were harvested by centrifugation at 4,000 rpm for 20 min and stored at -80°C.  
For the purification, the harvested cells were lysed by 3 mL lysis buffer which contains 0.5 
mg/mL lysozyme, 4 U/mL benzonase endonuclease, 1/10 Bugbuster solution, 10% glycerol, 
2.4 mM ThDP, and 9 mM MgCl2). After the incubation at room temperature for half hour, the 
lysates were incubated at 50 °C for half hour. Then the lysates were treated with 4,000 rpm 
centrifugation for 30 min. The supernatants were used as purified enzyme samples. The purity 
of these samples was identified by SDS-PAGE. Their concentration was measured by 
Brandford method.   
 
13.3.1.6. Identification of positive mutants 
 
The assay reaction was carried out on 96-well flat bottom plate. The reaction mixture 
contained 0.04 μg TK, 200 mM propanal, methoxypropanal or buthanal, 2.4 mM ThDP, 9 mM 
Mg2+, 2 mM TEA (pH 7.5) and 2 μl phenol red (0.1% , 2.82 mM). 50 mM LiHPA was added 
to start the reaction. The total volume in each well was 200 μl. The absorbance increase was 
measured at 560 nm by plate reader at 20°C. 
 
13.3.1.7. Determination of thermostability for positive mutants 
 
20 μl 0.5 mg/mL TK samples and 5 μl Sypro Orange (1:500) (Sigma) were mixed in a PCR 
plate. The real-time PCR program was 25°C-95°C, 1°C per min. The fluorescence data was 
recorded and processed by real time PCR software. 
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13.4.  Chemoenzymatic Synthesis of N-Acetyl-D-Lactosamine Precursors 
 
13.4.1. Cloning, expression and characterization of β-1,4-galactosyltransferase from 
Helicobacter pylori 
 
13.4.1.1. Cloning of β-1,4-galactosyltransferase from Helicobacter pylori 
 
The DNA sequence of the GalThpy gene from Helicobacter pylori was optimized for expression 
in E. coli and synthesized by the company Mr.Gene. NdeI and BamHI restriction enzyme sites 
were added at 5’- and 3’- terminuses, respectively, for further cloning work. The plasmid 
pMA-HPGT containing the synthesized GalThpy gene from the company Mr.Gene was 
transformed into E. coli Jm109 competent cells for plasmid amplification. The recombinant 
cells were cultured in 5 mL LB medium comprising 50 μg/mL ampicillin with 250 rpm 
shaking at 37°C overnight. The plasmid was extracted and digested by NdeI and BamHI, and 
then purified by gel extraction. After that, the GalThpy gene fragment was ligated into pET19b 
vector to construct the expression plasmid pET19b-GalThpy, which was then transformed into 
E. coli Jm109 competent cells for plasmid amplification and identification. The positive 
colonies were picked and cultured in 5 mL Amp-LB medium at 37°C with 250 rpm shaking 
overnight. The extracted plasmids were identified by NdeI and BamHI restriction 
endonuclease enzyme digestion and electrophoresis, as well as sequencing. Then, the 
identified final plasmid was transformed into E. coli BL21 Tuner competent cells. The positive 
colony (BL21T-pET19b-GalThpy) was picked and cultured in 5 mL Amp-LB medium at 37°C 
with 250 rpm shaking overnight and stored in 16% glycerol at -80°C. 
 
1 CATATGCTGC GCGTGTTTAT CATTAGCCTG AACCAGAAAG TTTGTGACAC 
CTTCGGACTG GTATTCCGTG ATACTACCAC CCTGCTGAAT AACATTAACG 
101 CCACACACCA CCAGGCACAG ATCTTTGATG CCATTTATAG CAAAACGTTT 
GAGGGCGGAC TGCACCCACT GGTCAAAAAA CATCTGCACC CGTATTTCAT 
201 TACCCAGAAC ATTAAAGACA TGGGCATTAC CACCAACCTG ATCAGCGAAG 
TGAGCAAATT CTATTATGCT CTGAAATATC ACGCCAAATT CATGTCACTG 
301 GGCGAACTGG GTTGTTATGC CAGCCATTAT TCCCTGTGGG AGAAATGTAT 
CGAGCTGAAC GAAGCCATTT GTATCCTGGA GGACGACATT ACACTGAAAG 
 Seite 142 
401 AGGACTTTAA AGAGGGCCTG GATTTCCTGG AAAAACACAT TCAGGAGCTG 
GGCTATGTTC GTCTGATGCA TCTGCTGTAT GACCCTAACG TGAAAAGCGA 
501 GCCTCTGAAC CATAAAAATC ATGAGATTCA GGAACGTGTC GGCATTATCA 
AAGCCTATAG CCATGGTGTT GGTACTCAGG GTTATGTGAT TACGCCGAAA 
601 ATTGCCAAAG TGTTCAAAAA ACATTCCCGT AAATGGGTGG TTCCGGTTGA 
TACGATCATG GATGCCACCT TTATCCACGG GGTGAAAAAT CTGGTACTGC 
701 AGCCGTTTGT GATCGCCGAT GATGAGCAAA TCAGCACCAT TGCCCGTAAA 
GAAGAGCCGT ATTCCCCAAA AATCGCTCTG ATGCGCGAAC TGCACTTCAA 
801 ATATCTGAAA TATTGGCAGT TTGTGTGAGG ATCC 
 
Sequence 13.1. Artificial gene sequence of GalThpy 
 
13.4.1.2. Expression of β-1,4-galactosyltransferase from Helicobacter pylori 
 
10 μl BL21T-pET19b-GalThpy was transferred into 250 mL LB medium and cultured at 37°C 
with 250 rpm shaking overnight. Then the 250 mL culture was transferred into 5 L TB 
medium and cultured in a 10 L fermenter at 37°C with 500 rpm stir until OD600 reached 0.5. 
0.1 mM IPTG was added into the culture for the expression induction at 28°C for at least 6 
hours. After that, the cells were harvested by centrifugation at 4,000 rpm for 20 min. The well 
cells were frozen and stored at -80°C. The recombinant GalThpy expression level was identified 
by SDS-PAGE. 
 
13.4.1.3. Rapid characterization of β-1,4-galactosyltransferase from Helicobacter 
pylori 
 
The rapid identification of recombinant GalThpy used a 100 μl reaction, in which it contained 3 
mM Glc-D-T-P-Acr as acceptor, 5 mM UDP-Gal as donor, 20 mM Tris (pH8.0) as buffer and 10 
mM Mn2+ as cofactor. 50 μl supernatant of cell lysate of BL21T-pET19b-GalThpy was added as 
catalyst to start the reaction. After 30 min, the Lac-D-T-P-Acr product was identified on TLC 
plate with mobile phase n-BuOH:aceton:AcOH:H2O=40:40:7:13 .  
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13.4.1.4. Coexpression of β-1,4-galactosyltransferase from Helicobacter pylori with 
chaperones 
 
The chaperone kit Chaperone Plasmid Set was purchased from Takara (Japan). The 
chaperone plasmids pG-KJE8, pGro7, pKJE7, pG-Tf2 and pTf16 were transformed into 
BL21(DE3) competent cells and cultured on LB-agar plates with chloramphenicol. The 
positive colonies were picked and cultured in LB medium with chloramphenicol at 37ºC 
overnight. Then the recombinants were stored in 16% glycerol at -80ºC. 
Chaperone BL21(DE3) cells was cultured in 5 ml LB medium with chloramphenicol at 37ºC 
with 250 rpm shaking for 16-18 h. 2.5 ml each culture was transferred into 250 ml SOB 
medium and cultured at 37ºC with 250 rpm shaking until OD600 reaches 0.6-0.8. Then the 
cultures were put in ice for 10 min. After that, the cells were harvested by 2,000g 
centrifugation at 4ºC for 10 min, followed by adding 80 ml cold TB medium to resuspend the 
cells. The cells were put in ice for 10 min again and centrifuged the resuspension at 2,000g 
4ºC for 10 min to remove the TB medium. Then 20ml TB medium was added and the cells 
were mixed gently. The resuspension was treated by ice for 10 min. Finally, 1.5 ml DMSO and 
75 mM DTT were added and mixed gently. The cells were frozen by liquid nitrogen and 
stored at -80ºC. 
The pET19b-GalThpy plasmid was transformed into competent chaperone cells and cultured on 
LB agar plate with ampicillin and chloramphenicol at 37ºC overnight. The positive colonies 
were picked and identified by plasmid identification. After that, these five recombinant cells 
were stored in 16% glycerol and stored at -80ºC. 
 
13.4.1.5. Gene modification of β-1,4-galactosyltransferase from Helicobacter pylori 
 
The pET19b-GalThpy was prepared as template for the PCR of the gene modification. Primers 
d27GalT19-f 5’- TGA GGA TCC GGC TGC TAA CAA AG -3’ and d27GalT19-b 5’- GGC AAT 
GGT GCT GAT TTG CTC AT -3’, and d27GalT21-f 5’- GGA TCC GAA TTC GAG CTC CGT -3’ 
and d27GalT21-b 5’- GGC AAT GGT GCT GAT TTG CTC AT -3’ were designed synthesized by 
Biomers (Germany). The PCR reaction used Phusion High-Fidelity DNA Polymerase 
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(Fermentas, Germany).  
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
DNA Polymerase:   0.5 μl 
ddH2O:    up to 50 μl 
 
97°C   2 min 
97°C   10 sec 
72°C   10 sec 
72°C   4 min   30 cycles 
72°C   10 min 
The PCR products were identified by electrophoresis and purified by gel extraction. Then, 
they were ligated into pUC19 vector for sub cloning. The ligated products were transformed 
into Jm109 competent cells and cultured on Amp-LB-agar plates at 37°C overnight. The 
positive colonies were picked and cultured in 5 mL amp-LB medium at 37°C with 250 rpm 
shaking overnight. Then their plasmids were extracted and identified by NdeI and BamHI 
restriction endonuclease enzyme digestion and electrophoresis. The positive plasmid was 
digested by NdeI and BamHI at 37°C overnight. The dGalTphy gene fragments were purified by 
gel extraction and then ligated into pET19b and pET21a vector to obtain pET19b-dGalThpy 
and pET21a-dGalThpy plasmid, respectively. The ligation products were transformed into 
Jm109 competent cells and cultured on Amp-LB-agar plates at 37°C overnight. The positive 
colonies were picked and cultured in 5 mL Amp-LB medium at 37°C with 250 rpm shaking 
overnight. Then their plasmids were extracted and identified by NdeI and BamHI restriction 
endonuclease enzyme digestion and electrophoresis, as well as sequencing. The positive 
plasmid was then transformed into BL21 Tuner competent cells and cultured on Amp-LB-agar 
plates at 37°C overnight. The positive colonies were picked and cultured in 5 mL amp-LB 
medium at 37°C with 250 rpm shaking overnight, and then stored in 16% glycerol at -80°C. 
10 μl BL21T-pET19b-dGalThpy and BL21T-pET21a-dGalThpy were transferred into 5 mL LB 
medium, respectively, and cultured at 37°C with 250 rpm shaking until OD reached 0.5. 0.1 
mM IPTG was added into the culture for the expression induction at 28°C with shaking 
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overnight. After that, the cells were harvested by centrifugation at 4,000 rpm for 20 min. The 
recombinant dGalThpy expression levels were identified by SDS-PAGE. The identification of 
recombinant dGalThpy activity was used the method described in 13.4.1.3. 
 
13.4.2. Cloning, expression and characterization of UDP-galactose 4-epimerase from 
Escherichia coli 
 
13.4.2.1. Cloning of UDP-galactose 4-epimerase from Escherichia coli 
 
The genome DNA of E. coli K12 was prepared as template for the PCR of GalEeco cloning. 
Primers GalEf (forward primer) 5’-GGA ATT CCA TAT GAG AGT TCT GGT TAC CGG TGG-3’ 
and GalEb (backward primer) 5’-CGC GGA TCC TTA ATC GGG ATA TCC CTG T-3’ were 
designed synthesized by Biomers (Germany).  
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
DNA Polymerase:   0.5 μl 
ddH2O:    up to 50 μl 
 
97°C   2 min 
97°C   10 sec 
72°C   3 min   30 cycles 
72°C   10 min 
The PCR product was identified by electrophoresis and purified by gel extraction. Then, it was 
ligated into pUC19 vector for sub cloning. The ligated product was transformed into Jm109 
competent cells and cultured on Amp-LB-agar plate at 37°C overnight. The positive colonies 
were picked and cultured in 5 mL amp-LB medium at 37°C with 250 rpm shaking overnight. 
Then the amplified plasmid was extracted and identified by NdeI and BamHI restriction 
endonuclease enzyme digestion and electrophoresis. The positive plasmid was digested by 
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NdeI and BamHI at 37°C overnight. The GalEeco gene fragment was purified by gel extraction 
and then ligated into pET19b vector to obtain pET19b-GalEeco plasmid. The ligation product 
was transformed into Jm109 competent cells and cultured on Amp-LB-agar plate at 37°C 
overnight. The positive colonies were picked and cultured in 5 mL Amp-LB medium at 37°C 
with 250 rpm shaking overnight. Then, the amplified plasmid was extracted and identified by 
NdeI and BamHI restriction endonuclease enzyme digestion and electrophoresis, as well as 
sequencing. The positive plasmid was then transformed into BL21 Tuner competent cells and 
cultured on Amp-LB-agar plate at 37°C overnight. The positive colonies were picked and 
cultured in 5 mL Amp-LB medium at 37°C with 250 rpm shaking overnight, and then stored in 
16% glycerol at -80°C. 
 
1 ATGAGAGTTC TGGTTACCGG TGGTAGCGGT TACATTGGAA GTCATACCTG 
TGTGCAATTA CTGCAAAACG GTCATGATGT CATCATTCTT GATAACCTCT 
101 GTAACAGTAA GCGCAGCGTA CTGCCTGTTA TCGAGCGTTT AGGCGGCAAA 
CATCCAACGT TTGTTGAAGG CGATATTCGT AACGAAGCGT TGATGACCGA 
201 GATCCTGCAC GATCACGCTA TCGACACCGT GATCCACTTC GCCGGGCTGA 
AAGCCGTGGG CGAATCGGTA CAAAAACCGC TGGAATATTA CGACAACAAT 
301 GTCAACGGCA CTCTGCGCCT GATTAGCGCC ATGCGCGCCG CTAACGTCAA 
AAACTTTATT TTTAGCTCCT CCGCCACCGT TTATGGCGAT CAGCCCAAAA 
401 TTCCATACGT TGAAAGCTTC CCGACCGGCA CACCGCAAAG CCCTTACGGC 
AAAAGCAAGC TGATGGTGGA ACAGATCCTC ACCGATCTGC AAAAAGCCCA 
501 GCCGGACTGG AGCATTGCCC TGCTGCGCTA CTTCAACCCG GTTGGCGCGC 
ATCCGTCGGG CGATATGGGC GAAGATCCGC AAGGCATTCC GAATAACCTG 
601 ATGCCATACA TCGCCCAGGT TGCTGTAGGC CGTCGCGACT CGCTGGCGAT 
TTTTGGTAAC GATTATCCGA CCGAAGATGG TACTGGCGTA CGCGATTACA 
701 TCCACGTAAT GGATCTGGCG GACGGTCACG TCGTGGCGAT GGAAAAACTG 
GCGAACAAGC CAGGCGTACA CATCTACAAC CTCGGCGCTG GCGTAGGCAA 
801 CAGCGTGCTG GACGTGGTTA ATGCCTTCAG CAAAGCCTGC GGCAAACCGG 
TTAATTATCA TTTTGCACCG CGTCGCGAGG GCGACCTTCC GGCCTACTGG 
901 GCGGACGCCA GCAAAGCCGA CCGTGAACTG AACTGGCGCG TAACGCGCAC 
ACTCGATGAA ATGGCGCAGG ACACCTGGCA CTGGCAGTCA CGCCATCCAC 
1001 AGGGATATCC CGATTAA 
 
Sequence 13.2. Gene sequence of GalEeco 
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13.4.2.2. Expression and purification of UDP-galactose 4-epimerase from Escherichia 
coli 
 
10 μl BL21T-pET19b-GalEeco was transferred into 250 mL LB medium and cultured at 37°C 
with 250 rpm shaking overnight. Then, the 250 mL culture was transferred into 5 L TB 
medium and cultured in a 10 L fermenter at 37°C with 500 rpm stir until OD reached 0.5. 0.1 
mM IPTG was added for the expression induction at 28°C for at least 6 hours. After that, the 
cells were harvested by centrifugation at 4,000 rpm for 20 min and stored at -80°C.  
For the purification, 20 g frozen cells were lysed in 200 mL resuspension buffer which 
contained 0.5 mg/mL lysozyme (Roth, Germany) and 0.5 M NaCl in 20 mM Tris (pH 7.5). 
The resuspension was treated by ultrasonic for 10 min in ice to obtain crude extract of the 
cells. After 12,000 rpm centrifugation for 30 min at 4°C, the supernatant (added 25 mM 
imidazole additionally) was loaded on 5 ml Ni-affinity columns (GE, USA) to purify the 
recombinant protein. After sample loading, the Ni-affinity columns were washed by 50 mM 
imidazole wash buffer. Then, the target protein was washed out by 200 mM imidazole eluate 
buffer. The buffer of the eluate was replaced by 2 mM Tris (pH 7.5) using ultrafiltration. The 
purity of the recombinant GalEeco was identified by SDS-PAGE electrophoresis and stored in 
50% glycerol at -20°C. 
 
13.4.3. Chemoenzymatic synthesis of LacNAc and LacNAc-D-T-P-Acr 
 
13.4.3.1. Enzymic synthesis of LacNAc 
 
100 mg GlcNAc (1 eq.) and 384 mg UDP-Glc (1.5 eq.) were added into 50 mL Tris buffer 
(pH8.0) containing 10 mM Mn2+. 1 mL supernatant of cell lysate of BL21T-pET-GalThpy and 5 
mg GalEeco were added to start the reaction. The pH was being adjusted for keeping at 8.0 by 
pH-stat during the reaction for overnight. When the reaction finished, 300 mL -20°C methanol 
was added to stop the reaction and precipitate the most of proteins in the reaction system. 
The precipitate was removed by filtration. The filtrate was concentrated into 10 mL and 
loaded on P-2 Biogel (Bio-Rad, Germany) column (3 cm × 100 cm). The products were 
further washed out by ddH2O and collected separately, and lyophilized for NMR 
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determination. Product: 152 mg white powder. Yield: 88%. 
 
13.4.3.2. Chemoenzymatic synthesis of LacNAc-D-T-P-Acr 
 
10-[5-(4-(((Z)-4-O-(β-D-galactopyranosyl-(1,4)-2-acetamido-2-deoxy-β-D-
glucopyranosyloxy)-but-2-enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-
on 
(LacNAc-D-T-P-Acr) 
 
100 mg GlcNAc-D-T-P-Acr (1 eq.) and 133.6 mg UDP-Glc (1.5 eq) were added into 50 mL 
Gly-Gly buffer (pH8.0) containing 10 mM Mn2+. 5 mL supernatant of cell lysate of BL21T-
pET-GalThpy and 5 mg GalEeco were added to start the reaction. The pH was being adjusted for 
keeping at 8.0 by pH-stat during the reaction for overnight. When the reaction finished, 300 
mL -20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated into 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected separately, and lyophilized for NMR 
determination. Product: 115 mg yellow powder. Yield: 92%. 
 
 
 
 
 
1H NMR (500 MHz, Deuterium Oxide) δ=7.74 – 7.62 (m, 2H, 17-, 21-H), 7.57 (s, 1H, 7-H), 
7.09 (m, 2H, 15-, 23-H), 6.72 (d, J = 8.9 Hz, 2H, 14-, 24-H), 6.64 (t, J = 7.3 Hz, 2H, 16-, 22-
H), 5.52-5.38 (m, 2H, 2-, 3-H), 4.57 (s, 2H, 5-H), 4.38 – 4.23 (m, 4H, 8-, 12-H), 4.10 – 3.89 
(m, 4H, 1a-, 1’’-, 1’-, 1b-H), 3.88 – 3.69 (m, 3H, 4-, 6’a-H), 3.69 – 3.44 (m, 9H, 6’b-, 4’’-, 6’’a-, 
6’’b-, 3’’-, 2’’-, 4’-, 5’’-, 3’-H), 3.44 – 3.35 (m, 2H, 5’-, 2’-H), 1.81 (s, 3H, 8’-H), 1.45-1.25 (m, 
2H, 11-H), 1.10-0.65 (m, 4H, 11-, 10-H) ppm. 
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13C NMR (126 MHz, Deuterium Oxide) δ=177.79 (C-7’), 174.11 (C-19), 143.90 (C-6), 140.58 
(C-15), 134.36 (C-23), 129.59 (C-2, -3), 128.78 (C-17, -21), 126.26 (C-13, -25), 124.47 (C-7), 
121.42 (C-16), 120.51 (C-22), 114.88 (C-14, -24), 103.01 (C-1’’), 99.90 (C-1’), 78.69 (C-4’), 
75.42 (C-3’’), 74.87 (C-5’’), 73.64 (C-5’), 72.62 (C-3’), 71.03 (C-2’), 69.53 (C-2’’), 68.61 (C-
4’’), 65.33 (C-4), 64.55 (C-1), 62.40 (C-5), 61.05 (C-6’’), 60.20 (C-6’), 49.93 (C-8), 45.23 (C-
12), 28.91 (C-9), 25.78 (C-8’), 22.70 (C-11), 22.33 (C-10) ppm. 
 
13.4.3.3. Chemoenzymatic synthesis of Lac-D-T-P-Acr 
 
10-[5-(4-(((Z)-4-O-(β-D-lactosyloxy)-but-2-enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-
10H-acridin-9-on 
(Lac-D-T-P-Acr) 
 
For the characterization GalThpy activity, as well as the structure of the product catalyzed by 
recombinant GalThpy, 50 mg Glc-D-T-P-Acr (1.5 eq.) and 71 mg UDP-Glc (1.5 eq) were added 
into 50 mL Gly-Gly buffer (pH8.0) containing 10 mM Mn2+. 1 mL supernatant of cell lysate of 
BL21T-pET-GalThpy and 5 mg GalEeco were added to start the reaction. The pH was being 
adjusted for keeping at 8.0 by pH-stat during the reaction for overnight. When the reaction 
finished, 300 mL -20°C methanol was added to stop the reaction and precipitate the most of 
proteins in the reaction system. The precipitate was removed by filtration. The filtrate was 
concentrated into 10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 
cm). The products were further washed out by ddH2O and collected separately, and 
lyophilized for NMR determination. Product: 54 mg yellow powder. Yield: 85%. 
 
 
 
 
 
 
 
 
 
 
 
1H-NMR (500 MHz, D2O): d = 8.45 (dd, J = 1.6, 8.0, 2H, 17-, 21-H.), 8.00 (s, 1H, 7-H), 7.85 
– 7.82 (m, 2H, 15-, 23-H), 7.72 (d, J = 8.7 Hz, 2H, 14-, 24-H), 7.34 (t, J = 7.3 Hz, 2H, 16-, 
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22-H), 5.80 – 5.70 (m, 2H, 2-, 3-H), 4.61 (s, 2H, 5-H), 4.48 – 4.45 (m, 4H, 8- 12-H), 4.40 – 
4.38 (m, 1H, 1a-H), 4.37 (d, J = 7.7, 1H, 1’’-H), 4.34 (d, J = 7.8, 1H, 1’-H), 4.31 – 4.29 (m, 
1H, 1b-H), 4.16 (d, J = 2.8, 2H, 4-H), 3.90 (dd, 1H, 6’a-H), 3.85 – 3.78 (m, 3H, 6’b-, 4’’-, 6’’a-
H), 3.72 – 3.69 (m, 1H, 6’’b-H), 3.60 – 3.49 (m, 5H, 3’’-, 2’’-, 4’-, 5’’-, 3’-H), 3.40 – 3.39 (m, 
1H, 5’-H), 3.29 – 3.25 (m, 1H, 2’-H), 2.06 – 2.03 (m, 2H, 9-H), 1.94 – 1.91 (m, 2H, 11-H), 
1.57 – 1.54 (m, 2H, 10-H) ppm. 
13C-NMR (126 MHz, D2O): d = 180.16 (C-19), 143.56 (C-6), 136.20 (C-15, -23), 130.76 (C-
2, -3), 128.64 (C-17, -21), 123.44 (C-13, -25), 123.11 (C-16, -22),117.14 (C-14, -24), 105.53 
(C-1’’), 103.49 (C-1’), 81.16 (C-4’), 77.50 (C-3’’), 76.93 (C-5’’), 76.89 (C-5’), 75.25 (C- 3’), 
75.10 (C-2’), 72.97 (C-2’’), 70.71 (C-4’’), 67.29 (C-4), 65.99 (C-1), 64.47 (C-5), 62.91 (C-6’’), 
62.41 (C-6’), 51.51 (C-8), 47.19 (C-12), 31.29 (C-9), 28.09 (C-11), 24.87 (C-10) ppm. 
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13.5.  Cloning, Expression and characterization of α-2,3- and 2,6-Sialyltransferases 
from Photobactirium sp.  
 
13.5.1. Cloning, expression and characterization of α-2,3-sialyltransferase from 
Photobacterium phosphoreum 
 
13.5.1.1. Cloning of α-2,3-sialyltransferase from Photobacterium phosphoreum 
 
The DNA sequence of 2,3SiaTpph gene from Photobacterium phosphoreum was optimized for 
expression in E. coli and synthesized by Mr. Gene Company (Germany). NdeI and BamHI 
restriction enzyme sites were added at 5’- and 3’- terminus for further cloning work, 
respectively. The plasmid pMA-PPST from Mr. Gene Company containing synthesized 
2,3SiaTpph gene was transformed into E. coli Jm109 competent cells for plasmid amplification. 
The recombinant cells were cultured at 37°C with 250 rpm shaking overnight. The plasmid 
was extracted and digested by NdeI and BamHI, and purified by gel extraction. Then, the 
2,3SiaTpph gene fragment was ligated into pET19b vector to construct the expression plasmid 
pET19b-SiaTpph, which was then transformed into E. coli Jm109 competent cells for plasmid 
amplification and identification. The positive colonies were picked and cultured in 5 mL Amp-
LB medium at 37°C with 250 rpm shaking overnight. The extracted plasmids were identified 
by NdeI and BamHI restriction endonuclease enzyme digestion and electrophoresis, as well as 
sequencing. Then the identified final plasmid was transformed into E. coli BL21 Tuner 
competent cells. The positive colony (BL21T-pET19b-SiaTpph) was picked and cultured in 5 
mL Amp-LB medium at 37°C with 250 rpm shaking overnight and stored in 16% glycerol at -
80°C. 
 
1 CATATGGACT CGAAACACAA CAACTCTGAC GGCAACATCA CCAAAAACAA 
AACGATTGAG GTCTATGTGG ACCGTGCTAC ACTGCCTACA ATTCAGCAGA 
101 TGACCCAGAT TATCAACGAG AACAGTAACA ACAAAAAACT GATTTCCTGG 
AGCCGCTATC CTATTAACGA CGAAACCCTG CTGGAAAGCA TTAATGGCTC 
201 ATTCTTCAAA AATCGCCCGG AGCTGATTAA AAGCCTGGAC TCCATGATTC 
TGACCAACGA GATCAAAAAA GTCATTATTA ACGGCAATAC GCTGTGGGCT 
301 GTCGACGTGG TAAACATTAT CAAAAGCATC GAGGCACTGG GCAAAAAAAC 
CGAGATCGAA CTGAACTTCT ATGATGATGG TAGCGCCGAG TATGTTCGCC 
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401 TGTATGATTT CTCTCGCCTG CCGGAAAGTG AACAGGAGTA TAAAATCTCC 
CTGTCGAAAG ACAACATCCA GAGCAGCATC AACGGTACTC AGCCGTTCGA 
501 TAACAGCATT GAAAACATCT ATGGCTTCAG CCAGCTGTAT CCGACAACCT 
ATCACATGCT GCGTGCCGAC ATCTTTGAAA CCAATCTGCC GCTGACTAGC 
601 CTGAAACGTG TCATTTCTAA CAACATCAAA CAAATGAAAT GGGACTATTT 
CACGACCTTT AACAGTCAAC AAAAAAACAA ATTCTATAAC TTCACCGGGT 
701 TTAATCCGGA GAAAATCAAA GAACAGTATA AAGCCAGCCC TCACGAAAAC 
TTCATCTTCA TTGGCACCAA TTCTGGTACT GCCACTGCCG AGCAACAAAT 
801 CGATATCCTG ACCGAGGCCA AAAAACCTGA TTCCCCGATC ATCACGAATA 
GCATCCAAGG ACTGGACCTG TTTTTCAAAG GTCATCCGTC AGCGACGTAT 
901 AACCAGCAGA TCATCGATGC CCATAACATG ATCGAGATTT ATAACAAAAT 
CCCGTTCGAA GCCCTGATTA TGACAGACGC TCTGCCAGAT GCCGTGGGTG 
1001 GTATGGGTTC TAGCGTTTTC TTCTCACTGC CAAACACCGT GGAGAACAAA 
TTCATCTTCT ATAAAAGCGA CACCGACATT GAGAATAACG CCCTGATCCA 
1101 GGTCATGATT GAGCTGAACA TTGTGAACCG TAACGATGTG AAACTGATCA 
GCGACCTGCA GTAAGGATCC 
 
Sequence 13.3. Artificial gene sequence of SiaTpph 
 
13.5.1.2. Expression and purification of α-2,3-sialyltransferase from Photobacterium 
phosphoreum 
 
10 μl BL21T-pET19b-SiaTpph was transferred into 250 mL LB medium and cultured at 37°C 
with 250 rpm shaking overnight. Then the 250 mL culture was transferred into 5 L TB 
medium and cultured in a 10 L fermenter at 37°C with 500 rpm stir until OD600 reached 0.5. 
0.1 mM IPTG was added for the expression induction at 28°C for at least 6 hours. After that, 
the cells were harvested by centrifugation at 4,000 rpm for 20 min and stored at -80°C.  
For the purification, 20 g frozen cells were lysed in 200 mL resuspension buffer which 
contained 0.5 mg/mL lysozyme (Roth, Germany) and 0.5 M NaCl in 20 mM Tris (pH 7.5). 
The resuspension was treated by ultrasonic for 10 min in ice to obtain crude extract of the 
cells. After 12,000 rpm centrifugation for 30 min at 4°C, the supernatant (added 25 mM 
imidazole additionally) was loaded on 5 ml Ni-affinity columns (GE, USA) to purify the 
recombinant protein. After sample loading, the Ni-affinity columns were washed by 50 mM 
imidazole wash buffer. Then, the target protein was washed out by 200 mM imidazole eluate 
buffer. The buffer of the eluate was replaced by 2 mM Tris (pH 7.5) using ultrafiltration. The 
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purity of the recombinant SiaTpph was identified by SDS-PAGE electrophoresis and stored in 
50% glycerol at -20°C. 
 
13.5.1.3. Characterization of α-2,3-sialyltransferase from Photobacterium 
phosphoreum 
 
The rapid identification of recombinant SiaTpph used a 100 μl reaction which contained 10 
mM Lac-D-T-P-Acr as acceptor, 10 mM CMP-Neu5Ac as donor, 20 mM Tris-HCl (pH8.6) with 
0.5 M NaCl and 0.1% Triton X100 as buffer. 50 μl supernatant of cell lysate of BL21T-pET-
SiaTpph was added for the reaction. After 30 min, the Neu5Ac-2,3-Lac-D-T-P-Acr product was 
identified on TLC plate with mobile phase n-BuOH:aceton:AcOH:H2O=40:40:7:13. 
 
10-[5-(4-(((Z)-4-O-((N-acetyl-α-D-neuraminic acid)-(2→3)-β-D-lactosyloxy)-but-2-
enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(Neu5Ac-2,3- Lac-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant SiaTpph, 20 mg Lac-D-
T-P-Acr (1 eq.) and 25 mg CMP-Neu5Ac (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) 
buffer with 0.5 M NaCl and 0.1% Triton × 100. 10 mg recombinant SiaTpph was added to start 
the reaction. The pH was being adjusted for keeping at 8.6 by pH-stat during the reaction for 
2-3 h. When the reaction finished, 300 mL -20°C methanol was added to stop the reaction and 
precipitate the most of proteins in the reaction system. The precipitate was removed by 
filtration. The filtrate was concentrated to 10 mL and loaded on Biogel P-2 (Bio-Rad, 
Germany) column (3 cm × 100 cm). The products were further washed out by ddH2O and 
collected and lyophilized for NMR determination. 
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1H NMR (500 MHz, Deuterium Oxide) δ=7.78 (dd, J = 8.0, 1.6 Hz, 2H, 17-, 21-H), 7.73 (s, 
1H, 7-H), 7.30 – 7.26 (m, 2H, 15-, 23-H), 6.93 – 6.77 (m, 4H, 24-, 14-, 16-, 22-H), 5.70 – 
5.48 (m, 2H, 2-, 3-H), 4.45 (s, 2H, 5-H), 4.26 (d, J = 8.0 Hz, 1H, 1’’-H), 4.23 – 4.06 (m, 4H, 
1’-, 1a-, 8-H), 4.05 (dd, J = 9.9, 3.1 Hz, 1H, 1b-H), 3.95 – 3.90 (m, 3H, 3’’-, 2-, 4-H), 3.87 – 
3.75 (m, 5H, 4’’-, 6’’’-, 9’’’a-, 6’-, 5’’’-H), 3.73 – 3.46 (m, 13H, 6’b-, 6’’-, 8’’’-, 7’’’-, 9’’’b-, 3’-, 4’’’-, 
4’-, 2’’-, 8-, 5’’-H), 3.37 – 3.28 (m, 1H, 5’-H), 3.20 (dd, J = 9.2, 8.0 Hz, 1H, 2’-H), 2.72 (dd, J 
= 12.4, 4.7 Hz, 1H, 3’’’a-H), 1.98 (s, 3H, 11’’’-H), 1.75 (t, J = 12.1 Hz, 1H, 3’’’b-H), 1.56 – 
1.50 (m, 2H, 9-H), 1.15 – 0.87 (m, 4H, 11-, 10-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ=178.13 (C-19), 174.90 (C-1’’’), 173.47 (C-10’’’), 
143.79 (C-6), 140.59 (C-13, -25), 134.57 (C-15, -23), 129.23 (C-2), 129.00 (C-3), 126.18 (C-
17, -21), 124.65 (C-7), 121.66 (C-16, -22), 120.33 (C-18, -20), 115.02 (C-14, -24), 103.28 
(C-1’’), 100.92 (C-1’), 100.31 (C-2’’’), 79.59 (C-4’), 74.63 (C-3’’), 73.69 (C-8’’’), 72.63 (C-5’), 
72.55 (C-5’’), 72.42 (C-3’), 71.80 (C-2’), 70.79 (C-6’’’), 68.52 (C-2’’), 68.40 (C-7’’’), 68.36 (C-
4’’’), 65.05 (C-4), 64.63 (C-1), 63.50 (C-9’’’), 62.67 (C-5), 62.27 (C-6’’), 60.22 (C-6’), 51.83 
(C-5’’’), 50.05 (C-8), 45.19 (C-12), 40.14 (C-3’’’), 28.77 (C-9), 25.73 (C-11), 22.60 (C-10), 
22.09 (C-11’’’) ppm. 
 
13.5.2. Cloning, expression and characterization of α-2,6-sialyltransferase from 
Photobacterium leiognathi JT-SHIZ-145 
 
13.5.2.1. Cloning of α-2,6-sialyltransferase from Photobacterium leiognathi JT-SHIZ-
145 
 
The DNA sequence of 2,6SiaTple gene from Photobacterium leiognathi JT-SHIZ-145 was 
optimized for expression in E. coli and synthesized by the Company Mr. Gene (Germany). 
NdeI and BamHI restriction enzyme sites were added at 5’- and 3’- terminuses for further 
cloning work, respectively. The plasmid pMA-PLST from Mr. Gene Company containing 
synthesized 2,6SiaTple gene was transformed into E. coli Jm109 competent cells for plasmid 
amplification. The recombinant cells were cultured at 37°C with 250 rpm shaking overnight. 
The plasmid was extracted and digested by NdeI and BamHI, and purified by gel extraction. 
Then, the 2,6SiaTple gene fragment was ligated into pET19b vector to construct the expression 
plasmid pET19b-SiaTple, which was then transformed into E. coli Jm109 competent cells for 
plasmid amplification and identification. The positive colonies were picked and cultured in 5 
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mL Amp-LB medium at 37°C with 250 rpm shaking overnight. The extracted plasmids were 
identified by NdeI and BamHI restriction endonuclease enzyme digestion and electrophoresis, 
as well as sequencing. Then the identified final plasmid was transformed into E. coli BL21 
Tuner competent cells. The positive colony (BL21T-pET19b-SiaTple) was picked and cultured 
in 5 mL Amp-LB medium at 37°C with 250 rpm shaking overnight and stored in 16% glycerol 
at -80°C. 
 
1 GGTACCCATA TGTGTAACGA CAACCAGAAT ACCGTAGACG TGGTGGTGAG 
TACAGTGAAC GATAATGTGA TCGAGAATAA CACCTATCAG GTGAAACCGA 
101 TCGATACTCC GACAACGTTT GACTCCTATT CCTGGATTCA GACCTGTGGC 
ACACCAATCC TGAAAGATGA CGAAAAATAT AGCCTGTCCT TCGACTTTGT 
201 TGCTCCGGAA CTGGACCAAG ACGAGAAATT TTGCTTCGAG TTTACCGGTG 
ATGTTGATGG AAAACGCTAT GTGACCCAGA CTAATCTGAC CGTGGTAGCA 
301 CCGACACTGG AAGTTTATGT GGATCATGCC TCTCTGCCTT CCCTGCAGCA 
GCTGATGAAA ATCATCCAAC AGAAAAACGA ATATTCCCAG AACGAACGCT 
401 TTATCAGTTG GGGCCGTATT CGCCTGACGG AGGACAATGC TGAGAAACTG 
AACGCCCACA TTTATCCTCT GGCGGGCAAT AATACAAGCC AAGAGCTGGT 
501 CGATGCCGTG ATTGATTATG CCGACTCCAA AAACCGCCTG AACCTGGAGC 
TGAACACTAA TACTGGTCAT TCCTTCCGTA ATATCGCTCC GATCCTGCGT 
601 GCAACCTCTT CTAAAAACAA TATCCTGATC AGCAATATCA ACCTGTATGA 
CGATGGTAGC GCCGAATATG TTAGCCTGTA TAACTGGAAA GACACGGACA 
701 ATAAAAGCCA AAAACTGAGC GACAGCTTCC TGGTACTGAA AGACTATCTG 
AACGGGATTA GCAGCGAAAA ACCAAATGGG ATCTATAGCA TCTATAACTG 
801 GCACCAGCTG TATCATTCGT CCTATTATTT TCTGCGCAAA GATTATCTGA 
CCGTGGAAAC GAAACTGCAC GATCTGCGTG AATATCTGGG CGGATCGCTG 
901 AAACAAATGT CATGGGACAC CTTTTCACAA CTGTCCAAAG GCGACAAAGA 
ACTGTTCCTG AACATCGTGG GCTTTGATCA AGAAAAACTG CAGCAAGAAT 
1001 ATCAGCAGAG CGAACTGCCG AATTTTGTGT TTACTGGGAC CACAACATGG 
GCAGGTGGCG AGACTAAAGA GTATTATGCC CAGCAGCAGG TGAATGTCGT 
1101 GAATAACGCC ATTAACGAAA CGAGCCCTTA TTATCTGGGC CGTGAGCACG 
ACCTGTTCTT CAAAGGTCAT CCTCGTGGGG GTATCATCAA CGACATCATT 
1201 CTGGGCAGCT TCAATAACAT GATCGATATC CCGGCCAAAG TGAGTTTTGA 
GGTTCTGATG ATGACCGGAA TGCTGCCTGA TACTGTGGGT GGTATTGCCT 
1301 CTTCGCTGTA TTTCTCCATT CCAGCCGAGA AAGTCAGCTT CATCGTGTTT 
ACCAGCAGTG ACACCATTAC AGACCGTGAA GATGCTCTGA AATCACCACT 
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1401 GGTTCAAGTC ATGATGACAC TGGGTATCGT GAAAGAGAAA GACGTCCTGT 
TTTGGTGCTG AGGATCCAAG CTT 
 
Sequence 13.4. Artificial gene sequence of SiaTple 
 
13.5.2.2. Expression and purification of α-2,6-sialyltransferase from Photobacterium 
leiognathi JT-SHIZ-145 
 
10 μl BL21T-pET19b-SiaTple was transferred into 250 mL LB medium and cultured at 37°C 
with 250 rpm shaking overnight. Then the 250 mL culture was transferred into 5 L TB 
medium and cultured in a 10 L fermenter at 37°C with 500 rpm stir until OD reached 0.5. 0.1 
mM IPTG was added for the expression induction at 28°C for at least 6 hours. After that, the 
cells were harvested by centrifugation at 4,000 rpm for 20 min and stored at -80°C.  
For the purification, 20 g frozen cells were lysed in 200 mL resuspension buffer which 
contained 0.5 mg/mL lysozyme (Roth, Germany) and 0.5 M NaCl in 20 mM Tris (pH 7.5). 
The resuspension was treated by ultrasonic for 10 min in ice to obtain crude extract of the 
cells. After 12,000 rpm centrifugation for 30 min at 4°C, the supernatant (added 25 mM 
imidazole additionally) was loaded on 5 ml Ni-affinity columns (GE, USA) to purify the 
recombinant protein. After sample loading, the Ni-affinity columns were washed by 50 mM 
imidazole wash buffer. Then, the target protein was washed out by 200 mM imidazole eluate 
buffer. The buffer of the eluate was replaced by 2 mM Tris (pH 7.5) using ultrafiltration. The 
purity of the recombinant 2,6SiaTple was identified by SDS-PAGE electrophoresis and stored in 
50% glycerol at -20°C. 
 
13.5.2.3. Characterization of α-2,6-sialyltransferase from Photobacterium leiognathi 
JT-SHIZ-145 
 
The rapid identification of recombinant 2,6SiaTple used a 100 μl reaction which contained 10 
mM Lac-D-T-P-Acr as acceptor, 10 mM CMP-Neu5Ac as donor, 20 mM Tris-HCl (pH8.6) with 
0.5 M NaCl and 0.1% Triton X100 as buffer. 50 μl supernatant of cell lysate of BL21T-pET-
SiaTpph was added for the reaction. After 30 min, the Neu5Ac-2,6-Lac-D-T-P-Acr product was 
identified on TLC plate with mobile phase n-BuOH:aceton:AcOH:H2O=40:40:7:13. 
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10-[5-(4-(((Z)-4-O-((N-acetyl-α-D-neuraminic acid)-(2→6)-β-D-lactosyloxy)-but-2-
enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(Neu5Ac-2,6- Lac-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,6SiaTple, 20 mg Lac-
D-T-P-Acr (1 eq.) and 25 mg CMP-Neu5Ac (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) 
buffer with 0.5 M NaCl and 0.1% Triton ×100. 10 mg recombinant SiaTpph was added to start 
the reaction. The pH was being adjusted for keeping at 8.6 by pH-stat during the reaction for 
2-3 h. When the reaction finished, 300 mL -20°C methanol was added to stop the reaction and 
precipitate the most of proteins in the reaction system. The precipitate was removed by 
filtration. The filtrate was concentrated to 10 mL and loaded on Biogel P-2 (Bio-Rad, 
Germany) column (3 cm × 100 cm). The products were further washed out by ddH2O and 
collected and lyophilized for NMR determination. 
 
 
 
 
 
 
 
1H NMR (500 MHz, Deuterium Oxide) δ=7.81 (m, 2H, 17- 21H), 7.74 (s, 1H, 7-H), 7.34 (dd, 
2H, 15-, 23-H), 7.02 – 6.82 (m, 4H, 14-, 24-, 16-, 22-H), 5.73 – 5.48 (m, 2H, 2-, 3-H), 4.46 (s, 
2H, 5-H), 4.30 (d, J = 7.8 Hz, 1H, 1’’-H), 4.27 (dd, J = 8.0, 1.6Hz, 1H, 1’-H), 4.24-4.13 (m, 
3H, 8-, 1a-H), 4.13-4.06 (m, 1H, 1b-H), 3.96 – 3.75 (m, 9H, 4-, 9’’’a-, 5’’’-, 8’’’-, 6’’’-, 6’a-, 6’’a-, 
4’’-H), 3.75 – 3.62 (m, 3H, 4’’’-, 5’’-, 6’b-H), 3.62 – 3.43 (m, 9H, 6’’b-, 3’’-, 9’’’-, 12-, 7’’’-, 3’-, 4’-, 
2’’-H), 3.41 – 3.32 (m, 1H, 5’-H), 3.22 (t, J = 8.1 Hz, 1H, 2’-H), 2.66 (dd, J = 12.4, 4.6Hz, 1H, 
3’’’a-H), 1.97 (s, 3H, 11’’’-H), 1.67 (t, J = 12.2 Hz, 1H, 3’’’-H), 1.62-1.50 (m, 2H, 9-H), 1.16 – 
0.92 (m, 4H, 11-, 10-H) ppm. 
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13C NMR (126 MHz, Deuterium Oxide) δ=178.13 (C-19), 174.90 (C-1’’’), 173.47 (C-10’’’), 
143.79 (C-6), 140.59 (C-13, -25), 134.57 (C-15, -23), 129.23 (C-2), 129.00 (C-3), 126.18 (C-
17, -21), 124.65 (C-7), 121.66 (C-16, -21), 120.33 (C-18, -20), 115.02 (C-14, -24), 103.28 
(C-1’’), 100.92 (C-1’), 100.31 (C-2’’’), 79.59 (C-4’),74.67 (C-3’’), 74.63 (C-8’’’), 73.69 (C-5’), 
72.63 (C-5’’), 72.55 (C-3’), 72.42 (C-2’),  71.80 (C-6’’’), 70.79 (C-2’’), 68.52 (C-7’’’), 68.40 (C-
4’’’), 68.36 (C-4’’), 65.05 (C-4), 64.63 (C-1), 63.50 (C-6’’), 62.67 (C-9’’’), 62.27 (C-5), 60.22 
(C-6’), 51.83 (C-5’’’), 50.05 (C-8), 45.19 (C-12), 40.14 (C-3’’’), 28.77 (C-9), 25.73 (C-11), 
22.60 (C-10), 22.09 (C-11’’’) ppm. 
 
13.5.3. Development of pH-based assay for sialyltransferases 
 
13.5.3.1. Calibration curve, limit of detection (LOD) and limit of quantification (LOQ) 
 
The standard curve of the assay method used a series of finial concentration of HCl from 0 
mM to 1.0 mM in a 96-well plate. The mixture also contained 1 mM CMP-Neu5Ac, 2 μg 
SiaTple, 2 μl 0.1% phenol red and 2 mM Tris-HCl (pH 8.0). Total volume was 200μl. The 
relationship between concentration of proton and absorbance was measured at 560 nm by 
Vmax plate reader (Beckman, USA) to obtain the standard curve y = ax + b. LOD was defined 
as LOD = 3.3Sb / ā, and LOQ was defined as LOD = 10Sb / ā, where Sb is the standard 
deviation of the control. 
 
13.5.3.2. Reaction system for assay 
 
The assay reaction was taken place on 96-well flat bottom plate. The reaction mixture 
contained 0-4 μl SiaT (dependent on the activity of SiaT), 20 mM acceptor, 2 mM Tris-HCl 
(pH 8.0) and 2 μl phenol red (0.1%, 2.82 mM). 1 mM CMP-Neu5Ac was added to start the 
reaction. The total volume in each well was 200 μl. The absorbance increase was measured at 
560 nm by plate reader at 20°C. 
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13.5.3.3. Dependence of rate on amount of SiaT 
 
The specific activity measurement at varying enzyme concentration used a series of amount of 
0-4 μg SiaTple. 20 mM Lac was used as the acceptor. Absorbance data for the first 60 sec was 
recorded and converted into concentration of proton according to the calibration curve for the 
activity calculation. 
 
13.5.4. Substrate tolerance screening of sialyltransferase 
 
13.5.4.1. Determination of acceptor specificity  
 
To screening the acceptor tolerance of SiaTs, the activities towards various acceptors were 
measured, including 20 mM acceptor, 2 mM Tris-HCl (pH 8.0) and 2 μl phenol red (0.1% , 
2.82 mM). 1 mM CMP-Neu5Ac was added to start the reaction. The total volume in each well 
was 200 μl. The absorbance increase was measured at 560 nm by plate reader at 20°C. 
 
13.5.4.2. Determination of kinetic constants 
 
The enzymatic kinetics towards both donor CMP-Neu5Ac and acceptor (galactose, methyl-α-
D-galactopyranoside, methyl-β-D-galactopyranoside and lactose) were determined at varying 
concentration of substrates. 1 mM CMP-Neu5Ac was used for the determination of kinetic 
constants for the acceptors. 20 mM Lac was used for the measurement of CMP-Neu5Ac 
kinetics. The reaction rate at each concentration was calculated according to the calculation 
curve and collected for non-linear fit to the Michaelis-Menten equation using Origin 8 
software to obtain enzymatic kinetic values. 
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13.6. Directed Evolution of Cytosine-5’-Monophosphate-N-Acetylneuraminate 
Synthetase from Neisseria meningitidis towards 5’-modified N-
Acetylneuraminate Analogues. 
 
13.6.1. Building of Phe192 and Phe193 single site mutagenesis libraries 
 
The construction of Phe192 and Phe193 single-site mutagenesis libraries of CSS used 
QuikChange Lighning Mutagenesis Kit. PCR primers CSSF192f 5'- C ATT AAT GAT ACT GCT 
TCA CTA ATT GCA AAT AAT TGT NNK TTT ATC GCC CCA ACC AAA CTT TAT -3' (forward 
primer) and CSSF192b 5'- ATA AAG TTT GGT TGG GGC GAT AAA MNN ACA ATT ATT TGC 
AAT TAG TGA AGC AGT ATC ATT AAT G -3’ (backward primer) and CSSF193f 5'- C ATT AAT 
GAT ACT GCT TCA CTA ATT GCA AAT AAT TGT TTT NNK ATC GCC CCA ACC AAA CTT TAT 
-3' (forward primer) and CSSF193b 5'- ATA AAG TTT GGT TGG GGC GAT MNN AAA ACA 
ATT ATT TGC AAT TAG TGA AGC AGT ATC ATT AAT G -3’ (backward primer) were designed 
for Phe192 and Phe193 sites, respectively. The PCR used CSS gene in vector pET21a(+) 
(pET21a-CSS) as template.  
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
QuikSolution reagent:  1.5 μl 
QuikChange Lightning Enzyme: 1 μl 
ddH2O:    up to 50 μl 
 
95°C   2 min 
95°C   30 sec 
68°C   10 sec 
68°C   3 min 40 sec 30 cycles 
68°C   10 min 
The PCR product was digested by 2 μl DpnI for 1 h at 37°C. Then 2 μl PCR product was 
transformed into BL21DE3 competent cells and cultured on ampicillin agar plates overnight at 
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37°C. 96 colonies were picked into 96-well plates containing 150 μl/well LB-ampicillin 
medium. After overnight culture at 37°C 900 rpm, 30 μl glycerol was added into each well. 
The whole plates were sealed with plastic lids and stored at -80°C.  
 
13.6.2. Building of Phe192-Phe193 double site mutagenesis library 
 
The construction of Phe192-Phe193 double-site mutagenesis libraries of CSS used 
QuikChange Lighning Mutagenesis Kit with two mutagenesis strategies. PCR primers 
CSSF192193Rf 5'- GCA ATT TAC ATT AAT GAT ACT GCT TCA CTA ATT GCA AAT AAT TGT 
NRT NRT ATC GCC CCA ACC AAA CTT TAT ATT ATG -3' (forward primer) and 
CSSF192193Rb 5'- CAT AAT ATA AAG TTT GGT TGG GGC GAT AYN AYN ACA ATT ATT TGC 
AAT TAG TGA AGC AGT ATC ATT AAT GTA AAT TGC -3’ (backward primer) and 
CSSF192193Df 5'- GCA ATT TAC ATT AAT GAT ACT GCT TCA CTA ATT GCA AAT AAT TGT 
NDT NDT ATC GCC CCA ACC AAA CTT TAT ATT ATG -3' (forward primer) and 
CSSF192193Db 5'- CAT AAT ATA AAG TTT GGT TGG GGC GAT AHN AHN ACA ATT ATT 
TGC AAT TAG TGA AGC AGT ATC ATT AAT GTA AAT TGC -3’ (backward primer) were 
designed for Phe192193R and Phe192193D libraries, respectively. The PCR used CSS gene in 
vector pET21a(+) (pET21a-CSS) as template. 
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
QuikSolution reagent:  1.5 μl 
QuikChange Lightning Enzyme: 1 μl 
ddH2O:    up to 50 μl 
 
95°C   2 min 
95°C   30 sec 
68°C   10 sec 
68°C   4 min   30 cycles 
68°C   10 min 
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The PCR process is described as follows: 95°C 2 min, (95°C 10 sec, 68°C 3 min 40 sec) 30 
cycles, 68°C 5 min. The PCR product was digested by 2 μl DpnI for 1 h at 37°C. Then 2 μl PCR 
product was transformed into BL21DE3 competent cells and cultured on ampicillin agar plates 
overnight at 37°C. 192 and 432 colonies were picked into 96-well plates containing 150 
μl/well LB-ampicillin medium for Phe192193R and Phe192193D libraries, respectively. After 
overnight culture at 37°C 900 rpm, 30 μl glycerol was added into each well. The whole plates 
were sealed with plastic lids and stored at -80°C.  
 
13.6.3. Screening of CSS mutants 
 
2 μl of each clone in libraries was transferred to individual wells in 96-well round bottom 
plates containing 150 μl/well LB growth media comprised 50 μg/mL ampicillin. The plates 
were sealed with plastic lids to avoid evaporation, and then incubated at 30°C, 1,000 rpm 
overnight. After that, 5 μl was transferred from each well to 96-deepwell plates with plastic 
lids containing 400 μl/well of LB-kanamycin growth medium containing 0.1 mM IPTG. The 
plates were then incubated at 30°C, 1,000 rpm overnight, until the amount of cells in each 
well reached the maximum. Cells were harvested by centrifugation at 4,000 rpm for 20 min. 
The culture medium was removed and the cell pellets could be stored at -80°C.  
The cell pellets were resuspended in 150 μl resuspension buffer (1/10 BugBuster solution 
(Novagen, Germany), 0.5 mg/mL lysozyme (Roth, Germany) and 4U/mL Benzonase 
endonuclease (Novagen, Germany)) and incubated in a shaker for 30 min at room 
temperature. Then, the cell lysate was centrifugated at 4,000 rpm for 30 min. 40 μl of the 
supernatant was transferred to a new 96-well flat bottom plate. 140 μl of substrate solution (2 
mM Tris (pH8.6), 10 mM MgCl2, 2.82 mM cresol red and 10 mM acceptor was added to each 
well. The reaction was initiated by the addition of 0.5 mM CTP. The total volume in each well 
was 200 μl. The OD increase was read by the plate-reader at 574 nm. 
16 (for single site libraries) or 24 (for double site libraries) positive colonies with the highest 
activity were picked from each plate into a new plate for the second round screening. 
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13.6.4. Verification by synthesis of neo-sialoconjugates 
 
 
10-[5-(4-(((Z)-4-O-((N-benzyloxy-acetyl -α-D-neuraminic acid)-(2→6)-β-D-lactosyloxy)-
but-2-enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(Neu5AcOBz-2,6-Lac-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,6SiaTple, 25.2 mg 
CTP (2 eq.) and 17.3 mg Neu5AcOBz (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) 
buffer with 0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS-F192C/F193Y and 20 μl PPase were 
added to start the reaction. When the CMP-activation was completed, 20 mg Lac-D-T-P-Acr (1 
eq.) and 5 mg recombinant SiaTple were added to start the reaction. The pH was being 
adjusted for keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction 
finished, 300 mL -20°C methanol was added to stop the reaction and precipitate the most of 
proteins in the reaction system. The precipitate was removed by filtration. The filtrate was 
concentrated to 10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 
cm). The products were further washed out by ddH2O and collected and lyophilized for NMR 
determination.   Product: 15.5 mg yellow powder. Yield: 50%. 
 
 
 
 
 
 
1H NMR (500 MHz, D2O) δ=7.88 (dd, J = 8.0, 1.1 Hz, 2H, 17-, 21-H), 7.74 (s, 1H, 7-H), 7.38 
(dd, J = 8.3, 6.3 Hz, 2H, 15-, 23-H), 7.29 – 7.18 (m, 5H, 14’’’-, 15’’’-, 16’’’-, 17’’’-, 18’’’-H), 
7.02 – 6.92 (m, 4H, 14-, 24-, 16-, 22-H), 5.75 – 5.57 (m, 2H, 2-, 3-H), 4.47 (d, J = 6.5 Hz, 4H, 
5-, 12’’’-H), 4.34 (d, J = 7.8 Hz, 1H, 1’’-H), 4.31 (d, J = 8.0 Hz, 1H, 1’-H), 4.21 (dt, J = 18.7, 
6.3 Hz, 3H, 1a-, 8-H), 4.12 (dd, J = 12.4, 7.1 Hz, 1H, 1b-H), 4.01 – 3.91 (m, 4H, 11’’’a-, 4-, 
9’’’a-H), 3.91 – 3.78 (m, 6H, ), 3.77 – 3.63 (m, 6H, 6’’’-, 8’’’-, 6’a-, 6’’a-, 5’’’-H), 3.62 – 3.44 (m, 
12H, 5’’-, 6’b-, 4’’’-, 3’’-, 6’’b-, 9’’’b-, 4’’-, 12-, 3’-, 4’-, 2’’-, 7’’’-H), 3.44 – 3.38 (m, 1H, 5’-H), 3.25 
 Seite 164 
(t, J = 8.5 Hz, 1H, 2’-H), 2.68 (dd, J = 12.4, 4.6 Hz, 1H, 3’’’a-H), 1.71 (t, J = 12.2 Hz, 1H, 
3’’’b-H), 1.63 – 1.52 (m, 2H, 9-H), 1.20 – 1.07 (m, 2H, 11-H), 1.06 – 0.96 (m, 2H, 10-H) ppm. 
13C NMR (126 MHz, D2O) δ=178.24 (C-19), 173.49 (C-1’’’), 173.16 (C-10’’’), 143.83 (C-6), 
140.68 (C-13, -25), 136.50 (C-13’’’), 134.62 (C-15, -23), 129.35 (C-2), 128.94 (C-3), 128.68 
(C-14’’’, -18’’’), 128.43 (C-15’’’, -17’’’, -16’’’), 126.26 (C-17, -21), 124.68 (C-7), 121.71 (C-16, -
22), 120.42 (C-18, -20), 115.09 (C-14, -24), 103.20 (C-1’’), 101.03 (C-1’), 100.22 (C-2’’’), 
79.66 (C-4’), 74.68 (C-5’), 74.63 (C-3’), 73.77 (C-5’’), 73.22, 72.66 (C-2’), 72.44 (C-4’’), 72.27 
(C-3’’), 71.91 (C-8’’’), 70.78 (C-2’’), 68.52 (C-7’’’), 68.44 (C-11’’’), 68.04 (C-4’’’), 65.10 (C-4), 
64.69 (C-1), 63.61 (C-9’’’), 62.73 (C-6’’), 62.28 (C-5), 60.28 (C-6’), 51.65 (C-5’’’), 50.06 (C-8), 
45.21 (C-12), 40.33 (C-3’’’), 28.80 (C-9), 25.79 (C-11), 22.63 (C-10) ppm. 
 
10-[5-(4-(((Z)-4-O-((N-azidopentanoyl -α-D-neuraminic acid)-(2→3)-β-D-lactosyloxy)-but-
2-enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
( NeuPenN3-2,6-Lac-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,6SiaTple, 25.2 mg 
CTP (2 eq.) and 16.4 mg NeuPenN3 (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) buffer 
with 0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS-F192S and 20 μl PPase were added to start 
the reaction. When the CMP-activation was completed, 20 mg Lac-D-T-P-Acr (1 eq.) and 5 mg 
recombinant SiaTple were added to start the reaction. The pH was being adjusted for keeping 
at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -20°C 
methanol was added to stop the reaction and precipitate the most of proteins in the reaction 
system. The precipitate was removed by filtration. The filtrate was concentrated to 10 mL and 
loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products were 
further washed out by ddH2O and collected and lyophilized for NMR determination.   Product: 
19.5 mg yellow powder. Yield: 64%. 
 
 
 
 
   Seite 165 
1H NMR (500 MHz, D2O) δ=7.84 (t, J = 8.9 Hz, 2H, 17-, 21-H), 7.74 (s, 1H, 7-H), 7.34 (t, J 
= 7.3 Hz, 2H, 15-, 23-H), 7.01 – 6.86 (m, 4H, 14-, 24-, 16-, 22-H), 5.74 – 5.56 (m, 2H, 2-, 3-
H), 4.46 (d, J = 4.2 Hz, 2H, 5-H), 4.33 (t, J = 7.7 Hz, 1H, 1’’-H), 4.30 (d, J = 8.0 Hz, 1H, 1’-
H), 4.25 – 4.15 (m, 3H, 1a-, 8-H), 4.11 (dd, J = 12.6, 7.0 Hz, 1H, 1b-H), 3.98 – 3.89 (m, 3H, 
4-, 9’’á-H), 3.90 – 3.77 (m, 5H, 6’’’-, 8’’’-, 6’a-, 6’’a-, 5’’’-H), 3.77 – 3.45 (m, 13H, 5’’-, 6’b-, 4’’-, 
4’’’-, 3’’-, 6’’b-, 12-, 9’’’b-, 3’-, 7’’’-, 4’-, 2’’-H), 3.42 – 3.36 (m, 1H, 5’-H), 3.22 (dt, J = 10.3, 7.5 
Hz, 3H, 2’-, 14’’’-H), 2.67 (dd, J = 12.3, 4.6 Hz, 1H, 3’’’a-H), 2.23 (t, J = 7.2 Hz, 2H, 11’’’-H), 
1.70 (t, J = 12.2 Hz, 1H, 3’’’b-H), 1.64 – 1.53 (m, 4H, 9-, 12’’’-H), 1.52 – 1.45 (m, 2H, 13’’’-H), 
1.17 – 1.06 (m, 2H, 11-H), 1.05 – 0.97 (m, 2H, 10-H) ppm. 
13C NMR (126 MHz, D2O) δ=178.12 (C-19), 177.28 (C-1’’’), 173.36 (C-10’’’), 143.82 (C-6), 
140.65 (C-13, -25), 134.57 (C-15, -23), 129.30 (C-2), 128.96 (C-3), 126.25 (C-17, -21), 
124.64 (C-7), 121.64 (C-16, -22), 120.41 (C-18, -20), 115.04 (C-14, -24), 103.26 (C-1’’), 
100.99 (C-1’), 100.19 (C-2’’’), 79.65 (C-4’), 74.69 (C-3’), 74.64 (C-5’), 73.71 (C-5’’), 72.65 (C-
4’’), 72.61 (C-3’’), 72.44 (C-2’), 71.76 (C-8’’’), 70.78 (C-2’’), 68.56 (C-7’’’), 68.46 (C-6’’’), 
68.15 (C-4’’’), 65.11 (C-4), 64.67 (C-1), 63.52 (C-9’’’), 62.72 (C-6’’), 62.30 (C-5), 60.27 (C-6’), 
51.78 (C-5’’’), 50.70 (C-14’’’), 50.04 (C-8), 45.21(C-12), 40.27 (C-3’’’), 35.30 (C-11’’’), 28.82 
(C-9), 27.50 (C-13’’’), 25.79 (C-11), 22.64 (C-10), 22.56 (C-12’’’) ppm. 
 
10-[5-(4-(((Z)-4-O-((N-(hex-5-ynoyl)-α-D-neuraminic acid)-(2→6)-β-D-lactosyloxy)-but-
2-enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(Neu5Hex-2,6-Lac-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,6SiaTple, 25.2 mg 
CTP (2 eq.) and 15.2 mg Neu5Hex (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) buffer 
with 0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS-F192S/F193Y and 20 μl PPase were added 
to start the reaction. When the CMP-activation was completed, 20 mg Lac-D-T-P-Acr (1 eq.) 
and 5 mg recombinant SiaTple were added to start the reaction. The pH was being adjusted for 
keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -
20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 20.7 mg yellow powder. Yield: 70%. 
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1H NMR (500 MHz, Deuterium Oxide) δ 7.84 (dd, J = 8.1, 1.6 Hz, 2H, 17-, 21-H), 7.75 (s, 1H, 
7-H), 7.36 (ddd, J = 8.4, 6.7, 1.6 Hz, 2H, 15-, 23-H), 7.01 – 6.88 (m, 4H, 14-, 24-, 16-, 22-H), 
5.71 – 5.54 (m, 2H, 5-H), 4.47 (s, 2H, 2-, 3-H), 4.32 (d, J = 7.8 Hz, 1H, 1’’-H), 4.28 (d, J = 
8.0 Hz, 1H, 1’-H), 4.24 – 4.16 (m, 3H, 1a-, 8-H), 4.10 (dd, J = 12.6, 6.9 Hz, 1H, 1b-H), 3.99 
– 3.88 (m, 3H, 4-, 9’’’a-H), 3.88 – 3.76 (m, 6H, 6’’’-, 8’’’-, 6a-, 6’’a-, 5’’’-H), 3.76 – 3.43 (m, 17H, 
5’’-, 6’b-, 4’’’-, 3’’-, 6’’b-, 9’’’b-, 3’-, 12-, 4’-, 7’’’-, 2’’-H), 3.38 (ddd, J = 9.3, 5.0, 2.3 Hz, 1H, 5’-H), 
3.23 (t, J = 8.5 Hz, 1H, 2’-H), 2.66 (dd, J = 12.4, 4.7 Hz, 1H, 3’’’a-H), 2.33 (ddd, J = 8.1, 6.0, 
2.1 Hz, 2H, 11’’’-H), 2.14 (tt, J = 6.9, 2.1 Hz, 2H, 13’’’-H), 1.75 – 1.64 (m, 3H, 12’’’-, 3’’’b-H), 
1.59 (t, J = 7.4 Hz, 2H, 9-H), 1.19 – 0.93 (m, 4H, 11-, 10-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ 178.19 (C-19), 176.85 (C-1’’’), 173.50 (C-10’’’), 
140.64 (C-13, -25), 134.61 (C-15, -23), 129.28 (C-2), 128.98 (C-3), 126.22 (C-17, -21), 
124.68 (C-7), 121.69 (C-16, -22), 120.38 (C-18, -20), 115.07 (C-14, -24), 103.26 (C-1’’), 
100.96 (C-1’), 100.28 (C-2’’’), 84.16 (C-14’’’), 79.63 (C-4’), 74.69 (C-5’), 74.63 (C-3’), 73.72 
(C-5’’), 72.64 (C-2’), 72.55 (C-4’’), 72.43 (C-3’’), 71.87 (C-8’’’), 70.79 (C-2’’), 69.98 (C-15’’’), 
68.57 (C-7’’’), 68.53 (C-6’’’), 68.26 (C-4’’’), 65.06 (C-4), 64.66 (C-1), 63.53 (C-9’’’), 62.71 (C-
6’’), 62.28 (C-5), 60.25 (C-6’), 51.77 (C-5’’’), 50.07 (C-8), 45.21 (C-12), 40.29 (C-3’’’), 34.61 
(C-11’’’), 28.79 (C-9), 25.77 (C-11), 24.01 (C-12’’’), 22.63 (C-10), 17.02(C-13’’’) ppm.   
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13.7. Directed Evolution of 2,6-Sialyltransferase from Photobacterium leiognathi JT-
SHIZ-145 towards α-Galactosides 
 
13.7.1. Building of Trp347 site mutagenesis library 
 
The construction of Trp347 single-site mutagenesis library of 2,6SiaTple used QuikChange 
Lighning Mutagenesis Kit. PCR primers PLSTW347f 5'- CG AAT TTT GTG TTT ACT GGG ACC 
ACA ACA NNS GCA GGT GGC GAG ACT -3' (forward primer) and PLSTW347b 5'- AGT CTC 
GCC ACC TGC SNN TGT TGT GGT CCC AGT AAA CAC AAA ATT CG -3’ (backward primer) 
were designed for Trp347 site. The PCR used artificial 2,6SiaTple gene, which has been 
optimized for the expression in E. coli, in vector pET19b (pET19-PLST) as template. 
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
QuikSolution reagent:  1.5 μl 
QuikChange Lightning Enzyme: 1 μl 
ddH2O:    up to 50 μl 
 
95°C   2 min 
95°C   30 sec 
72°C   10 sec 
68°C   4 min   30 cycles 
68°C   10 min 
The PCR product was digested by 2 μl DpnI for 1 h at 37°C. Then 2 μl PCR product was 
transformed into BL21DE3 competent cells and cultured on ampicillin agar plates overnight at 
37°C. 192 colonies were picked into 96-well plates containing 150 μl/well LB-ampicillin 
medium. After overnight culture at 37°C 900 rpm, 30 μl glycerol was added into each well. 
The whole plates were sealed with plastic lids and stored at -80°C.  
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13.7.2. Building of T345 site mutagenesis library 
 
The construction of Trp347Gly and Trp347Ala single-site mutants of 2,6SiaTple used 
QuikChange Lighning Mutagenesis Kit. PCR primers PLSTW347Gf 5'- G TTT ACT GGG ACC 
ACA ACA GGG GCA GGT GG -3' (forward primer) and PLSTW347Gb 5'- CC ACC TGC CCC 
TGT TGT GGT CCC AGT AAA C -3’ (backward primer); and PLSTW347Af 5'- GTG TTT ACT 
GGG ACC ACA ACA GCG GCA GGT GGC G -3' (forward primer) and PLSTW347Ab 5'- C GCC 
ACC TGC CGC TGT TGT GGT CCC AGT AAA CAC -3’ (backward primer) were designed for 
Trp347Gly and Trp347Ala mutants, respectively. The PCR used artificial 2,6SiaTple gene, 
which has been optimized for the expression in E. coli, in vector pET19b (pET19-PLST) as 
template.  
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
QuikSolution reagent:  1.5 μl 
QuikChange Lightning Enzyme: 1 μl 
ddH2O:    up to 50 μl 
 
95°C   2 min 
95°C   30 sec 
72°C   10 sec 
68°C   4 min   30 cycles 
68°C   10 min 
The PCR product was digested by 2 μl DpnI for 1 h at 37°C. Then 2 μl PCR products was 
transformed into Jm109 competent cells and cultured on ampicillin agar plates overnight at 
37°C. The positive colonies were picked into 5 mL LB-ampicillin medium. After overnight 
culture at 37°C 250 rpm, the amplified plasmids pET19-PLSTW347G and pET19-PLSTW347A 
were extracted, purified by silica column and sent for sequencing.  
The construction of Trp345 single-site mutagenesis library of 2,6SiaTple used QuikChange 
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Lighning Mutagenesis Kit. PCR primers PLSTTW345f 5'- TTT GTG TTT ACT GGG ACC NNS 
ACA GGG GCA GGT GGC GAG -3' (forward primer) and PLSTTW345b 5'- C GCC ACC TGC 
CCC SNN TGT GGT CCC AGT AAA CAC AAA ATT C -3’ (backward primer); and PLSTAW345f 
5'- TTT GTG TTT ACT GGG ACC NNS ACA GCG GCA GGT GGC GAG -3' (forward primer) and 
PLSTAW345b 5'- CTC GCC ACC TGC CGC TGT SNN GGT CCC AGT AAA CAC AAA -3’ 
(backward primer) were designed for Trp345 site. The PCR used pET19-PLSTW347G and 
pET19-PLSTW347A plasmids as templates.  
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
QuikSolution reagent:  1.5 μl 
QuikChange Lightning Enzyme: 1 μl 
ddH2O:    up to 50 μl 
 
95°C   2 min 
95°C   30 sec 
68°C   4 min   30 cycles 
68°C   10 min 
The PCR product was digested by 2 μl DpnI for 1 h at 37°C. Then 2 μl PCR product was 
transformed into BL21(DE3) competent cells and cultured on ampicillin agar plates overnight 
at 37°C. 96 colonies were picked into 96-well plates containing 150 μl/well LB-ampicillin 
medium. After overnight culture at 37°C 900 rpm, 30 μl glycerol was added into each well. 
The whole plates were sealed with plastic lids and stored at -80°C.  
 
13.7.3. Screening of mutagenesis libraries of SiaT 
 
2 μl of each clone in libraries was transferred to individual wells in 96-well round bottom 
plates containing 150 μl/well LB growth media comprised 30 μg/mL Amp. The plates were 
sealed with plastic lids to avoid evaporation, and then incubated at 30°C, 1,000 rpm overnight. 
After that, 5 μl was transferred from each well to 96-deepwell plates with plastic lids 
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containing 400 μl/well of LB-amp growth medium containing 0.1 mM IPTG. The plates were 
then incubated at 30°C, 1,000 rpm overnight, until the amount of cells in each well reached 
the maximum. Cells were harvested by centrifugation at 4,000 rpm for 20 min. The culture 
medium was removed and the cell pellets could be stored at -80°C.  
The cell pellets were resuspended in 150 μl resuspension buffer (1/10 BugBuster solution 
(Novagen, Germany), 0.5 mg/mL lysozyme (Roth, Germany) and 4U/mL Benzonase 
endonuclease (Novagen, Germany)) and incubated in a shaker for 30 min at room 
temperature. Then, the cell lysate was centrifugated at 4,000 rpm for 30 min. 40 μl of the 
supernatant was transferred to a new 96-well flat bottom plate. 140 μl of substrate solution (2 
mM Tris-HCl (pH 8.0), 0.28 mM phenol red and 50 mM Gal-α-O-CH3 was added to each well. 
The reaction was initiated by the addition of 1 mM CMP-Neu5Ac. The total volume in each 
well was 200 μl. The OD increase was read by the plate-reader at 560 nm. 
20 positive colonies with the highest activity were picked from each plate into a new plate for 
the second round screening and so on.  
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13.8.  Chemoenzymatic Synthesis of neo-2,3- and 2,6-Sialoconjugates 
 
13.8.1. Enzymatic  synthesis of sialic acids 
 
13.8.1.1. N-phenyacetyl-D-neuraminic acid (Neu5PhAc) 
 
50 mg ManNPhAc (1 eq.) and 58 mg pyruvate (3 eq.) were added into a 50 ml flask with 50 
mM PBS (pH 7.5). 5 mg aldolase was added to start the reaction for 12 h. When reaction was 
completed, 300 ml methanol was added. The flask was kept at -20°C for 30 min. Then the 
reaction mixture was filted to remove the precipitate. The supernatant was concentrated by 
rotary evaporator. The product was purified by Biogel P-2 with water as mobile phase. 40.9 
mg ManNPhAc (white powder) was harvested with a yield of 59%. 
 
N-phenylacetyl-D-neuraminic acid 
(Neu5PhAc) 
 
 
 
 
 
1H NMR (500 MHz, Deuterium Oxide) δ=7.43 – 7.38 (m, 2H, 13-, 17H), 7.37 – 7.32 (m, 3H, 
14-, 15-, 16-H), 4.08 – 3.95 (m, 2H, 4-, 6-H), 3.89 (t, J = 10.2 Hz, 1H, 5-H), 3.74 (dd, J = 
11.8, 2.8 Hz, 1H, 9a-H), 3.70 – 3.66 (m, 1H, 8-H), 3.64 (d, J = 6.9 Hz, 2H, 11-H), 3.48 (dd, J 
= 11.8, 6.5 Hz, 1H, 9b-H), 3.31 (dd, J = 9.0, 1.2 Hz, 1H, 7-H), 2.20 (dd, J = 13.0, 4.9 Hz, 
1H, 3a-H), 1.81 (dd, J = 13.0, 11.6 Hz, 1H, 3b-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ=175.35 (C-1), 170.30 (C-10), 135.19 (C-12), 
129.15 (C-15), 129.03 (C-14, -16), 127.39 (C-13, -17), 96.49 (C-2), 70.46 (C-6), 70.29 (C-8), 
68.63 (C-7), 67.12 (C-4), 63.40 (C-9), 52.43 (C-5), 42.75 (C-11), 39.58 (C-3) ppm. 
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13.8.2. Enzymatic synthesis of neo-2,3-sialoconjugates with various donors  
 
10-[5-(4-(((Z)-4-O-((N-acetyl-α-D-neuraminic acid)-(2→3)-β-D-lactosyloxy)-but-2-
enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(Neu5Ac-2,3-Lac-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,3SiaTpph, 25.2 mg 
CTP (2 eq.) and 13.1 mg Neu5Ac (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) buffer 
with 0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS and 20 μl PPase were added to start the 
reaction. When the CMP-activation was completed, 20 mg Lac-D-T-P-Acr (1 eq.) and 5 mg 
recombinant 2,3SiaTpph were added to start the reaction. The pH was being adjusted for 
keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -
20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 23.7 mg yellow powder. Yield: 84%. 
 
 
 
 
 
1H NMR (500 MHz, Deuterium Oxide) δ=7.78 (dd, J = 8.0, 1.6 Hz, 2H, 17-, 21-H), 7.73 (s, 
1H, 7-H), 7.30 – 7.26 (m, 2H, 15-, 23-H), 6.93 – 6.77 (m, 4H, 24-, 14-, 16-, 22-H), 5.70 – 
5.48 (m, 2H, 2-, 3-H), 4.45 (s, 2H, 5-H), 4.26 (d, J = 8.0 Hz, 1H, 1’’-H), 4.23 – 4.06 (m, 4H, 
1’-, 1a-, 8-H), 4.05 (dd, J = 9.9, 3.1 Hz, 1H, 1b-H), 3.95 – 3.90 (m, 3H, 3’’-, 2-, 4-H), 3.87 – 
3.75 (m, 5H, 4’’-, 6’’’-, 9’’’a-, 6’-, 5’’’-H), 3.73 – 3.46 (m, 13H, 6’b-, 6’’-, 8’’’-, 7’’’-, 9’’’b-, 3’-, 4’’’-, 
4’-, 2’’-, 8-, 5’’-H), 3.37 – 3.28 (m, 1H, 5’-H), 3.20 (dd, J = 9.2, 8.0 Hz, 1H, 2’-H), 2.72 (dd, J 
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= 12.4, 4.7 Hz, 1H, 3’’’a-H), 1.98 (s, 3H, 11’’’-H), 1.75 (t, J = 12.1 Hz, 1H, 3’’’b-H), 1.56 – 
1.50 (m, 2H, 9-H), 1.15 – 0.87 (m, 4H, 11-, 10-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ=178.13 (C-19), 174.90 (C-1’’’), 173.47 (C-10’’’), 
143.79 (C-6), 140.59 (C-13, -25), 134.57 (C-15, -23), 129.23 (C-2), 129.00 (C-3), 126.18 (C-
17, -21), 124.65 (C-7), 121.66 (C-16, -22), 120.33 (C-18, -20), 115.02 (C-14, -24), 103.28 
(C-1’’), 100.92 (C-1’), 100.31 (C-2’’’), 79.59 (C-4’), 74.63 (C-3’’), 73.69 (C-8’’’), 72.63 (C-5’), 
72.55 (C-5’’), 72.42 (C-3’), 71.80 (C-2’), 70.79 (C-6’’’), 68.52 (C-2’’), 68.40 (C-7’’’), 68.36 (C-
4’’’), 65.05 (C-4), 64.63 (C-1), 63.50 (C-9’’’), 62.67 (C-5), 62.27 (C-6’’), 60.22 (C-6’), 51.83 
(C-5’’’), 50.05 (C-8), 45.19 (C-12), 40.14 (C-3’’’), 28.77 (C-9), 25.73 (C-11), 22.60 (C-10), 
22.09 (C-11’’’) ppm. 
 
10-[5-(4-(((Z)-4-O-((N-glycolyl-α-D-neuraminic acid)-(2→3)-β-D-lactosyloxy)-but-2-
enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(Neu5Gc-2,3-Lac-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,3SiaTpph, 25.2 mg 
CTP (2 eq.) and 13.7 mg Neu5Gc (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) buffer 
with 0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS and 20 μl PPase were added to start the 
reaction. When the CMP-activation was completed, 20 mg Lac-D-T-P-Acr (1 eq.) and 5 mg 
recombinant 2,3SiaTpph were added to start the reaction. The pH was being adjusted for 
keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -
20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 22.1 mg yellow powder. Yield: 77%. 
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1H NMR (500 MHz, Deuterium Oxide) δ=7.72 (dd, J = 8.1, 1.3 Hz, 2H, 17-, 21-H), 7.64 (s, 
1H, 7-H), 7.30 – 7.18 (m, 2H, 15-, 23-H), 6.89 – 6.76 (m, 4H, 24-, 14-, 16-, 22-H), 5.62 – 
5.45 (m, 2H, 2-, 3-H), 4.36 (s, 2H, 5-H), 4.32 (d, J = 7.9 Hz, 1H, 1’’-H), 4.15 (d, J = 8.0 Hz, 
1H, 1’-H), 4.13-4.04 (m, 3H, 1a-, 8-H), 4.02 – 3.93 (m, 4H, 11’’’-, 1b-, 3’’-H), 3.87 – 3.79 (m, 
4H, 4-, 4’’-, 6’’’-, 9’’’a-H ), 3.79 – 3.57 (m, 12H, 6’a-, 5’’’-, 6’b-, 6’’-, 8’’’-, 7’’’-, 9’’’b-, 3’-, 4’’’-, 4’,- 
2’’-H), 3.57 – 3.46 (m, 3H, 8-, 5’’-H), 3.28 – 3.20 (m, 1H, 5’-H), 3.09 (dd, J = 9.2, 8.1 Hz, 1H, 
2’-H), 2.69 – 2.59 (m, 2H, 3’’’a-H), 1.66 (t, J = 12.1 Hz, 1H, 3’’’b-H), 1.55-1.35 (m, 2H, 9-H), 
1.09 – 0.80 (m, 4H, 11-, 10-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ=178.17 (C-19), 175.82 (C-1’’’), 173.95 (C-10’’’), 
143.87 (C-6), 140.65 (C-13, -25), 134.60 (C-15, -23), 129.28 (C-2), 129.05 (C-3), 126.25 (C-
17, -21), 124.66 (C-7), 121.68 (C-16, -22), 120.41 (C-18, -20), 115.05 (C-14, -24), 102.80 
(C-1’’), 101.13 (C-1’), 99.89 (C-2’’’), 78.42 (C-4’), 75.60 (C-3’’), 75.19 (C-8’’’), 74.80 (C-5’), 
74.45 (C-5’’), 72.74 (C-3’), 72.70 (C-2’), 71.86 (C-6’’’), 69.41 (C-2’’), 68.13 (C-7’’’), 67.53 (C-
4’’’), 65.10 (C-4), 64.73 (C-1), 62.65 (C-9’’’), 62.35 (C-5), 61.08 (C-6’’, -11’’’), 60.10 (C-6’), 
51.51 (C-5’’’), 50.09 (C-8), 45.24 (C-12), 39.81 (C-3’’’), 28.81 (C-9), 25.79 (C-11), 22.66 (C-
10) ppm. 
 
10-[5-(4-(((Z)-4-O-((3-deoxy-β-D-glycero-D-galacto-2-nonulopyronosonic acid)-(2→3)-β-
D-lactosyloxy)-but-2-enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(Kdn-2,3-Lac-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,3SiaTpph, 25.2 mg 
CTP (2 eq.) and 11.5 mg Kdn (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) buffer with 
0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS and 20 μl PPase were added to start the 
reaction. When the CMP-activation was completed, 20 mg Lac-D-T-P-Acr (1 eq.) and 5 mg 
recombinant 2,3SiaTpph were added to start the reaction. The pH was being adjusted for 
keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -
20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 23.4 mg yellow powder. Yield: 86%. 
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1H NMR (500 MHz, Deuterium Oxide) δ=7.83 (dd, J = 8.0, 1.6 Hz, 2H, 17-, 21-H), 7.76 (s, 
1H, 7-H), 7.38 – 7.26 (m, 2H, 15-, 23-H), 6.97 – 6.84 (m, 4H, 24-, 14-, 16-, 22-H), 5.75 – 
5.54 (m, 2H, 2-, 3-H), 4.48 (s, 2H, 5-H), 4.29 (d, J = 8.0 Hz, 1H, 1’’-H), 4.26 – 4.10 (m, 4H, 
1’-, 1a-, 8-H), 4.07 (dd, J = 9.8, 2.7 Hz, 1H, 1b-H), 4.00-3.92 (m, 3H, 3’’-, 2-, 4-H), 3.92 – 
3.82 (m, 4H, 4’’-, 6’’’-, 9’’’a-, 6’-H), 3.77 – 3.45 (m, 14H, 5’’’-, 6’b-, 6’’-, 8’’’-, 7’’’-, 9’’’b-, 3’-, 4’’’-, 
4’-, 2’’-, 8-, 5’’-H), 3.39-3.34 (m, 1H, 5’-H), 3.24 (dd, J = 9.2, 8.0 Hz, 1H, 2’-H), 2.70 (dd, J = 
12.5, 4.6 Hz, 1H, 3’’’a-H), 1.74 (t, J = 12.0 Hz, 1H, 3’’’b-H), 1.79 – 1.69 (m, 2H, 9-H), 1.18 – 
0.92 (m, 4H, 11-, 10-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ=178.05 (C-19), 174.11 (C-1’’’), 143.88 (C-6), 
140.61 (C-13, -25), 134.53 (C.15, -23), 129.29 (C-2), 129.04 (C-3), 126.25 (C-17, -21), 
124.62 (C-7), 121.61 (C-16, -22), 120.43 (C-18, -20), 114.97 (C-14, -24), 102.82 (C-1’’), 
101.17 (C-1’), 99.87 (C-2’’’), 78.43 (C-4’), 75.56 (C-3’’), 75.20 (C-8’’’), 74.79 (C-5’), 74.46 (C-
5’’), 73.99 (C-3’), 72.75 (C-2’), 72.14 (C-6’’’), 70.34 (C-2’’), 69.85 (C-7’’’), 69.40 (C-4’’’), 67.83 
(C-5’’’), 65.17 (C-4), 64.76 (C-1), 62.76 (C-9’’’), 62.37 (C-5), 61.06 (C-6’’), 60.11 (C-6’), 
50.05 (C-8), 45.24 (C-12), 39.39 (C-3’’’), 28.83 (C-9), 25.78 (C-11), 22.66 (C-10) ppm. 
 
10-[5-(4-(((Z)-4-O-((3-deoxy-α-D-glycero-D-gulo-2-nonulopyranosonic acid)-(2→3)-β-D-
lactosyloxy)-but-2-enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(epi-Kdn-2,3-Lac-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,3SiaTpph, 25.2 mg 
CTP (2 eq.) and 11.5 mg epi-Kdn (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) buffer 
with 0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS and 20 μl PPase were added to start the 
reaction. When the CMP-activation was completed, 20 mg Lac-D-T-P-Acr (1 eq.) and 5 mg 
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recombinant 2,3SiaTpph were added to start the reaction. The pH was being adjusted for 
keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -
20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 15.8 mg yellow powder. Yield: 58%. 
 
 
 
 
 
 
1H NMR (500 MHz, Deuterium Oxide) δ=7.75 – 7.67 (m, 2H, 17-, 21-H), 7.62 (s, 1H, 7-H), 
7.29 – 7.14 (m, 2H, 15-, 23-H), 6.89 – 6.68 (m, 4H, 24-, 14-, 16-, 22-H), 5.62 – 5.39 (m, 2H, 
2-, 3-H), 4.35 (s, 2H, 5-H), 4.15 (d, J = 8.0 Hz, 1H, 1’’-H), 4.12 – 3.96 (m, 5H, 1’-, 1a-, 8-, 1b-
H), 3.86 – 3.67 (m, 3H, 3’’-, 2-, 4-, 4’’-, 6’’’-, 9’’’a-, 6’-, 5’’’-H), 3.64 – 3.33 (m, 13H, 6’b-, 6’’-, 
8’’’-, 7’’’-, 9’’’b-, 3’-, 4’’’-, 4’-, 2’’-, 8-, 5’’-H), 3.26 – 3.20 (m, 1H, 5’-H), 3.10 (dd, J = 9.3, 8.0 Hz, 
1H, 2’-H), 2.34 (dd, J = 12.2, 4.6 Hz, 1H, 3’’’a-H), 1.82 (t, J = 12.4 Hz, 1H, 3’’’b-H), 1.50 – 
1.38 (m, 2H, 9-H), 1.03 – 0.83 (m, 4H, 11-, 10-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ=178.12 (C-19), 174.22 (C-1’’’), 143.88 (C-6), 
140.64 (C-13, -25), 134.56 (C.15, -23), 129.27 (C-2), 129.03 (C-3), 126.26 (C-17, -21), 
124.63 (C-7), 121.65 (C-16, -22), 120.42 (C-18, -20), 115.02 (C-14, -24), 102.71 (C-1’’), 
101.16 (C-1’), 100.13 (C-2’’’), 78.33 (C-4’), 75.54 (C-3’’), 75.22 (C-8’’’), 74.80 (C-5’), 74.44 
(C-5’’), 73.02 (C-3’), 72.75 (C-2’), 71.88 (C-6’’’), 71.68 (C-2’’), 69.55 (C-7’’’), 69.14 (C-4’’’), 
67.47 (C-5’’’), 65.13 (C-4), 64.75 (C-1), 62.35 (C-9’’’),  62.18 (C-5), 61.08 (C-6’’), 60.12 (C-
6’), 50.07 (C-8), 45.23 (C-12), 34.09 (C-3’’’), 28.82 (C-9), 25.79 (C-11), 22.66 (C-10) ppm. 
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10-[5-(4-(((Z)-4-O-((9-aido-N-acetyl-α-D-neuraminic acid)-(2→3)-β-D-lactosyloxy)-but-2-
enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(Neu5Ac9N3-2,3-Lac-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,3SiaTpph, 25.2 mg 
CTP (2 eq.) and 14.1 mg Neu5Ac9N3 (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) buffer 
with 0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS and 20 μl PPase were added to start the 
reaction. When the CMP-activation was completed, 20 mg Lac-D-T-P-Acr (1 eq.) and 5 mg 
recombinant 2,3SiaTpph were added to start the reaction. The pH was being adjusted for 
keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -
20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 23.7 mg yellow powder. Yield: 82%. 
 
 
 
 
 
1H NMR (500 MHz, Deuterium Oxide) δ=7.80 – 7.69 (m, 2H, 17-, 21-H), 7.65 (s, 1H, 7-H), 
7.31 – 7.08 (m, 2H, 15-, 23-H), 6.91 – 6.60 (m, 4H, 24-, 14-, 16-, 22-H), 5.65 – 5.41 (m, 2H, 
2-, 3-H), 4.38 (s, 2H, 5-H), 4.20 (d, J = 7.9 Hz, 1H, 1’’-H), 4.17 – 4.00 (m, 4H, 1’-, 1a-, 8-H), 
3.95 (dd, J = 9.8, 3.2 Hz, 1H, 1b-H), 3.92 – 3.84 (m, 3H, 3’’-, 2-, 4-H), 3.84 – 3.68 (m, 4H, 
4’’-, 6’’’-, 9’’’a-, 6’-H), 3.68 – 3.35 (m, 14H, 5’’’-, 6’b-, 6’’-, 8’’’-, 7’’’-, 9’’’b-, 3’-, 4’’’-, 4’-, 2’’-, 8-, 5’’-
H), 3.28 – 3.23 (m, 1H, 5’-H), 3.13 (dd, J = 9.1, 8.0 Hz, 1H, 2’-H), 2.65 (dd, J = 12.4, 4.6 Hz, 
1H, 3’’’a-H), 1.92 (s, 3H, 11’’’-H), 1.67 (t, J = 12.1 Hz, 1H, 3’’’b-H), 1.52 – 1.35 (m, 2H, 9-H), 
1.08 – 0.81 (m, 4H, 11-, 10-H) ppm. 
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13C NMR (126 MHz, Deuterium Oxide) δ=178.03 (C-19), 175.05 (C-1’’’), 173.80 (C-10’’’), 
143.88 (C-6), 140.62 (C-13, -25), 134.51 (C-15, -23), 129.30 (C-2), 129.04 (C-3), 126.29 (C-
17, -21), 124.59 (C-7), 121.59 (C-16, -22), 120.47 (C-18, -20), 114.95 (C-14, -24), 102.80 
(C-1’’), 101.12 (C-1’), 99.83 (C-2’’’), 78.36 (C-4’), 75.75 (C-3’’), 75.21 (C-8’’’), 74.82 (C-5’), 
74.45 (C-5’’), 72.78 (C-3’), 70.44 (C-2’), 69.36 (C-6’’’), 68.94 (C-2’’), 68.30 (C-7’’’), 67.46 (C-
4’’’), 65.17 (C-4), 64.69 (C-1), 62.38 (C-5), 61.04 (C-6’’’), 60.16 (C-6’), 53.24 (C-9’’’), 51.82 
(C-5’’’), 50.03 (C-8), 45.25 (C-12), 39.92 (C-3’’’), 28.86 (C-9), 25.79 (C-11), 22.68 (C-10), 
22.14 (C-11’’’) ppm. 
 
10-[5-(4-(((Z)-4-O-((N- phenylacetyl -α-D-neuraminic acid)-(2→3)-β-D-lactosyloxy)-but-2-
enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(Neu5NPhAc-2,3-Lac-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,3SiaTpph, 25.2 mg 
CTP (2 eq.) and 16.1 mg Neu5NPhAc (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) 
buffer with 0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS-F192A and 20 μl PPase were added 
to start the reaction. When the CMP-activation was completed, 20 mg Lac-D-T-P-Acr (1 eq.) 
and 5 mg recombinant 2,3SiaTpph were added to start the reaction. The pH was being adjusted 
for keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 
mL -20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 14.5 mg yellow powder. Yield: 48%. 
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1H NMR (500 MHz, Deuterium Oxide) δ=7.75 (dd, J = 8.1, 1.7 Hz, 2H, 17-, 21-H), 7.61 (s, 
1H, 7-H), 7.31 – 7.20 (m, 2H, 13’’’-, 17’’’-H), 7.19 – 7.05 (m, 5H, 15’’’-, 14’’’-, 16’’’-, 15-, 23-H), 
6.92 – 6.69 (m, 4H, 24-, 14-, 16-, 22-H), 5.63 – 5.37 (m, 2H, 2-, 3-H), 4.34 (s, 2H, 5-H), 4.14 
(d, J = 7.9 Hz, 1H, 1’’-H), 4.10 – 3.88 (m, 5H, 1’-, 1a-, 8-, 1b-H), 3.84 – 3.74 (m, 3H, 3’’-, 2-, 
4-H), 3.72 – 3.55 (m, 9H, 4’’-, 6’’’-, 9’’’a-, 6’-, 5’’’-, 11’’’-, 6’’-H), 3.54 – 3.30 (m, 11H, 6’b-, 8’’’-, 
7’’’-, 9’’’b-, 3’-, 4’’’-, 4’-, 2’’-, 8-, 5’’-H), 3.24 – 3.19 (m, 1H, 5’-H), 3.09 (dd, J = 9.2, 8.0 Hz, 1H, 
2’-H), 2.68 – 2.55 (m, 1H, 3’’’a-H), 1.63 (t, J = 12.0 Hz, 1H, 3’’’b-H), 1.52 – 1.35 (m, 2H, 9-H), 
1.11 – 0.77 (m, 4H, 11-, 10-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ 178.21 (C-19), 175.60 (C-1’’’), 173.88 (C-10’’’), 
143.85 (C-6), 140.71 (C-13, -25), 135.04 (C-15, -23), 134.61 (C-12’’’), 129.34 (C-14’’’), 
129.09 (C-2), 129.01 (C-3), 128.91 (C-13’’’, -15’’’), 127.30 (C-12’’’, -16’’’), 126.29 (C-17, -21), 
124.64 (C-7), 121.69 (C-16, -22), 120.48 (C-18, -20), 115.08 (C-14, -24), 102.82 (C-1’’), 
100.99 (C-1’), 99.81 (C-2’’’), 78.35 (C-4’), 75.62 (C-3’’), 75.21 (C-8’’’), 74.79 (C-5’), 74.44 (C-
5’’), 72.99 (C-3’), 72.74 (C-2’), 71.85 (C-6’’’), 69.37 (C-2’’), 68.32 (C-7’’’), 67.53 (C-4’’’), 65.08 
(C-4), 64.60 (C-1), 62.80 (C-9’’’), 62.35 (C-5), 61.05 (C-6’’), 60.03 (C-6’), 59.84 (C-12), 51.92 
(C-5’’’), 50.08 (C-8), 42.60 (C-11’’’), 39.95 (C-3’’’),28.84 (C-9), 25.82 (C-11), 22.69 (C-10) 
ppm. 
 
13.8.3. Enzymic synthesis of neo-2,6-sialoconjugates with various donors 
 
10-[5-(4-(((Z)-4-O-((N-acetyl-α-D-neuraminic acid)-(2→6)-β-D-galactopyranosyl-
(1,4)-2-acetamido-2-deoxy-β-D-glucopyranosyloxy)-but-2-enyloxy)methyl)-
1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(Neu5Ac-2,6-LacNAc-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,6SiaTple, 25.2 mg 
CTP (2 eq.) and 12.5 mg Neu5Ac (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) buffer 
with 0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS and 20 μl PPase were added to start the 
reaction. When the CMP-activation was completed, 20 mg LacNAc-D-T-P-Acr (1 eq.) and 5 mg 
recombinant 2,6SiaTple were added to start the reaction. The pH was being adjusted for 
keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -
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20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 22.8 mg yellow powder. Yield: 82%. 
 
 
 
 
 
 
 
1H NMR (500 MHz, Deuterium Oxide) δ=7.80 – 7.68 (m, 2H, 17-, 21-H), 7.63 (s, 1H, 7-H), 
7.23 (ddd, J = 8.6, 6.7, 1.6 Hz, 2H, 15-, 23-H), 6.89 – 6.74 (m, 4H, 14-, 24-, 16-, 22-H), 5.56 
– 5.42 (m, 2H, 2-, 3-H), 4.35 (s, 2H, 5-H), 4.24 (d, J = 7.9 Hz, 1H, 1’’-H), 4.14 – 3.92 (m, 4H, 
1’, 8-, 1a-H), 3.88 – 3.57 (m, 10H, 1b-, 4-, 9’’’a-, 5’’’-, 8’’’-, 6’’’-, 6’a-, 6’’a-, 4’’-H), 3.57 – 3.52 
(m, 3H, 4’’’-, 5’’-, 6’b-H), 3.51 – 3.34 (m, 9H, 6’’b-, 3’’-, 9’’’-, 12-, 7’’’-, 3’-, 4’-, 2’’-H), 3.34 – 0.28 
(m, 1H, 5’-H), 2.52 (dd, J = 12.4, 4.6 Hz, 1H, 3’’’a-H), 1.87 (s, 3H, 8’-H), 1.85 (s, 2H, 11’’’-H), 
1.55 (t, J = 12.1 Hz, 1H, 3’’’-H), 1.51 - 1.39 (m, 2H, 9-H), 1.08 – 0.80 (m, 4H, 11-, 10-H) 
ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ=178.16 (C-19), 174.95 (C-1’’’), 174.34 (C-7’’’), 
173.53 (C-10’’’), 143.85 (C-6), 140.65 (C-13, -25), 134.59 (C-15, -23), 129.51 (C-2), 128.88 
(C-3), 126.22 (C-17, -21), 124.68 (C-7), 121.68 (C-16, -21), 120.40 (C-18, -20), 115.06 (C-
14, -24), 103.56 (C-1’’), 100.24 (C-1’), 99.71 (C-2’’’), 80.72 (C-4’), 74.58 (C-3’’), 73.73 (C-8’’’), 
72.63 (C-5’), 72.58 (C-5’’), 72.54 (C-3’), 71.77 (C-2’), 70.79 (C-6’’’), 68.50 (C-7’’’), 68.48 (C-
4’’’), 68.27 (C-4’’), 65.13 (C-4), 64.52 (C-1), 63.37 (C-6’’), 62.75 (C-9’’’), 62.30 (C-5), 60.40 
(C-6’), 54.84 (C-2’’), 52.00 (C-5’’’), 50.08 (C-8), 45.22 (C-12), 40.18 (C-3’’’), 28.82 (C-9), 
25.78 (C-11), 22.65 (C-10), 22.37 (C-8’), 22.12 (C-11’’’) ppm. 
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10-[5-(4-(((Z)-4-O-((N-glycolyl-α-D-neuraminic acid)-(2→6)-β-D-galactopyranosyl-(1,4)-
2-acetamido-2-deoxy-β-D-glucopyranosyloxy)-but-2-enyloxy)methyl)-1H-1,2,3-triazol-1-
yl)pentyl]-10H-acridin-9-on 
(Neu5Gc- 2,6-LacNAc-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,6SiaTple, 25.2 mg 
CTP (2 eq.) and 13 mg Neu5Gc (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) buffer with 
0.5 M NaCl and 0.1% Triton×100. 5 mg CSS and 20 μl PPase were added to start the 
reaction. When the CMP-activation was completed, 20 mg LacNAc-D-T-P-Acr (1 eq.) and 5 mg 
recombinant 2,6SiaTple were added to start the reaction. The pH was being adjusted for 
keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -
20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 21.1 mg yellow powder. Yield: 75%. 
 
 
 
 
 
 
 
1H NMR (500 MHz, Deuterium Oxide) δ=7.76 – 7.68 (m, 2H, 17-, 21-H), 7.63 (s, 1H, 7-H), 
7.24 (ddd, J = 8.6, 6.8, 1.7 Hz, 2H, 15-, 23-H), 6.88 – 6.76 (m, 4H, 14-, 24-, 16-, 22-H), 5.55 
– 5.43 (m, 2H, 2-, 3-H), 4.35 (s, 2H, 5-H), 4.24 (d, J = 7.9 Hz, 1H, 1’’-H), 4.13 – 3.97 (m, 4H, 
1’, 8-, 1a-H), 3.96 (s, 2H, 11’’’H), 3.88 – 3.66 (m, 10H, 1b-, 4-, 9’’’a-, 5’’’-, 8’’’-, 6’’’-, 6’a-, 6’’a-, 
4’’-H), 3.67 – 3.56 (s, m, 3H, 4’’’-, 5’’-, 6’b-H), 3.57 – 3.35 (m, 9H, 6’’b-, 3’’-, 9’’’-, 12-, 7’’’-, 3’-, 
4’-, 2’’-H), 3.34 – 3.27 (m, 1H, 5’-H), 2.54 (dd, J = 12.4, 4.7 Hz, 1H, 3’’’a-H), 1.86 (s, 3H, 8’-
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H), 1.56 (t, J = 12.1 Hz, 4, 4.6 Hz, 1H, 3’’’a-H), 1.87 (s, 3H, 8’-H), 1.85 (s, 2H, 11’’’-H), 1.55 
(t, J = 12.1 Hz, 1H), 1.51 – 1.39 (m, 2H, 9-H), 1.05 – 0.82 (m, 4H, 11-, 10-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ=178.18 (C-19), 175.70 (C-1’’’), 174.37 (C-7’’’), 
173.55 (C-10’’’), 143.86 (C-6), 140.66 (C-13, -25), 134.60 (C-15, -23), 129.52 (C-2), 128.89 
(C-3), 126.23 (C-17, -21), 124.69 (C-7), 121.69 (C-16, -21), 120.40 (C-18, -20), 115.08 (C-
14, -24), 103.56 (C-1’’), 100.28 (C-1’), 99.72 (C-2’’’), 80.68 (C-4’), 74.59 (C-3’’), 73.74 (C-8’’’), 
72.57 (C-5’), 72.54 (C-5’’), 72.36 (C-3’), 71.83 (C-2’), 70.80 (C-6’’’), 68.47 (C-7’’’), 68.44 (C-
4’’’), 68.03 (C-4’’), 65.12 (C-4), 64.53 (C-1), 63.40 (C-6’’), 62.73 (C-9’’’), 62.30 (C-5), 61.10 
(C-11’’’), 60.40 (C-6’), 54.86 (C-2’’), 51.69 (C-5’’’), 50.09 (C-8), 45.23 (C-12), 40.23 (C-3’’’), 
28.82 (C-9), 25.79 (C-11), 22.65 (C-10), 22.39 (C-8’) ppm. 
 
10-[5-(4-(((Z)-4-O-((3-deoxy-β-D-glycero-D-galacto-2-nonulopyronosonic acid)-(2→6)-β-
D- galactopyranosyl-(1,4)-2-acetamido-2-deoxy-β-D-glucopyranosyloxy)-but-2-
enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(Kdn-2,6-LacNAc-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,6SiaTple, 25.2 mg 
CTP (2 eq.) and 11 mg Kdn (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) buffer with 0.5 
M NaCl and 0.1% Triton ×100. 5 mg CSS and 20 μl PPase were added to start the reaction. 
When the CMP-activation was completed, 20 mg LacNAc-D-T-P-Acr (1 eq.) and 5 mg 
recombinant 2,6SiaTple were added to start the reaction. The pH was being adjusted for 
keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -
20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 22.1 mg yellow powder. Yield: 82%. 
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1H NMR (500 MHz, Deuterium Oxide) δ=7.85 (dd, J = 8.1, 1.7 Hz, 2H, 17- 21H), 7.76 (s, 1H, 
7-H), 7.35 (ddd, J = 8.6, 6.8, 1.6 Hz, 2H, 15-, 23-H), 7.00 – 6.87 (m, 4H, 14-, 24-, 16-, 22-H), 
5.70 – 5.53 (m, 2H, 2-, 3-H), 4.47 (s, 2H, 5-H), 4.37 (d, J = 7.9 Hz, 1H, 1’’-H), 4.27 – 4.04 
(m, 4H, 1’, 8-, 1a-H), 4.03 – 3.72 (m, 10H, 1b-, 4-, 9’’’a-, 5’’’-, 8’’’-, 6’’’-, 6’a-, 6’’a-, 4’’-H), 3.72 – 
3.48 (m, 12H, 4’’’-, 5’’-, 6’b-, 6’’b-, 3’’-, 9’’’-, 12-, 7’’’-, 3’-, 4’-, 2’’-H), 3.47 – 3.42 (m, 1H, 5’-H), 
2.61 (dd, J = 12.4, 4.7 Hz, 1H, 3’’’a-H), 2.00 (s, 3H, 8’-H), 1.64 (t, J = 12.2 Hz, 1H, 3’’’-H), 
1.62 – 1.53 (m, 2H, 9-H), 1.20 – 0.94 (m, 4H, 11-, 10-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ=178.12 (C-19), 174.21 (C-1’’’), 173.70 (C-7’’’), 
143.87 (C-6), 140.65 (C-13, -25), 134.57 (C-15, -23), 129.54 (C-2), 128.87 (C-3), 126.25 (C-
17, -21), 124.66 (C-7), 121.66 (C-16, -21), 120.43 (C-18, -20), 115.05 (C-14, -24), 103.46 
(C-1’’), 100.12 (C-1’), 99.70 (C-2’’’), 80.43 (C-4’), 74.63 (C-3’’), 73.86 (C-8’’’), 73.59 (C-5’), 
72.53 (C-5’’), 72.49 (C-3’), 72.28 (C-2’), 70.76 (C-6’’’), 70.27 (C-7’’’), 70.08 (C-5’’’), 68.56 (C-
4’’’), 68.27 (C-4’’), 65.15 (C-4), 64.54 (C-1), 63.65 (C-6’’), 62.82 (C-9’’’), 62.32 (C-5), 60.32 
(C-6’), 54.93 (C-2’’), 50.07 (C-8), 45.24 (C-12), 39.85 (C-3’’’), 28.84 (C-9), 25.79 (C-11), 
22.67 (C-10), 22.44 (C-8’) ppm. 
 
10-[5-(4-(((Z)-4-O-((3-deoxy-α-D- glycero-D-gulo-2-nonulopyranosonic acid)-(2→6)-β-D- 
galactopyranosyl-(1,4)-2-acetamido-2-deoxy-β-D-glucopyranosyloxy)-but-2-
enyloxy)methyl)-1H-1,2,3-triazol-1-yl)pentyl]-10H-acridin-9-on 
(epi-Kdn-2,6-LacNAc-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,6SiaTple, 25.2 mg 
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CTP (2 eq.) and 11 mg epi-Kdn (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) buffer with 
0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS and 20 μl PPase were added to start the 
reaction. When the CMP-activation was completed, 20 mg LacNAc-D-T-P-Acr (1 eq.) and 5 mg 
recombinant 2,6SiaTple were added to start the reaction. The pH was being adjusted for 
keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -
20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 23.1 mg yellow powder. Yield: 86%. 
 
 
 
 
 
 
 
1H NMR (500 MHz, Deuterium Oxide) δ=7.84 (dd, J = 8.1, 1.7 Hz, 2H, 17- 21H), 7.76 (s, 1H, 
7-H), 7.34 (ddd, J = 8.5, 6.7, 1.6 Hz, 2H, 15-, 23-H), 6.99 – 6.86 (m, 4H, 14-, 24-, 16-, 22-H), 
5.62 (q, J = 5.2 Hz, 2H, 2-, 3-H), 4.47 (s, 2H, 5-H), 4.39 (d, J = 7.9 Hz, 1H, 1’’-H), 4.26 – 
4.06 (m, 4H, 1’, 8-, 1a-H), 4.05 – 3.72 (m, 12H, 1b-, 4-, 9’’’a-, 5’’’-, 8’’’-, 6’’’-, 6’a-, 6’’a-, 4’’-, 4’’’-, 
7’’’-H), 3.72 – 3.48 (m, 10H, 5’’-, 6’b-, 6’’b-, 3’’-, 9’’’-, 12-, 3’-, 4’-, 2’’-H), 3.47 – 3.42 (m, 1H, 5’-
H), 2.39 (dd, J = 12.2, 4.6 Hz, 1H, 3’’’a-H), 1.97 (s, 3H, 8’-H), 1.85 (t, J = 12.4 Hz, 1H, 3’’’-
H), 1.65 – 1.51 (m, 2H, 9-H), 1.16 – 0.95 (m, 4H, 11-, 10-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ=178.08 (C-19), 143.86 (C-6), 140.63 (C-13, -25), 
134.55 (C-15, -23), 129.52 (C-2), 128.86 (C-3), 126.23 (C-17, -21), 124.65 (C-7), 121.64 (C-
16, -21), 120.42 (C-18, -20), 115.02 (C-14, -24), 103.48 (C-1’’), 100.62 (C-1’), 99.83 (C-2’’’), 
80.26 (C-4’), 74.66 (C-3’’), 73.77 (C-8’’’), 73.17 (C-5’), 72.59 (C-5’’), 72.50 (C-3’), 71.99 (C-
2’), 71.12 (C-6’’’), 70.84 (C-7’’’), 69.46 (C-5’’’), 68.51 (C-4’’’), 67.61 (C-4’’), 65.16 (C-4), 64.55 
(C-1), 63.22 (C-6’’), 62.31 (C-9’’’), 62.21 (C-5), 60.32 (C-6’), 54.88 (C-2’’), 50.06 (C-8), 45.23 
(C-12), 34.54 (C-3’’’), 28.84 (C-9), 25.78 (C-11), 22.66 (C-10), 22.49 (C-8’) ppm. 
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10-[5-(4-(((Z)-4-O-(( 9-aido-N-acetyl-α-D-neuraminic acid)-(2→6)-β-D- galactopyranosyl-
(1,4)-2-acetamido-2-deoxy-β-D-glucopyranosyloxy)-but-2-enyloxy)methyl)-1H-1,2,3-
triazol-1-yl)pentyl]-10H-acridin-9-on 
(Neu5Ac9N3-2,6-LacNAc-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,6SiaTple, 25.2 mg 
CTP (2 eq.) and 13.5 mg Neu5Ac9N3 (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) buffer 
with 0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS and 20 μl PPase were added to start the 
reaction. When the CMP-activation was completed, 20 mg LacNAc-D-T-P-Acr (1 eq.) and 5 mg 
recombinant 2,6SiaTple were added to start the reaction. The pH was being adjusted for 
keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -
20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 22.2 mg yellow powder. Yield: 78%. 
 
 
 
 
 
 
 
1H NMR (500 MHz, Deuterium Oxide) δ=7.81 – 7.71 (m, 2H, 17-, 21-H), 7.65 (s, 1H, 7-H), 
7.33 – 7.15 (m, 2H, 15-, 23-H), 6.93 – 6.76 (m, 4H, 14-, 24-, 16-, 22-H), 5.58 – 5.43 (m, 2H, 
2-, 3-H), 4.37 (s, 2H, 5-H), 4.34 (d, J = 8.1 Hz, 1H, 1’’-H), 4.27 (d, J = 7.8 Hz, 1H, 1’-H), 
4.15 – 4.03 (m, 3H, 8-, 1a-H), 4.00 (dd, J = 12.8, 5.8 Hz, 1H, 1b-H), 3.92 – 3.78 (m, 5H, 4-, 
8’’’-, 6’’’-, 6’’a-H), 3.78 – 3.60 (m, 5H, 5’’’-, 5’’-, 6’-, 6’’a-, 4’’-H), 3.60 – 3.37 (m, 11H, 4’’’-, 6’’b-, 
3’’-, 9’’’a-, 12-, 7’’’-, 3’-, 4’-, 2’’-H), 3.36 – 3.29 (m, 2H, 2’-, 9’’’b-H), 2.54 (dd, J = 12.3, 4.7 Hz, 
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1H, 3’’’a-H), 1.90 (s, 3H, 8’-H), 1.88 (s, 2H, 11’’’-H), 1.57 (t, J = 12.2 Hz, 1H, 3’’’-H), 1.52-
1.40 (m, 2H, 9-H), 1.11 – 0.80 (m, 4H, 11-, 10-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ=178.13 (C-19), 174.90 (C-1’’’), 174.33 (C-7’’’), 
173.52 (C-10’’’), 143.86 , 140.67 , 134.57 , 129.55 , 128.87 , 126.26 , 124.65 , 121.65 , 
120.45 , 115.06 , 103.56 (C-1’’), 100.29 (C-1’), 99.70 (C-2’’’), 80.73 (C-4’), 74.58 (C-3’’), 
73.74 (C-8’’’), 72,65 (C-5’), 72.55 (C-5’’), 72.44 (C-3’), 70.78 (C-2’), 70.34 (C-6’’’), 69.18 (C-
7’’’), 68.44 (C-4’’’), 68.24 (C-4’’), 65.14 (C-4), 64.53 (C-1), 63.39 (C-6’’), 62.31 (C-5), 60.41 
(C-6’), 54.84 (C-2’’), 53.26 (C-9’’’), 52.00 (C-5’’’), 50.06 (C-8), 45.22 (C-12), 40.21 (C-3’’’), 
28.85 (C-9), 25.80 (C-11), 22.67 (C-10), 22.40 (C-8’), 22.14 (C-11’’’) ppm. 
 
10-[5-(4-(((Z)-4-O-((N-phenylacetyl-α-D-neuraminic acid)-(2→6)-β-D- galactopyranosyl-
(1,4)-2-acetamido-2-deoxy-β-D-glucopyranosyloxy)-but-2-enyloxy)methyl)-1H-1,2,3-
triazol-1-yl)pentyl]-10H-acridin-9-on 
(Neu5NPhAc-2,6-LacNAc-D-T-P-Acr) 
 
For the structure identification of the product catalyzed by recombinant 2,6SiaTple, 25.2 mg 
CTP (2 eq.) and 15.3 mg Neu5NPhAc (1.5 eq.) were added into 50 mL Tris-HCl (pH8.6) 
buffer with 0.5 M NaCl and 0.1% Triton ×100. 5 mg CSS and 20 μl PPase were added to start 
the reaction. When the CMP-activation was completed, 20 mg LacNAc-D-T-P-Acr (1 eq.) and 5 
mg recombinant 2,6SiaTple were added to start the reaction. The pH was being adjusted for 
keeping at 8.6 by pH-stat during the reaction for 2-3 h. When the reaction finished, 300 mL -
20°C methanol was added to stop the reaction and precipitate the most of proteins in the 
reaction system. The precipitate was removed by filtration. The filtrate was concentrated to 
10 mL and loaded on Biogel P-2 (Bio-Rad, Germany) column (3 cm × 100 cm). The products 
were further washed out by ddH2O and collected and lyophilized for NMR determination.   
Product: 15.2 mg yellow powder. Yield: 51%. 
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1H NMR (500 MHz, Deuterium Oxide) δ=7.74 (dd, J = 8.1, 1.6 Hz, 2H, 17-, 21-H), 7.59 (s, 
1H, 7-H), 7.25 – 7.13 (m, 2H, 13’’’-, 17’’’-H), 7.10 – 6.92 (m, 5H, 15’’’-, 14’’’-, 16’’’-, 15-, 23-H), 
6.86 – 6.70 (m, 4H, 24-, 14-, 16-, 22-H), 5.52 – 5.42 (m, 2H, 2-, 3-H), 4.31 (s, 2H, 5-H), 4.23 
(d, J = 7.9 Hz, 1H, 1’’-H), 4.04 (q, J = 5.2 Hz, 3H, 8-, 1a-H), 3.99 – 3.92 (m, 1H, 1b-H), 3.88 
– 3.71 (m, 5H, 1b-, 4-, 9’’’a-, 5’’’-H), 3.71 – 3.46 (m, 10H, 8’’’-, 6’’’-, 6-, 6’’a-, 4’’-, 4’’’-, 5’’-, 11’’’-
H), 3.46 – 3.29 (m, 9H, 6’’b-, 3’’-, 9’’’-, 12-, 7’’’-, 3’-, 4’-, 2’’-H), 3.16 (dd, J = 8.9, 1.7 Hz, 1H, 
2’-H), 2.52 (dd, J = 12.4, 4.3 Hz, 1H, 3’’’a-H), 1.73 (s, 3H, 8’-H), 1.56 (t, J = 11.8 Hz, 1H, 
3’’’b-H), 1.47 – 1.33 (m, 2H, 9-H), 1.05 – 0.80 (m, 4H, 11-, 10-H) ppm. 
13C NMR (126 MHz, Deuterium Oxide) δ=178.10 (C-19), 175.30 (C-1’’’), 174.22 (C-7’’’), 
173.62 (C-10’’’), 143.90 (C-6), 140.69 (C-13, -25), 135.06 (C-15, -23), 134.54 (C-12’’’), 
129.71 (C-15’’’), 129.01 (C-2), 128.76 (C-3), 128.71 (C-14’’’, -16’’’), 127.12 (C-13’’’, -17’’’), 
126.31 (C-17, -21), 124.59 (C-7), 121.63 (C-16, -22), 120.53 (C-18, -20), 115.03 (C-14, -24), 
103.63 (C-1’’), 100.07 (C-1’), 99.80 (C-2’’’), 81.04 (C-4’), 74.53 (C-3’’), 73.80 (C-8’’’), 72.60 
(C-5’), 72.57 (C-5’’), 72.54 (C-3’), 71.86 (C-2’), 70.78 (C-6’’’), 68.67 (C-7’’’), 68.47 (C-4’’’), 
67.96 (C-4’’), 65.27 (C-4), 64.64 (C-1), 63.40 (C-6’’), 62.90 (C-9’’’), 62.34 (C-5), 60.46 (C-6’), 
54.81 (C-2’’), 52.27 (C-5’’’), 50.02 (C-8), 45.21 (C-12), 42.60 (C-11’’’), 40.30 (C-3’’’), 28.90 
(C-9), 25.84 (C-11), 22.71 (C-10), 22.38 (C-8’) ppm. 
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13.9. Cloning, Expression and Characterization of a Potential 2,3-Sialyltransferase 
from Shewanella piezotolerans 
 
13.9.1. Cloning and expression of SiaTspi 
 
13.9.1.1. Cloning of SiaTspi-U 
 
The DNA sequence of SiaTspi gene from Shewanella piezotolerans with upstream sequence 
(SiaTspi-U) was optimized for expression in E. coli and synthesized by Mr. Gene Company. 
NdeI and BamHI restriction enzyme sites were added at 5’- and 3’-terminuses, respectively, for 
further cloning work. The plasmid pMA-SiaTspi-U containing synthesized SiaTspi-U gene from 
Mr. Gene Company was transformed into E. coli Jm109 competent cells for plasmid 
amplification. The recombinant cells were cultured in 5 mL LB medium comprising 50 μg/mL 
ampicillin at 37°C with 250 rpm shaking overnight. The amplified plasmid was extracted and 
digested by NdeI and BamHI, and then purified by gel extraction. After that, the SiaTspi-U gene 
fragment was ligated into pET19b vector to construct the expression plasmid pET-SiaTspi-U, 
which was then transformed into E. coli Jm109 competent cells for plasmid amplification and 
identification. The positive colonies were picked and cultured in 5 mL Amp-LB medium at 
37°C with 250 rpm shaking overnight. The extracted plasmids were identified by NdeI and 
BamHI restriction endonuclease enzyme digestion and electrophoresis, as well as sequencing. 
Then, the identified final plasmid was transformed into E. coli BL21 Tuner competent cells. 
The positive colony (BL21T-pET-SiaTspi-U) was picked and cultured in 5 mL Amp-LB medium 
at 37°C with 250 rpm shaking overnight and stored in 16% glycerol at -80°C. 
 
1 CATATGGTTG CCAGCAGCAG CTCAAATGCC CAGCAGTCTC CGTATGCCCT 
GGAAATCTAT ATCGACAAAG CCACTCTGCC TTCAGTACAA CAAGCGGCCA 
101 TGCTGGTGAA TAATCAGTCC CATAACCCGA AACTGATTTG TTGGCAACGT 
CATCCGGTGA ACGATGAAGC CCTGCTGCAG GGTATTAATG CCGCCTCTTT 
201 CGTGTCTATT GCCTCACTGT GTCAGCACGC CGCCACTCTG CTGGCTGGTC 
ATCCTCATAG CCATATCACC ATTTATGGTA ACACCTATTG GTCTAAAGAT 
301 CTGGCCCGTC TGATCCGTTA TCTGACTCGT ATCAGCGGTG TGGAGATCAA 
AAAACTGGAG CTGATCGACG ATGGTAGCAG CGAATATCAA AAAATGTTCT 
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401 ATTGGCAGCG CCTGTCTAGT GAAGAGCAAA CCCGTGACCT GGCCACTGGT 
CTGAAAAACC TGAAATCCTA TCTGTCCGGG AACGATAATA AACTGCTGCG 
501 TCTGCTGACC GGACATTCGA ACAAACTGCC ACGTCGTCTG TCATCTTTTA 
TGAACTGGCA CCAACTGTTT CCGACGACCT ATCACATGCT GCGTATGGAC 
601 TATCTGGATA AACCAGAACT GCATCAACTG AAACAATATC TGGGGAACAA 
TGCTCAACAA ATTCGCTGGA ACTATATTGC CGACAACCTG TTCGATGATG 
701 AACAACAGTC CCTGTTCTAT CAACTGCTGG GAATCTCTCT GGCAGAACAA 
AAACAACTGC GTGCGGGACG TCAACAACTG CACGACTTCA TGTTTATCGG 
801 GGTCGATTCA TCCAATGCCT CCAGCAAACT GCAGATTAAC GTGATTGCCG 
ATTCTCGTCA AGAAAGCGGA ATCATTCCTA CGATTACCGC TAAAAAAATG 
901 CTGTTCAAAG GCCACCCTTT CGCCAATTTC AATCAAACGA TCGTGGATGC 
CCATCAAATG GGAGAAATGC CGGCCATGAT CCCTTTCGAA ACCCTGATCA 
1001 TGACAGGAAA CCTGCCTCAG AAAGTCGGTG GAATGGCATC AAGTCTGTAT 
TTTTCCCTGC CGAACAACTA TCATATCGAG TATATCGTGT TCTCTGGCTC 
1101 CAAAAAAGAC CTGGAGCAAC ATGCTCTGCT GCAAATCATG CTGTATCTGA 
AAGTGATTAG CCCGGAACGT GTGTATTTTA GTGAACAATT CAAATCCTGC 
1201 TAAGGATCC 
 
Sequence 13.5. Artificial gene sequence of SiaTspi-U 
 
13.9.1.2. Cloning of SiaTspi 
 
The pET19b-SiaTspi-U was prepared as template for the PCR of the gene modification. Primers 
d31SWSTf 5’-CAT ATG CTG GTG AAT AAT CAG TTC CAT-3’ and d31SWSTb 5’-GGA TCC TTA 
GCA GGA TTT GAA TTG TTC-3’ were designed synthesized by Biomers (Germany). The PCR 
reaction used Phusion High-Fidelity DNA Polymerase (Fermentas, Germany).  
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
DNA Polymerase:   0.5 μl 
ddH2O:    up to 50 μl 
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97°C   2 min 
97°C   10 sec 
68°C   10 sec 
72°C   4 min   30 cycles 
72°C   10 min 
The PCR products were identified by electrophoresis and purified by gel extraction. Then, 
they were ligated into pUC19 vector for sub cloning. The ligated products were transformed 
into Jm109 competent cells and cultured on Amp-LB-agar plates at 37°C overnight. The 
positive colonies were picked and cultured in 5 mL amp-LB medium at 37°C with 250 rpm 
shaking overnight. Then their plasmids were extracted and identified by NdeI and BamHI 
restriction endonuclease enzyme digestion and electrophoresis. The positive plasmid was 
digested by NdeI and BamHI at 37°C overnight. The SiaTspi gene fragments were purified by 
gel extraction and then ligated into pET19b vector to obtain pET19b-SiaTspi plasmid. The 
ligation products were transformed into Jm109 competent cells and cultured on Amp-LB-agar 
plates at 37°C overnight. The positive colonies were picked and cultured in 5 mL Amp-LB 
medium at 37°C with 250 rpm shaking overnight. Then their plasmids were extracted and 
identified by NdeI and BamHI restriction endonuclease enzyme digestion and electrophoresis, 
as well as sequencing. The positive plasmid was then transformed into BL21 Tuner competent 
cells and cultured on Amp-LB-agar plates at 37°C overnight. The positive colonies were picked 
and cultured in 5 mL amp-LB medium at 37°C with 250 rpm shaking overnight, and then 
stored in 16% glycerol at -80°C. 
 
1 ATGCTGGTGA ATAATCAGTC CCATAACCCG AAACTGATTT GTTGGCAACG 
TCATCCGGTG AACGATGAAG CCCTGCTGCA GGGTATTAAT GCCGCCTCTT 
101 TCGTGTCTAT TGCCTCACTG TGTCAGCACG CCGCCACTCT GCTGGCTGGT 
CATCCTCATA GCCATATCAC CATTTATGGT AACACCTATT GGTCTAAAGA 
201 TCTGGCCCGT CTGATCCGTT ATCTGACTCG TATCAGCGGT GTGGAGATCA 
AAAAACTGGA GCTGATCGAC GATGGTAGCA GCGAATATCA AAAAATGTTC 
301 TATTGGCAGC GCCTGTCTAG TGAAGAGCAA ACCCGTGACC TGGCCACTGG 
TCTGAAAAAC CTGAAATCCT ATCTGTCCGG GAACGATAAT AAACTGCTGC 
401 GTCTGCTGAC CGGACATTCG AACAAACTGC CACGTCGTCT GTCATCTTTT 
ATGAACTGGC ACCAACTGTT TCCGACGACC TATCACATGC TGCGTATGGA 
501 CTATCTGGAT AAACCAGAAC TGCATCAACT GAAACAATAT CTGGGGAACA 
ATGCTCAACA AATTCGCTGG AACTATATTG CCGACAACCT GTTCGATGAT 
   Seite 191 
601 GAACAACAGT CCCTGTTCTA TCAACTGCTG GGAATCTCTC TGGCAGAACA 
AAAACAACTG CGTGCGGGAC GTCAACAACT GCACGACTTC ATGTTTATCG 
701 GGGTCGATTC ATCCAATGCC TCCAGCAAAC TGCAGATTAA CGTGATTGCC 
GATTCTCGTC AAGAAAGCGG AATCATTCCT ACGATTACCG CTAAAAAAAT 
801 GCTGTTCAAA GGCCACCCTT TCGCCAATTT CAATCAAACG ATCGTGGATG 
CCCATCAAAT GGGAGAAATG CCGGCCATGA TCCCTTTCGA AACCCTGATC 
901 ATGACAGGAA ACCTGCCTCA GAAAGTCGGT GGAATGGCAT CAAGTCTGTA 
TTTTTCCCTG CCGAACAACT ATCATATCGA GTATATCGTG TTCTCTGGCT 
1001 CCAAAAAAGA CCTGGAGCAA CATGCTCTGC TGCAAATCAT GCTGTATCTG 
AAAGTGATTA GCCCGGAACG TGTGTATTTT AGTGAACAAT TCAAATCCTG 
1101 CTAA 
 
Sequence 13.6. Artificial gene sequence of SiaTspi 
 
13.9.1.3. Cloning of dSiaTspi-U 
 
The pET19b-SiaTspi was prepared as template for the PCR of the gene modification. Primers 
dSMSTUf 5’-TCG AAC AAA CTG CCA CGT CGT-3’ and dSMSTUb 5’-CCC GGA CAG ATA GGA 
TTT CAG GT-3’ were designed synthesized by Biomers (Germany). The PCR reaction used 
Phusion High-Fidelity DNA Polymerase (Fermentas, Germany). 
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
DNA Polymerase:   0.5 μl 
ddH2O:    up to 50 μl 
 
97°C   2 min 
97°C   10 sec 
68°C   10 sec 
72°C   4 min   30 cycles 
72°C   10 min 
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The PCR products were identified by electrophoresis and purified by gel extraction. Then, 
they were ligated into pUC19 vector for sub cloning. The ligated products were transformed 
into Jm109 competent cells and cultured on Amp-LB-agar plates at 37°C overnight. The 
positive colonies were picked and cultured in 5 mL amp-LB medium at 37°C with 250 rpm 
shaking overnight. Then their plasmids were extracted and identified by NdeI and BamHI 
restriction endonuclease enzyme digestion and electrophoresis. The positive plasmid was 
digested by NdeI and BamHI at 37°C overnight. The dSiaTspi-U gene fragments were purified 
by gel extraction and then ligated into pET19b vector to obtain pET19b-dSiaTspi-U plasmid, 
respectively. The ligation products were transformed into Jm109 competent cells and cultured 
on Amp-LB-agar plates at 37°C overnight. The positive colonies were picked and cultured in 5 
mL Amp-LB medium at 37°C with 250 rpm shaking overnight. Then their plasmids were 
extracted and identified by NdeI and BamHI restriction endonuclease enzyme digestion and 
electrophoresis, as well as sequencing. The positive plasmid was then transformed into BL21 
Tuner competent cells and cultured on Amp-LB-agar plates at 37°C overnight. The positive 
colonies were picked and cultured in 5 mL amp-LB medium at 37°C with 250 rpm shaking 
overnight, and then stored in 16% glycerol at -80°C. 
 
1 CATATGGTTG CCAGCAGCAG CTCAAATGCC CAGCAGTCTC CGTATGCCCT 
GGAAATCTAT ATCGACAAAG CCACTCTGCC TTCAGTACAA CAAGCGGCCA 
101 TGCTGGTGAA TAATCAGTCC CATAACCCGA AACTGATTTG TTGGCAACGT 
CATCCGGTGA ACGATGAAGC CCTGCTGCAG GGTATTAATG CCGCCTCTTT 
201 CGTGTCTATT GCCTCACTGT GTCAGCACGC CGCCACTCTG CTGGCTGGTC 
ATCCTCATAG CCATATCACC ATTTATGGTA ACACCTATTG GTCTAAAGAT 
301 CTGGCCCGTC TGATCCGTTA TCTGACTCGT ATCAGCGGTG TGGAGATCAA 
AAAACTGGAG CTGATCGACG ATGGTAGCAG CGAATATCAA AAAATGTTCT 
401 ATTGGCAGCG CCTGTCTAGT GAAGAGCAAA CCCGTGACCT GGCCACTGGT 
CTGAAAAACC TGAAATCCTA TCTGTCCGGG TCGAACAAAC TGCCACGTCG 
501 TCTGTCATCT TTTATGAACT GGCACCAACT GTTTCCGACG ACCTATCACA 
TGCTGCGTAT GGACTATCTG GATAAACCAG AACTGCATCA ACTGAAACAA 
601 TATCTGGGGA ACAATGCTCA ACAAATTCGC TGGAACTATA TTGCCGACAA 
CCTGTTCGAT GATGAACAAC AGTCCCTGTT CTATCAACTG CTGGGAATCT 
701 CTCTGGCAGA ACAAAAACAA CTGCGTGCGG GACGTCAACA ACTGCACGAC 
TTCATGTTTA TCGGGGTCGA TTCATCCAAT GCCTCCAGCA AACTGCAGAT 
801 TAACGTGATT GCCGATTCTC GTCAAGAAAG CGGAATCATT CCTACGATTA 
CCGCTAAAAA AATGCTGTTC AAAGGCCACC CTTTCGCCAA TTTCAATCAA 
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901 ACGATCGTGG ATGCCCATCA AATGGGAGAA ATGCCGGCCA TGATCCCTTT 
CGAAACCCTG ATCATGACAG GAAACCTGCC TCAGAAAGTC GGTGGAATGG 
1001 CATCAAGTCT GTATTTTTCC CTGCCGAACA ACTATCATAT CGAGTATATC 
GTGTTCTCTG GCTCCAAAAA AGACCTGGAG CAACATGCTC TGCTGCAAAT 
1101 CATGCTGTAT CTGAAAGTGA TTAGCCCGGA ACGTGTGTAT TTTAGTGAAC 
AATTCAAATC CTGCTAAGGA TCC 
 
Sequence 13.7. Artificial gene sequence of dSiaTspi-U 
 
13.9.1.4. Expression of SiaTspi, SiaTspi-U and dSiaTspi-U 
 
10 μl BL21T-pET21a-SiaTspi, BL21T-pET19b-dSiaTspi-U and BL21T-pET19b-dSiaTspi-U were 
transferred into 5 mL LB medium, respectively, and cultured at 37°C with 250 rpm shaking 
until OD reached 0.5. 0.1 mM IPTG was added into the culture for the expression induction at 
28°C with shaking overnight. After that, the cells were harvested by centrifugation at 4,000 
rpm for 20 min. The expression levels of the recombinant SiaTspi, SiaTspi-U and dSiaTspi-U 
were identified by SDS-PAGE. The identification of recombinant SiaTspi, SiaTspi-U and dSiaTspi-
U activities were used the method described in 13.5.1.3. 
 
13.9.2. Optimization of expression of SiaTspi in E. coli 
 
13.9.2.1. Coexpression with chemprons 
 
The chaperone plasmids pG-KJE8, pGro7, pKJE7, pG-Tf2 and pTf16 were transformed into 
BL21DE3 competent cells and cultured on LB-agar plates with chloramphenicol. The positive 
colonies were picked and cultured in LB medium with chloramphenicol at 37ºC overnight. 
Then the recombinants were stored in 16% glycerol at -80ºC. 
Chaperone BL21(DE3) cells was cultured in 5 ml LB medium with chloramphenicol at 37ºC 
with 250 rpm shaking for 16-18 h. 2.5 ml each culture was transferred into 250 ml SOB 
medium and cultured at 37ºC with 250 rpm shaking until OD600 reaches 0.6-0.8. Then the 
cultures were put in ice for 10 min. After that, the cells were harvested by 2,000g 
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centrifugation at 4ºC for 10 min, followed by adding 80 ml cold TB medium to resuspend the 
cells. The cells were put in ice for 10 min again and centrifuged the resuspension at 2,000g 
4ºC for 10 min to remove the TB medium. Then 20ml TB medium was added and the cells 
were mixed gently. The resuspension was treated by ice for 10 min. Finally, 1.5 ml DMSO and 
75 mM DTT were added and mixed gently. The cells were frozen by liquid nitrogen and 
stored at -80ºC. 
The pET21a-SiaTspi, pET19b-SiaTspi-U and pET19b-dSiaTspi-U plasmids were transformed into 
the competent chaperone cells and cultured on LB agar plate with ampicillin and 
chloramphenicol at 37ºC overnight. The positive colonies were picked and identified by 
plasmid identification. After that, these five recombinant cells were stored in 16% glycerol 
and stored at -80ºC. 
10 μl Recombinant SiaTspi-chaperone BL21(DE3) cells were transferred into 5 ml LB-amp 
medium and cultured at 37ºC 250 rpm until OD600 reached 0.5. 0.1 mM IPTG was added to 
induce the recombinant protein expression. The induction was taken place at 28ºC 250 rpm 
overnight. The cells were harvested by centrifuge and lysate by ultrasonic treatment. The 
soluble expression level was identified by SDA-PAGE. 
 
13.9.2.2. Characterization of SiaTspi 
 
The identification of recombinant SiaTspi, SiaTspi-U and dSiaTspi-U activities were used the 
method described in 13.5.1.3. 
 
13.9.2.3. Optimization of expression at low temperature  
 
10 μl Recombinant SiaTspi-chaperone BL21(DE3) cells were transferred into 5 ml LB-amp 
medium and cultured at 37ºC 250 rpm until OD600 reached 0.5. 0.1 mM IPTG was added to 
induce the recombinant protein expression. The induction was taken place at 16ºC 250 rpm 
overnight. The cells were harvested by centrifuge and lysate by ultrasonic treatment. The 
soluble expression level was identified by SDS-PAGE. 
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13.9.2.4. Expression of SiaTspi in Yarrowia lipolytica expression system 
 
a) Expression plasmid contruction 
 
p64PT vector was transformed into E. coli Jm109 competent cells for plasmid amplification. 
The recombinant cells were cultured in 5 mL LB medium comprising 50 μg/mL ampicillin at 
37°C with 250 rpm shaking overnight. The plasmid was extracted and digested by SpnI and 
then purified by gel extraction.  
The pET19b-SiaTspi-U and pET19b-dSiaTspi were prepared as templates for the PCR of the 
SiaTspi-U and dSiaTspi-U amplification. Primers p64SiaTspi-f 5’- ATA TGC ATG CTC CAT CAT 
CAT CAT CAT CAT C-3’ and p64SiaTspi-b 5’- ATA TGC ATG CTT AGC AGG ATT TGA ATT 
GTT CAC-3’ were designed synthesized by Biomers (Germany). The PCR reaction used 
Phusion High-Fidelity DNA Polymerase (Fermentas, Germany). 
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
DNA Polymerase:   0.5 μl 
ddH2O:    up to 50 μl 
 
97°C   2 min 
97°C   10 sec 
65°C   10 sec 
72°C   4 min   30 cycles 
72°C   10 min 
The PCR products were identified by electrophoresis and purified by gel extraction. Then, 
they were ligated into pUC19 vector for sub cloning. The ligated products were transformed 
into Jm109 competent cells and cultured on Amp-LB-agar plates at 37°C overnight. The 
positive colonies were picked and cultured in 5 mL amp-LB medium at 37°C with 250 rpm 
shaking overnight. Then their plasmids were extracted and identified by SpnI restriction 
endonuclease enzyme digestion and electrophoresis. The positive plasmid was digested by 
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SpnI at 37°C overnight. The SiaTspi-U and dSiaTspi-U gene fragments were purified by gel 
extraction and then ligated into p64PT vector to obtain p64SiaTspi-U and p64dSiaTspi-U 
plasmids, respectively. The ligation products were transformed into Jm109 competent cells 
and cultured on Amp-LB-agar plates at 37°C overnight. The positive colonies were picked and 
cultured in 5 mL Amp-LB medium at 37°C with 250 rpm shaking overnight. Then their 
plasmids were extracted and identified by SpnI and NdeI restriction endonuclease enzyme 
digestion and electrophoresis independently, as well as sequencing. The positive recombinants 
were stored in 16% glycerol at -80°C. 
The plasmid p64SiaT-U and p64dSiaT-U were extracted from 50 ml culture. The 
concentration and purity of the plasmids were determined by spectrophotometry. The 
plasmids were diluted into 0.1 μg/μl and linearized by SacII overnight. 
 
b) Transformation of Yarrowia 
 
Yarrowia cells were transferred into 5 ml YPD medium pH 4.0 and shake at 28ºC 220 rpm for 
about 10-12 h. 50-100 μl cultures were transferred into 10 ml YPD medium pH 4.0 with cell 
density 1*105 /ml and incubated at 28ºC 220 rpm overnight until the cell density reached 
9*107 to 1.5*108 /ml. The cells were harvested by centrifuge 3500 rpm at 28ºC for 5 min. 
The cells were washed by 10 ml TE buffer 2 times. After that, about 20 ml 100 mM LiNAc pH 
6.0 was added to make the final cell density to 5×107 /ml. The suspension was incubated at 
28ºC for 1h. Then LiNAc was removed by centrifuge and 1/10V LiNAc was added to suspend 
the cells.  
1 μg Plasmid was added into a 2 ml tube and heated at 60ºC for 5 min and then put into ice. 
5 μgl Denatured Carrier-DNA (50 μg) was added and mixed. 100 μl Competent Yarrowia 
H222-S4 and H355 cells was then added into tube and mixed gently. The tubes were 
incubated at 28ºC for 15 min. Then 700 μl 40% PEG4000 was added and mixed gently. The 
tubes were incubated at 28ºC with shaking for 1h. After that, cells were incubated at 39ºC for 
10 min followed by adding 1.2 ml 100 mM LiNAc pH6.0. 200 μl suspension was spread on 
plates for 2 weeks culture at 28°C with enough O2.  
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c) Isolation of positive recombinant Yarrowia 
 
Four colonies for each recombinant (H222-S4-SiaT-U, H222-S4-dSiaT-U, H355-SiaT-U and 
H355-dSiaT-U) were picked and streaked on plates for isolation. Single colonies for each 
recombinant were picked and transferred into 10 ml YPD medium for 2 days culture at 28°C. 
800 μl of each culture was stored as glycerol stock with 20% glycerol. The rest cultures were 
used for screening and copy number measurement by PCR. 
 
d) Screening and copy number measurement by PCR 
 
10 ml 2 days culture was transferred into a 50 ml centrifugal tube followed by centrifugation 
at 3,500 for 5 min to remove the medium. The pellet was washed by 1 ml H2O and suspended 
in 500 μl lysate buffer in a 2 ml tube, which contains 100 mM Tris-HCl (pH 8.0), 50 mM 
EDTA and 1% w/v SDS. 400 μl Glass beams were added. The tubes were treated by FastPrep 
for 20 s 4 times. The lysate was transferred into a new tube and incubated at 65°C for 5 min 
and then on ice for 5 min. After that, 500 μl chloroform was added and centrifuged at 13,000 
rpm for 2 min. The supernatant was transferred into a new tube, and 1 ml ioropropanol was 
added. The mixture was incubated at room temperature for 5 min, and then centrifuged at 
13,000 rpm for 5 min. The pellet was washed by 200 μl cold ethanol and dissolved in 50 μl 
ddH2O with 1 μl 10 mg/ml RNase A and followed by incubation at 37°C for 2 h. 
The genome DNA prepared above was determined the concentration. 100 ng genome DNA for 
each sample was used as template for identification. The PCR primers were p64SiaTspi-f 5’- 
ATA TGC ATG CTC CAT CAT CAT CAT CAT CAT C-3’ and p64SiaTspi-b 5’- ATA TGC ATG CTT 
AGC AGG ATT TGA ATT GTT CAC-3’. The PCR reaction used Phusion High-Fidelity DNA 
Polymerase (Fermentas, Germany).  
PCR reaction: 
dsDNA template:   2 μl 
Primer 1:    2 μl 
Primer 2:    2 μl 
dNTP mix:    1 μl 
10×Reaction Buffer:   5 μl 
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DNA Polymerase:   0.5 μl 
ddH2O:    up to 50 μl 
 
97°C   2 min 
97°C   10 sec 
72°C   10 sec 
72°C   4 min   30 cycles 
72°C   10 min 
 
e) Fermantation of recobinant Yarrowia 
 
Recombinant Y. li was transferred into 50 ml YPD medium for pre-culture at 28ºC 220 rpm for 
12-24 h. The cells were harvested by centrifuge at 28ºC 3500 rpm for 5min, and then washed 
by 10 ml 1×Reader buffer one time. The washed cells were resuspended by 10 ml 1×Reader 
buffer and measured the cell density at OD600. The cells with final cell density of OD600 = 1 
were transferred into 100 ml fermentation medium (1×Reader buffer, 2% glucose, 100 mM 
potassium phosphate buffer pH 5.8,   Iron solution, vitamin solution and FeCl3) and cultured 
at 28ºC 220 rpm. The pH of the culture was measured and adjusted to 4.0 every 3 h. When 
the glucose was used out, add 1% ethanol for induction. The cell density and pH of the 
culture were measured every 3 h. Cell samples in each 3 h were taken for expression and 
activity determination. The induction can continue for 12-15 h up to 30 h. 
 
f) Identification of acctivity 
 
The cells were harvested by centrifuge at 28ºC 3500 rpm for 5min, and then washed by 10 ml 
TE buffer one time. After that, the cells were collected in 2 ml tubes with 1.5 ml glass beans. 
The tubes were fixed on vortex and shaked at maximum speed for 5 min. The crude extract 
was pipetted out into new tubes and centrifuged at 12,000 rpm for 10 min. The supernatant 
was taken out for activity determination.The rapid activity determination was destribed in 
13.9.2.2. 
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